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Abstract
Little is currently known about the long-term psychosocial effects of genetic
risk counselling for breast cancer. This thesis presents a series of three studies to
investigate the psychosocial effects of living with an increased risk ofbreast cancer.
The participants were women who had attended genetic risk counselling at least two
years previously, had subsequently been receiving regular clinical surveillance, but
were not eligible for genetic testing or prophylactic surgery. A qualitative study was
initially conducted to explore the long-term consequences of living with an increased
risk ofbreast cancer in terms of: the effect on everyday life, coping strategies and
needs for information and support. Twenty-five women took part in one of seven
telephone focus groups and subsequently completed a feedback questionnaire.
Qualitative analysis revealed six key issues, which provided a basis for further
research: (1) psychological adaptation, (2) behavioural adaptation, (3) family issues,
(4) clinical surveillance, (5) provision of information and (6) peer support. A cross-
sectional survey of 249 women was then conducted to generate quantitative data to
test and expand on the findings from the telephone focus group study. The survey
was designed to assess: the prevalence of general psychological morbidity; breast
cancer-specific distress; needs and preferences for information about familial risk of
breast cancer and the impact of a number of factors on distress. Levels of general
psychological and breast cancer-specific distress in this study were comparable to
those reported in the literature. Perceived likelihood of developing breast cancer,
coping style and satisfaction with social supports were predictive of distress. A
widespread need was identified for up-to-date information related to familial risk of
breast cancer with an overall preference for written information. A psycho-
educational intervention to meet the needs of these women was developed and
evaluated, ft consisted ofwritten information about scientific and psychosocial topics
related to familial risk of breast cancer. Participants in this study (n = 151) were
randomised to receive the information pack containing both scientific and
psychosocial topics or the scientific topics only or no information (control group).
Cancer worry and objective knowledge of scientific issues related to familial risk of
breast cancer were evaluated by postal questionnaire at two time-points, four weeks
apart. The results supported the hypotheses in that: the pack containing both
scientific and psychosocial topics of information significantly reduced cancer worry
and both versions of the information pack significantly improved knowledge relative
to the control group. The implications of the results of these studies are discussed in
relation to their methodological limitations, theoretical models of psychological
distress, clinical services and future research.
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Chapter 1: Review of the Literature on Familial Breast Cancer
There is a large amount of scientific literature on various aspects of familial
breast cancer. The topics covered in this review were selected on the basis ofbeing
particularly relevant to describing our current understanding of the experience of
living with an increased risk of breast cancer both from medical and psychological
perspectives. This chapter will: provide a review ofbreast cancer including its
aetiology, symptoms, screening, diagnosis, treatment and risk factors; discuss
familial breast cancer including risk assessment and management; review and
critique research on the psychosocial impact of genetic risk counselling for breast
cancer and give a rationale for the current work.
The literature searches were conducted using an Endnote database (held by
the Cancer Research UK Psychosocial Research Group in Edinburgh) of over 1,000
references about familial breast cancer (from 1946-2002) and the Web of Science
social science/science citation indices (1981-2002). A review of psychosocial
interventions in women with a family history of breast cancer is provided at the
beginning of Chapter 6. Discussion of the psychological theoretical models relevant
to living with an increased risk of breast cancer is included in Chapter 7.
1.1 Background to breast cancer
1.1.1 Introduction
Breast cancer is the commonest form of cancer in women both worldwide
and in the U.K. One million women worldwide are newly diagnosed with breast
cancer every year (McPherson et al., 2000) with over 38,000 of those being in the
U.K (Cancer Research UK, 2002). One in nine women (11%) in the U.K will
develop breast cancer during their lifetime. Of the people diagnosed with breast
cancer in the U.K every year, the majority are post-menopausal women, about 7,000
are women under the age of 50 and approximately 200 are men (Cancer Research
UK, 2002). Breast cancer accounts for more deaths in women in the U.K aged 40-50
than any other single cause. In excess of 14,000 women in the U.K die from breast
cancer each year (McPherson et al., 2000).
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1.1.2 Aetiology
Breast cancer is a malignant tumour in the cells of the breast. A number of
factors are involved in the development of all forms of cancer, including breast
cancer. These can be broadly classified into two groups: hereditary or environmental
factors. Most cases ofbreast cancer are sporadic. This means that they occur by
chance due to as yet unproven environmental factors.
However, all cancers are "genetic" in the sense that they are caused by
genetic mutations arising in a single cell (Emery et al., 2000). Usually cells with
mutations, which can occur by chance during cell division, are destroyed before they
result in cancer. However, if these cells do not die, several different genetic
mutations can accumulate in a cell, which transforms it into a cancer cell. The fact
that this process can take a considerable amount of time means that many forms of
cancer tend to manifest in older individuals. A cancerous tumour is formed by the
cancer cells continually reproducing. They can then invade and destroy neighbouring
tissue and even metastasise to areas further away in the body using the blood stream
or lymphatic system.
1.1.3 Symptoms
There are number of symptoms that may indicate breast cancer. These
include a lump in or thickening of the breast, nipple or armpit, a change in the size or
shape of the breast, an inverted nipple, dimpling of the skin, a rash, blood-stained
discharge and breast pain (Cancer Research UK, 2002). However, many of these
symptoms also indicate benign breast lumps. About 90% ofbreast lumps are found
to be benign on further examination and are usually cysts (fluid-filled sacs) or
fibroadenomas (fibrous glandular tissue) (Cancer Research UK, 2002).
The type and number of symptoms experienced can vary greatly between
individuals and depends on the stage of the breast cancer.
1.1.4 Screening and diagnosis
Breast cancer can be detected through various forms of screening such as
mammography, ultrasound, clinical breast examination (CBE) and breast self-
examination (BSE). Over 90% of all breast lumps, whether benign or malignant, are
found through breast self-examination (Cancer Research UK, 2002).
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Breast cancer can be diagnosed by several different types of biopsy which
remove a sample of cells (i.e. needle aspiration) or tissue (i.e. needle biopsy) from
the lump or the whole lump itself (i.e. surgical biopsy).
The TNM (tumour, nodes, metastases) system is used internationally to
classify breast cancer into four stages (Cancer Research UK, 2002). The first three
stages are known as primary breast cancer which has not spread to other parts of the
body, apart from the lymph nodes in the armpit. Stage four is known as secondary
breast cancer where the cancer has metastasised to other areas in the body. The grade
of breast cancer (extent to which the cells are different from normal cells) can be
classified as low, medium and high depending on how fast the cancer cells are
growing.
1.1.5 Treatment
There are a number of different treatments for breast cancer: local treatments
that target the breast (e.g. surgery, radiotherapy) and systemic treatments that target
cancer cells anywhere in the body (e.g. chemotherapy, hormone therapy). The most
appropriate treatment for an individual patient is influenced by a number of factors
such as their age, the stage and grade of breast cancer, the size of the tumour and
their overall health. Many of the treatments have both short-term (e.g. nausea,
tiredness, hair loss) and long-term side-effects (e.g. lymphoedema, early menopause,
infertility), which can have a negative impact on an individual's quality of life.
The success of treating breast cancer and the subsequent prognosis depends
on the stage of the cancer at diagnosis. For example, 85% ofwomen diagnosed with
localised breast cancer between 1985-1989 in the U.K lived for a minimum of five
further years compared to only 21% ofwomen diagnosed with metastatic breast
cancer (Cancer Research UK, 2002).
1.1.6 Risk factors
There are a number of factors that have been shown to put an individual at
risk of developing breast cancer: increasing age, geographical location (i.e. women in
developed countries are at higher risk), reproductive factors (i.e. early menarche, late
menopause, no pregnancies, late age at first pregnancy), having a family history of
breast cancer, personal history of benign breast disease, exposure to radiation,
obesity (in postmenopausal women), taking the oral contraceptive pill (and for 10
years following cessation) and hormone replacement therapy (and for 1-4 years
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following cessation) (McPherson et al., 2000). In addition to age (McPherson et al.,
2000), having a family history of breast cancer is "one of the strongest known risk
factors" for the disease (Emery et al., 2000). Women who have a first-degree relative
affected by breast cancer are two to three times more likely to develop breast cancer
in their lifetime than women of the same age, place ofbirth and marital status but
without any family history of the disease (Slattery and Kerber, 1993).
Smoking (Dixon & Steel, 2001) and dietary factors such as high fat intake
and high alcohol consumption are also probable risk factors, but further research is
needed to confirm their relationship to breast cancer (McPherson et al., 2000).
In terms of reducing the risk ofbreast cancer, ongoing research is
investigating potential protective factors such as hormonal drugs in women at
increased risk of breast cancer (e.g. Tamoxifen, Raloxifene), lifestyle factors (e.g.
diet, exercise) (McPherson et al., 2000) and breast-feeding in the general population
(Cancer Research UK, 2002).
1.1.7 Summary
Breast cancer is a common, yet potentially life-threatening disease. The
causes and prevention of breast cancer are not yet fully understood. As there is
currently no cure, good prognosis depends on early detection through a variety of
screening measures. Of the number of factors that have been shown to increase an
individual's risk of breast cancer, having a family history of the disease is one of the
most important.
1.2 Background to familial breast cancer
1.2.1 Introduction
Of the women who are diagnosed with breast cancer, about 10% report
having a family history of the disease (Narod, 2002).
A family history of cancer is the principal clinical indicator of an inherited
susceptibility to the disease. Research has suggested that inherited susceptibility to
breast cancer accounts for 4-10% of all cases of breast cancer (Arver et al., 2000).
Although multiple cases of cancer can occur by chance in some families, as the
disease is so widespread, it is likely that a family history indicates some form of
inherited susceptibility (Ponder, 2001). This may range from an almost definite
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indication of inherited susceptibility such as in the rare hereditary cancer syndromes
(e.g. Li-Fraumeni syndrome) to possible inherited susceptibility in familial clusters
of cancer (Ponder, 2001). In contrast, some individuals may have inherited a weak
predisposition to cancer without obvious familial clustering of the disease (e.g. they
may only have one relative with cancer) (Ponder, 2001).
1.2.2 Breast cancer susceptibility genes
In recent years, there have been major advances in our understanding of
inherited susceptibility to breast cancer. To date, a number of breast cancer
susceptibility genes have been identified. Of these genes BRCA1 (Miki et al., 1994)
and BRCA2 (Wooster et al., 1995) "are the most important 'high risk' genes" as
mutations in these genes account for most familial clusters of breast and ovarian
cancer (Antoniou et al., 2002).
BRCA1 and BRCA2 play a role in the suppression of tumours (Rosenthal &
Puck, 1999) and are located on chromosome 17q (Miki et al., 1994) and chromosome
13q respectively (Wooster et al., 1995). Both BRCA1 and BRCA2 are large genes
and numerous different mutations have been identified (Tonin et al., 1996). Some of
these mutations occur with unusual regularity across a particular population (e.g.
Ashkenazi Jews) whilst others are unique to a single family (Tonin et al., 1996).
These mutations include deletions or insertions of a component ofDeoxyribonucleic
Acid (DNA) (Tonin et al., 1996). In inherited forms of cancer, unlike sporadic
cancers, the genetic mutations are found in all cells (Emery et al., 2000) and
therefore can be passed down to future generations. Each child of an individual
carrying a genetic mutation has a 50% chance of inheriting that specific mutation and
it can be inherited from either their mother or their father.
1.2.3 Penetrance
The probability ofbeing diagnosed with breast cancer in an individual
carrying a mutation in one of the breast cancer susceptibility genes differs between
families and populations (Narod, 2002). This variation in penetrance could be due to
genetic factors (e.g. multiple mutations in a single cell or the influence of a
modifying gene) and lifestyle factors that can alter hormone levels (e.g. pregnancy,
oophorectomy and oral contraceptives) (Narod, 2002).
Therefore, different studies have produced different estimates for the
penetrance of BRCA1 and BRCA2. For example, Ford et al. (1994) examined 33
5
families with at least four members affected by breast or ovarian cancer before the
age of 60. They estimated that female BRCA1 mutation carriers had a 73% chance of
developing breast cancer by age 50, 87% by age 70, a 29% chance of developing
ovarian cancer by age 50 and 44% by age 70. They also found that male BRCA1
mutation carriers were also at increased risk of developing colon and prostate cancer.
Ford et al. (1998) have estimated that female BRCA2 mutation carriers have a 28%
chance of developing breast cancer by age 50, 84% by age 70 and 0.4% of
developing ovarian cancer by age 50 and 27% by age 70.
BRCA1 and BRCA2 mutations are related to the early onset ofbreast cancer
(Ford et ah, 1995). It has been estimated that 5.3% of all cases of breast cancer and
5.7% cases of ovarian cancer diagnosed under 40 years old are due to mutations in
BRCA1 (Ford et ah, 1995). Over one third ofwomen who develop breast cancer
aged under 29 are carriers of a mutation in BRCA1 or BRCA2 (Rosenthal & Puck,
1999). Early onset is due to the fact that if a genetic mutation in a breast cancer
susceptibility gene has been inherited, it will not take as long for other genetic
mutations to accumulate in a cell transforming it into a cancer cell. Research has also
shown that carriers of a BRCA1 mutation who have already been diagnosed with
breast or ovarian cancer are at increased risk of developing another breast or ovarian
cancer (Ford et ah, 1994).
In a study of 237 families worldwide where at least four members had breast
cancer, BRCA1 was estimated to be associated with breast cancer in over halfof the
families, BRCA2 in about one third and the remaining 16% was not accounted for by
either gene (Ford et ah, 1998). In families with at least one male member with breast
cancer, 77% of familial clusters of the disease were thought to be caused by BRCA2
mutations and 19% as a result of BRCA1 mutations (Ford et ah, 1998). Research
suggests that although mutations in BRCA1 cause an increased risk of breast cancer
in males, it is lower than that caused by BRCA2 mutations (Ford et ah, 1998) where
male carriers have been estimated to have a 6.92% chance of developing breast
cancer by age 80 (Thompson & Easton, 2001).
Other breast cancer susceptibility genes have been identified including p53
(Malkin et ah, 1990), PTEN (Nelen et ah, 1996) and most recently CHEK2 (The
CHEK2-Breast Cancer Consortium, 2002). CHEK2 mutations have been shown to
double the risk of breast cancer in women and increase it tenfold in men. However,
research suggests that other genes that confer susceptibility to breast cancer and that
account for a substantial proportion of familial breast cancer, have yet to be
discovered (Ford et ah, 1998).
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1.2.4 Summary
There is a substantial amount of uncertainty for an individual with a family
history of breast cancer. Although having a family history of breast cancer is likely to
signify some form of inherited susceptibility to the disease, the exact increase in risk
for an individual may not be clear. Of the few breast cancer susceptibility genes that
have been identified, penetrance is limited and can vary between families and
populations. Therefore, even if a specific mutation in one of these genes has been
identified in an individual, their risk of breast cancer and that of their siblings or
offspring is not definitive.
1.3 Assessment of familial breast cancer risk
1.3.1 Models for estimating breast cancer risk
A number ofmodels, used both clinically and for research purposes, have
been developed for predicting an individual's risk of developing breast cancer. These
models use information about an individual's family history of breast and ovarian
cancer and some models also include additional risk factors (Emery et al., 2000).
The Gail model (Gail et ah, 1989) calculates the likelihood of an individual
developing breast cancer based on several factors including their current age, age at
menarche and first live birth, the number of first-degree relatives with breast cancer
and number ofprevious breast biopsies. This model uses data collected from a subset
of nearly 300,000 women participating in a case-control study of breast cancer
screening (Baker, 1982).
The Claus model (Claus et ah, 1994) was derived from a case-control study
of 4730 breast cancer patients aged 20-54 years and their relatives (Claus et ah,
1991). It is a genetic model that uses data on the number of first-degree relatives with
breast cancer and the age at which they were diagnosed to estimate the probability of
an individual carrying a mutation in a breast cancer susceptibility gene.
However, each model can produce distinctly different estimates of breast
cancer risk (Emery et ah, 2000). For example, McTiernan et ah (2001) found that the
Gail model estimated breast cancer risks to be higher than those produced by the
Claus model for the majority of their participants with a family history of breast
cancer. There is also uncertainty regarding the validity of these models in wider
populations and their accuracy has not yet been confirmed (Emery et ah, 2000).
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Despite these limitations, it is considered that the models still offer a useful way of
estimating breast cancer risk (Eccles et al., 2000).
1.3.2 Breast cancer genetic risk counselling
In Scotland, guidelines have recently been produced for the assessment and
management ofwomen with a family history ofbreast cancer (Scottish Executive,
2001). Women with a family history of breast cancer are usually referred to a
regional genetics department by their General Practitioner (GP). Their family history
of cancer is evaluated by a genetic nurse/associate and is confirmed by checking
clinical records and a corresponding pedigree is produced. They are then classified as
low, medium or high risk according to specific criteria (Table 1). Low risk has been
defined as less than double the general population lifetime risk (of 9%), medium risk
is two to three times the population risk and high risk is more than three times the
population risk (Eccles et al., 2000).
Table 1: Summary of referral guidelines to breast cancer genetics services in




Low • Anyone not fulfilling medium or high risk criteria
Medium • One 1st degree relative with bilateral breast cancer
• One 1st degree relative with breast cancer diagnosed under 40
years or male at any age
• Two 1st or lbt and 2nd degree relatives with breast cancer
diagnosed under 60 years or ovarian cancer at any age on the
same side of the family
• Three 1st or 2nd degree relatives with breast or ovarian cancer
on the same side of the family (at least one first degree relative
unless history via father)
High • An individual with a mutation in BRCA1, BRCA2 or other
predisposing gene
• Untested 1st degree relatives of carriers ofmutations in a
predisposing gene
• 1st degree relatives of an individual with breast cancer (or 2nd
degree via intervening male relative) in a family with four or
more relatives affected with either breast or ovarian cancer or
male breast cancer in three generations
• One 1st degree relative (or 2nd degree via intervening male
relative) with breast and ovarian cancer
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Those women deemed to be at low risk are sent a letter of reassurance, which
contains advice on maintaining a healthy lifestyle and breast awareness and advises
them to join the National Breast Screening Programme from age 50-64. They are
returned to the care of their GP, who is also notified of their risk status. Women
estimated to be at moderate or high risk will receive genetic risk counselling by a
genetic counsellor or qualified geneticist.
The key aspects of assessing breast cancer risk are to gain and interpret an
accurate and thorough family history of cancer (Hoskins et ah, 1995). Breast cancer
genetic risk counselling aims to provide an individual with the necessary information
for them to accurately understand both their short-term and lifetime risk of
developing breast cancer (Goodwin, 2000). Accurate risk perceptions are vital in
making informed choices about risk management options (Goodwin, 2000).
The procedure of assessing the risk of breast cancer in women with a family
history of the disease varies slightly between and within countries. Likewise, the
format in which risk estimates are given to individuals can vary (e.g. percentages,
risk categories, odds ratios, lifetime risk, age-specific risk). It has been suggested that
the use of several of these formats within the consultation may assist risk
comprehension (Hopwood, 1997). As a woman's risk of breast cancer can change
over time, for example in response to a change in family history, their risk needs to
be assessed periodically to maintain an accurate estimate.
Breast cancer genetic risk counselling usually consists of discussing a number
of issues: the inheritance of a mutation in a breast cancer susceptibility gene, the
assessment of risk, options for risk management and genetic testing, psychosocial
issues such as psychological distress and family communication (Goodwin, 2000).
Guidelines for breast cancer genetic risk counselling have been developed. For
example, Hoskins et al. (1995) recommend that it should include the following
components: " (1) assess a woman's preconceived ideas about cancer aetiology, (2)
discuss her risk perception, (3) construct a detailed pedigree, (4) assess lifetime risk
of developing breast cancer based on empiric risk tables or based on the chance of
inheriting an autosomal dominant predisposition gene, (5) help guide families
towards appropriate surveillance, (6) identify families eligible for genetic testing and
refer to a specialised cancer genetics centre offering testing as indicated, and (7)
institute referrals for individuals who could benefit from psychological counselling".
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1.3.3 Summary
The process of assessing breast cancer risk through genetic risk counselling
varies both between and within countries. The risk provided is influenced by the
particular model used in its calculation and it can be represented in various formats.
However risk is assessed, the estimates given to individuals encompass a substantial
degree of uncertainty.
1.4 Management of familial breast cancer
1.4.1 Screening for breast cancer
Since it is currently not possible to prevent the development of breast cancer,
screening aims to reduce breast cancer mortality by detecting disease at an early
stage when treatment is more effective. Although breast cancer screening is widely
recommended for women at increased risk of breast cancer, its efficacy remains
controversial in women younger than age 50 (when breast tissue is generally more
dense).
A number of forms of screening are currently available for detecting breast
cancer. These are the traditional methods ofmammography, clinical breast
examination (CBE) and breast self-examination (BSE) or "breast awareness" and the
relatively new methods of ultrasound and magnetic resonance imaging (MRI). To
date, a limited number of studies have assessed the value of these different forms of
screening in young women with a family history ofbreast cancer.
Kollias et al. (1998) found that annual clinical breast-examination and
mammography every two years in 1371 British women with a family history of
breast cancer aged under 50 was just as effective at detecting breast cancer as the
U.K National Breast Cancer Screening Programme in women aged 50 or over. In the
women with a family history who had been screened on a regular basis, a greater
proportion (41%) of the cancers detected over the eight-year study period had a good
prognosis compared to the proportion (30%) in women with a family history of
breast cancer who had not received regular screening. Similar results were obtained
in a five-year study of 1259 British women with a family history of breast cancer
aged under 50 (Lalloo et al., 1998).
A European study ofwomen at increased risk of breast cancer showed that
75% of the 161 breast cancers diagnosed were detected through routine
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mammography and clinical breast-examination (Moller et al., 1999). The remaining
quarter of breast cancers were detected through breast self-examination. As 60% of
these breast cancers were caught at an early stage, the results could be seen to
support the value of breast self-examination in this group ofwomen (Moller et al.,
1999). In contrast, other studies have not found that breast self-examination improves
the early detection of breast cancer in women with a family history of the disease
(Tilanus-Linthorst et al., 2000). Indeed, recent recommendations have actually
advised against the promotion of breast self-examination in women in the general
population under 40 years (Baxter et al., 2001). This is due the lack of evidence for
the effectiveness of breast self-examination together with evidence suggesting
possible psychological distress and an increased risk of benign breast biopsy (Baxter
et al., 2001).
Macmillan et al. (2000) reports on the results of a national audit of 22 breast
units providing breast cancer screening to a total of 8783 British women with a
family history of the disease. Although the protocols for the frequency and type of
screening varied between units, all units offered mammography, 20 offered clinical
breast-examination and one offered ultrasound. The results showed that the rate of
detecting breast cancer in women with an increased risk of breast cancer under the
age of 50 was similar to the rate found in the U.K National Breast Screening
Programme ofwomen aged 50-64. However, the individual effectiveness of the
different methods of screening in this study was not evaluated.
Tilanus-Linthorst et al. (2000) investigated the effectiveness of detecting
breast cancer in women with a family history of breast cancer receiving clinical
surveillance compared to symptomatic women with a family history of the disease.
For four years, 294 women in the Netherlands aged 22-75 at moderate risk of breast
cancer received an annual clinical breast-examination and mammography and 384
women aged 20-74 at high risk received a clinical breast-examination every six
months and an annual mammography. One hundred and nine of the women at high
risk also received breast MRI. Clinical surveillance was shown to detect significantly
more breast cancers when they were at an early stage than in the symptomatic
women and was shown to be just as effective in women under 50 years as in women
aged over 50. The results suggest that a reduction in breast cancer mortality in
women aged under 50 would be equivalent to that achieved in the Dutch National
Breast Screening Programme. The study provides evidence for the effectiveness of
clinical breast-examination in pre-menopausal women with a family history of breast
cancer. It also suggests that MRI is effective in detecting breast cancers in women
with a family history of the disease which are not identified by clinical breast-
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examination or mammography. These findings have been supported by more recent
research in 196 Canadian women aged 26-59 at high risk of developing breast cancer
(Warner et al., 2001).
Although the results of these studies are encouraging in terms of the efficacy
ofbreast cancer screening in women with a family history of breast cancer under the
age of 50, further long-term multicentre research is warranted to confirm the value of
clinical surveillance in this population.
1.4.2 Current recommendations for the management of women at increased
risk of breast cancer
Recommendations for the management of breast cancer risk depend on the
woman's age and family history and also differ to some extent between and within
countries. The Scottish Executive (2001) advises that women who are estimated to be
at medium risk of developing breast cancer should begin breast cancer screening
when they are five years younger than the youngest age at which any relative was
diagnosed with breast cancer, but at no younger than 35 years or older than 40 years.
For medium risk women, mammography (two-view) is recommended to be carried
out every two years from age 35, yearly from age 40 and every three years from age
50-64 as part of the National Breast Screening Programme. Clinical breast-
examination for this group should be carried out yearly from age 35-64.
Women who are estimated to be at high risk of developing breast cancer
should begin breast cancer screening when they are five years younger than the
youngest age at which a relative was diagnosed with breast cancer (not younger than
25 years or older than 35 years). Mammography (two-view) is recommended to be
carried out every two years from age 25, yearly from age 40, every 18 months from
age 50 as part of the National Breast Screening Programme and every three years
from age 65. From age 25, clinical breast-examination should be performed every
year until age 64. In addition, women estimated to be at high risk ofbreast cancer
should begin ovarian cancer screening at age 35 or five years younger than the
youngest case of breast or ovarian cancer in their family.
1.4.3 Genetic testing
Access to genetic testing for mutations in breast cancer susceptibility genes
varies both between and within countries. Eccles et al. (2000) describe the current
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situation in the U.K, where genetic testing for breast cancer susceptibility has only
recently been introduced.
Predictive genetic testing is not offered to all unaffected women with a family
history of breast cancer. Only aminority of unaffected women at high risk ofbreast
cancer are usually eligible. These women are from the few families where a specific
mutation in BRCA1 or BRCA2 has already been found in the DNA of an individual
with breast cancer. The process of searching for genetic mutations in an affected
individual is a lengthy and expensive process that is not always informative. This is
because a number of breast cancer susceptibility genes remain unidentified and a
large proportion of genetic mutations in known genes are not able to be identified
using current techniques.
Unaffected women who are eligible for and choose to undergo predictive
genetic testing, receive thorough preparation and support during the process. It
usually involves two initial sessions with a specialist geneticist to gain appropriate
information about the test and to discuss their expectations and worries. Then there is
a "cooling off phase of at least four weeks to give the individual time to make a
final decision about taking the test, before the blood sample is taken. Results are
generally given face-to-face and appropriate follow-up and psychological support
can be arranged.
The results of a genetic test whether positive or negative can have a number
of important implications for the individual concerned. These include making
informed choices about clinical surveillance, prophylactic surgery and trials of
chemoprevention, psychological well-being, family relationships, treatment of breast
cancer (Eccles et al., 2000) and legal issues such as life assurance. For example, if a
woman is found to carry the genetic mutation that has been identified in her family
(i.e. a positive result), she can be offered a level of screening that is appropriate for
her risk together with prophylactic surgery and participation in a chemoprevention
trial. In contrast, a negative test result often means that additional breast cancer
screening out with the National Breast Screening Programme is not warranted.
1.4.4 Reducing the risk of breast cancer
In the absence of firm evidence regarding lifestyle factors, there are
effectively only two ways in which the risk of breast cancer may be reduced:
prophylactic surgery and chemoprevention by anti-oestrogen drugs.
In the U.K, prophylactic mastectomy and oophorectomy are usually only
offered to women at high risk of developing breast cancer and involve thorough
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preparation and support. Prophylactic mastectomy has been shown to be associated
with at least a 90% decrease in the breast cancer incidence in 639 women at
moderate or high risk of developing breast cancer (Hartmann et al., 1999). Rebbeck
et al. (1999) found that bilateral prophylactic oophorectomy was related to a decrease
in the risk of breast cancer in 43 women with a mutation in BRCA1.
Anti-oestrogen drugs such as Tamoxifen and Raloxifene are commonly used
to treat women already diagnosed with breast cancer. A meta-analysis of randomised
trials has shown that Tamoxifen can nearly halve the risk of contralateral breast
cancer in women already diagnosed with early-stage breast cancer (Early Breast
Cancer Trialist's Collaborative Group, 1998). The use of these drugs to prevent the
development of breast cancer in asymptomatic women at increased risk of the
disease has not yet been licensed in the U.K outside of research trials. However,
there are a number of ongoing worldwide randomised controlled trials investigating
the impact of these chemopreventative agents on the development of breast cancer in
women at increased risk of the disease such as the International Breast Cancer
Intervention Study (IBIS).
Although evidence for the effectiveness of prophylactic surgery and
chemoprevention in reducing the risk of breast cancer in women with a family
history of the disease is accumulating, further research is needed to provide
unequivocal evidence.
1.4.5 Familial breast cancer clinics
Major scientific advances in understanding cancer genetics and a
corresponding increase in media attention to breast cancer has led to growing public
awareness of family history as a risk factor for the disease. In order to meet the needs
of growing numbers ofwomen seeking information about their personal risk of
breast cancer and advice about risk management, familial breast cancer clinics have
been set up worldwide. The type of services that are offered by these clinics varies
between and within countries, but usually includes some form ofbreast cancer
screening.
Research has investigated the factors that motivate women to attend familial
breast cancer clinics. Brain et al. (2000) found that nearly one third of 833 first time
attendees of a familial breast cancer clinic were principally attending to gain
information about their risk of developing breast cancer. However, a minority of
participants did not want to or were unsure about receiving information about their
personal breast cancer risk. Other key reasons for attending included being aware of
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their family history (19%), gaining information about the risk of breast cancer in
other family members (13%), alleviating worry (11%), gaining information about
genetic testing (10%), receiving breast screening (7%) and gaining information about
ways to prevent breast cancer (6%).
1.4.6 The Ardmillan familial breast cancer clinic
The Ardmillan familial breast cancer clinic was set up in Edinburgh in 1992
for women in South East Scotland with a family history of breast cancer. The clinic,
which is now funded by Lothian Primary Care Trust, deals with a growing number of
referrals whilst maintaining follow-up services for over 1,000 women, some of
whom have been attending the clinic since it began.
The clinic provides a number of services through a multidisciplinary team of
geneticists, genetic counsellors, genetic breast care nurses, breast surgeons and
radiologists. These services include breast cancer genetic risk counselling, breast
cancer screening (i.e. mammography, clinical breast examination, ultrasound), breast
biopsy (i.e. fine needle aspiration), genetic testing for BRCA1/2 mutations (carried
out by the South East of Scotland Clinical Genetics Service) for women at high risk
of breast cancer, prophylactic surgery for high-risk women and the opportunity to
participate in research such as the International Breast Cancer Intervention Study
(IBIS) and the MRI Breast Screening Trial (MARIBS). The clinic offers these
services according to the Scottish Executive (2001) guidelines (section 1.3.2, page
8).
As in many other familial breast cancer clinics, there is no formal provision
of ongoing psychosocial support specifically for these women. However, women can
usually be referred to a clinical psychologist for psychological assessment and
support if required. Current guidelines suggest that psychological support should be
offered to "anyone undergoing predictive testing for mutations in cancer
predisposing genes known to exist in their families, anyone considering prophylactic
surgery and any individual with signs or symptoms of clinically significant
psychological disturbance" (Scottish Executive, 2001).
1.4.7 Summary
For the majority ofwomen in South East Scotland estimated to have an
increased risk ofbreast cancer, the clinical services they are offered are limited.
Although a substantial proportion of these women are likely to have expected to be
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offered predictive genetic testing, most are not eligible as a mutation in BRCA1 or
BRCA2 has not yet been identified in an affected relative. Likewise, the majority of
women will not be offered prophylactic surgery. Apart from participation in research
trials, the only services most women will be offered focus on breast cancer screening,
the efficacy ofwhich remains uncertain in this population.
1.5 Psychosocial impact of breast cancer genetic risk
counselling
1.5.1 Introduction
A large body of research has already started to address various psychosocial
aspects of familial breast cancer risk including: the sociodemographic and
psychological characteristics ofwomen attending familial breast cancer clinics; the
assessment and communication ofbreast cancer risk through genetic risk
counselling; psychosocial and health behaviour outcomes of genetic risk counselling;
decision-making about genetic testing and risk-reducing measures; the process and
outcomes of genetic testing.
Ofparticular interest to the current work is the substantial proportion of this
research which has investigated a range of psychosocial outcomes of genetic risk
counselling for breast cancer in healthy women with a family history of the disease.
These outcomes have included general psychological distress, breast cancer-specific
distress, perceived risk of developing breast cancer, knowledge of issues relevant to
breast cancer risk and adherence to breast cancer screening. Research has also
explored the relationship between these outcomes and the impact of additional
factors such as family bereavement from cancer.
A number of longitudinal studies have assessed these psychosocial factors
usually by a self-report questionnaire before and after counselling. However, the
post-counselling follow-up has generally been relatively short-term (i.e. from
immediately after genetic risk counselling to 6 months post-counselling) (e.g.
Lerman et ah, 1995, 1996; Gagnon et al., 1996; Cull et ah, 1998; Hopwood et ah,
1998; Watson et ah, 1998; Kent et ah, 2000; Brain et ah, 2002). Only a minority of
studies have assessed such outcomes at least one year after genetic risk counselling
(i.e. Evans et ah, 1994; Cull et ah, 1999; Schwartz et ah, 1999a; Watson et ah, 1999;
Hopwood et ah, 2001; Meiser et ah, 2001b; Bish et ah, 2002). In addition, a smaller
number of studies have conducted cross-sectional surveys ofwomen at increased risk
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ofbreast cancer who are maintained on regular clinical surveillance (i.e. Kash et al.,
1992; Valdimarsdottir et al., 1995; Lloyd et al., 1996; Zakowski et al., 1997, 2001).
The latter two groups of studies (i.e. one-year follow-up studies of genetic
risk counselling, cross-sectional surveys) will be reviewed and subjected to critical
analysis in the following sections according to psychosocial outcome variable.
1.5.1 a General psychological distress
A number of studies have investigated the impact of breast cancer genetic
risk counselling on general psychological distress using a variety of self-report
measures including the Brief Symptoms Inventory (BSI), Spielberger State-Trait
Anxiety Inventory (STAI), the General Health Questionnaire (GHQ), Beck
Depression Inventory (BDI) and the Hospital Anxiety and Depression Scale
(HADS).
Watson et al. (1999) evaluated 282 British women before breast cancer
genetic risk counselling, immediately following counselling and one, six and 12
months later. Almost one third ofparticipants were experiencing case-level distress
at the 12-month follow-up (GHQ-12 >3), despite the fact that 13% of the total
sample had been given some psychiatric treatment during the year that they had
participated in the study. This factor may have affected levels of distress thus
confounding the results. However, the authors do not report a comparison of the data
from those participants who had and had not received psychiatric treatment. The
prevalence ofpsychiatric morbidity obtained in this study compares to a reported
prevalence of 30% (using GHQ-12 threshold >3) in women in the general population
(Weich et al., 2001) and 36% (Plummer et al., 2000) to 50% (May, 1992) in general
practice patients. Although, Watson et al. (1999) did not find any significant changes
in general psychological distress between pre- and one year post-counselling, state
anxiety (STAI) significantly decreased immediately after counselling. This is in
contrast to the findings ofMeiser et al. (2001b) who did not find any significant
differences in depression or state anxiety (BDI and STAI) in 218 Australian women
between pre-counselling and 12 months post-counselling.
Approximately 400 British women completed assessments prior to,
immediately following and one year after breast cancer genetic risk counselling (Cull
et al., 1999). The participants were only those women who were found to be at
sufficiently increased risk of breast cancer to warrant clinical surveillance. The
authors do not state the proportion of participants at moderate or high risk and the
type of clinical services that would be offered to them. These factors may have
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influenced the psychosocial outcomes of genetic risk counselling. Trait anxiety
(STAI) assessed at baseline was significantly higher than a general population
sample, but comparable to women attending a breast screening clinic. State anxiety
(STAI) was significantly alleviated immediately following counselling and one-year
post-counselling. Levels of state anxiety immediately post-counselling were
comparable to a general population sample and significantly lower than breast
screening samples. General psychological distress (GHQ-30) was significantly
reduced immediately post-counselling, but was not significantly different from
baseline at the one-year follow-up. Women with higher levels of general
psychological distress prior to counselling had a greater risk ofbeing notably
distressed immediately after counselling.
Bish et al. (2002) found that in 26 British low-risk women, 76 moderate risk
and 46 high risk, there were no significant differences in general psychological
distress (GHQ-28 >5) or general anxiety and depression (HADS and STAI) between
pre- genetic risk counselling and 2 weeks, 6 months and 12 months post-counselling.
There were no significant differences between the low-, moderate- and high-risk
groups on any of these measures during the 12-months. Pre-counselling, 41% of
participants scored above the threshold to indicate a probable anxiety disorder, 11%
indicated a probable depressive disorder and 31% were suffering from case-level
general psychological distress. During the study period, 24% ofparticipants had
undergone BRCA1/2 genetic testing. The authors do not report a comparison of the
data of those participants who had and had not undergone testing to check for
differences on psychosocial outcomes, particularly psychological distress and
perceived likelihood of carrying a genetic mutation.
Kash et al. (1992) assessed 217 American women with a family history of
breast cancer who were enrolled in a breast cancer surveillance programme. It is not
clear whether the participants in this study had received genetic risk counselling or
how long they had been enrolled in the screening programme. Twenty-seven percent
of the sample was found to be experiencing levels of general psychological distress
(BSI) that would warrant psychological intervention. However, participants were
assessed either before or immediately after a routine breast cancer screening
appointment which may have resulted in a transient increase in distress levels.
Lloyd et al. (1996) compared 88 British women with a family history of
breast cancer to 62 age-matched controls without a family history. The women with a
family history had received breast cancer genetic risk counselling an average of 10.9
months previously (range = 2-25 months). About one third of the women in each
group indicated levels of general psychological distress (BSI > 63) that would
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warrant psychological intervention. This may be an overestimate since some
participants had only recently received genetic risk counselling and others may have
been approaching the time of a routine breast cancer screening appointment.
The research generally shows that although breast cancer genetic risk
counselling can significantly reduce general psychological distress immediately after
genetic risk counselling, this reduction is not maintained up to one year post-
counselling. One year after genetic risk counselling, levels of general psychological
distress are similar to those experienced prior to counselling. Despite the fact that
breast cancer genetic risk counselling has not been shown to be effective in
alleviating general psychological distress, there is no evidence that it actually
increases distress levels. However, a substantial proportion ofwomen who undergo
genetic risk counselling are still experiencing significant levels of distress up to 25
months after receiving their risk estimate.
1.5.1 b Breast cancer-specific distress
Breast cancer-specific distress has been investigated in relation to genetic risk
counselling using several measures including the Impact of Event Scale (IES), the
CancerWorry Scale (CWS) and the Cancer Anxiety and Helplessness Scale
(CAHS).
Bish et al. (2002) observed that a significant decrease in worry about
developing breast cancer (CWS) in women with a family history of the disease was
maintained up to one year post-genetic risk counselling regardless ofwhether the
participants were at low, moderate or high risk ofbreast cancer. However, the largest
decline in breast cancer worry was from before counselling to 2 weeks post-
counselling. Similarly, a significant reduction in intrusive and avoidant thoughts
about breast cancer risk was observed in women one year following breast cancer
genetic risk counselling (Meiser et al., 2001b).
Watson et al. (1999) did not find any significant changes in breast cancer-
specific distress (CAHS, IES) in women with a family history of the disease one year
after genetic risk counselling. In contrast, there was a significant reduction in the
perception of breast cancer worry as problematic (CWS). However, 23% of
participants indicated that they worried "frequently or constantly" about developing
breast cancer at one-year follow-up and this worry was a "definite or severe
problem" for 12% of the total sample. Although the authors report the proportion of
participants who were found to be at high risk of breast cancer, the proportion of
participants at moderate or low risk is not stated. This is important since the clinical
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services they were offered were influenced by their risk status and this in turn could
have affected levels of breast cancer-specific distress.
For 500 British women with a family history of breast cancer who were
assessed prior to breast cancer genetic risk counselling and between 2-21 months
post-counselling, worry about developing breast cancer (CWS) was not found to
have significantly changed (Hopwood et ah, 2001). Given the fact that some
participants had been assessed only two months after counselling whereas others had
been assessed after almost two years, this may have confounded the results.
Lloyd et al. (1996) showed that women with a family history of breast cancer
who had received genetic risk counselling up to 25 months previously had
significantly higher levels of intrusive and avoidance thoughts about breast cancer
than the control group who didn't have a family history of the disease.
Research on the impact of genetic risk counselling on breast cancer-specific
distress has produced contradictory results. Some studies have shown that genetic
risk counselling can significantly reduce breast cancer-specific distress up to one
year after counselling. In others, genetic risk counselling has repeatedly been shown
to be ineffective in alleviating breast cancer-specific distress. These differences in
findings may be due to variation in the procedure and content of genetic risk
counselling both between and within countries. Despite these discrepancies, the
research does suggest that a large number ofwomen may be suffering from high
levels of breast cancer-specific distress up to 21 months after genetic risk
counselling.
1.5.1 c Perceived risk of breast cancer
As perceived risk of breast cancer is likely to impact significantly on
emotional response and risk-management choices, assessment of perceived risk has
been commonly included in psychosocial studies in this area. Researchers have also
investigated the relationship of breast cancer risk perception both to general
psychological and breast cancer-specific distress. Various measurements of
perceived risk have been employed including percentage lifetime risks, age-specific
risks relative to the general population, odds ratios and categories of likelihood of
developing breast cancer.
Watson et al. (1999) found that although genetic risk counselling generally
improved the accuracy of perceived risk of breast cancer post-counselling, this
improvement declined at one-year post-counselling. A significant association was
found between perceived risk and objective risk of breast cancer up to one year post-
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counselling. Immediately post-counselling, 31% of participants reported an accurate
perception of their breast cancer risk, but only 17% did at one-year follow-up. The
women who overestimated their risk at the one-year follow-up indicated significantly
greater levels of intrusive and avoidant thoughts about breast cancer risk than the
women who underestimated or correctly estimated their risk. Accuracy ofperceived
risk was shown to predict levels of cancer worry at baseline and one year, where
over-estimators were more likely to have frequent or constant worries about breast
cancer and perceive it to be a problem than the women who underestimated or
correctly estimated their risk.
Accuracy of perceived risk was shown to significantly improve from baseline
to immediately post-counselling for women who initially over- or underestimated
their risk of developing breast cancer (Cull et al., 1999). Despite these improvements
both groups ofwomen continued to hold significantly inaccurate perceptions of their
risk and this was sustained up to the one-year follow-up. In addition, perceived risk
was found to increase again in the women who initially over-estimated their risk
between immediately post-counsel and one year later. Over-estimators only showed a
significant reduction in state anxiety immediately post-counselling. There was no
relationship between accuracy of perceived risk and state anxiety at the one-year
follow-up. The study did not provide any evidence that a change in perceived risk
was related to an alteration in general psychological distress.
Evans et al. (1994) assessed perception of breast cancer risk in 200 British
women both prior to and at least one year after genetic risk counselling. There were
significant improvements in the accuracy of perceived personal risk of developing
breast cancer at the one-year follow-up. However, the effect of these improvements
on levels of psychological distress was not assessed.
Bish et al. (2002) found that breast cancer genetic risk counselling did not
significantly alter perceived risk of developing breast cancer up to 12 months post-
counselling. However, a comparison of the mean values one year post-counselling
showed that the women at low risk accurately perceived the least risk and women at
moderate risk perceived a lower risk than the women at high risk.
The accuracy ofperceived risk of breast cancer was found to significantly
improve 2-21 months post-counselling with 42.1% giving a correct estimate, 28.8%
underestimating and 23.3% overestimating their risk (Hopwood et al., 2001). Women
who originally overestimated their breast cancer risk experienced a significant
decrease in worry about developing breast cancer. Three of the 500 participants had
undergone genetic testing for breast cancer susceptibility during the study period and
one was found to carry a genetic mutation. Although this was only a small proportion
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ofparticipants, their psychosocial outcomes may be different from those who had not
undergone testing which may have influenced the overall results.
Meiser et al. (2001b) observed that although the majority ofwomen correctly
perceived their risk ofbreast cancer one year post-counselling, 31% continued to
overestimate their risk and 14% still underestimated their risk. The reduction in
intrusive and avoidant thoughts about breast cancer risk were found to be predicted
by improvements in the perceived risk of developing breast cancer.
In contrast, Lloyd et al. (1996) found that only 19.4% of the women who had
attended breast cancer genetic risk counselling, perceived their risk of breast cancer
accurately, whereas 48.4% underestimated and 17.7% over estimated their risk.
Accuracy ofperceived risk was not found to be related to the time since genetic risk
counselling. Perception of a high risk ofbreast cancer was related to greater levels of
intrusive and avoidance thoughts about breast cancer.
Although research has provided evidence that breast cancer genetic risk
counselling can significantly improve the accuracy of a woman's perceived personal
risk of developing the disease, the extent of this improvement is not necessarily
sustained. A considerable proportion of the women who attend breast cancer genetic
risk counselling do not form an accurate perception of their risk up to 25 months
post-counselling. There is evidence that the accuracy ofperceived risk of breast
cancer is related to levels ofbreast cancer-specific distress. Women who initially
perceive themselves to be at high risk or who overestimate their risk may experience
greater or more sustained reduction in breast cancer-specific distress following
genetic risk counselling. However, this group ofwomen are still likely to be
suffering from heightened levels of breast cancer specific distress in the longer-term.
1.5.1 d Knowledge of issues relevant to breast cancer risk
Of the few studies that have investigated knowledge of breast cancer genetics
in women with a family history of the disease (i.e. Lerman et al., 1996; Wonderlick
& Fine, 1997; Cull et al., 1998; Bluman et al., 1999; Meiser et al., 2001a & b), only
one study has assessed this knowledge one-year post-genetic risk counselling (i.e.
Meiser et al., 2001b).
A 9-item true-false scale, adapted from a previous study (i.e. Lerman et al.,
1996) was used to assess knowledge of the inheritance of breast cancer susceptibility,
the associated risks, effectiveness of screening and risk-reducing methods in 218
Australian women (Meiser et al., 2001b). Responses to eight of the nine items
showed significant improvements at one-year post-counselling. In contrast, responses
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to the item "mammography will always detect breast cancer" did not significantly
improve. Although total knowledge scores significantly improved between
assessments, knowledge post-counselling was generally incomplete. The proportion
of participants able to give to correct response at the one-year follow-up, to each of
the knowledge items ranged from approximately 35-90%. Less than half of
participants were able to give the correct response to two of the nine items (i.e. "a
genetic test for breast cancer will also detect other abnormalities", "the gene for
breast cancer can also increase the risk for other cancers"). There was no evidence
that knowledge at the one-year follow-up was related to general or breast cancer-
specific distress. There are a number of limitations with the assessment of
knowledge in this study. The internal consistency of the scale was relatively low (i.e.
alpha coefficient = 0.59) in comparison with recommended levels (i.e. 0.8 or above,
Bryman & Cramer, 1997). This suggests that further psychometric development and
testing of the scale is needed. Given the fact that this was a multi-centre study
conducted in 20 different clinics across five Australian states, the content of the
genetic risk counselling sessions may have varied greatly. This may have affected the
psychosocial outcomes of the study, particularly in terms ofparticipants' knowledge.
This study provides evidence that despite improvements in knowledge
following genetic risk counselling, understanding of some of the key pieces of
relevant information was markedly lacking up to one year later.
1.5.1e Screening adherence
Several studies have assessed the impact of genetic risk counselling on
adherence to mammography, clinical breast-examination and breast self-
examination.
Lloyd et al. (1996) found that 90% ofwomen with a family history ofbreast
cancer reported performing breast self-examination 2-25 months after attending
genetic risk counselling compared to 76% of the control group without a family
history of the disease. 66% of the women with a family history ofbreast cancer
stated they performed breast self-examination every month, as recommended, and
40% reported they performed breast self-examination more often since attending for
genetic risk counselling.
Schwartz et al. (1999a) conducted a randomised controlled trial involving 430
American women aged 40-75. It compared breast cancer genetic risk counselling
with a control intervention consisting of general health education where risk
assessment was not provided. Self-reported adherence to mammography was similar
23
in both groups at the one-year follow-up providing evidence that genetic risk
counselling does not improve adherence to mammography in women already
recommended to have an annual mammogram from age 40 (American Cancer
Society, 2000). Genetic risk counselling was also shown to result in decreased use of
mammography in women who were less well educated which the authors suggest
could be due to the misinterpretation of receiving a lower risk estimate than they had
expected. These findings may be limited by the fact that adherence to mammography
was based on self-reports and was not verified by medical records. In addition, the
authors did not consider the social desirability of reporting adherence to
mammography in this group ofwomen.
Meiser et al. (2001b) observed a slight decrease in the proportion ofwomen
adhering to recommendations for mammography and a significant decrease in
adherence to clinical breast-examination one year after genetic risk counselling.
Adherence to mammography and clinical breast-examination at one-year was
relatively high, with 86% of the sample reporting adherence to either form of
screening. Although only half of the sample reported performing breast self-
examination at least monthly one year after genetic risk counselling, this was a slight
improvement in the proportion ofwomen who reported adherence to breast self-
examination prior to counselling. In contrast to previous research (i.e. Schwartz et
al., 1999a), women with lower levels of education were more likely to adhere to
mammography than women with higher levels of education.
Research has also evaluated the effect of attending for routine breast cancer
screening on psychological distress in women with a family history of the disease
and the effect distress on adherence to screening.
Valdimarsdottir et al. (1995) compared levels of psychological distress in 26
American women with a family history of breast cancer who were enrolled in a
breast cancer surveillance programme and 27 women without a family history of the
disease who were not attending such a programme. The women with a family history
were assessed immediately prior to a routine mammography, all received normal
results the same day and they were assessed a second time one month later. The
timing of the control group's assessments was matched with the women undergoing
mammography. Acute psychological distress, which was at a high level prior to
mammography, was alleviated one month later. The women with a family history
had significantly higher levels of general psychological distress and intrusive
thoughts about breast cancer than the control group both prior to mammography and
one month later after they had received their normal results. The number of
participants in this study is small which may limit the generalisability of the findings.
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The authors do not state how long participants had been enrolled in the screening
programme. Familiarly with breast cancer screening could have impacted on levels
of psychological distress. This limitation also applies to two additional studies that
selected participants from the same subject pool (i.e. Zakowski et al., 1997; 2001).
Zakowski et al. (1997) compared 46 American women with a family history
ofbreast cancer enrolled in a screening programme and 43 women without a family
history ofbreast cancer who were not enrolled in such a programme. The women
with a family history were assessed immediately prior to an annual mammography
and 4-8 weeks later after they had received their normal results. The control group
was assessed at similar intervals. There were significantly greater levels of intrusive
and avoidant thoughts about breast cancer in the women with a family history of the
disease than the control group at both assessments. However, there was no evidence
to suggest that undergoing mammography temporarily elevated levels of breast
cancer-specific distress.
In women with a family history of breast cancer enrolled in a surveillance
programme, high levels of cancer-related anxiety were shown to impair adherence to
clinical breast-examination as only 69% of the sample adhered to clinical breast-
examination recommendations (Kash et al., 1992). Similarly, high levels of general
anxiety reduced adherence to breast self-examination, as only 40% reported
performing breast self-examination on a monthly basis.
Therefore, research has not yet provided unambiguous evidence that genetic
risk counselling improves adherence to any form of breast cancer screening, although
there is some data to suggest improved adherence to breast self-examination. Studies
have also shown that attendance for routine breast cancer screening is associated
with a period of heightened general psychological distress and sustained high levels
of breast cancer specific distress which can both interfere with adherence to breast
cancer screening. There is evidence for an optimum level of anxiety in terms of
adherence to breast cancer screening, where higher or lower levels of anxiety could
impair adherence.
1.5.1f Other factors that may affect distress
A number of other factors have been investigated in terms of their impact on
general and breast cancer-specific distress including bereavement and certain
dispositional characteristics.
Zakowski et al. (1997) found significantly higher levels of breast cancer
specific distress and perceived risk of breast cancer in women with a family history
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of breast cancer whose parent had died from cancer than in those women who hadn't
experienced such a bereavement. Levels of breast cancer-specific distress in the latter
group were comparable to the control group without a family history of the disease
or death of a parent from cancer. Recency of bereavement was not shown to be
related to levels of breast cancer-specific distress or perceived risk of breast cancer.
The authors suggest that the death of a parent from cancer may heighten the
perceived risk ofbreast cancer and the belief that breast cancer is an incurable
disease. However, these results should be interpreted with caution as the number of
participants who had not experienced the death of a parent from cancer was relatively
small (i.e. 16).
Bereavement due to breast cancer had also been linked to breast cancer-
specific distress in women with a family history of the disease prior to breast cancer
genetic risk counselling (Hopwood et al., 2001). Women who were aged less than ten
years when their mother had died from breast cancer reported significantly less
worry about cancer than the women bereaved at any other age.
Zakowski et al. (2001) provided evidence that having a tendency to express
emotions externally may moderate general psychological distress in women with a
family history of breast cancer. One hundred and four women were assessed 1-2
months after receiving the normal results of a routine mammography. Emotional
expressivity was proposed to buffer the distressing effect of having intrusive
thoughts about breast cancer. The measure of emotional expressivity did not
distinguish between the type of emotions that were expressed (e.g. positive and
negative) but assessed a general tendency to express emotions outwardly. It is
therefore difficult to infer from these results the particular type of emotional
expression that may be adaptive for these women.
Cull et al. (1999) found evidence to suggest that having an external or chance
locus of control about your health could be related to heightened perceptions of
breast cancer risk and higher levels of distress in women attending breast cancer
genetic risk counselling.
There is evidence that bereavement from cancer in the family and the age at
which that occurred, emotional expressivity and health locus of control affect levels
of distress in women with a family history of breast cancer.
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1.5.2 Summary: critique of the literature on the psychosocial impact of
breast cancer genetic risk counselling
This review has identified several caveats concerning the research conducted
to date on the psychosocial impact of breast cancer genetic risk counselling. These
include: lack of long-term follow-up, heterogeneous samples with respect to risk and
little understanding of the needs ofwomen with an increased risk of breast cancer in
terms of information and support.
Although a large number of longitudinal studies have investigated the
psychosocial effects of breast cancer genetic risk counselling, the post-counselling
follow-up has tended to be relatively short-term. Of these studies, psychosocial
outcomes have often been assessed up to one year following counselling (i.e. Evans
et ah, 1994; Cull et al., 1999; Schwartz et al., 1999a; Watson et ah, 1999; Meiser et
al., 2001b; Bish et al., 2002) with few published studies to date extending beyond
this follow-up (i.e. Hopwood et al., 2001). Even then follow-up has only extended to
21 months in some but not all participants in the study (Hopwood et al., 2001). In
addition, several cross-sectional surveys assessing psychosocial factors have been
carried out ofwomen at increased risk of breast cancer who are maintained on
regular clinical surveillance (i.e. Kash et al., 1992; Valdimarsdottir et al., 1995;
Lloyd et al., 1996; Zakowski et al., 1997, 2001). However, these studies have not
always specified whether the participants had received genetic risk counselling or
how long they had been attending routine clinical surveillance. Of those studies that
had provided such details (i.e. Lloyd et al., 1996), the participants were a
heterogeneous sample with respect to the time elapsed since genetic risk counselling
which ranged from 2-25 months (Lloyd et al., 1996).
These longitudinal or cross-sectional studies have tended to investigate
samples ofwomen that vary greatly both in their objective risk of breast cancer and
their eligibility for genetic testing or risk-reducing measures.
It is then clear that there is a lack of knowledge about the psychosocial
consequences of living with an increased risk of breast cancer over a period of years,
particularly among British women who are not eligible for genetic testing or
prophylactic surgery. Indeed, this lack of research has been acknowledged in the
literature, although it has not yet been addressed: "Little is known of the long-term
psychological effect of perceiving that one has an increased risk for breast cancer"
(Chalmers et al., 2001).
The literature to date also lacks an investigation of the needs of all women at
increased risk ofbreast cancer in terms of information and support and what type of
27
services would be most effective in meeting these needs. Again, this deficit has
recently been acknowledged in the literature (i.e. Chalmers et ah, 2001) and is
beginning to be addressed. This lack of understanding is particularly relevant
regarding women at increased risk of breast cancer who are not eligible for genetic
testing or prophylactic surgery. The literature has suggested that these women
require general information about risk factors for breast cancer, including hereditary
factors and breast cancer screening (Ondrusek et ah, 1999). However, "the optimal
means of educating this large and heterogeneous group ofwomen is unknown"
(Ondrusek et al., 1999).
1.5.3 The uncertainty of having an increased risk of breast cancer
Uncertainty has been defined as "a condition of not knowing indisputably -
being unreliable, changeable or erratic" (Bottorff et al., 1998). Although the process
of breast cancer genetic risk counselling aims to reduce some of the uncertainty of
having a family history of breast cancer, a large amount of uncertainty still remains
for these women.
Breast cancer genetic risk counselling provides an individual with a risk
estimate representing the probabilities ofjust two possible outcomes (i.e. developing
breast cancer or not developing breast cancer). However, the nature ofprobabilities
means that the risk estimates are themselves "essentially uncertain" (van Zuuren et
al., 1997). They cannot provide a definitive answer about: whether an individual will
ever develop breast cancer; at what age they will be diagnosed; their prognosis; if
their children will also be at increased risk of the disease.
There is still controversy about the value of breast cancer screening practices
recommended to women who are at a significantly increased risk of the disease.
Until scientific advances provide effective methods to prevent the development of
breast cancer, these women face the prospect of years of clinical surveillance.
Therefore, these women face multiple uncertainties concerning their risk of
developing breast cancer and the screening methods currently offered to them.
A review of the literature on the psychosocial effects of uncertainty in acute
illness has provided strong evidence of relationship between greater uncertainty and
higher levels of psychological distress and this has been shown to continue over time
(Mishel, 1997). Numerous causes of uncertainty in acute illness have been
documented in the literature. Several of these causes may be particularly relevant to
the uncertainty of having an increased risk ofbreast cancer: perceived control, social
support and the provision of relevant information. Murphy (1999) has proposed that
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anxiety is just one of a number of different ways that individuals deal with the
uncertainty associated with having a family history of cancer: anxiety, fatalism,
denial, screening, information and genetic testing.
Given these multiple uncertainties, there is clearly a corresponding risk of
psychological morbidity in women with an increased risk ofbreast cancer.
Although it is currently not realistic to remove all the uncertainty that is
associated with having an increased risk ofbreast cancer, it may be possible to
reduce some of the uncertainty and render the remaining uncertainty easier to
manage. It is known that in acute illness uncertainty can be exacerbated if sources of
information such as health professionals are not readily available (Mishel, 1997).
Psychoeducational interventions have been shown to be effective in managing the
uncertainty experienced by cancer patients (e.g. Mishel et al., 2002) and could
perhaps meet the needs ofwomen living with an increased risk of breast cancer.
1.6 The current work
1.6.1 Rationale for area of research
A number of considerations from the psychological literature and from
clinicians involved in the management ofwomen at increased risk ofbreast cancer
informed the research questions addressed in this thesis.
Firstly, there is a lack of research on the psychosocial effects of living with an
increased risk of breast cancer for a number of years in women at increased risk of
breast cancer who are not eligible for genetic testing or prophylactic surgery. This
group ofwomen form a large proportion of the women estimated to be at increased
risk of the disease and their numbers are likely to continue to grow.
Secondly, it is clear that these women have to deal with continuing multiple
uncertainties concerning their increased risk of breast cancer. This could have
important implications in terms of psychological distress, the development of health
anxiety and the overall impact on their daily life. Research in individuals who are
acutely ill has already provided evidence of an association between greater degrees
of uncertainty and psychological distress.
Thirdly, research in women with an increased risk of breast cancer has shown
that a substantial proportion are experiencing significant levels of general
psychological and breast cancer-specific distress up to 25 months after attending for
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breast cancer genetic risk counselling. There could be a number of important
implications both for individuals, their families and the clinical services if chronic
psychological distress was found to be prevalent in women who have been living
with the knowledge of an increased risk of breast cancer for a number of years.
Research in American women with a family history of breast cancer has indicated
that high levels of distress are associated with non-adherence to breast self-
examination (e.g. Kash et al., 1992), clinical breast-examination (e.g. Kash et al.,
1992) and mammography (e.g. Lerman et al., 1993). If distress is also shown to
interfere with screening in British women and this surveillance is proven to be
effective in this population, chronic distress may elevate the risk of death from breast
cancer for those already estimated to be at increased risk of the disease. In addition,
there may be important implications for future generations within the same family.
Women who are living with an increased risk of breast cancer and who are
chronically distressed may represent maladaptive role models for the next generation
who are also likely to face living with this constant threat.
Fourthly, there is a lack of understanding about the needs of these women in
terms of information about issues relating to their increased risk of breast cancer and
support to help them cope. The general information they were given during genetic
risk counselling several years ago (e.g. about breast cancer genetics, breast cancer
screening methods) is now likely to be out-of date. The current clinical service,
whose main focus is the provision of regular clinical surveillance, does not formally
provide information or psychosocial support for these women. Clinicians at the
Ardmillan familial breast cancer clinic are concerned that insufficient time is
available during routine clinic appointments to address the possible needs of these
women for general information and support. However, it would be important to meet
these needs in an efficient and cost-effective manner which would not place further
pressures on the resources of the clinic.
1.6.2 Outline of research methodology
The current work was intended to investigate the psychosocial effects of
living with an increased risk ofbreast cancer in women who have been attending the
Ardmillan familial breast cancer clinic for regular clinical surveillance for at least
two years.
This work was initiated with an exploratory qualitative study to investigate
the psychosocial effects of living with an increased risk of breast cancer and to
confirm the concerns about these women's needs for information and psychosocial
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support that were not being met by the current clinical service. The novel
methodology of telephone focus groups was adopted which is described in Chapter 2.
The plan was then to conduct a larger cross-sectional survey to obtain
quantitative data about these needs. This type ofmethodology has been successfully
used in several studies ofwomen at increased risk of breast cancer who are
maintained on regular clinical surveillance (i.e. Kash et al., 1992; Valdimarsdottir et
ah, 1995; Lloyd et ah, 1996; Zakowski et ah, 1997, 2001).
The data collected in the cross-sectional survey were intended to inform the
development of a psychoeducational intervention that aimed to meet the needs of
these women. This intervention was proposed to be evaluated in a randomised
controlled trial, a methodology that has been used to effectively evaluate
psychological interventions in women with a family history ofbreast cancer (e.g.
Gagnon et ah, 1996; Lerman et ah, 1996; Cull et ah, 1998; Schwartz et ah, 1998;
Watson et ah, 1998; Audrain et ah, 1999; Kash et ah, 1999).
1.6.3 Rationale for measures to assess psychological distress
Psychological distress is a broad term that is used in this thesis to describe a
number of constructs including general psychological distress, general psychological
morbidity and breast cancer specific-distress (i.e. cancer worry, intrusive and
avoidant thoughts about breast cancer). The research intends to investigate the range
of levels and types of psychological distress that are being experienced by women
living with an increased risk of breast cancer. Ofparticular importance is the
investigation of high levels of distress that may indicate psychological morbidity.
Such levels of distress are likely to have a considerable negative impact on an
individual's daily life which therefore suggests that treatment should be offered.
The cross-sectional survey employed a measure of general psychological
distress (i.e. GHQ-12, Goldberg & Williams, 1991). This can screen for clinically
significant distress using a threshold score and therefore provides an estimate of the
prevalence ofpsychological morbidity (further details of the GHQ-12 are included in
Chapter 4, Section 4.6.4a, page 88). The psychological literature has shown that the
prevalence of general psychological morbidity in women with a family history of
breast cancer up to one-year post-counselling is similar to that found in women in the
general population. However, general psychological morbidity has not been assessed
in women who have been living with an increased risk of breast cancer for several
years. It would be important to compare this prevalence to the existing literature to
determine the need for psychological intervention in this group ofwomen.
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In addition, the cross-sectional survey used the somatic symptoms subscale
from the GHQ-28 (Goldberg & Hillier, 1979) for exploratory purposes (further
details of this subscale are included in Chapter 4, Section 4.6.4b, page 88). The use
of this subscale is not intended to provide a direct measure of general psychological
distress but rather gives an estimate of the frequency that somatic symptoms were
reported among participants. It was hoped that this type of data would enable us to
determine whether increasing vigilance to the health of these women resulted in
greater levels of somatic symptoms.
In the final study, the randomised controlled trial of the psychoeducational
intervention, the key psychological distress outcome was cancer worry. The results
of the cross-sectional survey suggested that the assessment of breast cancer-specific
distress was more relevant than general psychological distress in women living with
an increased risk ofbreast cancer for several years (as levels were higher compared
to general population comparison data). However, as yet no clinical thresholds for
measures of breast cancer-specific distress have been derived to indicate clinically
significant levels of distress. The 6-item Cancer Worry Scale (Watson et ah, 1998)
was selected as the key outcome of the trial. It has been shown to be
psychometrically sound, sensitive in and relevant to women at increased risk of
breast cancer (further details on the scale are included in Chapter 6, Section 6.10.2a,
page 151). Although clinical thresholds for the Cancer Worry Scale have not yet
been derived, statistically significant reductions in scores may be clinically
meaningful, although further research would be needed to determine the extent of
this importance.
1.6.4 Summary
There is a clear rationale for investigating the psychosocial effects of living
with an increased risk of breast cancer for several years and for the measures used to
assess psychological distress. The research presented in this thesis was conducted as
a series of three studies using different methodologies.
The first exploratory study formed the basis of and directed the design of
subsequent studies. It was conducted using the novel methodology of telephone
focus groups which is reviewed in the following chapter.
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Chapter 2: Review of the Telephone Focus Group
Methodology
2.1 Focus groups
2.1.1 Background to focus groups
Focus groups were originally derived from a methodology developed by
Robert Merton during the 2nd World War. Then a social researcher, Merton became
dissatisfied with the interviewing procedures that were being adopted in radio
research, so he decided to develop a new interviewing technique which could be used
with both individuals and groups (Merton, 1987). This new technique was soon
recognised as the "focussed interview". Even at that stage, Merton was promoting his
"qualitative focussed group-interviews" as "sources of new ideas and new
hypotheses" (Merton, 1987). Following the launch of the "focussed interview"
(Merton & Kendall, 1946) in the American Journal of Sociology, Merton's new
methodology did not seem to be employed widely by social researchers. However,
this initial reaction by researchers was in no way to predict the later widespread use
of the "focus group", derived from Merton's work.
2.1.2 What is a focus group?
Each of the definitions in Table 2 describes some of the central characteristics
of a focus group: qualitative methodology (i.e. Merton, 1987; Tobin, 1996), group
interaction (i.e. Kitzinger, 1995; Morgan, 1997; Tobin, 1996), group interview (i.e.
Kitzinger, 1995), gaining insight into a specific topic (i.e. Merton, 1987; Morgan,
1997).
Vaughn et al. (1996) identify the following central elements of focus groups:
• The aim of a focus group is to elicit of the opinions of a selected group of
individuals on a specific topic.
• The group is fairly homogeneous, consisting of a small number of members
(usually 6-12).
• A trained facilitator uses a prepared guide consisting of questions and probes to
elicit the participants' responses.
• Focus groups generate qualitative, not quantitative data, which therefore cannot
be generalised to a wider population.
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Table 2: Definitions of a focus group
. .a set of procedures for the collection and analysis of qualitative data that may
help us gain an enlarged sociological and psychological understanding in whatsoever
sphere ofhuman experience" (Merton, 1987).
"Focus groups are a form ofgroup interview that capitalises on communication
between research participants in order to generate data" (Kitzinger, 1995).
"The focus group is a qualitative information gathering technique that capitalizes on
stimulated interaction in a small group discussion" (Tobin, 1996).
"The hallmark of focus groups is their explicit use ofgroup interaction to produce
data and insights that would be less accessible without the interaction found in a
group" (Morgan, 1997).
Of these central elements, group interaction could be regarded as the key
feature of the focus group methodology. Unlike some of the other types of qualitative
research tools, focus groups may be seen to have some of the features of quantitative
research methods such as planning and structure, whilst maintaining their flexibility
in encouraging group interaction (Vaughn et al., 1996). Focus groups do not use the
group setting simply as an efficient means of data collection, but rather utilise group
interaction as a distinct part of their methodology (Kitzinger, 1995). Although focus
groups can be described as a type of group interview, the emphasis is not on a
question-response format, but rather on the group interaction. Participants may be
encouraged to contribute more to an active group setting, than for example, they
would in a one-to-one interview. As Morgan (1997) suggests: ".. .it is the
researcher's interest that provides the focus, whereas the data themselves come from
the group interaction". Group interaction may encourage participants to investigate
and clarify their own opinions. It may also encourage participants to voice their
opinions using everyday forms of interaction such as jokes and anecdotes (Kitzinger,
1995). As Kitzinger (1995) suggests, this may add to our understanding of a
particular issue because "Everyday forms of communication may tell us as much, if
not more, about what people know or experience". She goes on to add that " In this
sense focus groups reach the parts that other methods cannot reach, revealing
dimensions of understanding that often remain untapped by more conventional data
collection techniques".
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Focus groups also seem to offer incidental benefits to participants that are a
result of the focus group methodology and not part of the research aims. For
example, Kitzinger (1995) suggests that mutual support may be gained in the group
through participants expressing common feelings. The benefit that participants may
gain from attending a focus group is similar to that which they may gain from
attendance at a support group (Ferrell et al., 1997). In addition, Morgan (1995)
suggests that psychological incentives can be offered to participants when they are
offered the opportunity to voice their opinions on topics that may affect them. In this
way, focus groups can be empowering for some participants, particularly if they are
viewed as experts on a specific topic and if the research is applied in nature as
participants can realistically perceive their contributions making a difference in the
future (Gibbs, 1997).
Focus groups do tend to be a less time consuming method of data collection,
than for example, developing and implementing a valid and reliable measure. This
fact remains, even though a substantial amount of time is necessary to prepare the
focus group guide and to train the moderator. However, the turnaround in data
collection is relatively quick as a large amount of information can be elicited in short
amount of time. Therefore, the focus group method is an efficient means of
determining the range of experiences among a group of people (Seals et al., 1995).
2.1.3 The use of focus groups in psychological research
Although focus groups have long been used in market and business research,
they have only more recently been employed as a research tool in areas such as
psychology, health education and communication. It has been suggested that their
recent popularity, particularly in psychological research, stems from the growing
need to identify the opinions of "key stakeholders" (Vaughn et al., 1996). As
psychological research has begun to embrace qualitative methodologies, so the
investigation of research tools that have the potential to offer greater insight into key
issues has grown.
One of the important features of focus groups, which is particularly relevant
to psychological research, is that they provide insight into emotions connected to the
specific issues of interest (Vaughn et al., 1996). The focus group methodology is
ideal for investigating the reasons behind the way people think (Kitzinger, 1995). As
Gibbs (1997) states: "The main purpose of focus group research is to draw upon
respondents' attitudes, feelings, beliefs, experiences and reactions in a way in which
would not be feasible using other methods".
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The focus group methodology has been used in psychological research in a
number ofways including exploratory research, validation of the data collected using
other methodologies, service evaluation and development, and the development of
interventions and instruments. These focus group studies have involved a variety of
participants including women with a family history of breast or ovarian cancer (e.g.
Pasacreta, 1999; Ryan & Skinner, 1999; Tessaro et al., 1997).
2.1.3a Exploratory research
In order to explore the beliefs about breast cancer risk and preferences for
genetic risk counselling, Ryan & Skinner (1999) conducted focus groups with 29
women who had a first-degree relative with breast cancer. The qualitative results
contained nine main themes: breast cancer detection; information about risk; beliefs
about risk factors; beliefs about relatives' risk; desire for information;
misunderstanding about risk factors; interest in genetic risk counselling; preferences
for genetic risk counselling; genetic testing. The findings particularly highlighted
areas ofmisunderstanding about breast cancer risk such as risk-reduction through
lifestyle changes together with the need for information about personal risk of breast
cancer and risk management. Therefore, the study had important implications in
terms of the information provided during genetic risk counselling which required
further investigation.
2.1.3b Validation of data
Ferrell et al. (1997) investigated quality of life issues in long-term breast
cancer survivors. Twenty-one breast cancer patients who had been originally
diagnosed between 16-71 months previously initially took part in individual
interviews to identify personal concerns regarding their quality of life. Eleven of the
same women and five other breast cancer patients then participated in one of three
focus groups which were designed to validate the data collected from the one-to-one
interviews. The concerns identified by the focus groups were found to fall into four
general areas ofwell-being (i.e. physical, psychological, social, spiritual). In
addition, the participants gave advice to other women newly diagnosed with breast
cancer. The findings of the study had significant implications for clinical services
and future research which the authors planned to confirm in a larger quantitative
study.
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2.1.3c Service evaluation and development
Seals et al. (1995) conducted eight focus groups to investigate the needs and
concerns of 46 women with HIV/AIDS with regards to the current provision for them
within the social services. A range of needs was identified through the focus groups,
which could then be addressed by the appropriate organisations.
Similarly, Marcenko & Samost (1999) used focus groups to investigate the
experience ofmothers who were living with HIV/AIDS. They recruited 40 of these
women to take part in one of six focus groups designed to investigate their opinions
about the current structure of support services. Recommendations to the providers of
these services could then be made from the issues that were raised during the focus
groups.
In order to plan and develop new services and expand on existing services for
breast cancer patients, Tobin (1993) conducted 48 focus groups with breast cancer
patients, asymptomatic women and medical professionals. The discussions centred
on the process from detecting breast cancer to surgical options, decision- making
about other treatment options and breast cancer support services. The insight gained
through this study could then be used to develop services that were directly
addressing the needs of these women.
2.1.3d Intervention development
Borgers et al. (1993) utilised focus groups as part of a study combining
several different methodologies to explore "the information-seeking behaviour of
cancer outpatients". Six focus groups were used to identify the kinds of reasons why
cancer outpatients seek information during a consultation with their specialist. The
study aimed to provide sufficient insight to enable an educational intervention to be
developed.
Tessaro et al. (1997) also used the focus group methodology to design an
intervention which was aimed at helping women make informed decisions
concerning BRCA1 genetic testing. Breast cancer patients and asymptomatic women
with affected relatives discussed their knowledge and concerns about genetic testing
and their potential support needs during the decision-making process. The findings
from the focus groups highlighted several possible areas for intervention including
the provision of information both for these women and for the general public, the
involvement of physicians in the decision-making process and the effect of genetic
testing on relationships within the family.
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2.1.3e Instrument development
Three focus groups of 4-6 women at increased risk ofbreast/ovarian cancer
were conducted as part of the initial process of developing an instrument to screen
these women for susceptibility of significant psychosocial problems (Pasacreta,
1999). The results highlighted several possible risk factors on which further research
can build. The author commented: "The focus group method provided an excellent
avenue for beginning exploration regarding psychosocial issues associated with
being at increased risk for developing breast and ovarian cancer".
2.1.4 Preparing focus groups
There are a number of interdependent practical issues to consider when
preparing to undertake focus group research which include selecting participants,
deciding on the size, number and duration of the focus groups and developing a
moderator guide to outline the structure of the groups. The purpose and aims of the
research should inform all these issues (Vaughn et ah, 1996).
2.1.4a Participant selection
Since the data collected from focus group research comes directly from the
participants, identifying, selecting and recruiting appropriate participants is vital to
the success of the research. Focus group studies often use a purposive sampling
technique to select participants (where selection is based on criteria that aim to
predict how valuable each participant's contribution would be). Participants may be
selected at random if there is a large enough group of suitable recruits (Vaughn et ah,
1996).
Although it is often recommended in the focus group literature that the
participants in a focus group should form a homogenous group as far as their
sociodemographic characteristics are concerned (e.g. Greenbaum, 1998), Vaughn et
al. (1996) suggest that a heterogeneous group of participants may be more useful
when focus groups are used in exploratory research. Potential participants should
form a homogenous group in the sense that they all should share the same experience
which is at the heart of the research (Asbury, 1995). Vaughn et al. (1996)
recommend that when age is not an important factor, a relatively wide range in the
age of participants will be of benefit to the study. They also suggest that focus group
participants should be strangers (Vaughn et al., 1996), as the extent of acquaintance
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among participants is likely to affect the interaction within the group (Morgan,
1997). However, where any differences in the dynamics of the group are not of great
importance to the research, more practical issues such as the availability of
participants may influence this choice (Morgan, 1997).
An additional factor to consider concerns the preparation of the participants
themselves. Although participants should be made aware of the general purpose and
topic of the discussion beforehand, the researcher should not inform them of the
specific research questions to prevent sensitisation to the focus group issue (Vaughn
et al., 1996).
2.1.4b Focus group size
The size of a focus group is important as it affects the amount ofopportunity
participants can contribute to the discussion which in turn influences the data
collected. The literature presents a range of recommendations of focus group size; 4-
8 (Kitzinger, 1995), 4-12 (Tang & Davis, 1995), 6-10 (Morgan, 1997), 6-12 (Asbury,
1995;Vaughn et al., 1996), 8-10 (Greenbaum, 1998; Tobin, 1996).
Tang & Davis (1995) state that: "Among the many critical issues in using
focus group methods, the development of critical factors for the determination of the
size of a focus group remains a focal concern ...". However, there appears to be a
certain amount of uncertainty in the literature concerning the exact nature of these
critical factors. For example, Morgan (1997) suggests that there are several key
factors that should be considered when determining focus group size: the
participants' degree of interest in the topic (which may affect their contribution to the
group), the detail required from each participant, the management of participants and
the level ofmoderator involvement required. However, other researchers suggest that
the most important factor governing the number of participants in a single focus
group should be the research aims (Tang & Davis, 1995). These researchers go on to
propose four additional factors that can greatly ease the decision-making process.
These are: the number of questions to be asked, the time designated per question, the
focus group structure and its duration. Vaughn et al. (1996) simply recommend that
when deciding on the focus group size, it is important to ensure that the group is not
too small to prevent participants feeling that they have a duty to contribute almost
continuously. Similarly, in order to allow the moderator to communicate with each
participant and to ensure participants have enough time to make their opinions
known, the groups should not be too large (Vaughn et al., 1996).
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It has been recommended that focus groups used in an exploratory manner
should involve smaller numbers of participants per group, but the number of groups
should be larger (Tang & Davis, 1995).
2.1.4c Number of focus groups
Likewise, it can often be difficult to predict the number of focus groups that
will provide sufficient information to address the aims of the research. Vaughn et al.
(1996) suggest two factors that should be taken into account: the number of groups
could be considered sufficient both when all the results are repetitive and can easily
be predicted by the moderator and when a range ofparticipant's experiences has
been gained that allows sufficient insight into the topic of interest. Morgan (1997)
describes the degree of homogeneity between participants as the most salient factor
when determining the number of focus groups to conduct. This is in addition to the
degree of focus group structure and participant availability. Therefore, a greater
degree of participant variability both within and between groups will usually require
a larger number of groups to reach the point where no new information is generated.
2.1.4d Duration of focus groups
Although it is generally recommended in the literature that focus groups
should take between one and a half to two hours (e.g. Asbury, 1995; Tobin, 1996;
Vaughn et al., 1996), the duration of focus groups should be influenced by the nature
of the topic to be discussed, the size of the group and the homogeneity of the
participants within the group (Vaughn et al., 1996).
2.1.4e Moderator guide
Developing a good moderator guide has been described as "vital to an
effective focus group project" and requires care and consideration comparable to that
given to the development of a quantitative questionnaire (Greenbaum, 1998)."The
purpose of the moderator's guide is to serve as a map to chart the course of the focus
group interview from beginning to end" (Vaughn et al., 1996). It is usually a form of
semi-structured interview plan consisting ofmain questions and probe questions. The
latter are used to clarify responses to a preceding question, provide a prompt for
further exploration of topics and can assist in redirecting the discussion (Asbury,
1995). Tobin (1996) recommends that a well-prepared moderator guide usually
comprises of the following sections:
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• Introduction - where the purpose of the study is explained, both the moderator
and participants introduce themselves and some ground rules for the format of
the group are set.
• General questions - to allow participants to gently ease into the group setting.
• Specific questions - to gain responses to key issues.
• Closure - to enable the moderator to ask for any additional information, and to
thank the participants for taking part.
The amount of detail necessary for such a guide varies with the moderator's
level of comfort and experience of conducting focus groups together with the nature
of the issue to be covered (Vaughn et al., 1996). Decisions about the content of the
moderator's guide concerning the structure of the focus groups, the degree of
flexibility between groups and the extent to which the moderator will be involved in
the discussion, should be made on the basis of the research aims (Morgan, 1997).
Morgan (1997) proposes that the "funnel strategy" (where the focus group moves
from a less to a more structured discussion along its duration) is a good compromise
between these two contrasting approaches to moderator guide design. In this way,
participants' own experiences are discussed during the early stages of the focus
group, moving onto collecting their responses to questions regarding the researcher's
key interests during the later stages (Morgan, 1997). This type of approach, however,
can in no way be considered an easy option as changes in structure and shifts in
degree ofmoderation can be difficult to successfully achieve (Morgan, 1997). When
developing a moderator guide, some researchers such as Tang & Davis (1995) have
stressed the importance of conducting pilot tests of the moderator guide to determine
factors such as the amount of time to be allowed for each question and the wording
of questions. Morgan (1995) also highlights the importance of carrying out pilot
testing of the focus group questions through several one-to-one interviews.
2.1.5 Conducting focus groups
Sim (1998) identifies a number of reasons that contribute to the complex
nature of collecting focus group data: the data should pertain to both the content and
context ofparticipant contributions, each contribution should be accurately assigned
to a group member, the moderator should not be distracted from facilitating the
group by the data collection procedure and the technique used to record the data
should not exert any bias over participant contributions.
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2.1.5a The focus group moderator
The moderator plays a key role in the success of a focus group. As Vaughn et
al. (1996) suggest: " With the guidance of a moderator, individuals are capable of
reporting on their own cognitions, feelings and behaviours in an accurate and
forthright manner". Their major role centres around directing the focus group
discussion by posing questions and encouraging participation. They may also play an
important role during the focus group preparation, in terms of preparing the
moderator guide and recruiting participants and after the focus group, during data
analysis.
In order for the participants to contribute openly to the focus group, a
comfortable environment needs to be established quickly (Vaughn et al., 1996).
Asbury (1995) suggests that the moderator's hardest task may be making the
participants feel comfortable.
Vaughn et al. (1996) have proposed a number of recommendations for
moderating focus groups. There are a number of techniques that have been
documented to assist the moderator which are often incorporated into the
introduction section of the moderator guide, thus setting the tone for any subsequent
discussion. These include providing the participants with a clear explanation of the
purposes of the research, emphasising the value of all contributions, introducing the
moderator and inviting the participants to introduce themselves to the group using
their first names only. By using first names only, equality can be maintained between
the participants and the moderator which will help to put the participants at ease. As
it is likely that the moderator has sole responsibility for data collection, it is essential
that he or she has a complete understanding of the aims of the research in order to
elicit useful information from participants. However, the moderator's knowledge of
the field should not be allowed to overwhelm participants to the detriment of their
contribution to the group. In contrast, detailed responses can be gained from
participants by showing the moderator genuinely has insufficient knowledge of the
topic area. In order to make the best use of this potentially rich data source, open-
ended questions are recommended to initiate interaction. Then the moderator can use
probes to invite participants to clarify or expand on their responses or to encourage
quieter participants to become more involved in the discussion. The moderator
should encourage every member of the group to contribute and provide them all with
an equal opportunity of doing so.
An effective moderator maintains a dynamic role in a focus group (Vaughn et
al., 1996). Sim (1998) identifies a specific difficulty that the moderator faces:
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creating and maintaining an appropriate balance between active and passive
involvement in the focus groups. Active roles include redirecting the discussion if it
moves away from the topic of interest (Gibbs, 1997), generating responses if the
discussion dies out and ensuring that the discussion is brought to an appropriate
conclusion in the time allotted (Vaughn et ah, 1996). A moderator's main passive
role is to allow group interaction to continue where the discussion is running
smoothly (Vaughn et ah, 1996). Although they have to generate discussion on a topic
connected to their research interests, they must do so without leading the group into
confirming their own preconceived ideas (Sim, 1998). Moderators must both be in
control of the discussion and responsive to participants (Vaughn et ah, 1996).
The moderator clearly has both a demanding and challenging role, which
requires particular characteristics and skills (Gibbs, 1997), some ofwhich are
inherent to a person, whilst others can be learned (Greenbaum, 1998). These include:
"a superior listening ability, an excellent short-term auditory memory, well
organised, quick learner, high energy level, personable, well-above-average
intelligence" (Greenbaum, 1998). Moderators should also have good oral and written
communication skills, be able to make conclusions and recommendations from the
interpretation of the results (Greenbaum, 1998) and they must be sensitive to
responses and react with genuine interest and concern (Vaughn et ah, 1996). In
addition, participant responses may be influenced by the demographic characteristics
of the moderator such as their age, gender or ethnic group (Vaughn et ah, 1996).
As "the role of the moderator is a difficult one to fulfil adequately" (Sim,
1998), it may be necessary in many cases to train the moderator, particularly if they
lack experience facilitating focus groups (Vaughn et ah, 1996). This may involve
observing groups conducted by a more experienced moderator or conducting
informal, practice groups.
2.1.5b Recording the data
It is generally recommended that focus groups are audiotaped to allow the
moderator to focus their full attention on the group discussion (Sim, 1998). As this is
often the principal method of recording the data, it is crucial to ensure that the quality
and reliability of the recording is sufficient to allow an accurate transcription of the
data. Transcription is necessary for thorough data analysis. It can help to prevent
biased listening and missed data which can result from the moderator attempting to
analyse the data straight from the audiotape (Henderson, 1995). In addition, the
audiotape remains a valuable tool as it can act as a reference for a specific portion of
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a transcript where more details about the tone or emotions associated with a
particular response are required by the moderator. However, an audiotape alone does
not easily lend itself to the identification of participant contributions (Sim, 1998).
The researcher must either be very accurate at recognising participant voices, use a
video-recorder or write notes during the group (or designate this task to an assistant)
(Sim, 1998). Use of the latter two of these methods should neither discourage
participants from contributing nor detract from the facilitation of the group (Morgan,
1997). Kitzinger (1995) suggests that it may be useful to collect participants'
comments following the focus group either in the form of a brief questionnaire or a
one-to-one interview.
2.1.6 Analysing focus groups
Analysis of the data collected from focus groups is often the greatest
difficulty facing researchers who choose to adopt this methodology. It can become an
overwhelming task to transform the large amount of data collected into concise,
coherent results. Several authors have recognised the lack of guidance that is
available for researchers concerning the analysis of focus group data (e.g. Carey,
1995; Vaughn et ah, 1996; Wilkinson, 1998a). The literature reporting the results of
focus group studies often provides insufficient information about the analysis process
(Vaughn et ah, 1996). However, the "credibility and usefulness of results will be
enhanced through a careful documentation of steps and decisions in the analysis as
the raw data are transformed into understandable themes and patterns" (Asbury,
1995).
Given the lack of consensus concerning the type of technique that should be
used to analyse focus group results (Carey, 1995) and the researcher's desire to
produce credible work, deciding on the most appropriate analytic technique is not
straightforward. Analysis plans should be considered at the initial stages of
identifying the aims of the study as suitable questions should not be developed
without a view to how their responses will be analysed (Henderson, 1995). Asbury
(1995) suggests that both the aims of the research and the objectives of the written
research report will determine the most appropriate method of analysis. With regard
to exploratory focus group research, the analysis process will be directed by the
requirements of further research so that if, for example, the results are intended to
inform the development of a subsequent intervention, then the analysis may focus on
meeting these aims (Morgan, 1997).
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Focus group data can be analysed by the same qualitative techniques as
applied to one-to-one interviews (i.e. content or thematic analysis which can often be
assisted by computer programs such as NUDIST; discursive, rhetorical or
conversational analysis) (Wilkinson, 1998b).
Undertaking immediate summaries of the main issues discussed in the group
and adopting appropriate methods of transcription will facilitate the subsequent
analysis. Participant quotes should be used to support the focus group summary
(Vaughn et al., 1996). Vaughn et al. (1996) document their own method of analysing
focus group data which consists of five main stages: "identifying the big ideas (1);
unitizing the data (2); categorizing the units (3); negotiating categories (4);
identifying themes and use of theory (5)".
The reliability and validity of qualitative data has been omitted by many
researchers. In contrast, some researchers (e.g. Appleton, 1995; Carey, 1995;
Yardley, 2000) do regard these issues to be important concepts to consider when
conducting qualitative research, including focus groups. However, many criteria
traditionally applied to quantitative data (e.g. repeatability) to assess these concepts
are not applicable to qualitative research (Yardley, 2000). Yardley (2000) proposes
four key flexible principles that may act as indicators of good qualitative research:
"sensitivity to context, commitment and rigour, transparency and coherence and
impact and importance". Appleton (1995) attempted to address issues of reliability
and validity of a qualitative study in a number ofways. Validity of the qualitative
analysis of one-to-one interviews was assessed by ensuring the results were credible
with some of the study participants, involving a second researcher in the analysis
process to achieve consensus with the first researcher. Reliability was addressed in a
number ofways including attempting to keep interview skills consistent throughout
the 12 interviews (pilot interviews were undertaken to practice skills), audiotaping all
interviews and writing a detailed report of the whole study process.
There is also a lack of agreement amongst researchers as to the
appropriateness of assessing the inter-rater reliability of qualitative data (Armstrong
et al., 1997). Inter-rater reliability can be defined as "the extent to which two
reviewers reach similar conclusions from the same record" rather than multiple raters
identifying the same aspects of the data from the same record (Brennan & Hays,
1992). A number of statistics assess inter-rater reliability including the Kappa
statistic, which is used "when two or more judges consider the same entity and
express a judgment regarding that entity" (Brennan & Hays, 1992).
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2.1.7 Limitations of focus group research
There are a number of limitations of focus group research which can arise at
different stages in the research process from recruiting participants to interpreting the
results.
Individuals may be deterred from taking part in focus groups because they
may not be very confident or articulate, they might have problems communicating or
may not feel able to trust other people with personal information (Gibbs, 1997).
Therefore focus group participants may be biased in terms of being more self-
confident or willing to take risks than those who choose not to participate (Tobin,
1996).
As participants are speaking in the specific context of a focus group, the
views they express may not necessarily be the same as those they would give during
a one-to-one interview (Tobin, 1996). The opinions participants convey during the
group may be shaped by the views of others and new opinions may be formed during
the session (Vaughn et ah, 1996). Participants may be affected by the characteristics
of other group members, how the moderator phrases the questions and how secure
the participants feel with the confidentially of the group to give socially desirable
responses (Vaughn et al., 1996). Participants may not necessarily make equal
contributions to the focus group (i.e. every participant might not respond to every
question). This can be influenced by the behaviour of the moderator or other group
members together with the dynamics of the group.
Although the moderator has a key role in keeping the group members focused
on the topics of interest, they should have little influence over the interactions in the
group and the data that is produced (Gibbs, 1997).
Given the small number ofparticipants and potential biases, it is not
appropriate to generalise the results of focus groups research to a larger population
(Vaughn et al., 1996). Further research would be warranted to confirm the findings in
a larger sample.
2.1.8 Types of focus group
New methods of conducting focus groups in addition to the traditional face-
to-face groups have been developed in recent years (Greenbaum, 1998). These
involve the use of technologies such as videoconferencing, the Internet and the
telephone and have been described by Greenbaum (1998). Videoconferencing allows
observers who have an interest in the results to watch focus groups from a remote
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location. Conducting focus groups on the Internet is cost-effective as it allows
participants to remain in their own homes. These benefits are also true of telephone
focus groups which are conducted using telephone conferencing and will be
discussed in the following section.
2.2 Telephone conferencing
2.2.1 Practicalities
The facilities required for telephone conferencing are offered by a number of
organisations such as Community Network, a British charity providing these services
for other charities and non-profit-making organisations. Telephone conference
participants do not require any special equipment, only an ordinary telephone.
Participants can be telephoned by the telephone conference operator to connect them
to the conference call. The booking organisation is charged for all the calls. Usually
up to 10 people can participate in a single telephone conference and the session can
be audiotaped by the telephone conference organisation with the permission of the
participants. All conference calls are confidential to those participating.
Guidelines for facilitating telephone conferences have been devised by
British Broadcasting Services and Community Network (1999). It is advisable for
both the moderator and participants to be in a quiet location, free from distractions
and interruptions. It may be a good idea to put participants at ease whist they are
waiting for the rest of the group to join the conference call by maintaining a general
discussion. Participants could be asked initially to describe where they are sitting so
that other group members can picture them and to say their first name every time
before they speak so that everyone knows who is speaking. Silences during a
telephone conference seem much longer than when having a face-to-face discussion.
Although silences can be useful in telephone conference to give participants time to
think, the moderator should break up a long silence (e.g. 5-10 seconds).
2.2.2 Benefits and limitations
Research has been conducted to investigate the benefits and limitations of
telephone conferencing. Galinsky et al. (1997) conducted a questionnaire survey of
213 social work practitioners to investigate their experience and opinions of
providing group services through telephone conferencing or computer technology.
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Technology-based groups were seen to be more convenient, allow greater
accessibility and anonymity than face-to-face groups. However, the limitations
experienced were a lack of interpersonal cues (e.g. eye contact, facial expressions
and body language), technical difficulties (e.g. delays, faults and participants'
unease) and interference with the group dynamics (e.g. delayed communication, lack
of bonding, distractions and interruptions). Problems moderating a telephone
conference were also described including difficulties eliciting participation, dealing
with silences and having less control over the discussion.
In order to minimise these potential problems, Galinsky et al. (1997) suggest:
increasing cues (e.g. asking participants to identify themselves every time they
contribute, encouraging them to clarify opinions, prompting them to convey
emotions); technical difficulties need to be anticipated, minimised and efficiently
resolved (e.g. moderators should be trained and practised, participants should be
helped to feel at ease with the technology) and moderators may need to take a more
active role in directing the discussion than they would in a face-to-face group.
2.2.3 Telephone support groups
Telephone conferencing has been used in a variety of settings which
commonly include support groups. It is an "innovative means of offering health and
mental health services" where there may be numerous barriers to participating in
face-to-face groups (Galinsky et al., 1997).
Telephone groups are becoming a popular means ofproviding support for
various groups ofpeople including the elderly, individuals with HIV/AIDS and
cancer patients.
Twenty-three elderly people with disabilities participated in a series of
weekly telephone support groups over a 12-week period (Stewart et al., 2001b). Each
group was jointly led by a health professional and peer. The groups were recorded,
transcribed and qualitatively analysed. In addition, participants were also
individually interviewed following the last group. The findings indicated that the
groups had been effective in meeting needs for support, reducing loneliness and
improving coping in this group ofpeople.
Rounds et al. (1995) developed and evaluated a series of telephone support
groups for 29 people with HIV disease. This intervention aimed to "increase self-
efficacy, decrease social isolation and increase social support and enhance coping
related to living with HIV disease". Although not all of study aims were met,
participants were very satisfied with the intervention and reported experiencing
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substantial support and group bonding. Few problems in communicating in the
telephone conference environment were identified.
A pilot study was conducted to evaluate a telephone support group
intervention for male haemophiliacs with HIV/AIDS and family carers (Stewart et
al., 2001a). Eleven participants completed a series of 12 weekly telephone support
groups and were then individually interviewed about the intervention. The telephone
support groups were facilitated by a mental health nurse and a peer, who were
themselves interviewed after the intervention. Qualitative analysis revealed that
although the intervention had helped to meet the support needs of participants, it also
highlighted areas where the intervention could be improved.
Colon (1996) described a long-term series of telephone support groups to
provide psychosocial support for 12 cancer patients who were unable to attend a
face-to-face group. Wood et al. (1999) evaluated the impact of a series of four
telephone support groups for cancer patients (who had completed their radiotherapy
treatment but had not yet started follow-up appointments) on psychological distress.
The results supported the value of telephone support groups in this group ofpatients
and demonstrated that psychological distress had been alleviated in some, but not all
participants.
2.3 Telephone focus groups
Telephone focus groups are described by Greenbaum (1998). They take
place during a telephone conference call, where the moderator and participants can
all remain in separate locations. The duration of a telephone focus group is usually
one hour which is much less than the traditional face-to-face group. Telephone focus
groups offer greater anonymity than any other form of focus group and are a cost-
effective way of connecting people who live within a large radius.
As the telephone focus group is a relatively new methodology, references to it
in the published literature are scarce. Ruef & Turnbull (2001) investigated the
opinions of key stakeholders on information currently available to enhance quality of
life in people with challenging behaviour using telephone focus groups and one-to-
one interviews. Siriphant et al. (2001) conducted face-to-face and telephone focus
groups to gain the perspectives ofnurse practitioners on issues regarding oral cancer.
The results suggested future strategies to help reduce the number of deaths from oral
cancer.
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2.4 Rationale for using telephone focus groups to investigate
living with an increased risk of breast cancer
Qualitative methodologies have been promoted as the best means of
investigating an unknown area and generating hypotheses (Miles & Huberman,
1994). Of the variety of qualitative methodologies, focus groups are particularly
suited for use in exploratory research. They are ideal for generating hypotheses that
can subsequently be tested in further larger-scale research.
The focus group methodology offers particular advantages for exploring the
long-term psychosocial effects of living with an increased risk of breast cancer. The
focus group environment may enable participants to feel comfortable about sharing
their experiences and they may consequently give more open responses. Interaction
between group members and the moderator can enhance the data collected and may
reveal unexpected but valuable issues. Participants may also benefit from taking part
in a focus group as it may provide mutual support or may be empowering. Focus
groups enable data on a range of experiences to be collected efficiently. They have
previously been used effectively in women at increased risk of breast and ovarian
cancer.
Morgan (1997) suggests that in order to decide in the simplest way if focus
groups are the most appropriate methodology for a particular research topic, you
should predict the ease with which the discussion among the participants would flow.
If this simple rule is applied to test the suitability of using focus groups in the current
work, it does seem likely that women who have been living with an increased risk of
breast cancer over a number of years could share their experiences in some depth
with others in the same situation.
Conducting focus groups via a telephone conferencing system would
overcome the expense and inconvenience for participants who live within a large
area of attending a face-to-face session whilst maintaining many of the benefits of
the focus group methodology.
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Chapter 3: Telephone Focus Group Study to Explore the
Psychosocial Effects of Living with an Increased Risk of
Breast Cancer *
3.1 Introduction
The clinical services offered to the majority ofwomen estimated to be at
increased risk of breast cancer are generally limited to annual breast cancer screening
appointments. Most of these women are not eligible for genetic testing or
prophylactic surgery. Women who are living with an increased risk of breast cancer
face continuing multiple uncertainties regarding their own risk, the risk of family
members and the effectiveness of breast cancer screening methods currently offered
to them. Living with these multiple uncertainties and facing the prospect of years of
clinical surveillance may have important consequences for an individual including
psychological distress and adherence to breast cancer screening.
A review of the psychological literature (Chapter 1, Section 1.5, page 16)
highlighted a lack of knowledge about the psychosocial consequences of living with
an increased risk of breast cancer for the growing numbers ofwomen who have been
living with this risk a number of years. However, research has found evidence that a
substantial proportion ofwomen with a family history of breast cancer are
experiencing significant levels of psychological distress up to 25 months following
genetic risk counselling (e.g. Lloyd et al., 1996; Cull et al., 1999; Watson et al.,
1999; Hopwood et al., 2001; Meiser et al., 2001b; Bish et al., 2002). There is a clear
need to carry out similar research in the growing numbers of longer-term attendees of
familial breast cancer clinics (i.e. those who have been living with an increased risk
of breast cancer for over two years). In addition, there is limited understanding of the
needs of these women in terms of information about issues related to their increased
risk of breast cancer and psychosocial support to help them cope. Clinicians at the
familial breast cancer clinic have expressed concerns that such needs are not likely to
be met by the existing clinical service.
* Material from this chapter has been published (see Appendix I for a copy of the paper).
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The initial study was of an exploratory nature to gain these women's
perspectives of living with an increased risk ofbreast cancer and to identify any
needs for information or psychosocial support that were not being met by the existing
clinical service. Telephone focus groups were selected as the most appropriate
methodology to conduct the study (Chapter 2, Section 2.4, page 50). The results of
this preliminary study were intended to form the basis of subsequent studies.
3.2 Aims
This study aimed to explore the long-term psychosocial consequences for
women ofbeing informed about an increased risk of breast cancer in terms of:
• the effect on everyday life.
• the coping strategies used.
• unmet needs (information about breast cancer risk-related issues, psychosocial
support) in terms of the current service at the familial breast cancer clinic.
3.3 Design
This study adopted the novel methodology of telephone focus groups, which
uses the focus group methodology conducted via a telephone conferencing system. In
addition, feedback from the telephone focus groups was collected by postal
questionnaire.
3.4 Participant selection
Women with a family history of breast cancer in South East Scotland who
had participated in psychosocial studies conducted several years previously (i.e. Cull
et al., 1998; Cull et ah, 1999) were listed on a database. Each participant was
checked for her eligibility to participate in the study with a genetic breast care nurse,
using her clinical database of attendees at the familial breast cancer clinic (Eligibility
criteria are listed in Table 3.1). A sample of those meeting the study criteria was
invited to participate (i.e. by selecting every third participant from an alphabetical
list).
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Table 3.1: Eligibility criteria for the telephone focus group study
Inclusion criteria:
• Current attendance at the Ardmillan Familial Breast Cancer Clinic.
• Has attended the Ardmillan Familial Breast Cancer Clinic for at least two years.
Exclusion criteria:
• A previous diagnosis of cancer.
• Has had prophylactic surgery.
• Has undergone genetic testing.
• Current participation in any other psychosocial research in relation to their family
history ofbreast cancer.
• Current participation in the International Breast Cancer Intervention Study
(IBIS), Magnetic Resonance Imaging (MRI) Trial or the Cancer Genetics in the
Community Trial.
• Has participated in the pilot interviews prior to this study to develop the
moderator guide.
3.5 Measures and instruments
3.5.1 Sociodemographic variables
Several sociodemographic variables were obtained from the database from
which the participants were selected: age, number of years attending the familial
breast cancer clinic, objective breast cancer risk, marital status, number of children
and number of daughters.
3.5.2 Moderator guide
Twelve pilot interviews were conducted prior to this study with women at
increased risk of breast cancer who were attending the familial breast cancer clinic
for a routine breast cancer screening appointment. Data from these interviews were
used to develop standard stimulus questions and probes which formed the main
section of a semi-structured moderator guide (A copy of the moderator guide is in
Appendix II, page 1). This consisted of:
• an introduction to:
welcome participants.
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set ground rules (e.g. participants identify themselves before speaking by
their first name only).
allow participants to introduce themselves to the group.
• stimulus questions and probes to ensure that each group discussed the following
three main topics:
effects of living with an increased risk of breast cancer on everyday life (in
terms of: the way they do things, the way they think, the way they feel and
their relationships with other people in their family).
coping with an increased risk of breast cancer (in terms of: what has helped
them to cope and has anything been difficult to cope with),
unmet needs in terms of the current service (in terms of: do they have any
needs for additional services that are currently not being met and how should
these services best be provided).
• a conclusion to:
thank participants.
allow participants to say goodbye to the group.
3.5.3 Feedback questionnaire
A brief study-specific questionnaire was developed to: clarify some of the
opinions that were raised in the telephone focus groups about living with an
increased risk ofbreast cancer and service issues; provide feedback on participating
in a telephone focus group; collect information about participants concerning genetic
testing. The latter set of questions was included as it became apparent during the first
telephone focus group that one of the participants had undergone genetic testing.
Therefore, the responses to these questions provided additional information about
genetic testing to supplement that obtained from the clinical records (A copy of the
feedback questionnaire is in Appendix II, page 6). The questionnaire consisted of
these four main sections:
1. Living with an increased risk of breast cancer: Eight items concerning effects
on everyday life (e.g. How much has knowing about an increased risk of breast
cancer in your family changed the way you generally feel?) and difficulties
coping (e.g. Have you found it difficult to cope with knowing that there is an
increased risk of breast cancer in your family?). Responses were on a 4-point
Likert scale (1 = not at all, 2 = a little, 3 = quite a bit, 4 = very much) (except for
one item where responses were open-ended).
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2. Service issues: Ten items clarified unmet needs in terms of the current service.
Participants were asked to if they would like to be provided with: updated
information (and were asked to rank in order ofpreference a list of eight topics
related to familial risk of breast cancer), things to help them cope with any stress
they may be experiencing, the opportunity to meet up with other women in the
same situation, something for other family members and the opportunity to have
any questions answered outside of the clinic time. Responses were as yes/no
choice. Participants were asked to indicate their preferences for the format of
these services (e.g. written materials or personal contact?) by endorsing the
appropriate item. They were also asked about their access to the Internet and e-
mail and if this would be a convenient way for them to receive information
(responses were as yes/no choices).
3. Participating in a telephone focus group: Seven items provided feedback on
the acceptability of the telephone focus group methodology in terms of: the ease
ofmaking their opinions known, if they thought the leader handled the discussion
well, their comfort about sharing their experiences in the group, if they found
participating helpful and their overall experience of the telephone focus group.
Responses were on a 4-point Likert scale, which varied between items (e.g. from
1 = not at all to 4 = very much; from 1 = poor to 4 = excellent). Participants were
also asked if they had used telephone conferencing before, how many times and
for what purpose (i.e. job or home life).
4. Genetic testing: Four items identified if any participants had been through the
genetic testing process in terms of: if a faulty gene had been identified in their
family, if they had been tested for this faulty gene, if they had received the results
of this test and if they were found to carry the faulty gene. Responses were as a
yes/no/not applicable choice.
3.6 Procedure
The regional ethics committee approved the study. Each woman was sent a
letter asking if they would be willing to take part in a telephone discussion group to
share their experiences of living with an increased risk of breast cancer. They were
also sent an information sheet, two consent forms (one was specifically for
consenting to being audiotaped), a response sheet to indicate preferred days/times
within a two-week period and a freepost envelope. The General Practitioners of all
women consenting to participate were notified by letter.
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Those women who consented were allocated to a telephone focus group at a
time to suit their convenience and were sent a letter confirming the specific date and
time of their group. This letter also provided some brief instructions about
participating and notified them that they would be telephoned several days before
their scheduled group. During this short phone call, the moderator followed prepared
guidelines (A copy of the guidelines is in Appendix II, page 13) to ensure that the
women were still able to participate, to give them an opportunity to familiarise
themselves with the moderator's voice, to be introduced to the structure of the focus
group and to allow them to ask any questions.
The telephone focus groups were conducted following published guidelines
for focus groups (Greenbaum, 1998; Tobin, 1996; Vaughn et al., 1996), which were
modified for use with the telephone conferencing system. The moderator who
conducted the telephone focus groups (S.A) received prior training in telephone
conferencing (organised by British Broadcasting Services and Community Network)
and conducted several practice telephone focus groups with colleagues and
postgraduate students recruited from a health psychology e-mail network (Appleton,
2000).
The telephone conferencing system was operated by Community Network (a
centre for voluntary sector telephone conferencing). At the allotted time of each
telephone focus group session, the participants were telephoned by the Community
Network operator to connect them to the conference call (i.e. the participants were
not charged for the call), always beginning with the moderator. When all participants
had been connected, the moderator facilitated the group using the moderator guide.
All groups had the same moderator (S.A), lasted for no longer than one hour and
were audiotaped by Community Network. A protocol was in place in the event that
any participant became distressed during the session. Immediately after each group,
the moderator made a summary of the discussion. These summaries were compared
to the final outcome of the qualitative analysis as an indication of the reliability of
these results (see Table 3.2: Stage 2, Step 4).




The distribution of all continuous sociodemographic variables was assessed
to determine their parametric or non-parametric nature. The appropriate descriptive
statistics were generated to describe the study participants. Differences between
participants and non-participants on the sociodemographic variables were assessed
by independent samples t-tests (2-tailed), Mann-Whitney tests, chi-square tests or
Fisher's exact tests. Marital status was recoded as a dichotomous variable for
analysis using the Fisher's exact test (i.e. married or cohabiting vs. not married or
cohabiting). A significance level of 0.05 was used throughout. The data were
analysed using SPSS for Windows version 10.00 (1999).
The audiotapes of the telephone focus groups were transcribed verbatim
before undergoing a qualitative analysis. They were analysed independently by three
researchers using a modified version of published guidelines for analysing focus
group data (Vaughn et al., 1996). The process by which quotes, themes and key
issues were identified in two main stages is explained in Table 3.2 . A rigorous
record of the whole analysis process was kept including all independent analyses and
the result of all negotiations. Although the majority of the analysis process was
completed by hand, WORD macros were created to allow the text to be
automatically copied from the transcripts into new files.
The feedback questionnaire was quantitatively analysed in terms of
frequencies and percentages.
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Table 3.2: Qualitative analysis of the telephone focus group data
Stage 1.
For each ofthe three research areas separately (i.e. Effect, Coping, Services):
1. Informative quotes identified (SA, AF, GR)*.
2. Consensus achieved on a final list of quotes (SA, AF, GR).
3. Themes developed from the quotes (SA).
4. Reliability of themes assessed. Quotes independently assigned to themes (AF,
GR). Inter-rater reliability between pairs of the three raters calculated using
Cohen's Kappa.
5. Discrepancies negotiated to achieve consensus on a final set of themes with
supporting quotes (SA, AF, GR).
Stage 2.
Completed by SA only:
1. Themes and supporting quotes from each of the three research areas collapsed to
form one dataset of 44 themes and 756 quotes.
2. Extraction of 29 themes supported by quotes from at least 3/7 transcripts.
3. Related themes grouped to form six key issues.
4. Reliability of six key issues assessed by comparing to the moderator's summaries
of the telephone focus groups.
* initials refer to the named authors (for a copy of the published paper see Appendix I).
3.8 Results
3.8.1 Participants
Of the 214 women listed on the database ofwomen with a family history of
breast cancer, 155 were eligible to participate in the study (59 women did not meet
the study criteria). From these 155 women, a sample of 52 was initially identified by
selecting every third woman (from a list arranged alphabetically by surname). The
clinical case notes for two women could not be located to gain their contact details.
Therefore, 50 women were invited to participate in the study. Twenty-six women
responded ofwhom 22 were willing to participate. Two women were not willing for
personal reasons (i.e. her husband had just been made redundant; she felt that she
currently had too much going on in her life) and two were not available as they
would be on holiday over the scheduled study period. The 24 women who did not
respond to the initial invitation were not contacted for a second time. Due to the low
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initial response rate, a second group of 30 women was identified two weeks later by
randomly sampling the remaining 103 potential participants. Twenty of these women
were invited to participate (the clinic case notes for 10 women could not be located
to gain their contact details). Seven women replied to the invitation ofwhom six
were willing to participate and one woman was not willing for personal reasons (i.e.
she felt participation might unbalance her strategies for coping with her increased
risk). The 13 women who did not respond were not contacted for a second time.
Therefore, 28 women in total consented to participate in the study and 25
women actually took part. The availability of one woman could not be
accommodated into the focus group schedule (she was only available for 2 hours
during the 2 week study period) and two women pulled out of their telephone focus
group at the last minute for personal reasons (i.e. her mother had recently received a
diagnosis of recurrent breast cancer; she was unavailable at the last minute). There
were no significant differences between the participants (n = 25) and non-participants
(n = 45) in terms of their age, number of years attending the familial breast cancer
clinic, objective breast cancer risk, marital status, number of children and number of
daughters.
Seven telephone focus groups were conducted over a period of nine days of
which five groups had four participants and the remaining two groups comprised
three and two participants. Six of the groups took place on weekdays and one was on
a Saturday. Four of the groups took place in the morning and five were conducted in
the evening.
Participants ranged in age from 27-51 years (mean = 41.3, SD = 5.9). They
had been attending the clinic for between 2.5 - 6.5 years (mean = 5.2, SD = 1.2).
Their objective lifetime risk of breast cancer which had been provided during genetic
risk counselling ranged from 20-40% (mean = 27%, SD = 7.1). The majority were
married or co-habiting (80%), had children (76%) and of those that had children,
63% had at least one daughter.
3.8.2 Qualitative analysis
The results are presented in two main sections: key issues and additional
issues. The thematic structure of the six key issues is shown in Table 3.3.
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Table 3.3: Structure of the key issues






Psychological • Chronic emotions and 75 1
adaptation cognitions
• Acute emotions and 31 1
cognitions
• Sensitivity to breast 27 7
cancer cues
• Time and age 23 6
• Focusing on the present 16 5
• Avoidance 18 6
• Positive thinking 7 5
• Decisions and plans 22 6
• Reassessment of life 24 7
and priorities
Behavioural • General health 25 7
adaptation behaviours
• Control 6 4
• Breast Self- 12 6
Examination
Family issues • Family 52 7
• Emotional support 14 6
• Breast cancer survivors 13 4
• Children 35 7
Clinical
surveillance
• Frequency of clinic
appointments
12 3
• Duration of clinic 7 3
appointments
• Continuous support 5 3
• Clinical services 21 6
• Specialist care 30 7










• Type of information 37 7
• Method of information 28 6
presentation
• Family involvement 14 6
• Immediate telephone 17 6
contact
Peer support • Support from other




Inter-rater agreement between pairs of the three raters to assess the reliability
of the themes was good (Kappa = 0.61 - 0.79) according to published guidelines (i.e.
Altman, 1991). The six key issues reflected the main issues included in the
moderator's summaries of the telephone focus groups.
The additional issues consisted of topics arising in the focus groups that were
not included in the qualitative analysis. Nevertheless, these topics had some
relevance to the aims of the study and therefore supplement the information provided
in the key issues.
3.8.3 Key issues
3.8.3a Psychological adaptation
The themes associated with psychological adaptation to knowing about an
increased risk of breast cancer in the family were: chronic emotions and cognitions;
acute emotions and cognitions; sensitivity to breast cancer cues; time and age;
focusing on the present; avoidance; positive thinking; decisions and plans;
reassessment of life and priorities (quotes from the telephone focus groups to support
the themes associated with psychological adaptation are listed in Table 3.4).
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Table 3.4: Psychological adaptation
Chronic emotions and cognitions:
"I think maybe the hardest thing I've had to do is to accept that this (breast cancer)
will be an ongoing fear, there will never come a time in my life when I will know, at
least with current medicine as it is, there probably will never come a time when I will
think, well this is something I won't get".
Acute emotions and cognitions:
"I had a biopsy recently as well and it nearly put me through the couch when they
decided they were going to do it.. .1 was amazed at the feelings that I had when they
said, you know, 'we need to test this here' and the reaction was really quite strong".
Sensitivity to breast cancer cues:
"I would describe myself as being a bit of cancer phobe.... My reaction tends to be if
somebody's ill, my first reaction is, 'Oh God it's cancer' or if there's something
wrong with me or people close to me like my partner or my son, my first reaction is,
'I hope it's not cancer'.
Time and age: (changes in emotions or cognitions over time or with age)
".. .it's when the time of the year comes, May/June period, that's when it actually,
you're facing it front on and that for me is the hardest thing to cope with, waiting for
the mammogram, waiting for the results and wondering if it's positive, how you're
going to cope with it and then you get the letter through to say it's negative and then
you sigh another sigh of relief for another year".
Focusing on the present:
"I tend to get on with whatever's going on in my life at the moment and deal with
whatever happens when it does".
Avoidance: (ofbreast cancer cues)
"I will avoid it (breast cancer), watching it on the television. I won't avoid talking to
anybody about it. I won't watch it. I won't confront myselfwith it on a continual
basis from the television or anything like that".
Positive thinking:
"I'm an optimist by nature I suppose, I'm not a worrier and then I have good health
in general so I sort of feel .. .that I should be able to cope with this and my overall
robust immune system and it will minimise the risk and that's generally the sort of
attitude I've taken and these things all help".
Decisions andplans:
"I haven't had to cope with it but always at the back ofmy mind is the question -
what would I do if it was suggested I underwent, say, a preventative mastectomy? If I
was asked or that was suggested to me that would be very, very difficult - what do I
do? Obviously I haven't had to face that yet but that would be a very difficult thing,




".. .every time I get the all clear from a mammogram or from a physical examination
by GP, it feels like, a sort of, well, you know, new lease of life isn't quite the right
expression but I think, well I'm still OK and I am immensely thankful, so in terms of
sort of valuing life and current state of health, it makes me very appreciative every
time I feel I'm still OK".
A common way of adjusting to knowing about an increased risk in the long
term was described as "taking one day at a time". Women discussing their chronic
emotions and cognitions commonly felt there was nothing to be gained from
considering uncertain future scenarios. Other women described varying levels of
breast cancer worry from mild or subconscious to severe worry and intrusive
thoughts.
Acute emotional and cognitive responses such as anxiety, depression, shock,
surprise and feelings of neglect were described as being triggered by risk related
events such as being initially informed about their increased risk (by a health
professional), receiving an appointment letter, waiting for an overdue appointment,
having a mammography or biopsy and receiving the results (even if they showed no
signs of breast cancer).
Some women described a heightened sensitivity to breast cancer cues such as
changes in their breasts, media reports about breast cancer and illness in the family.
One woman described herself as a "cancer phobe" as her first reaction to any illness
in her family tended to be "I hope it's not cancer". This heightened sensitivity to
breast cancer cues either prompted increased vigilance through breast self-
examination, greater interest in media reports, increased anxiety or the avoidance of
these cues.
Emotional and cognitive fluctuations over time were described, particularly in
relation to the annual screening cycle. Breast cancer awareness, fear or worry
commonly increased as the women approached the age at which an affected relative
had been diagnosed with breast cancer: an effect described as "a psychological cut¬
off date", like "a time bomb" or "a big shadow". Conversely, once this age had been
passed, any increase in anxiety levels gradually subsided.
The women described a variety of cognitive strategies for coping with the
knowledge of their increased risk such as focusing on the present, avoiding
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potentially worrying breast cancer cues and thinkingpositively about the situation by
adopting an optimistic attitude about the future.
Although knowing about their increased risk had generally not affected the
women's decision-making orplanning for the future, anxiety was expressed about
having to make important choices in the future regarding genetic testing or
preventative surgery.
Knowing about their increased risk of breast cancer had prompted several
women to reassess their lives andpriorities in positive ways such as living life to the
full and prioritising their health.
3.8.3b Behavioural adaptation
There were three themes that were related to behavioural adaptation. These
were general health behaviours, control and breast self-examination (quotes from the
telephone focus groups to support the themes associated with behavioural adaptation
are listed in Table 3.5).
Table 3.5: Behavioural adaptation
General health behaviours:
"I think I'm quite careful most of the time about doing anything that I think I can do
to decrease my chances of getting breast cancer in terms of eating quite healthily and
making sure I take quite a lot of exercise. Also being aware of stress levels, not
necessarily doing relaxation exercises but being aware when I am stressed and
always sort of thinking I should do more relaxation techniques, the things that I feel I
can do to, if you like, take charge ofmy health as much as I can".
Control:
".. .all these things help you to feel you are in control of the situation rather than the
situation is in control of your life so I think it is very important to do things, positive
things, to make you feel you are doing all you can, you know, not to have it (breast
cancer)".
Breast self-examination:
"I feel that going to the clinic has been the most positive thing that's ever happened
and just while I remember it, because I go to the clinic.. .1 don't religiously check
myself for lumps every month but that is the one trigger, cause I'm terribly forgetful
but that triggers my memory every so often - 'all right you never did it last month but
you better do it this month' - so it's making me go through something that I might
possibly not bother doing".
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Although some women were already maintaining a healthy lifestyle, for many
knowing about their increased risk had prompted them to adopt new general health
behaviours such as a healthy diet, exercise, stopping smoking, use of natural
remedies and stress management
These women described how adopting these behaviours had helped them to
gain some control over their increased risk. Others described making a conscious
effort to pass these healthy attitudes on to other family members, especially their
children.
For many women, knowing about their increased risk and attending the clinic
prompted increased vigilance about performing breast self-examination. However,
one woman chose not to perform breast self-examination in order to avoid
exacerbating her existing anxieties.
3.8.3c Family issues
The themes associated with family issues were family, emotional support,
breast cancer survivors and children (quotes from the telephone focus groups to
support the themes associated with family issues are listed in Table 3.6).
Table 3.6: Family issues
Family:
"Having an increased risk of breast cancer doesn't (just) affect you, it affects
everybody around you as well".
Emotional support:
".. .with having two sisters we discuss it (breast cancer risk) an awful lot which I
think helps enormously because we are all in the same position and I think we get a
lot of strength from the fact that we all discuss it and we are all very close".
Breast cancer survivors:
"I'm lucky in the fact as well that I have you know, more surviving relatives that
have had breast cancer and are fine and that's a big inspiration you know, you think
well it's beatable it's not a death sentence".
Children:
".. .1 can cope with sort of having the gene or whatever but it suddenly dawned on
me about my own two daughters and I think as time's gone on, I felt, God, I hope
not. I can cope with it myself but I wonder about my children, maybe that's over the
years I've thought that now".
65
Some women openly discussed their increased risk with otherfamily
members. This commonly resulted in closer relationships with mothers or sisters who
had breast cancer or who were also at increased risk. Partners were often described as
lacking insight into the women's feelings, which limited the discussion and the
support provided. For these women, their increased risk was very much a family
affair, involving family members in visits to the clinic and raising their relatives'
awareness of cancer. Women, in families where a close relative was suffering from
breast cancer or where discussion about breast cancer was generally avoided,
described their reluctance to discuss their increased risk with family members. Other
women regarded their increased risk very much as their own problem and thought it
unnecessary to involve others at this stage.
Two main sources of emotional support were described by the women:
family and friends, particularly mothers and sisters, and professionals such as the
clinic staff and counsellors. Breast cancer survivors, who tended to be the women's
mothers, were also an important source of strength and support.
The women commonly expressed concerns about the implications of their
increased risk for their children, especially their daughters. Women with young
children were predominantly worried about their children's ability to cope if they
developed breast cancer. This reflected their own experience of losing their mothers
at a very young age. Women with older children described their growing concerns
regarding their children's own inherited risk.
3.8.3d Clinical surveillance
A number of themes were discussed that related to clinical surveillance.
These were frequency of clinic appointments, duration of clinic appointments,
continuous support, clinical services, specialist care and reassurance and security
(quotes from the telephone focus groups to support the themes associated with
clinical surveillance are listed in Table 3.7).
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Table 3.7: Clinical surveillance
Frequency ofclinic appointments:
. .what was an annual visit at the moment seems to be about 18 months but I'm not
sure if it's going to be longer and I don't have particular difficulty if it ends up that
the clinic, for me, ends up being every two years but I would rather know that than at
the moment think that I'm six months late and that apparently I'm on an emergency
cancellation list kind of thing. I think I would much rather know, well look, we either
provide the resources to ensure that we can have it annually. If really it's not
necessary annually then let's make it every two years but let's, you know, I'd rather
not be thinking well perhaps I'm six months late, I'd rather think I've got six months
to go to the next one".
Duration ofclinic appointments:
".. .when I did get my appointment I was in and out I mean very, very quickly
without time to discuss anything.. .1 almost felt last time that I was inconveniencing
them, although they never purposely make me feel that way, I felt that I was taking
up time".
Continuous support:
"I sometimes think it's true what they say, I mean an hour a year is better than
nothing, but what happens for the rest of the year. You're out there on your own".
Clinical services:
"I've been going to the clinic for about five years and straight from the word go I
was offered a mammogram on an annual basis and I have to say that concerned me
because I don't know that I really want this x-ray every year because that could put
me at risk, you know, that could may be prompt something to grow that's just maybe
not going to if I hadn't had the x-ray".
Specialist care:
"The most positive, the turning point I felt, was when I was referred to the breast
clinic at Ardmillan .. .because not all the medical profession can deal with people
who have a high risk and they don't always have the knowledge, the specialist
knowledge. Whereas when you go to Ardmillan, I do feel that at least you feel once
a year you are being checked over and you are in the right place and you have
contact with them and that makes a big difference".
Reassurance and security:
"I think the fact that knowing that you can attend the clinic once a year really makes
quite a difference to stopping you from worrying and having the same sort of
apprehension, if you like, in the back of your mind, because you always know that
although you may check yourself there is always someone else there, you know, to
do the extra check for you, just to make doubly certain".
67
Many women described how their annual clinic appointments had become
less frequent with a shorter duration. Some women were concerned that these
changes in service provision added to existing uncertainties and could be damaging
to their health. Several women emphasised a need for some alternative form of
continuous support to compensate for the existing clinical pressures.
Although several women felt very closely monitored by the current clinical
services, some women described their concerns about the possible side effects of
mammography together with reservations about participating in research trials.
Many women expressed how privileged they felt to be receiving such
specialist care and how confident they felt both with the expertise of the staff and the
equipment. Much importance was placed on the clinical service, in terms of
alleviating any anxieties, providing the opportunity for the early detection ofbreast
cancer and informing them of any significant medical advances.
Feelings of reassurance both from the clinic and their own general
practitioner were frequently voiced, particularly when the women found breast-self
examination difficult. They also found that the clinic provided them with a sense of
security as they were always aware that help was just a phone call away. Many
women found this a comfort and an aid to coping with their increased risk.
3.8.3e Provision of information
Themes relating to the provision of information were knowledge, getting a
balance, type of information, method of information presentation, family
involvement and immediate telephone contact (quotes from the telephone focus
groups to support the themes associated with the provision of information are listed
in Table 3.8).
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Table 3.8: Provision of information
Knowledge:
"I think that knowledge and information, the more knowledge and information you
have, the easier it is to cope with things and the more it helps you".
Getting a balance:
"I think it's dangerous. I think people can dwell on things that aren't there and are
maybe never going to happen. I think it's very hard to get the balance right and
probably very hard when you're trying to provide a service as well".
Type ofinformation:
"I think information of the right sort, coming from the right people, would make
quite a great deal of difference to know that what you were getting was, you know,
probably not what you were reading in the daily papers which you can never believe
or not".
Method of information presentation:
"I think people these days, they like to be informed, they want to know what's going
on and what research is showing. But, you know, to have it explained in a way they
can grasp and understand and I think that's a problem with being sent stuff in the
post, ifpeople don't understand it, there's nobody to ask or to question. I think that
would be the beauty of having an informal type of meeting where people could
maybe get the chance to talk to people after the presentations or whatever. I think
that would be invaluable".
Family involvement:
"I think that it would probably be a good idea for partners to attend (a meeting)
because it might help them to understand what it feels like for women to be under
this sort of increased risk. I think that some partners kind of shut themselves off from
it and don't take any notice of it. It might help their understanding. Yes, I think for
partners, it would be good for them to attend".
Immediate telephone contact:
"I also think that possibly a telephone help-line maybe a good idea so that as
someone else mentioned had quite problem getting through. I did as well at one
point trying to get to speak to someone, for something I wanted to ask about and I
really had quite a struggle to get to actually speak to someone. I think if there was a
telephone help-line set up, possibly even may be just certain hours throughout the
day not necessarily the whole time, that someone could just pick up a telephone,
rather than having to wait on their appointment every year. I think that would be
quite helpful".
Discussion about the role of knowledge in coping with an increased risk
uncovered contrasting experiences. Many women found that being informed about
breast cancer-related issues had helped them to cope by aiding their decision-making
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and decreasing anxiety. In contrast, other women felt that this sort of information
often added to existing concerns. Several women felt that undergoing genetic testing
to allow them to know whether or not they were carrying a breast cancer gene
mutation would certainly help them to cope by decreasing some of the uncertainty of
developing breast cancer. Some women suggested it was about getting a balance
between being informed and increasing worry, but this was often difficult to
maintain.
The women commonly expressed a need for specific types of information,
particularly up-to-date, professionally approved, detailed information on a variety of
topics including the clinical services available (particularly genetic testing), scientific
research (concerning breast cancer treatments, current trials and genetics),
preventative measures (such as diet), hormone replacement therapy, the oral
contraceptive pill and stress management.
A variety of opinions were expressed about the best methods ofpresenting
this information. There was a widespread positive response to the idea ofpresenting
this information via an organised face-to-face meeting which would provide the
women with a direct opportunity to ask questions.
Written information was seen to be very convenient and a valuable reference,
but generally supplementary to gaining information on a face-to-face basis. Other
suggestions to be kept informed included a newsletter, web site and Internet news
group.
Discussion about involving the family uncovered some differences of opinion
about who should attend an organised meeting. Several women thought that all
family members should attend, others felt that it would only be beneficial for their
partners and some expressed their reluctance to attend if other family members were
invited. These women preferred to relay any relevant information to their families.
Many women described problems contacting the clinic and would welcome
some form of immediate telephone contact, such as a telephone help-line, for gaining
instant advice from a specialist clinician. Several women felt that access to such a
service would provide them with an extra source of reassurance.
3.8.3f Peer support
Table summarises the theme relating to peer support, which was supportfrom
other women in the same situation (a quote from the telephone focus groups to
support the theme associated with peer support is in Table 3.9).
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Table 3.9: Peer support
Supportfrom other women in the same situation:
".. .if I was to go to some sort of group meeting where people were in a similar
position to me, I suspect that's the group where I might feel comfortable and be able
to say, 'Look maybe I am worried', where I might not say that at home because if I
have had somebody who's had breast cancer.. .1 certainly am the one being terribly
positive with her (my mother) and therefore would not want to take her along and her
hear me say, 'maybe I have been worried', so I'd quite like I think the idea of the
empathy with a group with similar circumstances".
Many women suggested that it would be beneficial to have some form of
contact with other women in the same situation either face-to-face, by telephone or
via an Internet chat room. They felt that it would be helpful to share their experiences
in a support group setting or as part of a social event. Several women thought that
they would feel sufficiently comfortable in a group ofwoman in the same situation to
be able to openly voice their concerns. One woman, who had a positive view ofher
increased risk, felt that she could provide support to other women, who perhaps were
finding it difficult to cope.
3.8.4 Additional issues
There were a number of additional issues that were discussed in the telephone
focus groups that were not included in the qualitative analysis, but have some
relevance to the aims of the study.
Firstly, from the large amount of discussion concerning genetic testing for
breast cancer, it was apparent that a lack of knowledge had resulted in confusion for
some of these women. Several of the women's relatives had given blood for genetic
testing several years previously, but the family had not received any updated
information about this process since that time. Some of these women felt that this
information was purposely being kept from them and several even thought that the
psychological questionnaires they were completing in conjunction with their annual
appointments at the clinic, were in fact screening tools to assess whether or not they
could cope with this genetic information.
Secondly, many women highlighted the inconsistent and unreliable nature of
a large proportion ofmedia reports about breast cancer issues such as the sensitivity
of screening, possible risks associated with the pill and preventative dietary factors.
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They found these conflicting reports very unhelpful and in some cases, anxiety
provoking.
Thirdly, several women expressed their lack of confidence both in the
sensitivity ofmammography and the effectiveness of carrying out breast self-
examination.
Fourthly, a number ofwomen expressed a strong interest in actively helping
to support the funding of the clinic in any way that they could.
Lastly, one woman described the reluctance of health professionals outside of
the familial breast cancer clinic to give her advice about a possible breast cancer
symptom. Although she tried to seek immediate advice from an alternative source,
she was nevertheless referred back to the clinic to wait for an appointment.
3.8.5 Feedback questionnaire
All 25 participants returned completed feedback questionnaires.
3.8.5a Living with an increased risk of breast cancer
The majority ofparticipants reported that knowing about an increased risk of
breast cancer in their family had changed their everyday lives in terms of: the way
they did things (a little: n = 17, 68%; quite a bit: n = 3, 12%; very much: n = 1, 4%),
the way they thought about their life in general (a little: n = 15, 60%; quite a bit: n =
5, 20%; very much: n = 2, 8%), the way they generally felt (a little: n = 10, 40%;
quite a bit: n = 6, 24%) and their relationships with other people in their family (a
little: n = 11, 44%; quite a bit: n = 4, 16%; very much: n = 1, 4%).
Two questions asked participants about the extent to which knowing about
their increased risk had affected their lives in positive ways (e.g. encouraging them to
maintain a healthy lifestyle) or negative ways (e.g. causing them worry). With
respect to positive effects, 19 participants (76%) reported not at all/a little and six
(24%) reported quite a bit/very much. With respect to negative effects, 11
participants (44%) reported not at all, 12 (48%) reported a little and two (8%)
reported quite a bit. No participants rated the negative effects as very much.
More than half of the participants had found it a little or quite a bit difficult
to cope with the knowledge of their increased risk (n = 14, 56%). Things that were
particularly difficult to cope with included concerns about their children's own risk
of developing breast cancer, the constant fear of a breast cancer diagnosis, finding a
lump in the breast, approaching the age when their mother had died of breast cancer
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and the decreasing frequency of routine appointments at the familial breast cancer
clinic.
3.8.5b Service issues
All participants reported that they would like to be provided with updated
information on a variety of topics related to familial risk of breast cancer. Of the 20
women (80%) who listed the given topics of information in order of preference as
requested, half ranked "current breast cancer research" as the most important topic, a
quarter thought that information about "breast cancer screening" was the most
important topic and for the remainder of participants other topics were their first
choice (i.e. breast cancer treatment: n = 2, 10%; maintaining a healthy lifestyle: n =
2, 10%; genetic testing: n = 1, 5%).
The majority of participants indicated they would like information on stress
management strategies (n = 19, 76%), the opportunity to meet up with other women
in the same situation (n = 22, 88%) and the opportunity to have any questions
answered outside of the clinic time (n = 23, 92%). Approximately half of the
participants (n = 12, 48%) stated they would like to be provided with a service for
other family members. With respect to the format of any additional services, 56% of
participants (n = 14) indicated a general preference for written materials rather than
personal contact, 60% (n = 15) preferred organised meetings rather than one-to-one
sessions and 55% (n = 14) preferred face-to-face rather than telephone contact. Of
the 10 participants (40%) who had access to the Internet and e-mail facilities, nine
indicated that this would be a convenient way to send or give them access to
information on topics related to familial risk of breast cancer.
3.8.5c Participating in a telephone focus group
The vast majority of participants had found it easy to make their opinions
known during the telephone focus group (a little: n = 3, 12%; quite a bit: n = 12,
48%; very much: n = 9, 36%). All participants thought that the leader handled the
discussion well (quite a bit: n = 6, 24%; very much: n = 19, 76%). Only one woman
did not feel comfortable about sharing her experiences in a telephone focus group.
Most participants had found it helpful to share their experiences with women in the
same situation (a little: n = 4, 16%; quite a bit: n = 6, 24%; very much: n = 14, 56%).
84% of participants (n = 21) rated their general experience of taking part in a
telephone focus group as good or excellent.
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For nearly all of the participants (n = 23, 92%), this was the first time that
they had taken part in a telephone conference call. The remaining two women often
used telephone conferencing at work.
3.8.5d Genetic testing
Two participants reported that a faulty breast cancer gene had been identified
in their family. Although both of these women stated that they had been tested for
this faulty gene, only one woman had already received the test results and was found
to be carrying the faulty gene.
3.9 Discussion
The telephone focus group methodology used in this study provided a rich
source of information about the psychosocial consequences of living with an
increased risk of breast cancer. As the information gained from later focus groups
began to reiterate that collected from earlier groups, it encouraged us to believe that
we had elicited the full range of issues for these women. The qualitative data were
supported by the quantitative results of the feedback questionnaire.
3.9.1 Participants
The low response (47%) and participation (36%) rates were disappointing.
This may in part be explained by the practical difficulties of gaining accurate contact
information for women who only attend the clinic on an annual basis and the
relatively short time frame offered for reply and participation. Scepticism among the
women about the use of such a novel methodology may also have acted as a barrier
towards participation. Therefore, the 25 participants may not be representative of the
other 45 women invited to participate. Although these two groups did not differ
significantly on the six demographic measures assessed, the participants may be
biased in terms of the coping strategies they used (e.g. the invitation to participate
may act as a breast cancer cue, stimulating an avoidant response) and may be
unrepresentative in terms ofpsychological distress (e.g. highly distressed individuals
may not have responded to the invitation). However, the aim of exploratory focus
group research is not to generalise the findings to a larger sample, but to represent a
range of participant views (Vaughn et al., 1996). The data collected did encompass a
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wide range of opinions and experiences indicating that they are likely to reflect the
important issues in this group. In any case, the intention was to test out the
representativeness of the issues identified in a larger sample ofwomen using more
conventional questionnaire methodology.
3.9.2 Telephone focus group methodology
The use of telephone conferencing methods to conduct focus groups was a
novel approach to research in this area. The methodology was shown to be a very
useful and convenient means of accessing a wide range of experiences. With
thorough preparation of the moderator guide and training in facilitating telephone
conferences, the groups were relatively easy to organise and conduct. They only
required an hour of the participants' time in the convenience of their own homes,
which was important since many of the participants led busy lives. The groups were
very cost-effective to run in comparison with the likely costs of conducting a face-to-
face group (i.e. hiring a location, providing refreshments and covering participants'
travel expenses). For example, in 1999 the total cost of running and recording a one-
hour telephone focus group on a weekday evening for five people (including the
moderator) was £28. The groups could have been made more cost-effective by
including more participants in each group. However, following a review of the
literature on focus group size and training in conducting telephone conferences, it
was considered that four participants should be the maximum number per group for
this study.
Participant feedback about the telephone focus groups was extremely
positive. Any initial scepticism among participants was quickly dispelled as the
anonymity of the telephone conferencing system made them feel less inhibited about
sharing their experiences. No participants became distressed during their group or
deliberately left the session before it had finished. Many participants expressed how
beneficial they found this experience and were keen to participate again or follow up
the group with a face-to-face meeting. There was also evidence that some women
had started to "bond" with other members of the group despite the lack of face-to-
face contact: as one woman commented, "I enjoyed the experience and even felt
momentarily 'bereft' when I said goodbye to the other participants".
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3.9.3 What are the psychosocial effects of living with an increased risk of
breast cancer on everyday life?
This study provided an important insight into the women's experience of the
long-term psychosocial effects ofknowing about their increased risk ofbreast cancer
on their everyday life.
Firstly, there was wide variation in the levels of anxiety and distress that
these women described experiencing in the years since they first attended the clinic.
A few participants reported experiencing severe worry and intrusive thoughts about
breast cancer on a daily basis. There is a clear need to assess both the prevalence and
type ofpsychological morbidity (e.g. general psychological distress, breast cancer-
specific distress) in women who have been living with an increased breast cancer for
a number of years and who are receiving appropriate clinical surveillance. This
would enable interventions that aim to prevent or reduce psychological distress to be
developed and targeted appropriately.
Secondly, anxiety and distress were often described as fluctuating over time
in response to breast cancer-related cues such as approaching the time of a clinic
appointment. Previous research provides evidence that levels of acute psychological
distress in women with a family history of breast cancer are high immediately prior
to routine mammography and are lowered after receiving normal results
(Valdimarsdottir et al., 1995). Our findings suggest that the impact of such cues may
be related to the individual's level of chronic anxiety or distress such that in
chronically distressed individuals breast cancer cues further elevate their consistently
high levels of distress. The possible relationship between chronic distress and a
heightened sensitivity to breast cancer cues requires further investigation in a larger
sample ofwomen at increased risk ofbreast cancer.
3.9.4 What sorts of coping strategies are being used by women living with an
increased risk of breast cancer?
There was evidence that the women in this study drew on a number of
important internal and external coping resources including positive cognitions,
knowledge about breast cancer-related issues, clinical surveillance and family
members. Of the range of cognitive and behavioural coping strategies that were
described, particular strategies such as cognitive avoidance were described as
minimising anxiety and distress over time which may suggest that they have an
adaptive role in the long-term. Behavioural coping strategies such as excessive
76
reassurance seeking were used in times of acute anxiety and distress. The use of
behavioural coping strategies associated with adopting a healthy lifestyle was seen to
be adaptive by promoting a degree of perceived control over a woman's increased
risk. The findings of this study then suggest the incidental benefits that could
accumulate by including a general health behaviour component as part of an
educational intervention. Although the biological role of particular health behaviours
in the prevention of breast cancer remains unclear, these behaviours may represent
adaptive coping resources to be accessed in times of personal stress (Ingledew et al.,
1996).
The long-term role of specific coping strategies, particularly cognitive
avoidance, requires further investigation in terms of specific outcomes such as
reduced psychological distress and cancer worry. Interventions can then be aimed at
promoting the use of those strategies that are shown to be adaptive in the long-term.
3.9.5 Are there any needs for information or psychosocial support that are
not being met by the existing service at the familial breast cancer clinic?
Every woman in this study indicated at least one support need that was not
being met by the existing clinical service. Of top priority was the provision of
information on a wide variety of scientific and psychosocial issues related to familial
risk ofbreast cancer. There was a general preference for this information to be
presented by an expert via a group meeting with supplementary written materials.
Currently the support provided to these women is limited to an annual clinic
appointment focusing on breast cancer screening. This need for additional support
services may be further strengthened by growing number of referrals to the familial
breast cancer clinic. Without a corresponding increase in resources, this places
increasing pressures on the clinic, whose focus is likely to be new referrals for
genetic risk counselling. This results in less frequent and shorter follow-up
appointments for women who have been attending the clinic for several years.
3.9.6 Methodological Issues
3.9.6a Participants
There were several methodological issues concerning the sample ofwomen
who participated in the study.
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Responses to the feedback questionnaire identified two protocol violations
(i.e. two women had undergone genetic testing for a breast cancer gene mutation that
had been identified in their family). This suggests that the clinical records used to
check participants' eligibility for the study were not up-to-date concerning genetic
testing. However, the data collected from these two women both in terms of their
contributions to the focus groups and responses to the feedback questionnaire were
retained in the analysis. Although, the inclusion of these two women rendered the
sample less homogenous with respect to the clinical services they had received, it
was deemed important to include the data they had provided. When interpreting the
data, it is important to consider the different experience of the two women and the
effect it may have had on the data they provided (e.g. the type of information or
psychosocial support they required).
The data collected both from the telephone focus groups and feedback
questionnaire incidentally identified some variables that may have affected the
participants' responses, particularly in terms of the levels of distress they reported
experiencing: the time since the women's last appointment at the familial breast
cancer clinic varied greatly (i.e. from a few days ago up to 18 months ago), many
women described having family histories of other forms of cancer, six women were
health professionals, two were currently suffering from ill health and one woman did
not perceive herself to be at increased risk of breast cancer.
In addition the participants described different experiences of breast cancer in
the family, which seemed to shape their view ofbreast cancer as a disease. Research
in women at increased risk ofbreast cancer suggests that personal experience of
breast cancer mediates the relationship between beliefs about the disease and certain
psychological outcomes (Rees, 2002, personal communication). Other studies have
also shown that these beliefs are associated with the use of specific coping strategies
(Heijmans, 1998; Scharloo et ah, 1998). Therefore, it maybe important in future
research in women who have been living with an increased risk ofbreast cancer for a
number of years to assess the impact of different family histories of breast cancer and
experiences of the disease in the family on various psychosocial factors such as
psychological distress and coping strategies.
3.9.6b Moderator guide
The participants uncovered a number of difficulties during the telephone
focus groups with questions contained in the moderator guide. Despite briefing
participants on the topics for discussion beforehand, several women commented on
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the difficulty in answering the questions without sufficient time for consideration. In
addition, particular questions posed specific problems for participants. For example,
one woman found it difficult to identify the everyday effects of living with an
increased risk of breast cancer as she had lived all her life with the knowledge that
breast cancer was in the family. Therefore, it may have been better to acknowledge
these possible difficulties with particular questions before the questions were posed,
in order to reassure participants and encourage them to consider the questions
carefully. Several participants also expressed difficulties discussing the question:
"Overall, would you say that knowing about an increased risk of breast cancer in the
family has had a positive or negative effect on your life?". They found it difficult to
regard any aspects of having a family history of breast cancer as positive. It may
have been better to separate the positive and negative aspects of this question. The
moderator could ask about the negative before the positive aspects so as not to
assume that there were necessarily any positive effects of living with an increased
risk of breast cancer.
3.9.6c Group dynamics
As the moderator holds a key role in eliciting the data from focus groups
(Vaughn et al., 1996), their input could be an unavoidable confounding factor in
participants' responses. The dynamics of each focus group varied slightly in that
some required more moderator input than others. In the few groups where the
participants took a while to "warm up", the moderator had to repeat and rephrase the
initial questions in order to elicit any response. In other groups where all of the
participants had a vast amount to contribute from the outset, the moderator
channelled her efforts into directing the discussion and probing for deeper insights.
Although the moderator attempted to monitor how often each participant in the group
had contributed so the quieter participants could be directly encouraged to respond, a
few groups had one participant that clearly contributed less than the other group
members. It could be this minority that had reported finding it difficult to make their
opinions known. Despite these differences in moderator input, all participants were
pleased with the way in which the moderator handled their group's discussion.
3.9.6d Telephone conferencing
Although the telephone focus groups generally proceeded smoothly, several
unanticipated technical difficulties with the telephone conferencing system were
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experienced in a minority of groups. Firstly, some participants could not be heard
clearly during the focus group, which rendered the sound quality of the audiotape to
be relatively poor. Secondly, there was always a small amount of dialogue that was
not recorded due to the telephone conferencing operator turning the audiotape to
begin recording on the second side. Thirdly, one transcript was incomplete, as the
operator had failed to turn the audiotape over. In addition, the telephone operator
accidentally disconnected two participants during the groups. One woman was
reconnected after only a few minutes and the other woman, who could not be
reconnected, was telephoned individually by the moderator following the session.
Feedback on these technical difficulties was given to Community Network, the
organisation who operated the telephone conference calls.
3.9.6e Qualitative analysis
Analysing the focus group data was a very lengthy and rigorous process
which posed unique difficulties. Despite the fact that the themes were only developed
by one researcher, the inter-rater reliability of the independent quote to theme
assignment between pairs of the three raters was shown to be good, according to
published guidelines (i.e. Altman, 1991). The three researchers, however, did
experience several difficulties during the qualitative analysis process. During the
initial stage of identifying informative quotes, it was difficult to distinguish between
quotes that were evidence of an everyday effect and quotes that referred to the
coping strategy adopted (e.g. "I check myself every time I have a bath"). This type of
difficulty was resolved either through discussion or by taking the view of the
majority of raters. In addition, much discussion between the researchers during this
stage was concerned with the inclusion of isolated quotes, which simply expressed
agreement with a previous remark, but were meaningless on their own (e.g. "I agree
as well"). All three raters agreed not to extract such quotes for use in the qualitative
analysis. During the stage where the quotes were independently assigned to the
themes, the two researchers often found it difficult to assign each quote to one theme
only, when they deemed the quote to be relevant to more than one theme. In such




There are a number ofpotentially important issues for further investigation
that have arisen from this exploratory research. These include the prevalence of and
type ofpsychological distress and needs for information on issues related to familial
risk ofbreast cancer and psychosocial support. Further research is needed to confirm
and expand on the findings from this small selected sample in a larger sample of
women living with an increased risk of breast cancer.
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Chapter 4: Cross-sectional Study to Investigate the Impact of
Appraisal, Coping Style, Social Support and Breast Cancer
Cues on Psychological Distress in Women Living with an
Increased Risk of Breast Cancer
4.1 Introduction
The telephone foeus group study (Chapter 3) explored the psychosocial
effects of living with an increased risk of breast cancer for a number of years. It
provided qualitative evidence of between- and within-individual differences in terms
of levels of distress and the coping strategies adopted and between-individual
variation in the impact of breast cancer cues on levels of distress. It also highlighted
a need for information about breast cancer-risk related issues and psychosocial
support.
The results of the telephone focus group study together with a review of the
psychological literature, particularly on women with a family history of breast
cancer, identified areas that warranted further quantitative investigation in a larger
sample ofwomen living with an increased risk of breast cancer.
A number of key variables were identified that could impact on the
relationship between psychological distress and living with an increased risk of
breast cancer: appraisal, coping style, social support and breast cancer cues.
Appraisal is concerned with a person's judgements about the importance of a
particular situation for them and about whether they have adequate resources to cope
(Folkman & Greer, 2000). Research in women with a family history of breast cancer
has assessed appraisal in terms of perceived risk of developing breast cancer (e.g.
Evans et ah, 1994; Lloyd et al., 1996; Cull et ah, 1999; Watson et al., 1999; Meiser et
al., 2001b; Bish et al., 2002) and perceived control over developing breast cancer
(e.g. Audrain et al., 1997). It has provided evidence that appraisal is related to
psychological distress, as women who perceive themselves to be at high risk of
breast cancer (or who overestimate their risk) and those who perceive less control
over their risk are likely to experience greater levels ofpsychological distress. These
findings were supported by the results of the telephone focus group study (e.g. "I'm
not entirely convinced that I am at increased risk.. .my mother was diagnosed as
having breast cancer when she was in her mid-sixties and I am of the opinion that it
could probably be anybody.. .it's not putting us at an increased risk.. .1 don't think
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about it all the time"; . .it's important to me to feel that there are some things that I
can take a bit of charge over").
The results of the telephone focus group study suggested that these women
adopted a variety of coping strategies at different times and in different situations
associated with their increased risk ofbreast cancer. Coping is a complex variable to
which there are two main approaches in the psychological literature: coping process
and coping style. Coping process refers to coping as a state, which is influenced by
context and time (Lazarus, 1993). In contrast, coping style refers to coping as a stable
trait or disposition and emphasises the consistency of coping across different
situations and over time (Lazams, 1993). Although the coping process approach was
favoured by the results of the telephone focus group study, it would not have been
appropriate to assess coping process in a cross-sectional survey. Given the multiple
influences on coping process and the lack of appropriate measures to assess coping
processes specifically in women with a family history ofbreast cancer, research in
this population has tended to investigate coping as a style. Monitoring and Blunting
(Miller, 1987) are dimensions of coping style that have been assessed in several
studies ofwomen with a family history of breast cancer (e.g. Schwartz et al., 1995;
Lerman et al., 1996; Audrain et al., 1997; Cull et al., 1999). Monitoring assesses a
style of coping with threat-related cues by information-seeking, whereas Blunting
describes the avoidance of such cues (Miller, 1987). These dimensions of coping
style are particularly relevant to women living with an increased risk ofbreast cancer
population and have already been linked to their levels of psychological distress (i.e.
Schwartz et al., 1995; Lerman et al., 1996; Audrain et al., 1997). A new measure,
The Uncertainty Response Scale (URS), has recently been developed to assess styles
of coping with uncertainty (Greco & Roger, 2001). A wealth of research using
experimental manipulations of uncertainty has provided evidence that uncertainty is
a powerful stressor (Greco & Roger, 2001). The URS was developed in an attempt to
investigate the role ofpersonality factors (i.e. coping style) in influencing responses
to uncertain situations. The measure assesses coping with uncertainty in terms of
emotional and cognitive responses. It may be particularly pertinent to assess these
dimensions of coping style in women who are living with the multiple uncertainties
of having an increased risk of breast cancer.
Social support is a general term referring to the various forms of support
given by a person's social contacts including emotional and practical support
(Weinman et al., 1995). It is typically considered to be "a resource or asset which
may be mobilized in times of crisis to protect against threats to health" (Weinman et
al., 1995). The findings of the telephone focus group study highlighted the role of
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social support in coping with an increased risk of breast cancer: . .with having two
sisters we discuss it an awful lot which I think helps enormously because we are all
in the same position and I think we get a lot of strength from the fact that we all
discuss it and we are all very close". The small number of studies to date that have
assessed social support in women with a family history of breast cancer (i.e. Kash et
ah, 1992; Gagnon et ah, 1996) have provided evidence that low levels of perceived
social support both in terms of quantity and quality are associated with greater levels
of psychological distress.
Breast cancer cues are internal (e.g. changes in the breast) or external (e.g.
media reports about breast cancer) events which may prompt an individual to think
about their increased risk of breast cancer (Appleton et ah, 2000). The results of the
telephone focus group study suggested that fluctuations in levels of distress over time
were in response to breast cancer cues such as approaching the time of a breast
cancer screening appointment. This supports the findings of research in women with
a family history of breast cancer where the high levels of psychological distress that
were experienced immediately prior to routine mammography, were reduced after
receiving normal results (Valdimarsdottir et ah, 1995).
In addition to the key variables, several exploratory variables were identified
from the results of the telephone focus group study and the literature review which
could affect levels of psychological distress in these women: sociodemographic
variables, family history details, somatic symptoms and psychiatric history.
Regarding somatic symptoms, there was a concern that an increase in vigilance to
their health could result in these women experiencing a greater level of somatic
symptoms. The analysis of these variables was subsidiary to the key variables which
remained the main focus of the study.
4.2 Aims
The aims of the study were to:
1. Assess the prevalence of general psychological morbidity (in terms ofGHQ-12
probable psychiatric "caseness") among women living with an increased risk of
breast cancer.
2. Assess the psychological status ofwomen living with an increased risk of breast
cancer in terms of general psychological distress (somatic symptoms) and breast
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cancer-specific distress (intrusive and avoidant thoughts about breast cancer risk
and worry about breast cancer risk-related issues).
3. Assess the prevalence of information needs and preferences in women living with
an increased risk ofbreast cancer.
4. Investigate the impact of appraisal, coping style, social support and breast cancer
cues on general psychological distress (GHQ-12 "case-level" distress) and breast
cancer-specific distress (intrusive and avoidant thoughts about breast cancer risk
and worry about breast cancer risk-related issues) in women living with an
increased risk of breast cancer.
4.3 Hypotheses
The hypotheses tested related to the 4th aim of the study.
1. Appraisal:
a. Women who perceive themselves to be at a greater risk of developing breast
cancer will show greater levels of psychological distress than women who
perceive themselves to be at a lower risk.
b. Women who perceive themselves to have less control over their risk of
developing breast cancer will show greater levels ofpsychological distress
than women who perceive themselves to have greater control over their risk.
2. Coping Style:
a. Women with a high Monitoring coping style will show greater psychological
distress than women with a low Monitoring coping style.
b. Women with a high Monitoring coping style will show greater intrusive
thoughts about breast cancer than women with a low Monitoring coping style.
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c. Women with a high score on Emotional Uncertainty will show greater
psychological distress than women with a low score on Emotional
Uncertainty.
3. Social Support:
Women who are less satisfied with their social supports will show greater
psychological distress than women with greater satisfaction with their social
supports.
4. Breast Cancer Cues:
Women who are approaching the age when their mother was diagnosed with
breast cancer will show greater psychological distress than women who are
much younger or older than their mother was at her diagnosis.
4.4 Design
This was a cross-sectional study in which participants were assessed by postal
questionnaire. It was not practical to ask participants to complete the questionnaire
when they attended the familial breast cancer clinic as their appointments were at
least at yearly intervals. Therefore, a postal methodology was deemed to be the most
appropriate way of collecting data from a large number of participants living within a
wide radius and in a relatively short space of time. Postal questionnaires have been
used successfully by a number of studies in women with a family history of breast
cancer (e.g. Cull et al., 1998; Hopwood et al., 2001; Watson et al., 1999).
4.5 Participant selection
The Department ofClinical Genetics (Western General Hospital, Edinburgh)
maintains a database ofwomen with a family history ofbreast cancer in South East
Scotland who have received genetic risk counselling. All women who met the study
criteria in Table 4.1 were invited to participate.
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Table 4.1: Eligibility criteria for the cross-sectional study
Inclusion criteria:
• Current attendance at the Ardmillan Familial Breast Cancer Clinic.
• Has attended the Ardmillan Familial Breast Cancer Clinic for at least two years.
Exclusion criteria:
• A previous diagnosis of cancer.
• Has had prophylactic surgery.
• Has undergone genetic testing.
• Participation in any psychosocial research in relation to their family history of
breast cancer in the last six months.
• Current participation in the International Breast Cancer Intervention Study
(IBIS); Magnetic Resonance Imaging (MRI) Trial or the Cancer Genetics in the
Community Trial.
Additional exclusion criteria as assessed by their General Practitioner (GP):
• Currently suffering from serious physical illness.
• Currently suffering from alcoholism, schizophrenia or organic brain damage.
4.6 Measures
A copy of the cross-sectional study questionnaire is in Appendix II, page 15.
4.6.1 Sociodemographic variables
The following sociodemographic variables were recorded: age, number of
years of attendance at the familial breast cancer clinic, marital status,
number/age/gender of children, education, ethnicity, occupation and current medical
conditions.
4.6.2 Family history of breast cancer
Family history of breast cancer was assessed in terms of: the number of
relatives diagnosed with breast cancer, which relatives had been diagnosed with
breast cancer, the age at which they had been diagnosed, their current health status
and the number of these relatives personally known to the respondent.
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4.6.3 Psychiatric history
Two items were used to assess psychiatric history: "Have you ever been
treated for nervous or emotional problems such as anxiety or depression in the past at
any time?", "Have you ever had an admission to hospital for nervous problems?".
Responses were on a simple yes/no format, where participants were asked to provide
further details if they answered yes. These items have previously been used in cancer
outpatients (Cull et ah, 2001b).
4.6.4 General psychological distress
4.6.4a 12-item General Health Questionnaire (GHQ-12)
The 12-item version of the GHQ is a first-stage screening test to detect
current psychiatric disorders in individuals from community and non-psychiatric
clinical populations (Goldberg & Williams, 1991). Respondents are asked about
recent and current disruptions in their normal functioning and not enduring traits
(Goldberg & Williams, 1991). As a screening test, the GHQ-12 was not designed to
produce clinical diagnoses, but to estimate the probability of psychiatric illness
(Goldberg & Williams, 1991). A clinical interview would be needed to confirm a
psychiatric diagnosis for those who screen positive (Goldberg & Williams, 1991).
The GHQ-12 is a standardised measure which has been subjected to thorough
psychometric testing (Goldberg & Williams, 1991). It has been shown to be as
effective a screening measure as the longer 28-item version of the GHQ (Goldberg et
ah, 1997). Responses were scored using the GHQ method of scoring (0,0,1,1) and
were summed to produce a total score of 0-12. A threshold score of>3 was used to
indicate probable psychiatric "caseness". This threshold has previously been applied
to general population (i.e. Weich et ah, 2001) and general practice samples (i.e. May,
1992; Plummer et ah, 2000), families undergoing genetic testing for BRCA1
(Watson et ah, 1996) and first-time attendees of breast cancer genetic risk
counselling (Watson et ah, 1998,1999).
4.6.4b Somatic symptoms
The somatic symptoms subscale is one of four subscales that form the 28-
item version of the General Health Questionnaire (GHQ-28) (Goldberg & Hillier,
1979). The ethics committee refused permission for the use of the GHQ-28 in this
study on the grounds that the depression subscale items might cause distress in a
postal survey. They did give permission for the somatic symptoms subscale to be
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retained for exploratory purposes. The somatic symptoms subscale does not generate
a psychiatric diagnosis, but rather denotes "dimensions of symptomatology"
(Goldberg & Williams, 1991). It contains seven items (that do not repeat any of the
items in the GHQ-12) which focus on recent and current somatic symptoms such as
"a feeling of tightness or pressure in your head". A number of studies have examined
the psychometric properties of the GHQ-28 (Goldberg & Williams, 1991).
Responses were scored using the GHQ method of scoring (0,0,1,1) and were
summed to produce a total score of 0-7. Data on the somatic symptoms subscale is
available for women in the general population attending a breast screening program
(Ellman et ah, 1989) and first-time attendees of breast cancer genetic risk counselling
(Hopwood et ah, 1998). Results on the subscale have been recorded in different
ways: as a score of at least one point (i.e. Ellman et ah, 1989) and using the GHQ-28
threshold of >5 (i.e. Hopwood et ah, 1998).
4.6.5 Breast cancer-specific distress
4.6.5a Impact of Event Scale (IES)
This 15-item scale was originally developed "to assess current subjective
distress for any life event" (Horowitz et ah, 1979). It consists of two subscales:
Intrusion (7 items) which focuses on invasive images/thoughts and Avoidance (8
items) which focuses on evasion of certain thoughts, feelings and reminders
(Horowitz et ah, 1979). The scale has been modified for use in women at increased
risk of breast cancer to determine levels of breast cancer-specific distress in terms of
intrusive and avoidant thoughts about breast cancer risk in the past week (Kash et ah,
1992). Responses are on a 4-point Likert scale which were assigned weighted scores
of 0 (not at all), 1 (rarely), 3 (sometimes) and 5 (often). Scores were summed to
produce two subscale scores: Intrusion (0-35) and Avoidance (0-40). These subscale
scores were also summed to produce a total Impact ofEvent Scale score of 0-75
where higher scores represent greater breast-cancer specific distress. Following the
work of others using this instrument in women at increased risk of breast cancer (i.e.
Lloyd et ah, 1996; Thewes et ah, 2001), an opt-out box was included for women who
had not thought about their risk of breast cancer in the past week. Systematic
psychometric testing of the scale has confirmed that it is reliable, valid and
acceptable in women at increased risk of breast cancer (Thewes et ah, 2001). The
scale has been extensively used in women with a family history of breast cancer (e.g.
Audrain et ah, 1997, 1999; Baider et ah, 1999; Gagnon et ah, 1996; Lerman et ah,
1993, 1994, 1995, 1996; Lloyd et ah, 1996; McCaul et ah, 1998; Meiser et ah, 2000,
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2001a & b; Schwartz et al., 1998, 1999b; Smith et al., 1999; Valdimarsdottir et ah,
1995; Watson et ah, 1996, 1999; Zakowski et ah, 1997, 2001).
4.6.5b Worry about breast cancer risk-related issues
Using the qualitative results of our previous telephone focus group study,
seven individual items were developed to reflect a range of probable concerns of this
population regarding their increased risk of breast cancer. Participants were asked to
indicate on a 4-point Likert scale (not at all/ a little/moderately/very worried) how
worried they had been about each of the following issues in the past week:
developing breast cancer anytime now/in the future, the possibility of having to make
future decisions about their increased risk such as genetic testing or prophylactic
surgery, the frequency of clinic appointments, dying from breast cancer and leaving
their children, their children's risk of developing breast cancer, other concern).
4.6.6 Information needs and preferences
A 21-item checklist was designed using issues raised by the telephone focus
group study to assess the participants' needs and preferences for information related
to familial risk of breast cancer. Participants were asked if they would be interested
in 11 different topics of information related to familial risk of breast cancer
(scientific research concerning breast cancer genetics/screening/treatment, research
conducted at the Ardmillan familial breast cancer clinic, genetic testing, prophylactic
surgery, hormone replacement therapy, the oral contraceptive pill, maintaining a
healthy lifestyle, ways to help you deal with any stress you may be experiencing,
another topic) and four different formats for receiving information (written, group
meeting for women attending the familial breast cancer clinic/for women and their
families, telephone discussion group). They were asked to indicate their interest by
endorsing the appropriate item. An option was also provided for participants to
endorse if they were not interested in any of the formats listed. The number of topics




A single item assessed perceived risk of developing breast cancer in
comparison with the general population: "Do you think that your risk of ever
90
developing breast cancer is..Responses were on a 4-point Likert scale (lower/the
same as/ slightly higher/much higher than the general population). Similar items
have previously been used to assess perceptions of risk in women with a family
history of breast and/or ovarian cancer (e.g. Audrain et al., 1997; Lerman et al., 1993,
1994; Lloyd et al., 1996; Watson et al., 1999).
4.6.7b Perceived likelihood
A single item was used to measure perceived likelihood of developing breast
cancer: "How likely do you feel it is that you will ever develop breast cancer?".
Responses were on a 5-point Likert scale (very unlikely/unlikely/likely/very
likely/inevitable). A number of studies have used similar items to assess perceived
likelihood in women with a family history ofbreast cancer (e.g. Gagnon et al., 1996;
Kent et al., 2000; Lerman et al., 1993, 1994) and ovarian cancer (e.g. Cull et al.,
2001a).
4.6.7c Perceived change in risk
In order to determine any perceived change in breast cancer risk since first
attending the familial breast cancer clinic, a single item was devised specifically for
this study: "Since you first started attending the Ardmillan Familial Breast Cancer
Clinic do you think that your risk of ever developing breast cancer has...?".
Response-options were: increased/decreased/stayed the same/not sure.
4.6.7d Perceived control
A single item was used which has been developed to assess perceived control
over developing breast/ovarian cancer in women at increased risk ("How much
control do you feel you have over whether you develop breast cancer?") (Audrain et
al., 1997). Responses were on a 4-point Likert scale (none at all/a bit/moderate/a lot).
4.6.8 Psychological traits: coping style
4.6.8a Miller Behavioural Style Scale (abbreviated version) (MBSS)
The MBSS was designed to assess styles of coping with threat-related cues
(Miller, 1987). The scale assesses two dimensions: Monitoring (information seeking)
and Blunting (distraction). Respondents are asked how they would react to several
different stressful scenarios, with a choice of four Monitoring options and four
Blunting options. They can endorse as many responses as are applicable. Internal
consistency of the Monitoring and Blunting subscales in terms of alpha coefficients
have been reported as .75 to.79 and .67 to .69 respectively (Miller, 1987). Test-retest
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reliability has been shown to be satisfactory at .72 (Monitoring) and .75 (Blunting)
(Miller, 1987). An abbreviated version of the scale has been developed to have
greater face validity, particularly for British medical patients (Steptoe, 1989). This
version of the scale consists of two of the four original scenarios (i.e. visit to the
dentist, threat ofjob loss) both followed by four Monitoring options (e.g. "I would
ask the dentist exactly what he or she was going to do") and four Blunting options
(e.g. "I would try to think about pleasant memories"). Total scores for each of the
two dimensions are produced by summing the number ofMonitoring or Blunting
options endorsed: Monitoring (range 0-8), Blunting (range 0-8). Greater scores on
each of these dimensions represent more Monitoring or Blunting (Miller, 1987). The
abbreviated MBSS has been shown to adequately reflect responses to the full version
of the scale and to be acceptable in samples of British students and cancer patients
(Steptoe, 1989). It has also been used in women who have recently undergone a
breast biopsy (Andrykowski et al., 2001), women at increased risk of breast cancer
(Cull et al., 1999) and ovarian cancer (Cull et al., 2001a; Wardle, 1995).
4.6.8b Uncertainty Response Scale (URS)
The URS is a recently developed 48-item scale designed to measure "styles
of coping with uncertainty" (Greco & Roger, 2001). It attempts to predict individual
or personality differences in responses to uncertain situations (Greco & Roger,
2001). The scale consists of three factors ofwhich two were used in this study:
Emotional Uncertainty (EU) (15 items regarding emotional responses to uncertainty
e.g. "I get worried when a situation is uncertain") and Cognitive Uncertainty (CU)
(17 items regarding cognitive responses to uncertainty e.g. "When I feel uncertain, I
try to take decisive steps to clarify the situation"). Responses to the 32 items used in
this study were on a 4-point Likert scale: never/sometimes/ often/always. Scores
were summed on EU and CU to produce totals ranging from 15-60 and 17-68
respectively. This scale has undergone thorough psychometric analysis including
internal consistency (alpha coefficient) of .89 (EU), .85 (CU) and test-retest
reliability of .79 (EU) and .80 (CU) (Greco & Roger, 2001). In the present study, the
high internal consistency of the two factors was confirmed: alpha coefficients of .92
(EU) and .86 (CU). The Emotional Uncertainty factor has been found to be
predictive ofboth psychological and physiological reactions to the expectation of an
experimental threat (Greco & Roger, 2001) and has also been shown to predict
deteriorating health status in undergraduate students (Greco & Roger, 1999).
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4.6.9 Social support
The 6-item version of the Social Support Questionnaire (SSQ6) was designed
to assess two dimensions ofperceived social support: number (perceived availability)
of supports and satisfaction with supports (Sarason et al., 1987). For each item,
respondents are asked to list all the people (by giving the person's initials and their
relationship to the respondent), up to a maximum ofnine, they can rely on for a
particular type of support (e.g. "Whom can you really count on to distract you from
your worries when you feel under stress?"). They are then required to rate on a 6-
point scale (from 6 = very satisfied to 1 = very dissatisfied) their level of satisfaction
with the type of support indicated in the question. The scale produces two total
scores by summing the number of supports listed (0-54) and the ratings of
satisfaction with supports (6-36). This version of the scale has been subjected to
thorough psychometric testing and has shown high internal consistency ofboth
subscales (alpha coefficient = .90 to .93) (Sarason et al., 1987). As no norms or
thresholds have been derived for the SSQ6, individual scores represent relative
measures of support, rather than indicators of low or high levels of perceived social
support (Weinman et al., 1995). This version of the scale has been used in a number
ofpopulations including university students (Steptoe & Wardle, 2001) and the male
partners ofHIV-positive men (Gray & Hedge, 1999).
4.6.10 Breast cancer cues
Directed by the results of the previous telephone focus group study, a
checklist of 10 items was developed to assess whether participants had experienced
any breast cancer cues in the past week. The items included: "Have you read,
watched or listened to anything about breast cancer?"; "Have you examined your
breasts?"; "Have you been waiting for the results ofmammogram or breast biopsy?".
The number of items endorsed was summed to produce a total from 0-10.
4.7 Procedure
Ethical approval for the study was obtained from the regional ethics
committee. The GPs of all women meeting the study criteria were contacted by letter.
They were asked to confirm whether their patients could be invited to participate on
the basis of the additional exclusion criteria (Table 4.1). They were sent a copy of the
93
letter of invitation and information sheet designed for participants. A response was
requested by Freepost envelope or fax. GPs who had not responded within two
weeks were sent a reminder letter and were telephoned weekly for up to two further
weeks if they still had not replied.
All women opted in to the study by their GP were then sent a letter inviting
them to take part in the study together with an information sheet and consent form.
They were asked to reply using the Freepost envelope provided. Reminder letters
were sent to all non-respondents after three weeks. Those who consented were sent a
questionnaire, which they were asked to return within two weeks in the Freepost
envelope provided. If a completed questionnaire was not received from them within
three weeks, the participant was sent a reminder letter.
The GP of any participant who scored above the threshold (i.e. > 3) on the
GHQ-12 was promptly notified by letter of their patient's score.
4.8 Statistical analysis
The distribution of all continuous variables was assessed to determine their
parametric or non-parametric nature. The appropriate descriptive statistics were
generated to describe the study participants. Differences between two independent
groups were analysed with independent samples t-tests (2-tailed), Mann-Whitney,
chi-square or Fisher's exact tests.
Univariate analyses in terms of simple linear or logistic regression were
initially conducted to test the extent to which the hypothesised or exploratory
variables predicted the psychological distress variables.
The results of the univariate analyses informed the selection of variables for
multivariate analysis. Multiple linear regression (stepwise selection) or multiple
logistic regression (forward stepwise selection using the likelihood ratio test) were
used to determine the combination of hypothesised/exploratory variables that best
predicted the eight psychological distress variables. The criterion for entering
variables into a model was p < 0.05 and for removing variables was p > 0.10.
The absence of one or more scores on a scale resulted in that total score being
classified as missing. A significance level of 0.05 was used throughout.
When conducting multiple statistical tests on a set of data, it is likely that
some results will be significant by chance (Campbell & Machin, 1999). The analysis
was directed by the study hypotheses, thus limiting the number of statistical tests.
The results of secondary or exploratory analyses should be interpreted with caution
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(Altman, 1991) as the results require confirmation in further studies (Campbell &
Machin, 1999).
The data were analysed using SPSS for Windows version 10.00 (1999).
4.9 Results
4.9.1 Participants
Figure 4 shows the participant recruitment to the study.
Of the 2455 women identified from the database ofwomen with a family
history of breast cancer in South East Scotland, there was insufficient data available
for 414 women to confirm their eligibility. Of the remaining women, 1631 did not
meet the eligibility criteria (Table 4.1): 509 had been discharged from the Ardmillan
Familial Breast Cancer Clinic; 525 had attended the clinic for less than two years; 41
had a previous diagnosis of cancer; 15 had prophylactic surgery; 8 had genetic
testing; 348 had participated in psychosocial research in relation to their family
history of breast cancer in the last six months; 176 were participating in the IBIS,
MRI trial or Cancer Genetics in the Community Trial; 9 for other reasons.
Of the 410 women who met the initial eligibility criteria, seven women were
not registered with their listed GP and details of their new GP were not recorded at
Lothian Flealth Board. Therefore, these women were excluded as their GPs could not
be contacted to confirm their eligibility. Twenty-eight of the remaining women were
excluded on the basis of information from their GP (GPs could list more than one
reason): 4 had a previous diagnosis of cancer; 8 had a serious physical illness; 3 had
alcoholism, schizophrenia or organic brain damage; 17 for other reasons. In addition,
one GP refused to disclose their patient's eligibility for entering the study. Two GPs
did not respond about their patients despite two letters and two telephone messages.
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Figure 4: Participant recruitment to the cross-sectional study
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There were 372 women who met the initial eligibility criteria and whose GPs
gave permission for them to be invited. Of the women who were invited to
participate, 21 refused and 66 did not respond to the initial invitation or reminder
letter. Of the 285 who consented, 259 returned a completed questionnaire. In 10
women, protocol violations were identified and their data were removed from the
analysis (four were recent recruits to IBIS, two were recent recruits to the MRI trial,
two had been discharged from the clinic, one had not yet attended for her first
screening appointment, one was participating in the Cancer Genetics in the
Community Trial). The sample to be analysed was 249. The participation rate for the
study was 69% (249/362). There were no significant differences between participants
(n = 249) and non-participants (n = 161) on age and number of years attendance at
the familial breast cancer clinic.
4.9.2 Sociodemographic variables
Participants ranged in age from 28-62 years (mean = 43.4, SD = 6.5). The
mean number of years they had been attending the familial breast cancer clinic was
4.5 (SD = 1.7, range = 2.1-7.9). Eighty percent of participants had at least one child
(range = 0-4) and of those women, 71% had at least one daughter (range 0-3). The
children ranged in age from two months to 36 years. Eighty-two percent of
participants (n = 200) were married or living with a partner, 9% (n = 23) were
divorced or separated, 8% (n = 20) were single and two women (1%) were widowed.
Thirty-three percent of participants (n = 82) had only received schooling until age 16,
15% (n = 37) had attended school/further education/training until age 18, 25% (n =
61) had received further education or training after age 18 and 27% (n = 68) were
university graduates. All but one participant were ofwhite ethnicity. Most
participants were employed either full-time (n = 114, 46%), part-time (n = 95, 38%)
or self-employed (n = 1) with 27 (11%) having home duties, seven were unemployed
(3%) and five were retired (2%). Thirty percent of participants (n = 73) reported
currently suffering from a medical condition. These conditions were diverse (e.g.
multiple sclerosis, asthma, recent injury). A quarter of these women gave details of
more than one condition.
4.9.3 Family history of breast cancer
The number of relatives of each participant who had been diagnosed with
breast cancer ranged from 0-11 (mean = 2.3, SD = 1.3). For the woman with no
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relatives with breast cancer, her increased risk ofbreast cancer arose from her family
history of ovarian cancer. Of the 552 relatives listed as having breast cancer, 264
(48%) were first-degree relatives (e.g. sister: n = 72, 13%), 202 (37%) were second-
degree relatives (e.g. aunt: n = 136, 25%) and 86 (16%) were more distant relatives
(e.g. great aunt: n = 35, 6%). The age at which these relatives were diagnosed with
breast cancer ranged from 24-95 years. The majority of these relatives had died from
breast cancer (n = 290, 53%) whereas 16% (n = 88) had died from other causes, 4%
(n = 22) were alive but unwell and 27% remained alive and well (n = 148). The mean
number of these relatives personally known by participants was 2.1 (SD = 1.1, range
= 0-6).
The mothers of 189 participants (76%) had been diagnosed with breast
cancer. The mean age at which the mothers were diagnosed was 48.4 years (SD =
11.8, range = 26-82). At the time of this assessment, participants were in an age
range from 34 years younger to 15years older than the age at which their mother was
diagnosed with breast cancer (mean = 5.64 years younger, SD = 10.85). A large
proportion of the mothers had died from breast cancer (n = 97, 53%) or other causes
(n = 28, 15%) whereas 28% (n = 51) were alive and well and 4% (n = 7) were alive
but unwell.
4.9.4 Psychiatric history
Thirty-four percent ofparticipants (n = 82) indicated that they had been
treated for nervous or emotional problems in the past. These problems included
anxiety (e.g. panic attacks), depression (e.g. post-natal), bereavement, agoraphobia,
post-traumatic stress disorder, work-related stress, PMT and anorexia. The
treatments described included medication, counselling and Cognitive Behavioural
Therapy. Only eight women (3%) stated they had ever been admitted to hospital for
nervous problems.
4.9.5 General psychological distress
The median GHQ-12 total score was 0 (range 0-12). Sixty-five women scored
at least three on the GHQ-12 which meant that the prevalence of general
psychological morbidity (in terms of GHQ-12 probable psychiatric "caseness") was
26%.
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The mean score on the somatic symptoms subscale of the GHQ-28 was 1.38
(SD = 1.90, range 0-7). Forty-six percent (n = 113) of participants scored at least one
on this subscale and 10% (n = 24) scored at least five.
As an aid to the interpretation of GHQ data from this uncontrolled study,
comparative data derived from the literature are presented in Table 4.2.
4.9.6 Breast cancer-specific distress
Forty-four percent of the women (n = 109) indicated that they had thought
about the risk of breast cancer in the past week and therefore completed the Impact
ofEvent Scale.
There were no significant differences between those who completed the IES
(IES group) and those who did not (no IES group) on GHQ-12 "case-level" distress,
perceived control over developing breast cancer, total satisfaction with social
supports and the difference between the age ofmother at diagnosis ofbreast cancer
and the current age of the woman.
However, there were significant differences between the IES and no IES
groups on Monitoring (t = -3.37, df= 241, p = .00), Emotional Uncertainty (z = -
4.30, p < .00) and somatic symptoms (z = -2.57, p = .01). The IES group had
significantly higher mean scores on Monitoring (4.25 compared to 3.54) and higher
median scores on Emotional Uncertainty (32 compared to 29) and somatic symptoms
(1 compared to 0). There were significant differences between the IES and no IES
groups on perceived likelihood of developing breast cancer (likely/unlikely) (x =
16.38, df= 1, p < .00) where only 24% of those women who perceived their risk as
unlikely, had completed the IES. Significantly more women in the IES group than no
IES group were worried about a variety of breast cancer risk-related issues:
developing breast cancer now (worried/not worried) (x2 = 68.12, df= 1, p < .00);
developing breast cancer in the future (x2 = 87.43, df= l.P< .00); dying from breast
cancer and leaving their children (x2= 70.47, df= 1, p < .00); their children's risk of
developing breast cancer (x = 31.50, df= 1, p < .00).
The mean scores were 7.39 for Intrusion (SD = 6.07, range = 0-27), 11.12 for
Avoidance (SD = 7.82, range = 0-30) and 18.48 for the total IES score (SD = 12.35,
range = 0-57). As an aid to the interpretation of IES data from this uncontrolled
study, comparative data derived from the literature are presented in Table 4.2.
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The most common worry regarding breast cancer was about developing
breast cancer in the future: 61% of participants had been worried about this in the
past week (Table 4.3). Thirty-eight percent had been worried about the possibility of
having to make future decisions about their increased risk such as genetic testing or
prophylactic surgery, 35% had been worried about developing breast cancer anytime
now and 17% had been worried about the frequency of their appointments at the
familial breast cancer clinic. Of the women that had children, 47% had been worried
about their children's risk of developing breast cancer and 42% about dying from
breast cancer and leaving their children. Other worries about breast cancer risk-
related issues included HRT, breast symptoms and lifestyle issues. 181 women
(73%) indicated that they had been worried in the past week about at least one of the
seven issues related to breast cancer risk that were listed.
Table 4.3: Frequency of worries about breast cancer risk-related issues
Worry about: Not at all A little Moderately Very
worried worried worried worried
Developing breast cancer 97 107 39 5
in the future (39%) (43%) (16%) (2%)
The possibility of having 153 68 20 6
to make future decisions (62%) (28%) (8%) (2%)
about your increased risk
such as genetic testing or
prophylactic surgery
Developing breast cancer 161 68 14 4
anytime now (65%) (28%) (6%) (2%)
The frequency of your 205 31 8 4
appointments at the (83%) (13%) (3%) (2%)
familial breast cancer
clinic
Your children's own risk 104 59 22 12
of developing breast (53%) (30%) (11%) (6%)
cancer
Dying from breast cancer 116 62 14 7
and leaving your children (58%) (31%) (7%) (4%)
Other Not 25 7 6
applicable (66%) (18%) (16%)
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4.9.7 Information needs and preferences
Participants expressed a widespread interest in receiving information on
various topics related to familial risk ofbreast cancer (Table 4.4). The mean number
of topics endorsed was 4.93 (SD = 2.49, range = 0-11). Ninety-five percent of
participants (n = 236) indicted that they would be interested in receiving at least one
of the 11 topics of information listed on the questionnaire. Some women also
requested other topics of information which were not already listed. These included
natural alternatives to HRT, other forms of cancer such as ovarian cancer and dietary
advice.
The most popular format for receiving such information was as written
information (n = 209, 85%). In contrast, less than halfof participants (n = 98, 40%)
expressed an interest in attending a group meeting in Edinburgh only for women
attending the familial breast cancer clinic (where experts would present the
information and be available to answer any questions), 21% (n = 52) were interested
in attending such a group meeting where their families would also be able to attend
and 11% (n = 26) were interested in telephone discussion groups with other women
in the same situation (where expert information would be presented and they would
have the opportunity to discuss the information as a group and ask any questions).
The mean number of information formats endorsed was 1.56 (SD = 0.92, range = 0-
4). Ninety-one percent of participants (n =226) indicated that they would be
interested in at least one of the four information formats listed. 20 women (8%)
indicated that they were not interested in any of the information formats listed.
Table 4.4: Topics of information related to familial risk of breast cancer
Topic of Information Frequency
Breast cancer genetics 179 (72%)
Research conducted at the Ardmillan Familial Breast Cancer Clinic 168 (68%)
Genetic testing 166 (67%)
Breast cancer treatment 157 (63%)
Breast cancer screening 148 (59%)
Maintaining a healthy lifestyle 123 (49%)
Hormone Replacement Therapy (HRT) 103 (41%)
Ways to help you deal with any stress you may be experiencing 101 (41%)
Prophylactic surgery 40 (16%)
The oral contraceptive pill 33 (13%)
Another topic 11 (4%)
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4.9.8 Appraisal
Most participants thought that their risk of ever developing breast cancer was
slightly higher (n = 156, 63%) or much higher (n = 75, 31%) than the general
population whilst just 14 women (6%) thought their risk was the same as the general
population and one women thought her risk was lower than the general population.
Only a minority of participants felt that it was very unlikely (n = 1) or
unlikely (n = 75, 31%) that they would ever develop breast cancer. In contrast, 55%
(n = 131) thought that it was likely, 13% (n = 32) very likely and one woman thought
that it was inevitable that she would ever develop breast cancer.
The vast majority ofparticipants (n = 186, 76%) thought that their risk of
ever developing breast cancer had stayed the same since they first started attending
the familial breast cancer clinic. Forty women (16%) thought their risk had
decreased, nine (n = 4%) increased and 11 (5%) were not sure.
Although 37% (n = 92) of participants felt that they had no control over
whether they ever developed breast cancer, 40% (n = 98) felt they had a bit, 21% (n
= 51) a moderate amount and 2% (n = 6) felt they had a lot of control over ever
developing breast cancer.
4.9.9 Psychological traits: coping style
The mean score for the Monitoring subscale was 3.84 (SD = 1.65, range = 0-
8) and for the Blunting subscale was 1.97 (SD = 1.35, range = 0-6).
The mean Emotional Uncertainty score was 31.23 (SD = 7.62, range = 18-56)
and the mean score for Cognitive Uncertainty was 46.03 (SD = 7.44, range = 29-67).
Data derived from these two coping style scales in published studies are
presented for comparative purposes in Table 4.5.
4.9.10 Social support
The total number of social supports listed by participants ranged from 0-54
(mean = 22.19, SD = 11.15). Total satisfaction with supports ranged from 6-36
(mean = 30.84, SD = 5.42). A wide variety of social supports were listed including
family members, friends, religious figures, work colleagues and pets. The three most
frequently listed supports were: friend (n = 1831, 34.2%), husband/partner (n = 975,
18.2%) and sister (n = 600, 11.2%). Comparative data from the literature using the
SSQ-6 are presented in Table 4.5.
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4.9.11 Breast cancer cues
One hundred and ninety-two women (77%) indicated that in the past week
they had experienced at least one of the nine breast cancer cues listed. One hundred
and eighteen women (61%) had examined their breasts, 116 (60%) had read, watched
or listened to something about breast cancer, 32 (17%) had experienced a significant
family event concerning breast cancer such the birthday of a deceased relative, 28
(14%) had spoken to a close relative or friend about their risk of breast cancer, 27
(14%) had relatives or friends who had been diagnosed or treated for breast cancer,
eight (4%) had been waiting for the results of a mammogram or breast biopsy, six
(3%) had received the results of a mammogram or breast biopsy and three (2%) had
undergone a breast biopsy or related medical investigation. Thirty-eight women
(20%) listed another breast cancer cue that they had experienced in the past week.
These included participating in this study, the death of a relative or friend from
cancer and experiencing breast symptoms.
4.9.12 Investigating psychological distress
The following sections of results relate to the fourth aim of the study and
therefore tested the study hypotheses.
The hypothesised variables were: perceived risk; perceived likelihood;
perceived control; Monitoring; Emotional Uncertainty; total satisfaction with social
supports; difference between the age ofmother at diagnosis of breast cancer and
current age ofwoman.
The exploratory variables were: sociodemographic variables; psychiatric
history; family history of breast cancer; GHQ-12 "case-level" distress; somatic
symptoms; Blunting; Cognitive Uncertainty.
The psychological distress variables were: GHQ-12 "case-level" distress;
Intrusion; Avoidance; total IES score; worry about developing breast cancer anytime
now/developing breast cancer in the future/dying from breast cancer and leaving
their children/their children's own risk of developing breast cancer.
4.9.12a Predicting GHQ-12 "case-level" distress
Univariate analyses showed that eight variables were significant single
predictors of GHQ-12 "case-level" distress: Emotional Uncertainty, total satisfaction
with supports, age, marital status (married or living with a partner/not married or
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living with a partner), medical conditions, psychiatric history, psychiatric
hospitalisation and Cognitive Uncertainty (Table 4.6).
Table 4.6: Significant single predictors of GHQ-12 "case-level" distress
Variable P Odds ratio 95% CI
Emotional Uncertainty a .00 1.11 1.07 to 1.16
Total satisfaction with supports .01 .93 .88 to .98
Age .03 1.05 1.01 to 1.10
Marital status .02 .43 .22 to .86
Medical conditions .00 2.52 1.39 to 4.59
Psychiatric history .00 3.05 1.68 to 5.51
Psychiatric hospitalisation .03 4.92 1.14 to 21.19
Cognitive Uncertainty .03 1.05 1.01 to 1.09
a
italics indicates a hypothesised variable
All of the variables found to be significant single predictors ofGHQ-12
"case-level" distress were entered into a multiple logistic regression model. Three
variables were initially found to make a significant contribution to the prediction of
GHQ-12 "case-level" distress: psychiatric history, age and Emotional Uncertainty.
However, the 95% confidence intervals for age (1.00 to 1.13) included an odds ratio
of one, which indicated there could be no change in odds if the model was
extrapolated to a wider population. A further multiple regression analysis was carried
out only entering the remaining two variables, which were both retained in the model
(Table 4.7).






























The odds of exhibiting GHQ-12 "case-level" distress:
• increases by 2.17 when a woman has a psychiatric history relative to if she has no
psychiatric history.
• increases by 1.11 for each point increase in the Emotional Uncertainty subscale
score.
For example the odds of exhibiting GHQ-12 "case-level" distress for a
woman who has no psychiatric history and has an:
• Emotional Uncertainty score of 20 = 0.08
• Emotional Uncertainty score of 50 = 1.50
The model accounted for 22% of the "variation" in GHQ-12 "case-level"
distress (p < 0.00) and correctly classified 78% of participants (29%; n = 18 cases/
96%; n = 168 noncases).
4.9.12b Predicting worry about developing breast cancer anytime now
Four variables were shown by univariate analyses to be significant single
predictors of responses to the item regarding worry about developing breast cancer
anytime now (worried/not worried): perceived likelihood of developing breast
cancer (unlikely/likely), Emotional Uncertainty, Monitoring and somatic symptoms
(Table 4.8).
Table 4.8: Significant single predictors of worry about developing breast cancer
anytime now
Variable P Odds ratio 95% CI
Perceived likelihood ofdeveloping
breast cancera
.00 3.01 1.58 to 5.74
Emotional Uncertainty .00 1.06 1.02 to 1.09
Monitoring .01 1.26 1.07 to 1.48
Somatic symptoms .04 1.15 1.01 to 1.32
a
italics indicates a hypothesised variable
All of the variables found to be significant single predictors of responses to
the item regarding worry about developing breast cancer anytime now were entered
into a multiple logistic regression model. Two variables made a significant
contribution to the prediction of responses to this item: perceived likelihood of
developing breast cancer and Emotional Uncertainty (Table 4.9).
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Table 4.9: Multiple logistic regression to predict worry about developing breast




























italics indicates a hypothesised variable
c
value for model
The odds of being worried about developing breast cancer anytime now:
• increases by 3.24 when a woman perceives her risk of breast cancer as likely
rather than unlikely.
• increases by 1.06 for each point increase in the Emotional Uncertainty subscale
score.
For example the odds of being worried about developing breast cancer
anytime now for a woman who feels she is likely to ever develop breast cancer and
has an:
• Emotional Uncertainty score of 20 = 1.80
• Emotional Uncertainty score of 50 = 10.55
The model accounted for 13% of the "variation" in worry about developing
breast cancer anytime now (p < 0.00) and correctly classified 67% of participants
(21%; n = 17 worried/91%; n = 136 not worried).
4.9.12c Predicting worry about developing breast cancer in the future
Univariate analyses revealed three significant single predictors of responses
to the item regarding worry about developing breast cancer in the future (worried/not
worried): perceived likelihood of developing breast cancer (unlikely/likely),
Emotional Uncertainty and Monitoring (Table 4.10).
108
Table 4.10: Significant single predictors of worry about developing breast cancer in
the future
Variable P Odds ratio 95% CI
Perceived likelihood ofdeveloping
breast cancera
.00 2.89 1.65 to 5.09
Emotional Uncertainty .00 1.08 1.03 to 1.12
Monitoring .01 1.25 1.07 to 1.48
a
italics indicates a hypothesised variable
These three variables were entered into a multiple logistic regression model
and all were shown to make a significant contribution to the prediction of responses
to the item regarding worry about developing breast cancer in the future (Table 4.11).
Table 4.11: Multiple logistic regression to predict worry about developing breast
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italics indicates a hypothesised variable
c
value for model
The odds ofbeing worried about developing breast cancer in the future:
• increases by 2.91 when a woman perceives her risk of breast cancer as likely
rather than unlikely.
• increases by 1.24 for each point increase in the Monitoring subscale score.
• increases by 1.07 for each point increase in the Emotional Uncertainty subscale
score.
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For example, the odds of being worried about developing breast cancer in the
future for a woman who feels she is likely ever to develop breast cancer:
• has a Monitoring score of 0 and an Emotional Uncertainty score of 31 = 2.91
• has a Monitoring score of 8 and an Emotional Uncertainty score of 31 = 16.10
• has a Monitoring score of 4 and an Emotional Uncertainty score of 20 = 3.38
• has a Monitoring score of 4 and an Emotional Uncertainty score of 50 = 23.08
The model accounted for 18% of the "variation" in worry about developing
breast cancer in the future (p < 0.00) and correctly classified 68% of participants
(84%; n = 117 worried/45%; n = 42 not worried).
4.9.12d Predicting worry about dying from breast cancer and leaving their
children
Univariate analyses showed four significant single predictors of responses to
the item regarding worry about dying from breast cancer and leaving their children
(worried/not worried): perceived likelihood of developing breast cancer
(unlikely/likely), Emotional Uncertainty, Monitoring and age (Table 4.12).
Table 4.12: Significant single predictors ofworry about dying from breast cancer and
leaving their children
Variable P Odds ratio 95% CI
Perceived likelihood ofdeveloping
breast cancera
.01 2.36 1.22 to 4.56
Emotional Uncertainty .00 1.09 1.04 to 1.13
Monitoring .01 1.29 1.07 to 1.55
Age .02 .94 .90 to .99
a
italics indicates a hypothesised variable
All of these significant single predictors of responses to the item regarding
worry about dying from breast cancer and leaving their children were entered into a
multiple logistic regression model. The four variables entered were all shown to
make a significant contribution to the prediction of responses to this item (Table
4.13).
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Table 4.13: Multiple logistic regression to predict worry about dying from breast

















.86 .37 1 .02 2.36 1.15
to
4.83





.07 .02 1 .00 1.08 1.03
to
1.13






italics indicates a hypothesised variable
c
value for model
The odds of being worried about dying from breast cancer and leaving their
children:
• increases by 2.36 when a woman perceives her risk ofbreast cancer as likely
rather than unlikely.
• increases by 1.26 for each point increase in the Monitoring subscale score.
• increases by 1.08 for each point increase in the Emotional Uncertainty subscale
score.
• decreases by 0.94 for each additional year of a woman's age.
For example, the odds of being worried about dying from breast cancer and
leaving their children for a woman who feels she is likely ever to develop breast
cancer:
• is age 43, has a Monitoring score of 0 and an Emotional Uncertainty score of 31
= 1.79
• is age 43, has a Monitoring score of 8 and an Emotional Uncertainty score of 31
= 11.19
• is age 43, has a Monitoring score of 4 and an Emotional Uncertainty score of 20
= 2.01
• is age 43, has a Monitoring score of 4 and an Emotional Uncertainty score of 50
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= 17.92
• is age 30, has a Monitoring score of 4 and an Emotional Uncertainty score of 31
= 9.64
• is age 60, has a Monitoring score of 4 and an Emotional Uncertainty score of 31
= 1.64
The model accounted for 20% of the "variation" in worry about dying from
breast cancer and leaving their children (p < 0.00) and correctly classified 66% of
participants (48%; n = 37 worried/78%; n = 85 not worried).
4.9.12e Predicting worry about their children's risk of developing breast
cancer
Four variables were shown by univariate analyses to be significant single
predictors of responses to the item regarding worry about their children's risk of
developing breast cancer (worried/not worried): Emotional Uncertainty, psychiatric
history, number of daughters and GHQ-12 "case-level" distress (Table 4.14).
Table 4.14: Significant single predictors of worry about their children's risk of
developing breast cancer
Variable P Odds ratio 95% CI
Emotional Uncertaintya .05 1.04 1.00 to 1.08
Psychiatric history .00 2.60 1.40 to 4.82
Number of daughters .00 2.22 1.48 to 3.34
GHQ-12 "case-level" distress .02 2.26 1.17 to 4.37
a
italics indicates a hypothesised variable
All of these variables were entered into a multiple logistic regression model
to determine the best prediction of responses to the item regarding worry about their
children's risk of developing breast cancer. Two variables made a significant
contribution to the prediction of responses to this item (Table 4.15).
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Table 4.15: Multiple logistic regression to predict worry about their children's risk of

























The odds of being worried about their children's risk of developing breast
cancer:
• increases by 3.18 when a woman has a psychiatric history relative to no
psychiatric history.
• increases by 2.58 for each additional daughter.
For example, the odds of being worried about their children's risk of
developing breast cancer for a woman with no psychiatric history and:
• 1 daughter = 0.62
• 3 daughters = 5.15
The model accounted for 19% of the "variation" in worry about their
children's risk of developing breast cancer (p < 0.00) and correctly classified 65% of
participants (54%; n = 48 worried/75%; n = 74 not worried).
4.9.12f Predicting intrusive thoughts about breast cancer risk
Four variables were found to be significant single predictors of scores on the
Intrusion subscale of the IES on univariate analyses: Emotional Uncertainty, marital
status (married or living with a partner/not married or living with a partner),
education to age 16 (education to age 16 only/education after age 16) and Blunting
(Table 4.16). These variables were subsequently entered into a multiple linear
regression model.
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t P 95% CI
Emotional Uncertainty b .38 4.01 .00 .15 to .43
Marital status -.28 -2.83 .01 -6.92 to-1.22
Education: to age 16 .33 3.40 .00 1.62 to 6.16
Blunting -.29 -2.97 .00 -2.05 to -.41
a
standardised (Beta)
italics indicates a hypothesised variable
Two variables made a significant contribution to the prediction of scores on
the Intrusion subscale: education to age 16 and Emotional Uncertainty (Table 4.17).
Table 4.17: Multiple linear regression to predict scores on the Intrusion subscale of





















Higher scores on the Intrusion subscale were predicted by being educated to
age 16 only and having higher scores on the Emotional Uncertainty subscale. For
example, predicted scores on the Intrusion subscale for a woman who has been:
• educated to age 16 only and has an Emotional Uncertainty score of 31 = 8.69
• educated after age 16 and has an Emotional Uncertainty score of 31 = 5.40
• educated to age 16 only and has an Emotional Uncertainty score of 20 = 6.82
• educated to age 16 only and has an Emotional Uncertainty score of 50 = 11.92
The model accounted for 12% of the variance in Intrusion subscale scores (p
= .00).
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4.9.12g Predicting avoidant thoughts about breast cancer risk
Univariate analyses showed that four variables were significant single
predictors of scores on the Avoidance subscale of the IES: Emotional Uncertainty,
marital status (married or living with a partner/not married or living with a partner),
education: to age 16 (education to age 16 only/education after age 16) and education:
university graduate (university graduate/not) (Table 4.18). These variables were
subsequently entered into a multiple linear regression model.




t P 95% CI
Emotional Uncertainty b .23 2.31 .02 .03 to .43
Marital status -.38 -4.04 .00 -10.77 to
-3.68
Education: to age 16 .27 2.73 .01 1.14 to 7.25
Education: university
graduate




italics indicates a hypothesised variable
Marital status and education to age 16 made a significant contribution to
scores on the Avoidance subscale (Table 4.19).
Table 4.19: Multiple linear regression to predict scores on the Avoidance subscale of
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Higher scores on the Avoidance subscale were predicted by not being married
or living with partner and being educated to age 16 only. For example, predicted
scores on the Avoidance subscale for a woman who is:
• married or living with a partner and has been educated to age 16 only = 12.39
• not married or living with a partner and has been educated to age 16 only = 20.45
• married or living with a partner and has been educated after age 16 = 6.73
• not married or living with a partner and has been educated after age 16 = 14.79
The model accounted for 30% of the variance in Avoidance subscale scores
(p < .00).
4.9.12h Predicting total Impact of Event Scale (IES) score
Six variables were found to be significant single predictors of total IES score:
Emotional Uncertainty, marital status (married or living with a partner/not married or
living with a partner), education to age 16 (education to age 16 only/education after
age 16), education: university graduate (university graduate/not), occupation
(employed/not employed) and Blunting (Table 4.20). These variables were
subsequently entered into a multiple linear regression model.
Table 4.20: Significant single predictors of total IES score
Variable Regression
coefficient3
t P 95% CI
Emotional Uncertaintyb .35 3.59 .00 .25 to .86
Marital status -.37 -3.78 .00 -16.72 to -5.21
Education: to age 16 .34 3.53 .00 3.62 to 12.92
Education: university -.21 -2.09 .04 -10.36 to -.26
graduate
Occupation -.21 -2.13 .04 -14.40 to -.49




italics indicates a hypothesised variable
Two variables made a significant contribution to the prediction of the total
IES score: education to age 16 and marital status (Table 4.21).
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Higher total IES scores were predicted by being educated to age 16 only and
not being married or living with a partner. For example, predicted scores on total IES
for a woman who has been:
• educated to age 16 only and is married or living with a partner = 21.11
• educated after age 16 and is married or living with a partner = 12.96
• educated to age 16 only and is not married or living with a partner = 30.39
• educated after age 16 and is not married or living with a partner = 22.24
The model accounted for 18% of the variance in total IES scores (p < .00).
4.9.121 Summary of results investigating psychological distress
Table 4.22 lists the variables that formed the best predictive models for each
of the psychological distress variables.
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Table 4.22: Summary of results investigating psychological distress
Psychological distress variable Predictor
GHQ-12 "case-level" distress Psychiatric history
Emotional Uncertainty coping stylea
Worry about developing breast cancer
anytime now
Perceived likelihood ofdeveloping breast
cancer
Emotional Uncertainty coping style
Worry about developing breast cancer in
the future
Perceived likelihood ofdeveloping breast
cancer
Monitoring coping style
Emotional Uncertainty coping style
Worry about dying from breast cancer
and leaving their children
Perceived likelihood ofdeveloping breast
cancer
Monitoring coping style
Emotional Uncertainty coping style
Age




Intrusive thoughts about breast cancer
risk
Education to age 16
Emotional Uncertainty coping style
Avoidant thoughts about breast cancer
risk
Marital status
Education to age 16
Total Intrusive and Avoidant thoughts
about breast cancer risk
Education to age 16
Marital status
a
italics indicates a hypothesised variable
4.10 Discussion
4.10.1 Participants
The participation rate for the study was good (69%). The participants were
representative of the 410 women who met the initial eligibility criteria in terms of
age and number of years they had been attending the familial breast cancer clinic.
The vast majority of participants were ofwhite ethnicity (only one woman
was of non-white ethnicity). This reflects the predominantly white population in
Scotland where in 1999 only 1.6% were of an ethnic minority background (Scottish
Executive, 2002).
The participants in this study were also highly educated with over half being
educated after age 18. Similar findings have been shown in other studies that have
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recruited participants from the same familial breast cancer clinic (i.e. Rees, 2000,
Personal communication; Cull et al, 1998), from other U.K clinics (e.g. Brain et al,
1999) and clinics internationally (e.g. Meiser et al., 2000, 2001b; Rimer et al., 1996).
Indeed, a higher educational level has been shown to predict participation in a trial of
breast cancer genetic risk counselling (Rimer et al., 1996). This tendency for breast
cancer genetic risk counselling to attract highly educated women poses a potential
problem that needs to be addressed by familial breast cancer clinics. Greater focus
should perhaps be given to investigating effective ways ofpromoting attendance
among less educated women and exploring their needs for information and support
which are likely to be different from the highly-educated sample in this study.
Participants and non-participants could only be compared on a limited
number of variables. It was not possible to ascertain whether the sample described
here was biased with respect to variables such as psychological distress and coping
style. It is likely that more distressed women chose not to participate in the study,
particularly if they had a blunting coping style or were avoidant of breast cancer
cues. However, a range of levels of general psychological and breast-cancer-specific
distress were represented among participants.
4.10.2 Were the study aims met and hypotheses supported?
Aim 1: To assess the prevalence of general psychological morbidity (in terms of
GHQ- 12 probable psychiatric "caseness") in women living with an increased
risk of breast cancer.
Twenty-six percent of participants exhibited "case-level" distress using a
threshold of three points or more on the GHQ-12.
The prevalence of probable psychiatric morbidity obtained in this study is
lower than that obtained in general population samples using the same measure and
threshold (i.e. May, 1992; Plummer et al., 2000; Weich et al., 2001). However, these
samples may not be comparable to the participants in the present study on a number
of factors including age, gender and social deprivation. Although age has not been
shown to have a strong influence on GHQ score, some studies have found that scores
in women have a tendency to decrease with age (Goldberg & Williams, 1991). There
is evidence that the prevalence of GHQ "case-level" distress is higher among women
than men (Goldberg & Williams, 1991). In terms of social deprivation, there is
limited evidence that greater prevalence is found in lower social classes and urban
populations, but strong evidence of higher prevalence in the unemployed (Goldberg
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& Williams, 1991). In addition, the fact that in two of these studies (i.e. May, 1992;
Plummer et al., 2000) the participants were attending their general practice at the
time of assessment, may have increased their levels of distress.
The prevalence of probable psychiatric morbidity is similar to that observed
using the same measure and threshold in a sample of 249 women 12 months after
genetic risk counselling (Watson et al., 1999) and is slightly lower than that obtained
in a sample of 91 women six months after breast cancer genetic risk counselling
(Watson et al., 1998). Similar results have been obtained in women attending for
breast cancer genetic risk counselling using the GHQ-30 (i.e. Rees, 2000, Personal
communication; Cull et al, 1998, 1999) where about one third of each sample
exhibited "case-level" distress. This suggests that the prevalence of general
psychological morbidity is similar in women who have been attending a familial
breast cancer clinic for several years as in women who have recently attended breast
cancer genetic risk counselling.
Aim 2: To assess the psychological status of women living with an increased risk
of breast cancer in terms of general psychological distress (somatic symptoms)
and breast cancer-specific distress (intrusive and avoidant thoughts about
breast cancer risk and worry about breast cancer risk-related issues)
The extent to which participants reported experiencing somatic symptoms
(10% scored at least five points out of seven) was comparable to Hopwood et al.'s
findings using the same GHQ-28 subscale in women three months after breast cancer
genetic risk counselling where 12% scored at least five points (Hopwood et al.,
1998). Forty six percent of participants scored at least one point which is a slightly
higher proportion than that reported for British women in the general population
three months after receiving routine breast cancer screening (34%) (Ellman et al.,
1989). However, the mean age of that sample was 53.9 years compared to 43.4 years
in the present study. Differences in the age of the samples could help to account for
differences in the results regarding somatic symptoms, given the evidence of an
effect of age on GHQ scores. The results of our previous telephone focus group study
suggest that women living with an increased risk of breast cancer may have an
increased awareness ofbodily symptoms as they are well informed about breast
symptoms and are likely to have witnessed the symptoms of other relatives affected
by breast cancer: "You have a heightened awareness of the possibility of breast
cancer and you're always watching".
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There was evidence that the minority ofwomen (44%) who had thought
about the risk of breast cancer in the past week and had therefore completed the
Impact ofEvent Scale were different from the women who had not completed the
scale in terms of coping style, somatic symptoms, appraisal and worry about breast
cancer-risk related issues. The results suggest that these women were more likely to
have higher scores on the Monitoring subscale, Emotional Uncertainty subscale and
somatic symptoms subscale, were more likely to perceive themselves as likely to
develop breast cancer and to worry about breast cancer risk-related issues.
As far as intrusive and avoidant thoughts about breast cancer risk were
concerned, the results were similar to other studies ofwomen attending a familial
breast cancer clinic (e.g. Rees, 2000, Personal communication; Watson et ah, 1999)
and substantially higher than in women in the general population (e.g. Lloyd et al.,
1996; Rees, 2000, Personal communication). Although these results imply that this
type ofbreast cancer-specific distress does not generally decrease the longer women
attend a familial breast cancer clinic, such intrusive and avoidant thoughts may only
be a problem for a subset ofwomen (less than half of participants indicated that they
had thought about the risk of breast cancer in the past week).
Worries about issues relating to breast cancer risk were common with a large
proportion ofwomen (73%) being worried in the past week by at least one of the
issues related to breast cancer risk that were listed. By far the most common worry
was about developing breast cancer in the future, which represents a realistic concern
for these women.
Aim 3: To assess the prevalence of information needs and preferences in women
living with an increased risk of breast cancer.
The results confirmed the findings of the telephone focus group study as a
common need for up-to-date information related to familial risk of breast cancer was
identified. Although the most frequently requested topics were on scientific subjects
such as breast cancer genetics and genetic testing, a large proportion ofparticipants
also expressed a need for psychosocial topics such as maintaining a healthy lifestyle
and stress management.
Over 90% of participants indicated that they would be interested in receiving
at least one of the 11 topics of information listed and at least one of the four
information formats listed. However, in contrast to the results of the telephone focus
group study where written materials were regarded as supplementary to a group
meeting, in this study there was an overall preference (85%) for the information to be
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presented in a written format. The variation in preferences may reflect differences in
the samples of the two studies. Given that the telephone focus group participants
were a small group ofwomen who volunteered to take part in a telephone discussion
group, they may be more likely to prefer receiving information in an interactive
environment such as a group meeting.
Aim 4: To investigate the impact of appraisal, coping style, social support and
breast cancer cues on general psychological distress (GHQ-12 "case-level"
distress) and breast cancer-specific distress (intrusive and avoidant thoughts
about breast cancer risk and worry about breast cancer risk-related issues) in
women living with an increased risk of breast cancer.
This aim was met by testing the study hypotheses through univariate
analyses. Further multivariate analyses then identified the combination of variables
that best predicted general psychological and breast cancer-specific distress.
Hypothesis la: Women who perceive themselves to be at a greater risk of
developing breast cancer will show greater levels of psychological distress than
women who perceive themselves to be at a lower risk.
There was a substantial amount of support for this hypothesis: perceiving
your risk of developing breast cancer as likely (rather than unlikely) independently
predicted being worried about a number ofbreast cancer-risk-related issues (i.e.
developing breast cancer anytime now, developing breast cancer in the future, dying
from breast cancer and leaving their children). For example, a woman was three
times more likely to be worried about developing breast cancer now if she perceived
herself as likely rather than unlikely to develop breast cancer.
Previous research in women with a family history of breast cancer has shown
that greater perceived likelihood of developing breast cancer in the future is
associated with increased general psychological and breast cancer-specific distress
(Erblich et al., 2000).
Hypothesis lb: Women who perceive themselves to have less control over their
risk of developing breast cancer will show greater levels of psychological
distress than women who perceive themselves to have greater control over their
risk.
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There was no evidence that perceiving less control over developing breast
cancer was related to greater general psychological or breast cancer-specific distress.
These findings are in contrast to previous research. For example, Cull et al. (2001a)
found that having an internal locus of control regarding your health (i.e. perceiving
control of your health through your own behaviour) was significantly associated with
GHQ-30 "case-level" distress in women attending a familial ovarian cancer clinic.
High perceptions of control over breast cancer risk have previously been found to be
predictive of low levels of general psychological distress and fewer intrusive
thoughts in women with a family history ofbreast or ovarian cancer (Audrain et al.,
1997).
The lack of support for this hypothesis from the present study could be due to
the fact that the participants had been living with the knowledge of their increased
risk of breast cancer for several years. During this time a relationship between
perceived control and psychological distress may become less pronounced as the
women gain more experience of living with an increased risk of breast cancer and
perhaps learn to minimise the psychological impact of their beliefs.
Hypothesis 2a: Women with a high Monitoring coping style will show greater
psychological distress than women with a low Monitoring coping style.
A higher score on the Monitoring subscale was found independently to
predict being worried about: developing breast cancer anytime now, developing
breast cancer in the future and dying from breast cancer and leaving their children.
As expected, those women who have a tendency to scan for cues related a specific
threat (Miller 1987), are likely to experience more worry about breast cancer risk-
related issues. Likewise, Wardle et al. (1995) have shown that Monitoring made an
independent contribution to the prediction of cancer worry in women with a family
history of ovarian cancer where greater Monitoring predicted greater worry.
Hypothesis 2b: Women with a high Monitoring coping style will show greater
intrusive thoughts about breast cancer than women with a low Monitoring
coping style.
There was no evidence to support the hypothesis as Monitoring was not
found to be predictive of intrusive thoughts about breast cancer risk. In contrast to
the present findings, Schwartz et al. (1995) found that a high level ofMonitoring was
related to greater intrusive thoughts about breast cancer in women at increased risk of
123
ovarian cancer. However, in the current study a higher score on the Blunting subscale
was found to independently predict fewer intrusive thoughts about breast cancer risk
and a smaller total IES score. It does seem plausible that women who tend to cope
with threat-related cues by distraction (Miller 1987) would experience less intrusive
thoughts about their risk of breast cancer. This finding supports Myers & Derakshan
(2000), who suggest that Monitoring and Blunting remain separate constructs (i.e.
low Monitoring and high Blunting are not equivalent) which should be analysed as
such (i.e. two subscale scores rather than a total score).
Hypothesis 2c: Women with a high score on Emotional Uncertainty will show
greater psychological distress than women with a low score on Emotional
Uncertainty.
Higher scores on the Emotional Uncertainty subscale were shown
independently to predict GHQ-12 case-level distress, being worried about a number
ofbreast cancer risk-related issues (i.e. developing breast cancer anytime now,
developing breast cancer in the future, dying from breast cancer and leaving their
children, their children's risk of developing breast cancer), intrusive and avoidant
thoughts about breast cancer risk. The 95% confidence intervals for worry about their
children's risk of developing breast cancer included an odds ratio of 1, which
indicates this result should be interpreted with caution. However, the results still
provide a large amount of support for the hypothesis in terms of the other measures
ofpsychological distress.
These findings suggest that women who have a tendency to respond to
uncertain situations in emotional ways (e.g. anger, anxiety, depression) are more
likely to experience negative psychological effects of living with an increased risk of
breast cancer. Emotional Uncertainty has been shown to be associated with "a lack of
detachment from stressful situations" and is suggested to represent a maladaptive
style of coping with uncertain situations through becoming distressed (Greco &
Roger, 2001). Greater distress and uncertainty have been reported during an
experimental manipulation of uncertainty by individuals scoring high on the
Emotional Uncertainty subscale (Greco & Roger, 2001). As coping style may not be
amenable to intervention, it may be pertinent for future research to investigate the
provision of additional psychological support to those women who score highly on
the Emotional Uncertainty subscale.
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Hypothesis 3: Women who are less satisfied with their social supports will show
greater psychological distress than women with greater satisfaction with their
social supports.
There was some support for this hypothesis as lower total satisfaction with
social supports was independently found to predict GHQ-12 "case-level" distress.
However, the results did not show any relationship between total satisfaction with
social supports and breast cancer-specific distress. There are several possible
explanations for these results. Even women with good social support may not be
completely protected from the potential distress associated with being at increased
risk ofbreast cancer. An alternative explanation may be due the nature of the
instrument used to assess social support. The SSQ-6 assessed social support in
general and did not specifically refer to support coping with particular difficulties
such as those associated with having an increased risk of breast cancer (e.g. support
when waiting for the results of a mammogram). Future studies could develop a
measure to assess such specific social support and investigate the impact of this
support on breast cancer-specific distress.
Hypothesis 4: Women who are approaching the age when their mother was
diagnosed with breast cancer will show greater psychological distress than
women who are much younger or older than their mother at diagnosis.
The results did not provide any evidence to support the hypothesis. The
difference between age of the participant's mother at diagnosis of breast cancer and
the current age of the participant herselfwas not related to the participant's levels of
general psychological or breast cancer-specific distress. This is in contrast to the
qualitative findings of the telephone focus group study where participants commonly
described an increase in anxiety as they approached the age at which an affected
relative had been diagnosed with breast cancer (e.g. "My mum was diagnosed at 40
but she didn't die till she was 42 so I'll be 40 this year... it's coming over me like a
big shadow"). Several women also described their anxieties gradually being
alleviated as they passed this age. Differences in chronic levels of distress may have
masked any changes in distress due to this breast cancer cue. Therefore, a
longitudinal study may be more appropriate to investigate levels of chronic distress
and changes in distress as a woman approaches, reaches and passes the same age
when her mother was diagnosed with breast cancer.
125
4.10.3 Predicting "case-level" distress
The factors identified as being important in predicting GHQ-12 "case-level"
distress were having a psychiatric history and having tendency to cope with uncertain
situations in emotional ways (Emotional Uncertainty coping style was already shown
to be important in univariate analyses).
These results support the findings of Cull et al. (2001b). They found that
cancer patients who reported a past psychiatric history were twice as likely to be
identified as cases on clinical interview than patients without such a history.
Hopwood et al. (1998) have also shown that significantly more women who had a
self-reported psychiatric history were confirmed to have a psychiatric disorder three
months after attending breast cancer genetic risk counselling than women who had
not reported such a history.
4.10.4 Predicting intrusive and avoidant thoughts about breast cancer risk
Levels of intrusive and avoidant thoughts about breast cancer risk (including
total IES score) were shown to be predicted by different combinations of three
variables: being educated to age 16 only, being unmarried or not living with a partner
and having tendency to cope with uncertain situations in emotional ways (Emotional
Uncertainty coping style was already shown to be important in univariate analyses).
Women who are less well educated may be not be well informed about
relevant breast cancer risk-related issues. Therefore they may experience unresolved
uncertainty surrounding these issues, which may increase their levels of breast
cancer-specific distress. Baider et al. (1999) found that being less well educated was
related to greater intrusive thoughts about breast cancer amongst women with a
family history of breast cancer who were attending an educational programme about
the diagnosis and genetics of breast cancer.
The finding that being unmarried or not living with a partner was important in
predicting greater avoidant thoughts and total IES score may reflect a lack of
adequate social support in this group ofwomen. However, total satisfaction with
social supports was not found to be independently predictive of intrusive or avoidant
thoughts about breast cancer risk. The SSQ-6 may be too general a measure of social
support to be sensitive to detect support specific to coping with an increased risk of
breast cancer. Research in women with a family history of breast or ovarian cancer
has found that being married was related to lower levels of general psychological
distress (i.e. Audrain et al., 1997; Baider et al., 1999).
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4.10.5 Predicting worry about breast cancer risk-related issues
Three factors were found to be important in predicting worry about a number
of breast cancer-risk related issues: perceiving your risk of developing breast cancer
as likely (rather than unlikely), having tendency to cope with uncertain situations in
emotional ways and having a Monitoring coping style. These findings were not
surprising, given the support provided for the study hypotheses by univariate
analyses.
Being younger was also important in predicting worry about dying from
breast cancer and leaving their children. As younger women may be more likely to
have young children than older women, it seems plausible that they would be more
concerned about leaving their children at an age when they cannot look after
themselves. This reflects the findings of the telephone focus group study where
women with young children described a major concern about their children's ability
to cope if they developed breast cancer which mirrored their own experience of
losing their mothers at a very young age: "We were very small when my mother died
and I'd hate to leave my children now so I think when you bring small ones into the
equation that certainly worried me more".
As far as predicting worry about their children's risk ofbreast cancer, only
two factors made an significant contribution: having a psychiatric history and having
more daughters. It is not clear why having a psychiatric history was only important in
predicting worry about other people. There was evidence from the telephone focus
group study that having daughters was particularly linked to worry about their
children's risk of breast cancer. This was commonly described by women with
daughters: "I can cope with sort of having the gene or whatever but it suddenly
dawned on me about my own two daughters.. .1 can cope with it myself but I wonder
about my children, maybe that's over the years I've thought that now".
4.11 Methodological issues
There were a number ofmethodological issues concerning the study that
should be noted.
Due to the shortage ofwell-developed measures for some of the key
constructs of the study (i.e. information needs and preferences, breast cancer cues,
worry about breast cancer risk-related issues), a number of study-specific items were
developed. Several methodological difficulties were experienced with some of these
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items. One participant did not understand the term "prophylactic surgery" which was
used in one of the information needs and preferences items. It became apparent
during the course of the study that other ad hoc items were worded in a slightly
ambiguous or unclear manner. For example, the response "alive but unwell" to the
family history items concerning the status of relatives with breast cancer did not
indicate if breast cancer was the cause of the ill-health. It may have been better to
separate the two breast cancer cues items about waiting for/receiving the results of a
mammography or breast biopsy into two parts, one referring to the results of a
mammogram and the other to the results of a breast biopsy. In this way, a routine
visit to the clinic may have been distinguished from an additional appointment. The
item regarding worry about the frequency of their clinic appointments was confusing
for some participants. It may have been clearer to use infrequency rather than
frequency or to have asked participants if their worry was about too few or too many
appointments. For some of the ad hoc items developed to assess breast cancer cues
and information needs and preferences, there was a relatively large proportion of
missing data. This may have been minimised if the responses were in a yes/no format
rather than a checklist to endorse.
In addition to the methodological issues experienced with some of the ad hoc
items, there were also problems with some of the standard measures. Although the
Uncertainty Response Scale was shown to be a useful measure of coping style in this
group ofwomen, the use of "discern" in one of the items was found to be confusing
by one participant. There was a substantial amount ofmissing data on the SSQ-6,
which may have been due to the large amount and format of the information
requested by this measure (several participants commented that this measure was
difficult to complete).
Inconsistencies were apparent between completing the Impact ofEvent Scale
(IES) opt-out box (i.e. indicating they had not thought about the risk of breast cancer
in the past week), being worried about a breast cancer risk-related issue and having
experienced a breast cancer cue in the past week. Of the 138 women who completed
the IES opt-out box, a substantial proportion indicated that they had been worried in
the past week about a breast cancer risk-related issue (e.g. 35% had been worried
about developing breast cancer in the future, 23% had been worried about their
children's risk of developing breast cancer), or indicated that they had experienced a
breast cancer cue in the past week (e.g. 33% had experienced a media report about
breast cancer, 38% had examined their breasts). These findings suggest that opting-
out of completing the IES does not necessarily indicate that an individual has not
thought about their breast cancer risk in the past week as it could reasonably be
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assumed that worry about a breast cancer-risk related issue must have involved some
degree of thought about breast cancer risk. Alternatively, participants may not have
read or responded appropriately to the time-frame specified by the questions. Further
investigations on the use and validity of the IES opt-out box would be required.
There were a number of limitations in the models produced by multiple
logistic regression. The amount of "variation" in psychological distress accounted for
by the models ranged from 13-22%. The proportion of participants correctly
classified as exhibiting "case-level" distress/being worried about a breast cancer risk-
related issue or not ranged from 65-78% between models. The models generally
correctly classified greater proportions ofwomen who did not exhibit "case-level"
distress or who weren't worried than those who showed "case-level" distress or who
were worried. This is reflected in the fact that all of the deviance plots of the multiple
logistic regression models did not appear to be normally distributed which would
indicate that there were a number ofwomen for which the models didn't fit very
well. The classification plots also highlighted women with high probabilities of being
classified in the incorrect group (e.g. as worried instead ofnot worried). The model
ofworry about developing breast cancer anytime now produced a significant Hosmer
& Lemeshow test (p = .015) which indicates that the model did not fit the data very
well. Only 21% of the worried women were correctly classified. All of these results
suggest that there was substantial room for improvement in the predictive value of
the models produced, particularly for distressed or worried women whom it would be
important to accurately identify.
Likewise the multiple linear regression models may have several
methodological limitations. As 138 women ticked IES opt-out box indicating that
they had not thought about the risk of breast cancer in the past week, the sample
included in these models was about one third of total sample. In addition, the
multiple linear regression models did not account for the majority (12-30%) of the
variance in Intrusion, Avoidance and total IES score. Given these potential biases
and limitations, the models should be interpreted with caution.
The participants may have experienced additional breast cancer cues during
the study that may have affected their responses to the questionnaire. National breast
cancer awareness month took place during the study period (22% of participants
completed their questionnaire during this month). Several women also commented
that participating in the study had made a large impact on the amount they had
thought about their breast cancer risk. Although this breast cancer cue is obviously




There were several limitations of the study in terms of the constructs that
were investigated and the interpretation of the results.
Several factors that were likely to influence psychological distress were not
investigated in the study.
Firstly, participants were originally asked to provide dates of their last and
next scheduled appointment at the familial breast cancer clinic and to indicate if they
had attended the clinic in the past week. A sample of these responses were compared
and checked with the clinical case notes and were found to be unreliable. As it was
outside the scope of this study to collect this data from 249 participant's case notes,
the clinic appointment data were excluded from any analysis. Participants in the
telephone focus group study described experiencing a period of heightened emotions
as they approached and attended their routine appointment at the familial breast
cancer clinic: " I tend to blank it out when I walk out of there (the familial breast
cancer clinic) until a week before I'm due to go back again and I start to think about
it during that week". Future studies could test the hypothesis that women who have
either recently attended a familial breast cancer clinic or who are approaching the
day of their next routine appointment will show greater psychological distress than
women with a greater distance in time to their last or next appointment.
Secondly, the participants' accuracy of their perceived risk of developing
breast cancer was not assessed in this study. There were two problems with the
objective breast cancer risk estimates recorded for each participant on the clinical
database: (1) they were in a different non-comparable format (i.e. percentages,
categories, ranges) for different women; (2) they were recorded during genetic risk
counselling several years previously and were not necessarily up-to-date. Therefore,
without access to an accurate and comparable estimate of breast cancer risk, the
participants' accuracy of their perceived risk in terms of under-, over- and correct
estimates could not be assessed. In addition, participants' change in their perceived
risk of breast cancer since first attending the clinic could not be compared to a
possible change in their objective breast cancer risk (e.g. due to a change in their
family history). A number of studies have investigated the relationship between
accuracy of breast or ovarian cancer risk perception and psychological distress (e.g.
Cull et al, 1998, 1999, 2001a; Hopwood et al., 1998, 2001; Watson et al., 1998,
1999). For example, Cull et al. (2001a) found that twice as many participants who
overestimated their ovarian cancer susceptibility exhibited "case-level" general
psychological distress than women who were under-estimators. First-time attendees
130
ofbreast cancer genetic risk counselling who over-estimate their risk of breast cancer
were shown to be more likely to have frequent or constant worries about cancer than
those women who under- or correctly estimated their risk (Watson et al., 1999).
Thirdly, one participant reported the effect of a recent bereavement on her
questionnaire responses (her mother had died from oesophageal cancer during the
study period). Experiencing a recent bereavement of a personally known relative
from breast cancer has been found to be associated with greater general
psychological distress in women attending a familial breast cancer clinic (Rees,
2000, Personal communication). There are sound theoretical explanations for the
influence ofpersonal experience of breast cancer in the family, including
bereavements, on emotional and cognitive responses to personal risk of developing
breast cancer (Rees et al., 2001).
Research has shown that a number of aspects of experiencing breast cancer in the
family predict general psychological distress and cancer worry (Rees, 2000, Personal
communication).
There were also limitations with the interpretation of results.
Although the items concerning worry about breast cancer-risk-related issues
assessed the actual content of these worries, they did not indicate to what extent these
worries interfered with their everyday life. The Cancer Worry Scale (original items:
Lerman et al., 1991a, 1991b, 1993, 1994; 6-item scale: Watson et al., 1998) contains
six items to assess the effect ofworry about cancer on daily functioning in terms of
its frequency and severity. The scale has now been subjected to thorough
psychometric testing and has performed satisfactorily (i.e. Brain et al., 1999; Rees,
2000, Personal communication; Hopwood et al., 2001). It may be appropriate to use
this scale in future research to investigate cancer-specific worry.
As this study was of a cross-sectional design, the results that demonstrate a
relationship between a particular variable and psychological distress do not indicate a
causal link between these variables. Therefore, further longitudinal research would
be needed to investigate the causes of both general psychological distress and breast
cancer-specific distress in this population. This would allow appropriate
interventions to prevent or minimise psychological distress to be designed and
evaluated.
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4.13 Clinical implications and future research
This study of long-term attendees of a familial breast cancer clinic found a
similar prevalence of "case-level" general psychological distress and similar levels of
breast cancer-specific distress as shown in first-time attendees. A subset ofwomen
were shown to experience thoughts and worries about cancer which had a
considerable detrimental impact on their daily lives. Further longitudinal research is
needed to investigate the severity and persistence of these worries and to determine if
there is a need for psychological help among these women. This would enable the
development of appropriate psychological interventions to reduce severe distress in
this group ofwomen.
This study also highlighted the importance of a number of sociodemographic,
appraisal, coping style and social support factors in predicting general psychological
and breast cancer-specific distress. The exact role of these factors in causing distress
warrants further research which would enable a greater understanding of the causes,
prevention and reduction of distress in this group ofwomen.
Participants expressed clear needs for up-to-date and reliable information on
issues related to familial risk of breast cancer. These results informed both the
content and format of a subsequent intervention designed to meet the needs of these
women.
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Chapter 5: The Development of a Psychoeducational
Intervention for Women Living with an Increased Risk of
Breast Cancer
5.1 Introduction
Research in cancer patients has linked poor provision of information with
adverse psychological and physical outcomes (Thomas et ah, 1999). This research
has also shown that patient well-being can improve with the increased provision of
information (Thomas et ah, 1999). Many participants in the telephone focus group
study (Chapter 3) found that being well informed on relevant issues had decreased
their anxiety and assisted their decision-making: ".. .the more knowledge and
information you have, the easier it is to cope with things and the more it helps you".
Little published information has been produced specifically for women with a
family history of breast cancer. The information available to date includes leaflets
and web pages about breast cancer genetics and genetic testing (e.g. National Cancer
Institute, 1997), a book covering a number of issues relevant to women with a family
history of breast cancer (i.e. Kelly, 2000) and a leaflet about familial breast/ovarian
cancer for women who suspect they may be at increased risk of the disease (i.e.
Cancer Research Campaign, 1999). This information, which predominantly targets
American women and covers scientific issues related to familial breast cancer, has
not been written specifically to address the needs of long-term attendees of a familial
breast cancer clinic.
Of the variety of interventions in women with a family history of breast
cancer involving information giving (e.g. Audrain et al., 1999; Cull et ah, 1998;
Esplen et ah, 2000; Gagnon et ah, 1996; Kash et ah, 1999; Lerman et ah, 1996;
Schwartz et ah, 1998; Watson et ah, 1998; Wellisch et ah, 1999) only one has
focussed on a purely written intervention. Gagnon et ah (1996) carried out a pilot
randomised controlled trial of a series ofnewsletters as part of a larger longitudinal
study. The newsletters aimed to improve accuracy ofperceived risk of breast cancer,
to decrease both general psychological and cancer-specific distress and to improve
adherence to breast self-examination. Four consecutive issues of a written newsletter
were sent to 41 American women who were attending breast cancer genetic risk
counselling. These newsletters contained information and advice on breast cancer
screening (clinical breast examination, mammography, breast self-examination), diet
and cancer, breast cancer risk factors and genetic counselling. However, a
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comparison of the newsletter group (n = 26) and control group (n = 23) showed no
significant differences on the key outcomes post-intervention (about a month after
the last issues of the newsletter had been received). The lack of evidence may be due
to a number ofmethodological limitations of the study including: a lack of data about
whether the newsletters were actually read, extensive media coverage on breast
cancer during the study period (Gagnon et al., 1996) and the small sample size.
It is therefore evident that there is a lack of both published written
information covering scientific and psychosocial issues and published
psychoeducational interventions for British women who are long-term attendees of a
familial breast cancer clinic.
5.2 Rationale
Like most familial breast cancer clinics in the U.K, the Ardmillan familial
breast cancer clinic in the South East of Scotland does not routinely provide long-
term attendees with education or psychosocial support. For these women, contact
with the clinic is limited to routine appointments, which may be at least at yearly
intervals. During these follow-up appointments, there is an opportunity to update a
woman's family history and the appropriate breast cancer screening such as clinical
breast examination or mammography is performed. Due to growing numbers of
referrals to familial breast cancer clinics and hence pressures on the resources of staff
time, these follow-up appointments are also likely to become shorter and less
frequent. Therefore the opportunity at the clinic to be updated on relevant scientific
developments or discuss psychosocial issues may be increasingly restricted. As one
participant in the telephone focus group study expressed (Chapter 3): "I don't think
I've been (to the clinic) for more than a year so I suppose I feel slightly out of touch
with what's going on". There were also concerns expressed by clinicians that some
of these women may not be receiving adequate information or support.
All of the 25 participants in the telephone focus group study (Chapter 3) of
long-term attendees of the clinic highlighted at least one unmet need in terms of
information or support related to their risk of breast cancer. Providing reliable
information on topics related to familial breast cancer was seen to be an important
addition to the existing clinical service: "I personally would like to maybe receive a
newsletter or something.. .some sort of information or something that makes you
think, well you know I'm not just going to be thought of once a year".
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In the subsequent cross-sectional questionnaire study (Chapter 4) of 249
long-term attendees of the clinic, the results of the telephone focus group study
regarding unmet needs were confirmed. A widespread need for up-to-date
information related to familial risk of breast cancer was identified. The eight most
popular topics of information requested were: breast cancer genetics (72%), research
conducted at the familial breast cancer clinic (68%), genetic testing (67%), breast
cancer treatment (63%), breast cancer screening (59%), healthy lifestyle (49%),
stress management (41%) and hormone replacement therapy (41%). There was also a
general preference for this information to be in a written form (84%) rather than
group meetings with (21%) or without their families (40%) or telephone discussion
groups (11%).
In terms of scientific information, it seems important to provide these women
with up-to-date reliable information on issues about familial risk of breast cancer that
may concern them. Given the scientific advances in this area in recent years, the
information these women received when they initially attended for genetic risk
counselling several years previously, may now be out of date. In addition, some of
the information about breast cancer these women can access such as through the
Internet may not necessarily be reliable or applicable to them. These women already
live with the chronic uncertainty about whether or when they will develop breast
cancer. If additional uncertainties could be clarified or resolved their burden would
perhaps be reduced.
Long-term attendees of a familial breast cancer clinic are likely to vary in
their ability to cope with uncertainty (Appleton et al., 2000). As breast cancer
represents a realistic concern for these women, worry about their risk is
understandable. However, a subset of these women may experience chronic distress,
which adversely affects them in their everyday lives (Appleton et al., 2000). A recent
review of self-help treatments has shown that written information can be beneficial
for primary care patients suffering from anxiety or depressive disorders (Bower et
al., 2001). Therefore, psychosocial or self-help information to help reduce worry is
likely to be useful for those women who may be suffering from similar psychological
disorders. Although these women commonly have relatives with breast cancer and
family members who are also attending a familial breast cancer clinic, they do not
necessarily gain emotional support for coping with their increased risk from these
channels: "They (my sisters) say when they are going (to the clinic) but apart from
that it's never, we don't discuss the risk and any anxieties that any of us have got -
we should I don't know why we don't" (from the telephone focus group study,
Chapter 3).
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Given this evidence, a psychoeducational written intervention was developed
to meet the needs of these women. It was designed both to update and augment the
information these women previously received at the clinic. The written format would
allow the information to be accessible as required thus providing an immediate
source of advice.
5.3 Aim
The aim was to develop a psychoeducational written information pack for
long-term attendees of a familial breast cancer clinic consisting of scientific and
psychosocial information with the intention of 1) improving knowledge of scientific
topics of information related to familial risk of breast cancer 2) reducing cancer
worry.
5.4 Development
Figure 5 describes the 12 stages of developing the information pack.
A review of the literature on the development ofpatient information was
carried out (1). This identified a number of recommendations for producing good
quality patient health information (i.e. Ewles et al., 1985; Coulter et ah, 1998; Centre
for Health Information Quality, 1997, 1999, 2000; Plain English Campaign, 2001a &
b). These guidelines informed the development procedure.
The structure of the information pack was based on the eight topics of
information most often requested in the cross-sectional study (Chapter 4) (2). These
were classified as six scientific topics and two psychosocial topics.
A multidisciplinary steering group chaired by a postgraduate health
psychologist (S.A) was set up to develop the information pack (3). The group
consisted of a specialist registrar in clinical genetics (S.G-M), a consultant clinical
psychologist (A.C) and a consultant in clinical genetics (M.P). The lead writer for
five of the scientific topics was S.G-M and S.A was the lead writer for the two
psychosocial topics and remaining scientific topic (i.e. research conducted at the
familial breast cancer clinic). Two additional topics were also devised to complement
the main topics: a general introduction to breast cancer (lead writer S.G-M.) and a
sources of information topic (lead writer S.A).
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Figure 5: Stages of developing the information pack
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A review of the current scientific literature and existing information resources
(leaflets, web pages) for women with a family history ofbreast cancer (available
internationally) was undertaken in order to identify areas in these topics where (4):
Existing patient information was appropriate for this group ofwomen.
Existing patient information could be modified to be relevant for this group of
women.
No appropriate patient information existed but information from a journal article
or book could be used if reworded.
No relevant information existed in any form so it would have to be written from
scratch.
Each topic was divided into sections under headings and sub-headings by the
lead writers (5) (see Table 5.1 for examples). The information was derived from the
current scientific literature and/or existing patient information resources and/or
written from scratch. This information was then organised under the headings and
sub-headings (6). In order to produce the topic summarising the scientific and
psychosocial research conducted at the familial breast cancer clinic, S.A. collected
and edited summaries of the studies from the appropriate researchers and organised
them into a coherent topic.




What is genetic testing?
Who should be tested? Women at moderate
risk of breast cancer
Women at high risk
ofbreast cancer
What do genetic test results mean?
Healthy
lifestyle
Lifestyle and the risk of breast cancer:
what does the research show?
If there is no clear evidence that lifestyle
causes breast cancer, why should I
maintain a healthy lifestyle?








The draft topics were circulated within the steering group and alterations
suggested (7). The topics were then modified by the lead writers before being re¬
circulated within the steering group. The topics (except the research summary and
sources of information) were also reviewed by another appropriate health
professional (7) (introduction, breast cancer genetics and genetic testing were
reviewed by a genetics associate and a consultant in clinical genetics; breast cancer
screening, HRT and diagnosis and treatment ofbreast cancer were reviewed by a
consultant breast surgeon; healthy lifestyle was reviewed by a consultant clinical
psychologist and worry about breast cancer was reviewed by a health psychologist
and consultant clinical psychologist). This process of reviewing and altering the
topics was repeated until a satisfactory final draft of the information pack was
produced (8).
The final draft of the information pack which contained 10 topics and three
published leaflets was evaluated by health professionals (9) and subjected to pilot
testing on women at increased risk of breast cancer (10). The three published leaflets
were selected on their relevance, potential helpfulness, clarity, presentation and cost.
Minor revisions to the content, structure and presentation of the information were
made in consultation with the steering group and an appropriate health professional
to produce a final version of the information pack (11). Readability of the
information pack was then assessed (12).
5.5 Professional evaluation
Each of the 10 draft topics in the information pack was independently
evaluated by 1-3 health professionals (from a group of seven: a professor in medical
science, a consultant gynaecologist, two genetic breast care nurses, a clinical
psychologist and two health psychologists) who all had experience ofworking with
women with a family history ofbreast/ovarian cancer and had not been involved in
the preparation of those materials. These health professionals were given details of
the aim, target sample and intended randomised controlled trial of the information
pack. They rated the topics on four different dimensions (content, clarity,
presentation and overall quality) on a 4-point scale from poor to very good (a copy of
the evaluation form is in Appendix II, page 31). In addition they were asked to
indicate if any relevant information was missing and if any irrelevant information
was included. A summary of the ratings for all of the topics is shown in Table 5.2.
The results show that at least 86% of the ratings for all of the topics on each aspect
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were "good" or "very good". Minor additions to some of the topics were suggested
including information on dietary supplements and further details on HRT breast
cancer treatment, the National Breast Screening Programme and participating in
studies at the familial breast cancer clinic.
Table 5.2: Professional evaluation of the topics of information
Total ratings for the 10 topics (n == 21)'
Dimension: Poor Adequate Good Very Good
Content 0 2 7 12
(10%) (33%) (57%)
Clarity 0 3 8 10
(14%) (38%) (48%)
Presentation 2* 0 2 6 12
(10%) (29%) (57%)
Overall Quality 0 2 7 12
(10%) (33%) (57%)
1
21 total ratings = 2 health professionals rated 2 topics (4 ratings), 3 health professionals rated 3
topics (9 ratings) and 2 health professionals rated 4 topics (8 ratings)
2
The raters evaluated a draft document which was not in its final presentation format (i.e. without a
file, topic dividers, title page and introduction to the pack)
* 4% = missing data
5.6 Pilot testing
The draft information pack was pilot tested on a small group ofwomen living
with an increased risk of breast cancer. The 25 women who participated in the
telephone focus group study (Chapter 3) were invited by post to evaluate the draft
information pack. Twelve women replied ofwhom eight were able to participate
during the scheduled period of time. These women were sent the draft information
pack and then telephoned at least one week later to evaluate the information pack.
Respondents were asked to rate the information pack as a whole on seven
different dimensions (whether it covered the right amount of information/detail; was
easy to understand/use; contained information new to the respondent; was upsetting;
overall helpfulness) on a 10-point scale (a copy of the list of questions is in Appendix
II, page 33). They were asked how much of the information pack they had read,
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whether any relevant information was missing or irrelevant information included and
whether they thought the printed leaflets were a useful addition.
Feedback on the draft information pack was extremely good (a summary of
ratings is shown in Table 5.3).
Table 5.3: Results ofpilot testing the information pack (N = 8)
Dimension Scoring Mode Frequency of Range
0 10 mode (n = 8)
Amount of too little too much 5 6 3-8
information
Amount of detail not enough too much 5 5 3-8
Easy to
understand
very easy very difficult 0 6 0-8
Information new none all 8 3 2-8
Information none all 0 8 0
upsetting
Easy to use very easy very difficult 0 8 0
Overall not at all very 10 6 8-10
helpfulness
Although seven out of the eight participants had read all 10 topics of
information, they had not all read the three accompanying leaflets. There were mixed
views about the inclusion of the three leaflets, some women thought they were not
really necessary or helpful and others thought they were extremely useful. The main
suggestions for improving the information pack were: simplification of the
information given about breast cancer genetics and genetic testing including clearer
diagrams, inclusion of information about the diagnosis of breast cancer and who to
ask for advice about HRT.
All 12 women who offered to evaluate the information pack were sent a copy
of the final information pack once the randomised controlled trial was completed.
5.7 Presentation
Several aspects of presentation were considered according to published
guidelines (i.e. Ewles et al., 1985; Coulter et al., 1998; Centre for Health Information
Quality, 1997,1999, 2000; Plain English Campaign, 2001a & b): word/sentence
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length, text size/style, explanations of scientific/medical terms, layout of text,
summary ofmain points, use of diagrams/icons, suggested further reading, ease of
finding specific topics/other relevant pages.
The information pack was structured to provide the women with optional
levels of detail: a low amount of detail was provided by the key points boxes
summarising the main aspects of each topic; a moderate amount of detail was
provided by the main text and if a high amount of detail was required, individuals
could use the further reading sections provided at the end of each topic.
The presentation of the information pack was designed to be attractive and
easy to use, whilst remaining inexpensive. The topics were separated by coloured
cardboard dividers and placed in an A4-ring binder file with the accompanying
leaflets included in a plastic pocket at the back of the file. A title page, introduction
to the information pack, list of authors and contents pages were also included.
5.8 Readability
It is recommended that health information should be developed using a
readability tool to ensure the information is suitable for the intended audience (Ewles
et ah, 1985; Centre for Health Information Quality, 1997; Coulter et al., 1998). Of
the numerous readability tests available, two tests, which considered sentence length
and word difficulty, were selected to assess the readability of the information pack.
These tests were selected on the basis that they were quick, easy to use (could be
manually undertaken) and had previously been used to assess publications written for
the British population.
5.8.1 The Gobbledygook Test
The Gobbledygook test assesses the readability ofwritten materials for adults
and is based on the assumption that when polysyllabic words are put into long
sentences comprehension generally becomes more difficult (Ewles et al., 1985). The
test was modified by the Plain English Campaign from R.Gunning's Frequency of
Gobbledygook (FOG) formula (Ewles et al., 1985). The test enables you to calculate
an average sentence length and a percentage of long words in a sample of text (100
words) that when summed produces the test score (Ewles et al., 1985). As the test
score increases, readability decreases. This is repeated using three different samples
of text to produce a mean test score (Ewles et al., 1985). We used samples of text
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from two scientific topics (breast cancer genetics and options for women with a
family history of breast cancer) and one psychosocial topic (worry about breast
cancer). The mean test score for the information pack was 37. Comparisons scores of
U.K daily newspapers produced by the National Consumer Council in 1980 were
"The Sun" (26) and "The Guardian" (39) (Ewles et ah, 1985).
5.8.2 The SMOG Test (Simple Measure of Gobbledygook)
The SMOG test provides an estimate of the education level necessary for
understanding written material (McLaughlin, 1969). The formula uses the total
number ofpolysyllabic words in three samples of 10 consecutive sentences from a
piece ofwritten material (McLaughlin, 1969). We used samples from the same three
topics that were used in the Gobbledygook test. The resulting American educational
level or grade can be converted to a U.K reading age by a simple calculation (Beaver
et ah, 1997). The reading score obtained for the information pack was 94 (i.e.
expected reading ability of an 18 year old in the U.K). Published comparison scores
include an article in the "British Medical Journal" on healthy eating (122) and an
article in the Radio Times magazine (49) (Beaver et ah, 1997).
5.8.3 Limitations of readability tests
The results of the readability tests suggest that a fairly high level of reading
ability would be required to read the information pack. However, in terms of reading
ability, our intended recipients are unlikely to be representative of the general
population. They are likely to be highly educated (e.g. just over half ofparticipants in
our previous cross-sectional study had received further education/training after age
18) as is commonly found in recipients of health screening (Rimer et ah, 1996).
Although readability tools are a useful estimate ofwhether health information
is suitable for a specific group of people, these tests do not consider numerous other
factors, which may influence the complex process of reading (Smith et ah, 1998).
These include the presentation of the information (including diagrams), the situation
in which the information is read (which may be stressful), certain characteristics of
the reader and their familiarity with relevant vocabulary (e.g. recipients of the
information pack are likely to be familiar with some of the terms associated with
familial breast cancer) (Smith et ah, 1998).
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5.9 Final contents of the information pack
The final version of the information pack contained 10 topics of information
(total of 45 A4-pages of text and diagrams) and three published leaflets to
accompany topics 3, 4 and 9 (see Table 5.4 for a summary of contents and Appendix
III for a copy of the information pack).
Two versions of the information pack were produced for use in the
subsequent randomised controlled trial: The scientific and psychosocial information
pack (which contained all 10 topics and three leaflets) and the scientific information
pack (which contained all topics and leaflets except the two psychosocial topics and
accompanying "How to.. .stop worrying " leaflet).
5.10 Discussion
The development of the information pack for women living with an increased
risk of breast cancer was an iterative process involving a multi-disciplinary steering
group, professional evaluation, pilot testing and assessment of readability. The
format and content of the information pack were based on data collected in previous
studies (see Chapters 3 and 4) and were supported by research findings on written
interventions in other populations.
The information pack that was produced contained up-to-date and reliable
information covering both scientific and psychosocial topics related to familial risk
of breast cancer. It aimed to improve knowledge and reduce cancer worry.
Evaluation of the information pack by a number of health professionals confirmed
that the quality was good. Feedback from several women attending the familial
breast cancer clinic suggested that the information pack was extremely relevant for
this group ofwomen.
The effectiveness of the information pack was then evaluated in a randomised
controlled trial.
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Table 5.4: Summary of the contents of the information pack
Topic Title of topic/leaflet Description
1 Introduction to breast cancer Explains the development of cancer,
its causes and gives a general
background to breast cancer
2 Breast cancer genetics Describes genes, genetic mutations
and their role in the inheritance of
susceptibility to breast cancer
3 Genetic testing Explains the process of and criteria for
genetic testing for BRCA1/2
Cancer genetics Leaflet produced by the South East of
Scotland Clinical Genetics Service
which outlines criteria for familial
cancer screening programmes and
advice about genetic testing
4 Options for women with a
family history of breast cancer
Covers screening (mammography,
clinical breast examination, breast
awareness) and risk reduction
(prophylactic surgery, Tamoxifen)
Breast awareness Leaflet produced by Breast Cancer
Care which gives practical advice on
being breast aware
5 Hormone replacement therapy
(HRT)
Includes a summary of research on
HRT and the risk of breast cancer
6 Diagnosis and treatment of
breast cancer
Includes a summary of the diagnostic
procedure and local/systemic
treatments for breast cancer
7 Research at the Ardmillan
familial breast cancer clinic
A summary of recent scientific and
psychosocial research conducted at the
familial breast cancer clinic
8* Healthy lifestyle Includes a summary of research on
lifestyle and breast cancer risk and
guidelines on several aspects of
maintaining a healthy lifestyle
9* Worry about breast cancer Includes advice on how to critically
appraise media reports about breast
cancer and self-help strategies for
relieving worry
How to... stop worrying Leaflet produced by MIND which
suggests a variety ofways to help
reduce worry.
10 Sources of Information Lists useful local, national and
international organisations and their
contact details (including web page
address) and the references that were
used to write the pack
* Indicates psychosocial topic of information
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Chapter 6: Randomised Controlled Trial of a
Psychoeducational Intervention in Women Living with an
Increased risk of Breast Cancer
6.1 Introduction
A number of interventions have been evaluated in women with a family
history of breast cancer (e.g. Gagnon et ah, 1996; Lerman et ah, 1996; Cull et ah,
1998; Schwartz et ah, 1998; Watson et ah, 1998; Audrain et ah, 1999; Kash et al.,
1999; Wellisch et ah, 1999; Esplen et ah, 2000). These have varied greatly in terms
of their aims (e.g. reducing psychological distress, improving adherence to breast
self-examination), sample (e.g. first-degree relatives of recently diagnosed breast
cancer patients, high-risk women maintained on regular clinical surveillance) and
format of the intervention (e.g. newsletter, Problem-Solving Training). The studies of
particular interest to the current trial have investigated the impact of
psychoeducational group interventions in American women at high-risk of
developing breast cancer (i.e. Kash et ah, 1999, Wellisch et ah, 1999).
Wellisch et ah (1999) carried out a pilot study of a short-term group
intervention that provided education, psychological support and skills training in
order to treat psychological distress. Thirty-three women, enrolled in a high-risk
breast cancer surveillance program, received the intervention which consisted of a
weekly group meeting lasting for 2.5 hours for six consecutive weeks. Each group
meeting included educational (e.g. genetics, nutrition, relaxation, medical
information) and psychological components (e.g. share experiences, family
relationships, coping, anger management), which were led by an appropriate health
professional. Several variables were assessed pre- and post-intervention
(immediately after the last group session) ofwhich only generalised anxiety and
depression have so far been reported. Statistically significant reductions both in
depression and state anxiety were observed. However, as the authors acknowledge,
there are a number ofmethodological limitations of the study: the lack of control
group/long-term follow-up and small sample size.
Kash et al. (1999) have reported the preliminary results of a randomised
controlled trial of a similar psychoeducational group intervention. The intervention is
being evaluated in relation to knowledge of breast cancer, beliefs about breast
cancer, breast cancer-specific anxiety, quality of life, adherence to breast cancer
screening and coping skills. At the time of reporting, 192 women at high-risk for
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breast cancer had been randomised to the intervention or control condition. The
intervention consisted of educational, social support enhancement, problem-solving
and cognitive restructuring components in 1.5-hour group sessions every week for
six weeks with additional sessions at six months and one year. Women in the
intervention group experienced a statistically significant decrease in breast cancer-
specific anxiety and perceived risk and improvement in knowledge between their
first assessment prior to randomisation and their fourth assessment one year later.
Despite the fact that the full details of these two American studies have yet to
be published, the preliminary results are nevertheless encouraging. There is now a
need to investigate whether long-term attendees of a British familial breast cancer
clinic would benefit from similar psychoeducational intervention.
6.2 Rationale
For long-term attendees of the Ardmillan familial breast cancer clinic in
South East Scotland, contact with the clinic is limited to follow-up breast cancer
screening appointments. These appointments are generally scheduled at yearly
intervals, but their frequency and duration has become increasingly limited as
clinical services are stretched by a growth in referrals and the number ofwomen
under surveillance accrues. This leads to the impetus for more stringent criteria for
surveillance. Clinical services other than breast cancer screening such as
psychosocial support or education are not routinely provided for this group of
women.
The cross-sectional study (Chapter 4) confirmed the results of the telephone
focus group study (Chapter 3) in terms of a widespread need for up-to-date, reliable
information related to familial risk of breast cancer in women living with an
increased risk of the disease. There was an overall preference for the information to
be presented in a written format. The cross-sectional study also showed a high
prevalence of worries about breast cancer risk-related issues.
Given the need for information and the prevalence ofworry in women living
with an increased risk of breast cancer, a psychoeducational written intervention was
developed (Chapter 5). It intended to provide these women with access to up-to-date
information on scientific and psychosocial topics related to familial risk of breast




• To determine the impact of a psychoeducational written intervention on cancer
worry (primary outcome) and objective knowledge of breast cancer risk-related
topics (secondary outcome).
Subsidiary aims:
• To explore the impact of a psychoeducational written intervention on breast
cancer specific-distress (as measured by the Impact of Event Scale), generalised
psychological distress (as measured by the GHQ-12) and appraisal (as measured
by perceived risk, perceived likelihood and perceived control over developing
breast cancer).
• To evaluate the acceptability of the psychoeducational written intervention for
women living with an increased risk of breast cancer.
6.4 Hypotheses
The hypotheses relate to the main aim of the study.
• The addition of Scientific + Psychosocial Written Information to standard care
(Group 1) will reduce cancer worry to a greater extent than the addition of
Scientific Written Information alone (Group 2) (standard care refers to the
regular clinical surveillance provided by the familial breast cancer clinic in
accordance with clinical guidelines based on age and family history: see Section
1.4.2, page 12).
• Scientific Written Information in addition to standard care (Group 2) will reduce
cancer worry to a greater extent than standard care alone (Group 3).
• Written Information in addition to standard care (Groups 1 and 2) will improve
objective knowledge of breast cancer risk-related topics to a greater extent than
standard care alone (Group 3).
148
6.5 Design
A randomised controlled trial comparing three groups ofparticipants:
Group 1: Scientific + Psychosocial information pack in addition to standard care.
Group 2: Scientific information pack in addition to standard care.
Group 3: Standard care (control group).
All three groups were assessed at baseline (prior to receiving the information
pack) and post-intervention (approximately four weeks later) by postal questionnaire.
6.6 Participant selection
Women who participated in the cross-sectional study (n = 249) (see Section
4.5, page 86 for eligibility criteria and Section 4.9, page 95 for recruitment to the
cross-sectional study) who met the additional criteria in Table 6.1 were invited to
participate.
Table 6.1: Entry criteria for the randomised controlled trial
Inclusion criteria:
• Indicated in the cross-sectional questionnaire study that they were interested in at
least one of the intervention options listed.
Exclusion criteria:
Since participating in the cross-sectional questionnaire study:
• Been discharged from the clinic.
• Joined the International Breast Cancer Intervention Study (IBIS) or Magnetic
Resonance Imaging (MRI) Trial.
• Undergone genetic testing.
6.7 Sample size calculation
A recent study of 116 women who attended the Ardmillan Familial Breast
Cancer Clinic in South East Scotland, found that CancerWorry Scale (CWS) scores
149
were fairly normally distributed and ranged from 6-19, mean = 10.65, standard
deviation = 2.58 (Rees, 2000, Personal communication). When estimating sample
sizes, an "effect size" of 0.5 is generally regarded as moderately large (Fayers &
Machin, 2000).
Given that there is a lack of data to suggest what constitutes a clinically
significant change on the CWS, the calculations for the present study were based on
an effect size of 0.5 (0.5 x 2.58 = 1.3) where the mean change in scores has been
rounded up to 1.5 (to allow for greater variability in CWS scores in this sample).
To detect a difference of 1.5 on the CWS with an 80% power at a
significance level of 5%, a minimum sample size of 138 (i.e. 46 women in each of
the three intervention groups) was required.
6.8 Randomisation
Participants were randomised to one of the three intervention groups at the
point of recruitment (i.e. when they had returned a consent form agreeing to
participate). Restricted randomisation using the random permuted blocks method
(Pocock, 1983) was undertaken to ensure that there were equal numbers of
participants in each of the three intervention groups. For each block of three
participants, there was a different random order of the three intervention groups. The
numbers 1-6 were assigned to the six different possible orders of the three
intervention groups (If S = scientific group, P = psychosocial + scientific group and
C = control group, then: 1 = SPC, 2 = SCP, 3 = CSP, 4 = CPS, 5 = PCS and 6 =
PSC). A table of random numbers from 1-6 was generated in Microsoft Excel and
participants were assigned to the corresponding order of the intervention groups.
6.9 Intervention
The intervention was a psychoeducational written information pack
consisting of scientific and psychosocial topics of information and three





Sociodemographic and risk variables:
Data were already available from the cross-sectional study (data collected
August 2000 - January 2001) to describe the sociodemographic characteristics of the
women participating in this study in terms of their: education, marital status,
occupation and number of children.
Several additional characteristics of the women were assessed at baseline:
age, number of years of attendance at the familial breast cancer clinic and objective
breast/ovarian cancer risk. A standard estimate of both breast and ovarian cancer risk
were devised by a specialist registrar in clinical genetics (advised by a consultant in
clinical genetics). The risk estimates originally given to the women during genetic
risk counselling were extracted from the case notes. These were updated using
current clinical guidelines for deriving individual risk estimates from family history
(i.e. Scottish Executive, 2001) and additional epidemiological information to give the
standard estimates reported in this study. Objective breast cancer risk was classified
as: low (<17% lifetime risk), medium low (17-19%), medium (20-22%), medium
high (23-25%), high (>25%). Objective ovarian cancer risk was classified as: low
(<3% lifetime risk), medium (3-5%), high (>5%).
Coping style:
Data from assessments of the following coping styles were also extracted
from the cross-sectional study: monitoring, blunting, emotional uncertainty and
cognitive uncertainty.
6.10.2 Baseline and Post-intervention
6.10.2a Key outcomes
Cancer Worry Scale (CWS):
This 6-item scale assesses concerns about developing cancer and the impact
of cancer worry on daily functioning in terms of its frequency and severity (a copy of
the scale is included in Appendix II page 36). It was based on a number of items that
were originally used to assess worry about cancer in American women with a family
history ofbreast cancer (Lerrnan et al., 1991a, 1991b, 1993, 1994). More recently it
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has been modified to form a 6-item scale applicable to British women (Watson et al.,
1998). Responses are organised on a 4-point Likert scale (e.g. "How much of a
problem is worrying about cancer to you?" 1 = not at all, 4 = severe problem) and are
summed to produce a total score of 6-24. The higher the total score, the greater the
cancer worry. Clinical threshold scores for this scale have not yet been derived.
The psychometric data available on the scale are satisfactory: internal
consistency (Brain et al., 1999: Alpha = .86; Hopwood et al., 2001: Alpha = .86;
Rees, 2000, Personal communication: Alpha = .80), test-retest reliability (Rees,
2000, Personal communication: .742), concurrent validation with the GHQ-30 total
score (Rees, 2000, Personal communication: .347, p<0.01) and the Impact of Event
Scale total score (Rees, 2000, Personal communication: .572, p<0.01). A principal
components factor analysis has also been undertaken on the scale confirming its
appropriateness as a unitary scale (one factor was extracted explaining 59.5% of the
variance) (Hopwood et al., 2001).
It has been used to assess breast cancer worry in British women with a family
history ofbreast cancer both before (Brain et al., 1999; Hopwood et al., 2001;
Watson et al., 1998) and after genetic risk counselling (Hopwood et al., 2001; Rees,
2000, Personal communication; Watson et al., 1998). It has also previously been
used in women attending the same familial breast cancer clinic as the women in the
present study (Rees, 2000, Personal communication).
Objective knowledge ofbreast cancer risk-related topics:
Thirty-six items were devised specifically for this study to assess objective
knowledge of breast cancer risk-related topics (a copy of these items is included in
Appendix II page 36). These items were devised by the multidisciplinary group who
developed the information pack and were based on the key points covered in the
scientific topics of information about breast cancer genetics, genetic testing, breast
cancer screening and HRT. The items were designed to assess understanding of key
points of information (as determined by appropriate health professionals) rather than
simply recall of information (e.g. "The main cause of all breast cancer is: inherited
genetic susceptibility?"). The responses were formatted as true, false or don't know.
The number of correct, incorrect and don't know responses were summed separately
to produce three total scores all ranging from 0-36.
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6.10.2b Exploratory variables (i.e. variables that may be affected by the
intervention)
Breast cancer-specific distress:
The Impact ofEvent Scale (Horowitz et al., 1979) is a 15-item scale which
determines levels of breast cancer-specific distress in terms of intrusive and avoidant
thoughts about breast cancer in the past week (Kash et al., 1992) (see Section 4.6.5a,
page 89 for a full description of the scale).
Generalpsychological distress:
The 12-item version of the General Health Questionnaire (GHQ-12) is a first-
stage screening test to detect current psychiatric disorders in community and non-
psychiatric clinical locations (Goldberg & Williams, 1991). Responses are in four
categories, were scored 0,0,1,1 and a threshold score of three was used to detect
"case-level" distress (see Section 4.6.4a, page 88 for a full description of the scale).
Appraisal:
Three single items were used to assess perceived risk of developing breast
cancer in relation to the general population, perceived likelihood of developing
breast cancer and perceived control over developing breast cancer (see Section 4.6.7,
page 90 for a full description of the items).
6.10.2c Additional variables
Waitingfor results:
One study-specific item asked participants if they were currently waiting for
the results of a mammogram or breast biopsy. The responses were on a simple yes/no
format.
6.10.3 Post-intervention only
Evaluation ofthe intervention (Groups 1 and 2 only):
A number of items were used to obtain feedback from the women on the
information pack in terms of (a copy of the items is included in Appendix II page
45):
• the number of times they read the topics/leaflets
• when they last read any of the information pack
• to what extent the information included in each topic was new to them
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• if they discussed or gave the information pack to anyone else
• if they found any topics/leaflets difficult to understand, upsetting or helpful
• if they had changed or intend to change any of their health behaviours as a result
of reading the information pack
• if they intended to obtain any of the further reading listed
• if they thought any topics were missing from the pack
• if the information pack covers their need for information and support
Other breast cancer information (Group 3 only i.e. standard care):
Participants were asked if they had read any information related to familial
risk of breast cancer in the past month.
6.11 Procedure
The Regional Ethics Committee approved the study. Figure 6.1 shows the
study procedure.
Potential participants were sent a letter inviting them to take part together
with an information sheet explaining the randomisation procedure, a consent form
and Freepost envelope. They were asked to return the consent form in the Freepost
envelope indicating whether or not they were willing to participate. With the
participant's permission, their GP received a letter informing them that their patient
had agreed to participate together with a copy of the information sheet. If a
completed consent form was not received within three weeks, the participant was
sent a reminder.
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Figure 6.1: Summary of the procedure for the randomised controlled trial
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Participants who consented to the study were sent the baseline questionnaire
and letter notifying them to which of the three groups they had been randomised. On
return of the completed baseline questionnaire (a copy is in Appendix II, page 36),
participants in Groups 1 (scientific and psychosocial information) and 2 (scientific
information) were sent the appropriate information pack and covering letter. If a
completed baseline questionnaire was not received within three weeks, the
participant was sent a reminder. The post-intervention questionnaire (a copy of the
questionnaire for Group 1 is in Appendix II, page 45) and covering letter were sent to
participants four weeks after sending them an information pack (Groups 1 and 2) or
four weeks after they returned a completed baseline questionnaire (Group 3 - control
group). If a completed post-intervention questionnaire was not received within three
weeks, participants were sent a reminder. If a completed post-intervention
questionnaire still had not been received within six weeks, participants were sent a
second reminder. At the end of the post-intervention questionnaire Groups 2 and 3
were offered the full written information pack (i.e. Group 2: Psychosocial topics,
Group 3: Scientific and Psychosocial topics). Any participant in these groups who
requested the full information pack was sent it immediately together with a letter
thanking them for participating in the study.
The GP was promptly notified by letter if their patient was found to score
above the clinical case threshold (i.e. >3) on the GHQ-12 at either baseline or post-
intervention (on recruitment to the study, participants had given their consent for
their GP to be passed any information collected during the study).
Any participants in Groups 1 or 2 who indicated that they found some of the
topics in the information pack upsetting were immediately contacted by post to ask if
it would be possible to discuss their upset on the telephone.
6.12 Statistical analysis
The distribution of all continuous variables was assessed for each randomised
group to determine their parametric or non-parametric nature. The appropriate
descriptive statistics were generated to describe the study participants. Differences
between two independent groups were analysed with independent samples t-tests (2-
tailed) or Mann-Whitney tests.
Cancer worry: Comparisons of the three randomised groups on CWS total score at
baseline and post-intervention were made using the Kruskal-Wallis test. Changes in
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CWS total score between baseline and post-intervention were assessed for each of
the three groups (only for women with data at both assessments) by the Wilcoxon
matched-pairs signed-rank test. Individual changes in CWS total score from baseline
to post-intervention were calculated and median changes, ranges and proportions of
changes (increased/stayed the same/decreased) were compared for the three groups.
Objective knowledge ofbreast cancer risk-related topics: Comparisons of the three
randomised groups on objective knowledge: total correct, total incorrect and total
don't know at baseline and post-intervention were made using the Kruskal-Wallis
test. Changes in the objective knowledge totals between baseline and post-
intervention were assessed for each of the three groups (only for women with data at
both assessments) by the Wilcoxon matched-pairs signed-rank test. Individual
changes in objective knowledge total scores from baseline to post-intervention were
calculated and median changes, ranges and proportions of changes (increased/stayed
the same/decreased) were compared for the three groups.
Sociodemographic and Exploratory variables: Comparisons of the three randomised
groups on the demographic and exploratory variables at baseline and post-
intervention were made using the chi square test (2-tailed), one-way ANOVA or
Kruskal-Wallis test. Changes in the exploratory variables between baseline and post-
intervention were assessed for each of the three groups (only for women with data at
both assessments) by the McNemar test orWilcoxon matched-pairs signed-rank test.
Spearman's rank correlation (2-tailed) was used where appropriate.
Evaluation ofthe information pack: The appropriate descriptive statistics were
generated to summarise feedback on the information pack. Comparisons of Group 1
and Group 2 were made using chi square tests (2-tailed).
A number of categorical variables were recoded for the purposes of between-
group/within-group analysis: breast cancer risk estimate (low or medium
low/medium/medium high or high), perceived likelihood of developing breast cancer
(unlikely/likely), perceived control over developing breast cancer (no control/some
control), marital status (married or living with a partner/not married or living with a
partner) and occupation (employed/not employed).
The absence of one or more scores on a scale resulted in that total score being
classified as missing. As there is missing data across the various measures for the
sample at both assessment points, the numbers analysed for each variable will be
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specified throughout. Data were analysed on an intention-to-treat basis. A
significance level of 0.05 was used throughout. The data were analysed using SPSS




Figure 6.2 summarises participant recruitment to the study. Of the 249
women who participated in the cross-sectional questionnaire study, 41 did not meet
the additional criteria to participate in the intervention study (17 had been discharged
from the clinic since participating in the cross-sectional study for various reasons
such as they had been referred to the National Breast Screening Programme or they
were deemed to be at low risk, two were recent recruits to the MRI trial and 22
indicated in the cross-sectional study that they were not interested in any of the
intervention options listed).
Of the 208 women who were invited to participate in the randomised
controlled trial, 11 refused (only one woman gave a reason: moving house), two
women responded too late to be randomised (three months after the initial invitation)
and 23 women did not reply to the invitation. Of the 172 women who consented to
participate, were randomised and sent the baseline questionnaire, 8 (from Group 1 =
1; Group 2 = 4; Group 3 = 3) did not return the questionnaire and one woman
(randomised to Group 3) was excluded from the analysis because of a protocol
violation (she had been discharged from the clinic prior to randomisation and
therefore should not have been invited to participate). Therefore, 163 baseline
questionnaires were included in the analysis (Group 1 = 56, Group 2 = 53, Group 3 =
54).
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Group 1 Group 2 Group 3
(n = 56) (n = 53) (n = 54)
Group 1 (n = 51) Group 2 (n = 49) Group 3 (n = 51)
Figure 6.2: Progress of participants through the randomised controlled trial
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There were no significant differences between the participants at baseline (n
= 163) and non-participants (n = 45 including the eight women who didn't return the
baseline questionnaire and the woman who was excluded from data analysis) on any
of the sociodemographic or psychological trait variables extracted from the cross-
sectional questionnaire study or characteristics assessed at baseline (age, number of
years clinic attendance and objective breast cancer risk). Although differences
between participants and non-participants on objective ovarian cancer risk could not
be tested as the number ofwomen in each category was too small, the data were
nevertheless comparable (low: n = 137, 91%/n = 35, 92%; medium: n = 12, 8%/n =
3, 8%; high: n = 1, l%/n = 0).
6.13.1b Sociodemographic and risk variables
The mean age of participants was 43.9 years (SD = 6.57) and ranged from 28-
62 years. They had been attending the Ardmillan Familial Breast Cancer Clinic for
2.75- 8.51 years (mean = 5.26, SD = 1.72). The majority of participants were married
or living with a partner (n = 137, 86%) with the remainder being single (n = 11, 7%)
or divorced/separated (n = 11, 7%). The median number of children was 2 (range 0-
4). As far as education was concerned, 53 women (33%) had received schooling until
age 16 only whereas 27 (17%) had attended school/further education/training until
age 18, 38 (24%) had further education or training after age 18 and 44 (27%) were
university graduates. Most participants were employed either full-time (n = 73, 45%)
or part-time (n = 62, 38%) with 18 women (11%) having home duties, six were
unemployed (4%) and four were retired (3%).
The majority were estimated to be at medium risk of breast cancer (n = 80,
53%) with 41 (27%) assigned a medium high risk, 15 (10%) medium low, nine (6%)
low and five (3%) high. Most participants had a low risk of ovarian cancer (n = 137,
91%) with 12 (8%) at medium risk and one woman (1%) at high risk. As the clinical
case notes for 13 participants were unable to be located, their objective breast and
ovarian cancer risks were not calculated.
There were no significant differences between the three groups on any of the
sociodemographic or risk variables apart from objective ovarian cancer risk where
the numbers in each category were too small to be tested.
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6.13.1c Coping Style
The mean score for the whole sample on the Monitoring subscale was 3.9
(SD = 1.57) and on the Blunting subscale was 1.94 (SD = 1.32). The median score on
the Emotional Uncertainty subscale was 30 (range = 20-56). There were no
significant differences between the three groups at baseline on any of these coping
style variables. However, the three groups were significantly different in their scores
on the Cognitive Uncertainty subscale (F (2, 156) = 3.103, p = .048) (Table 6.2). A
correlation that was approaching significance was observed between scores on the
Cognitive Uncertainty subscale and baseline scores on the Cancer Worry Scale
(Spearman's rho = 0.152, p = .056).






Group 1 Group 2 Group 3
N 159 52 53 54
Mean 46.39 45.35 45.34 48.43
SD 7.49 7.72 6.61 7.78
6.13.1 d Psychological distress
The median CancerWorry Scale (CWS) score for the total sample at baseline
was 9 (range = 6-21).
Seventy-one women (44%) indicated at baseline that they had thought about
the risk ofbreast cancer in the past week. The median score on the intrusion subscale
of the IES for the total sample at baseline was 6 (range = 0-33), the median score on
the avoidance subscale of the IES was 9 (0-30) and median total IES score was 14
(range = 0-59).
The median GHQ-12 total score at baseline was 0 (range 0-12). Forty-seven
women (29%) were suffering from "case-level" distress (score of>3).
Table 6.3 compares scores on the psychological distress measures for each of
the three groups at baseline. There were no significant differences between the three
groups on any of the psychological distress measures at baseline. The small sample
sizes for the IES scores are due to fact that the majority of participants did not
complete the IES as they had not thought about the risk of breast cancer in the past
week (i.e. there was only a small amount ofmissing data).
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Table 6.3: Comparison of the three groups at baseline
Variable Group 1 Group 2 Group 3
CancerWorry Scale N 56 53 53
Median 9 9 10





N 48 46 46
Median 17.5 17 15
Range 6-28 8-35 7-31
Median 9 8 8
Range 3-18 1-19 1-15
Median 9 10.5 12





N 21 21 29
Median 8 6 5
Range 0-33 0-25 0-27
N 19 20 28
Median 9 8 9
Range 0-26 0-23 0-30
N 19 20 28
Median 18 12.5 13




N 56 51 54
Median 1 0 0
Range 0-11 0-12 0-12
Case 17(30%) 10(20%) 20 (37%)










N 56 53 54
Lower than 1 (2%) 0 0
The same as 4 (7%) 5 (9%) 0
Slightly
higher than
37 (66%) 35 (66%) 40 (74%)
Much higher
than
14 (25%) 13 (25%) 14 (26%)
N 56 51 52
Unlikely 15 (27%) 13 (26%) 17(33%)
Likely 41 (73%) 38 (75%) 35 (67%)
N 56 53 54
None at all 18 (32%) 21 (40%) 16(30%)
Some 38 (68%) 32 (60%) 38 (70%)
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6.13.1 e Objective knowledge
Objective knowledge of breast cancer risk-related topics at baseline was
generally poor (the distribution of responses to the individual objective knowledge
items is in Appendix II, page 60). The mean number of correct responses for the
whole sample was 16.4 (SD = 6), which represents 44% of the total questions. The
mean number of incorrect responses was 8.5 (SD = 3.5), corresponding to 24% of the
total questions. The mean number of responses the participants didn't know was 11.1
(SD = 5.5), representing 31% of the total questions.
Table 6.3 compares the objective knowledge total scores for each of the three
groups at baseline. There were no significant differences between the three groups at
baseline on any of the objective knowledge total scores.
6.13.1f Appraisal
The majority of participants at baseline thought that their risk of ever
developing breast cancer was slightly higher (n = 112, 69%) or much higher (n = 41,
25%) than the general population. Nine women (6%) perceived their risk to be the
same as the general population and one woman (1%) thought that her risk was lower
than the general population.
At baseline, most participants felt that it was at least likely that they would
ever develop breast cancer (likely: n = 91, 57%; very likely: n = 21, 13%; inevitable:
n = 2, 1%). Forty-four women (28%) felt that they were unlikely to ever develop
breast cancer and only one woman (1%) felt she was very unlikely.
Most participants at baseline felt they had some control over whether they
ever developed breast cancer (a bit: n = 71, 44%; moderate: n = 33, 20%; a lot: n = 4,
3%) compared to 55 (34%) who felt that they didn't have any control.
Table 6.3 compares the scores on appraisal measures for each of the three
groups at baseline. There were no significant differences between the three groups at
baseline on perceived likelihood of developing breast cancer or perceived control
over developing breast cancer. Due to the small numbers of participants in some
categories, between-group differences in perceived risk (relative to the general
population) could not be tested (the categories could not meaningfully or effectively
be combined).
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6.13.1 g Waiting for results
Nine women (6%) at baseline (three women in each group) stated they were
currently waiting for the results of a mammogram or breast biopsy (between-group
differences were not tested due to small numbers in one category).
6.13.2 Post-intervention
6.13.2a Participants
Figure 6.2 summarises the participants' progress through the study. Twelve
women (from Group 1=5; Group 2 = 4; Group 3 = 3) dropped out of the study
between baseline and post-intervention (i.e. they did not return the post-intervention
questionnaire).
The number ofwomen completing both questionnaires was 151 (Group 1 =
51, Group 2 = 49, Group 3 = 51), therefore exceeding the minimum sample size
requirement of 138. The participation rate for the completing both questionnaires
was 73% (151/208). The number ofweeks between completing the baseline (data
collected April-June 2001) and post-intervention (data collected June-September
2001) questionnaires ranged from 4.71-17.57 (mean = 7.51, SD = 2.5). The majority
of participants in Groups 2 and 3 post-intervention requested to be sent the full
information pack (Group 2: n = 35, 71%, Group 3: n = 48, 94%).
Differences between participants who only completed the baseline
questionnaire (baseline only group, n = 12) and those who completed both
questionnaires (study sample, n = 151) could not be tested due to the small sample
size. Scores on the psychological distress and objective knowledge measures in these
two groups were comparable at baseline (Table 6.4). However, the Impact ofEvent
Scale median scores for the baseline only group were more than twice those of the
study sample (Table 6.4).
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Table 6.4: Comparison of participants who only completed the baseline
questionnaire (Group A) and those who completed both questionnaires (Group B)
on psychological distress and objective knowledge
Variable Group A Group B
Cancer worry N 12 150
Median 8.50 9.50
Range 6-21 6-20
Objective knowledge: N 10 130
Total correct Median 16 16
Range 6-28 6-35
Total incorrect Median 9.5 8
Range 1-14 1-19
Total don't know Median 11 11
Range 5-18 0-23
IES:
Intrusion N 4 67
Median 13.5 5
Range 11-18 0-33







GHQ-12: N 11 150
Total Median 0 0
Range 0-11 0-12
"Case-level" distress Frequency 3 44
Percentage 27% 29%
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6.13.2b Comparison of the three groups post-intervention
Table 6.5 summarises scores for each of the three groups on the
psychological distress, objective knowledge and appraisal variables post-
intervention.
Fifty-two women (35%) post-intervention indicated that they had thought
about the risk of breast cancer in the past week and therefore completed the IES.
Eight women (5%) post-intervention stated they were currently waiting for
the results of a mammogram or breast biopsy (four in Group 1 and four in Group 3).
Only one of these eight women (from Group 3) had indicated at baseline that she was
waiting for her results.
There were no significant differences on any of these variables between the
three groups post-intervention apart from on objective knowledge and perceived
control (perceived risk and waiting for results were not tested due to small numbers
in some categories). There were significant differences between the three groups on
objective knowledge: total correct (y2 = 37.387, df= 2, p = .000), objective
knowledge: total incorrect (y2 = 6.760, df= 2, p = .034), objective knowledge: total
don't know (y2 = 37.487, df = 2, p = .000) and perceived control (%2 = 7.711, df= 2,
p = .021).
Of the women in Group 3 who were asked if they had read any information
related to familial risk of breast cancer in the past month, only two (4%) had read any
such information which covered breast awareness (n = 1) and genetic testing (n = 1).
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Table 6.5: Comparison of the three groups post-intervention
Variable Group 1 Group 2 Group 3
Cancer worry N 50 49 50
Median 9 9 9





N 39 39 44
Median 24 27 15
Range 3-33 11-36 5-33
Median 8 7 9
Range 2-18 0-13 2-17
Median 2 1 12.50





N 13 17 20
Median 9 11 3.5
Range 0-13 0-35 0-25
N 14 15 20
Median 10.5 16 5.5
Range 0-29 0-40 0-30
N 13 15 20
Median 18 30 8.5




N 51 49 49
Median 0 0 0
Range 0-11 0-12 0-10
Case 7 (14%) 7 (14%) 12 (25%)










N 50 48 51
Lower than 0 0 0
The same as 6 (12%) 3 (6%) 2 (4%)
Slightly
higher than




N 47 46 50
Unlikely 16(34%) 19(41%) 14 (28%)
Likely 31 (66%) 27 (59%) 36 (72%)
N 50 48 51
None at all 6 (12%) 14 (29%) 18(35%)
Some 44 (88%) 34(71%) 33 (65%)
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6.13.2c Participant feedback on the information packs
Feedback on the two different versions of the information pack was obtained
as part of the post-intervention assessment ofwomen in Group 1 (n = 51) and Group
2 (n = 49) only.
In Group 1, who were sent 13 topics of information and leaflets, the mean
number of topics/leaflets read by participants was 11.80 (SD = 3.11). In Group 2,
who were sent 10 topics/leaflets, the corresponding mean was 9.73 (SD = 0.89).
Eighty percent of the women in Group 1 had read all of their information pack
compared to 89% in Group 2. Two women (both in Group 1) had not read any of
their information pack. Every topic of information had been read at least once by no
less than 90% of the participants who received that topic. None of the topics of
information were read by considerably fewer participants than any of the other
topics. The three accompanying published leaflets were less widely read as each one
had not been read by 10-20% ofparticipants.
Most of the women in Groups 1 and 2 had read the information pack more
than two weeks ago (n = 47, 47%) with 18 women (18%) reading it 1-2 weeks ago
and 34 (34%) in the past week. There were no significant differences between
Groups 1 and 2 on when they had last read any of the information pack.
The majority ofparticipants in both groups (60%- 95%) thought that the
information included in every topic was at least "a little" new to them with up to
41% regarding most of the information in a particular topic as new (i.e. genetic
testing) and up to 18% regarding all the information in a particular topic as new (i.e.
HRT).
Forty-five percent ofwomen in Group 1 (n = 23) and 27% in Group 2 (n =
13) had discussed the infonnation in their pack with somebody else. Nine women
(18%) in Group 1 and seven (14%) in Group 2 stated that someone else had read the
information in their pack. The other people listed as discussing or reading the
information pack included husbands, friends, sisters, daughters and mothers.
Only 12 participants (12%) in both groups found any of the topics difficult to
understand. The topics that were most frequently found to be difficult to understand
were "breast cancer genetics" (n = 8) and "genetic testing" (n = 7).
Similarly, only five women (5%) found any of the topics of information
upsetting. The topics found to be upsetting were: breast cancer genetics; genetic
testing; options for women with a family history of breast cancer; hormone
replacement therapy; diagnosis and treatment ofbreast cancer (one woman listed two
topics as upsetting).
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Participants generally found all of the topics of information and leaflets at
least a little helpful. Although half of the topics were rated as "not at all helpful" this
was only by one or two women. A large proportion of the women (23-45%) rated
each topic as "very much helpful". The three published leaflets were commonly
regarded as helpful (a little, quite a bit, very much) with about half of participants
(48-54%) who received the particular leaflet rating it as "quite a bit helpful". Even
though each leaflet was rated as "not at all helpful" it was only by 2-10% of
participants.
As far as changing or intending to change certain health behaviours were
concerned, almost halfofGroups 1 and 2 reported becoming or intending to become
more breast aware since reading the information pack (Table 6.6).
Table 6.6: Health behaviour change: breast awareness
Being Breast Aware: Group 1 and
Group 2
N 95
Since reading the information pack,
I have become more breast aware
20 (21%)
Since reading the information pack,
I intend to become more breast aware
25 (26%)
I was already being breast aware 49 (52%)
In spite ofreading the information pack,
I don't intend to become more breast aware
1 (1%)
Halfof the women in Group 1 (n = 24) reported that since reading the
information pack they had adopted or intended to adopt a healthier lifestyle (Table
6.7). These women reported that they had already changed or intended to change
several different aspects of their lifestyle: increase exercise (n = 22, 92%), healthier
diet (n = 17, 71%), increase skin protection from the sun (n = 5, 21%), reduce
alcohol intake (n = 3, 13%), stop smoking (n = 2, 8%).
Likewise, over half of the women in Group 1 reported using or intending to
use the techniques to relieve their worries about breast cancer (Table 6.8).
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Table 6.7: Health behaviour change: healthier lifestyle
Having a Healthier Lifestyle: Group 1
N 48
Since reading the information pack,
I have adopted a healthier lifestyle
4 (8%)
Since reading the information pack,
I intend to adopt a healthier lifestyle
20 (42%)
I was already adopting a healthy lifestyle 24 (50%)
In spite ofreading the information pack,
I don't intend to adopt a healthier lifestyle
0
Table 6.8: Health behaviour change: relieving worry
Ways to Relieve Worries about Breast Cancer: Group 1
N 46
Since reading the information pack,
I have been using the techniques to relieve
worry about breast cancer
4 (9%)
Since reading the information pack,
I intend to use the techniques to relieve worry
about breast cancer
22 (48%)
I was already using techniques to relieve worry
about breast cancer
14 (30%)
In spite ofreading the information pack,
I don't intend to use the techniques to relieve
worry about breast cancer
6(13%)
Twenty-seven percent of participants (n = 24) in Groups 1 and 2 thought that
they would obtain some of the further reading listed in the information pack. Of these
24 women, seven mentioned that they would look at some of the websites listed, five
women wanted to obtain further information about HRT and five women wanted to
obtain further information about breast cancer genetics/genetic testing (categories
were not mutually exclusive).
Only one woman in Group 1 (1%) and five women in Group 2 (10%) thought
that there was any information not included in the pack that they would have liked to
know. The topics of information that were thought to be missing by the five women
in Group 2 were (the woman in Group 1 did not specific what she thought was
missing): more details on genetic testing (n = 1), more details on new cancer
treatments (n = 1), lifestyle (n = 1) and contact information for the Ardmillan clinic
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(n = 1) (missing data: n = 1). The last two of these topics listed as missing were
included in the psychosocial section of the information pack.
Ninety-two percent of Group 1 (n = 44) and 98% of Group 2 (n = 48) thought
that the information pack covered their need for information and support. The other
types of service that were suggested by the remaining five women (four in Group 2
and one in Group 1) were: genetic testing (n = 1), more detailed information pack (n
= 1), information on current breast cancer research and alternative treatments (n = 1)
(missing data: n = 2).
6.13.3 Comparison between baseline and post-intervention for each group
6.13.3a Cancer Worry
Table 6.9 presents scores on the CWS for the three groups at baseline and
post-intervention for women with complete data. Group 1 (z = -2.133, p = .033) and
Group 3 (z = -2.449, p = .014) showed a significant decrease in CWS score from
baseline to post-intervention. In Group 2, there was no significant change in CWS
score.
Table 6.9: Cancer worry scale scores at baseline and post-intervention for
participants with complete data






Baseline Median 9.5 9 10
Range 6-20 6-17 6-17
Post-in terven tion Median 9 9 9
Range 6-16 6-24 6-16
Table 6.10 shows changes in CWS score for each of the three groups. CWS
score had decreased for 54% of the women from Group 1, compared to 35% of
Group 2 and 45% of Group 3. The median change in CWS score for Group 1 was -1,
representing a decline of one point on the scale. This compared to a median change
of 0 in Groups 2 and 3. Changes in the CWS scores from baseline to post-
intervention ranged from a reduction of seven points to an increase of five points in
Group 1, from a reduction of five points to an increase of 12 points in Group 2 and a
reduction of five points to an increase of two points in Group 3.
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Examination of changes in individual items of the CWS for Group 3
indicated that the only item to have improved to a level approaching significance was
"during the past month, how often have you thought about your own chances of
developing cancer?" (p = .057). Eleven of the 49 women in this group who had
answered this question as "sometimes/often/almost all of the time" at baseline, had
responded "not at all or rarely" post-intervention.
Table 6.10: Change in Cancer Worry Scale scores from baseline to post-intervention
Change in
CWS scores
Group 1 Group 2 Group 3
Total N 50 49 49
Median -1 0 0
Range -7 to 5 -5 to 12 -5 to 2
Decreased N 27 17 22
% 54 35 45
Range of decrease 1-7 1-5 1-5
Same N 13 16 18
% 26 33 37
Increased N 10 16 9
% 20 33 18
Range of increase 1-5 1-12 1-2
6.13.3b Objective knowledge of breast cancer risk-related topics
Table 6.11 presents scores on objective knowledge for the three groups at
baseline and post-intervention for women with complete data. In Group 1 and Group
2, there was a significant increase in Objective knowledge: total correct (z = -4.605,
p = .000, z = -5.090, p = .000) and a significant decrease in Objective knowledge:
total don't know from baseline to post-intervention (z = -4.579, p = .000, z = -5.000,
p = .000). In Group 2, there was also a significant decrease in Objective knowledge:
total incorrect (z = -2.210, p = .027). However, there were no significant changes in
Group 1 on Objective knowledge: total incorrect. Examination of the individual
knowledge items revealed persistent misunderstandings in Group 1 where over half
of the group post-intervention still gave the incorrect response (i.e. "Genetic testing:
can find mistakes in all the genes that cause an inherited genetic susceptibility to
breast cancer", 58%; "The following are designed to reduce the risk of breast cancer
developing: mammography", 63%; "clinical breast-examination", 69%; "breast
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awareness", 71%; "Mammography: is proven to be useful for women under 50 with
a family history of breast cancer", 78%). In Group 3, there were no significant
changes between baseline and post-intervention on any of the knowledge totals.
Table 6.11: Objective knowledge total scores at baseline and post-intervention for
participants with complete data
Objective knowledge Group 1 Group 2 Group 3
(n = 35) (n = 36) (n =38)
Total correct:
Baseline Median 15 17 14.5
Range 6-27 8-35 7-31
Post-in terven tion Median 23 27.5 15.5
Range 3-33 11-36 6-33
Total incorrect:
Baseline Median 9 7.5 7.5
Range 3-18 1-14 1-15
Post-in terven tion Median 8 7 9
Range 2-18 0-13 2-17
Total "don't know":
Baseline Median 10 11 12.5
Range 2-23 0-21 1-22
Post-in terven tion Median 3 1 11.5
Range 0-26 0-16 0-25
Tables 6.12, 6.13 and 6.14 shows changes in the three objective knowledge
total scores between baseline and post-intervention for each of the three groups.
With reference to changes in the total number of correct responses to the
objective knowledge items (Table 6.12), most of the women in Groups 1 and 2 (86%
and 94%) had given a greater number of correct responses post-intervention than
they had at baseline, compared to only 53% of Group 3. The median changes in total
correct scores for Groups 1 and 2 (7 and 8.5) were higher than the median change
score of 1 in Group 3, representing a greater improvement in Groups 1 and 2 than in
Group 3.
Table 6.13 shows over half ofGroups 1 and 2 (51% and 61%) gave fewer
incorrect responses post-intervention than at baseline. This compares to only 37% of
Group 3. The median change in the total number of incorrect responses was -1 for
Groups 1 and 2, representing fewer incorrect responses compared to a median change
of 1 in Group 3, reflecting greater incorrect responses.
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A large proportion of the women in Group 1 (83%) and Group 2 (92%) gave
fewer "don't know" responses post-intervention than at baseline (Table 6.14). This
compares to 61% ofGroup 3. Although the median changes for all groups
represented fewer "don't know" responses at post-intervention than baseline, the
greatest change was in Group 2 (-8.5).
Table 6.12: Change in scores on Objective knowledge: total correct from baseline to
post-intervention
Change in scores on
Objective knowledge:
total correct
Group 1 Group 2 Group 3
Total N 35 36 38
Median 7 8.5 1
Range -5 to 20 -3 to 20 -7 to 11
Decreased N 3 1 14




Same N 2 1 4
% 6 3 11
Increased N 30 34 20
% 86 94 53
Range of 1-20 1-20 1-11
increase
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Table 6.13: Change in scores on Objective knowledge: total incorrect from baseline
to post-intervention
Change in scores on
Objective knowledge:
total incorrect
Group 1 Group 2 Group 3
Total N 35 36 38
Median -1 -1 1
Range -8 to 7 -7 to 5 -6 to 8
Decreased N 18 22 14




Same N 6 5 3
% 17 14 8
Increased N 11 9 21
% 31 25 55
Range of 1-7 1-5 1-8
increase
Table 6.14: Change in scores on Objective knowledge: total don't know from
baseline to post-intervention
Change in scores on
Objective knowledge:
total don't know
Group 1 Group 2 Group 3
Total N 35 36 38
Median -5 -8.5 -1
Range -20 to 4 -19 to 5 -10 to 6
Decreased N 29 33 23




Same N 2 1 1
% 6 3 3
Increased N 4 2 14
% 11 6 37
Range of 1-4 1-5 1-6
increase
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6.13.3c Breast cancer-specific distress: Impact of Event Scale (IES)
A summary of IES scores for the three groups at baseline and post-
intervention for women with complete data is in Table 6.15. In Groups 1 and 2, there
were no significant changes between baseline and post-intervention on any of the
three IES scores. However, in Group 3 there was a significant decrease in scores on
the intrusion subscale from baseline to post-intervention (z = -2.248, p = .025) but no
significant changes on avoidance and total IES scores.
Table 6.15: IES scores at baseline and post-intervention for participants with
complete data
IES scores Group 1 Group 2 Group 3
Intrusion: N 9 13 16
Baseline Median 10 7 6.5
Range 0-33 0-25 0-27
Post-in terven tion Median 9 11 4
Range 0-12 0-35 0-25
Avoidance: N 9 10 15
Baseline Median 9 7.5 10
Range 0-26 0-23 0-30
Post-in terven tion Median 8 17.5 7
Range 0-17 0-40 0-30
IES total : N 8 10 15
Baseline Median 18.5 14 14
Range 0-59 2-47 0-51
Post-in terven tion Median 16.5 27.5 11
Range 0-27 0-75 0-51
6.13.3d General Psychological Distress: GHQ-12
Table 6.16 presents GHQ-12 total scores and the proportion of participants
suffering from "case-level" distress in the three groups at baseline and post-
intervention for participants with complete data. There were no significant changes
in any of the three groups on GHQ-12 total or "case-level" distress between baseline
and post-intervention. However, the number ofGHQ-12 cases in Group 1 decreased
to a level approaching statistical significance (p = .057).
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Table 6.16: GHQ-12 total scores and "case-level" distress at baseline and post-










Median 1 0 0
Range 0-11 0-12 0-12
Median 0 0 0




Case 15 (29%) 10(21%) 17 (35%)
Non-Case 36 (71%) 38 (79%) 32 (65%)
Case 7 (14%) 7(15%) 12 (25%)
Non-Case 44 (86%) 41 (85%) 37 (76%)
6.13.3e Appraisal*
A summary of perceived risk, perceived likelihood and perceived control
over developing breast cancer for the three groups at baseline and post-intervention
for participants with complete data is shown in Table 6.17. There were no significant
changes within the groups on any of the appraisal measures apart from a significant
decrease in perceived likelihood for Group 2 (p = .039) and a significant increase in
perceived control (p = .004) for Group 1 (within-group differences on perceived risk
could not be tested due to the small numbers in some categories).
*
Although, individual changes in perceived risk and perceived likelihood between baseline and post-
intervention were not calculated given the exploratory nature of this analysis, the data were checked
for extreme shifts. Participants who altered their perceived risk or perceived likelihood between
baseline and post-intervention did not change by more than one of the original categories.
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Table 6.17: Appraisal variables at baseline and post-intervention for women with
complete data
Appraisal Group 1 Group 2 Group 3
Perceived risk of N 50 48 51
developing breast cancer:*
Baseline Lower than 1 (2%) 0 0
The same as 4 (8%) 4 (8%) 0
Slightly
higher than
35 (70%) 31 (65%) 37 (73%)
Much higher
than
10 (20%) 13 (27%) 14 (28%)
Post-in terven tion Lower than 0 0 0
The same as 6 (12%) 3 (6%) 2 (4%)
Slightly
higher than
37 (74%) 35 (73%) 36 (71%)
Much higher
than
7 (14%) 10 (21%) 13 (26%)
Perceived likelihood of N 47 45 50
developing breast cancer:
Baseline Unlikely 13 (28%) 12 (27%) 16(32%)
Likely 34 (72%) 33 (73%) 34 (68%)
Post-in terven tion Unlikely 16 (34%) 19 (42%) 14 (28%)
Likely 31 (66%) 26 (58%) 36 (72%)
Perceived control over N 50 48 51
developing breast cancer:
Baseline None at all 15 (30%) 20 (42%) 16(31%)
Some 35 (70%) 28 (58%) 35 (69%)
Post-intervention None at all 6 (12%) 14 (29%) 18(35%)
Some 44 (88%) 34 (71%) 33 (65%)
* in relation to the general population.
6.14 Discussion
6.14.1 Participants
Compliance with the study was good as the participation rate for completing
both questionnaires was 73%. There were no statistically significant differences
between the participants at baseline and the non-participants on several
sociodemographic and coping style measures. This was despite the fact that the
participants were self-selected as they had all expressed an interest in at least one of
the intervention options listed in the cross-sectional questionnaire study. However,
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the results suggest that the small number of participants who dropped out of the
study may have been biased with respect to high levels of intrusive and avoidant
thoughts about breast cancer. This suggests that these women may have dropped out
of the study in an effort to reduce their high levels ofbreast cancer-specific distress.
Therefore, the post-intervention results should be interpreted with caution (this is
further discussed in Section 6.14.6, page 189).
At baseline, there were no significant differences between the three groups
apart from on the coping style variable "Cognitive uncertainty" (CU) that was
extracted from the cross-sectional questionnaire study. CU is a style of coping with
uncertainty through cognitive means: "CU assesses the need to plan ahead of time,
and to seek clarification and gather information, as strategies for avoiding
ambiguity" (Greco & Roger, 2001). Group 3 scored significantly higher at baseline
on CU than the other two groups. In addition, a positive correlation that was
approaching significance was observed between CU and baseline cancer worry. This
may have affected outcome ofGroup 3 which will be discussed in Section 6.14.2b,
page 180.
6.14.2 Aim 1: To determine the impact of a psychoeducational written
intervention on cancer worry (primary outcome) and objective knowledge of
breast cancer risk-related topics (secondary outcome).
6.14.2a Hypothesis 1: The addition of Scientific + Psychosocial Written
Information to standard care (Group 1) will reduce cancer worry to a greater
extent than the addition of Scientific Written Information alone (Group 2).
At baseline, the median CancerWorry Scale (CWS) score for the total sample
(median = 9) was slightly lower than for those reported in women prior to attending
breast cancer genetic risk counselling (Watson et al, 1998: median =11; Hopwood et
al, 2001: median =11) and 2-21 months post-counselling (Hopwood et al, 2001:
median =11). This may suggest that cancer worry generally declines in the years
following genetic risk counselling. However, further longitudinal research would be
needed to assess the course of cancer worry in these women over a period of years. It
is understandable that these women would be worried about breast cancer given the
uncertainty associated with having a family history, however 54% ofparticipants at
baseline reported that worrying about cancer was a problem for them.
The findings of the study provide evidence to support hypothesis 1. There
was a statistically significant decrease in the cancer worry of Group 1 from baseline
to post-intervention and no corresponding decrease in the cancer worry of Group 2.
On average, CWS scores decreased by one point in Group 1 and stayed the same in
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Group 2. For over half of the participants in Group 1, CWS scores had decreased
between baseline and post-intervention compared to 35% of Group 2. The lack of
impact of the scientific topics of information alone on cancer worry suggests that the
psychosocial topics played a key role in the reduction of cancer worry in Group 1.
The results contrast those of a previous written intervention in American women
with a family history of breast cancer where neither general psychological nor breast
cancer-specific distress were significantly reduced (i.e. Gagnon et al., 1996).
Although the cancer worry of Group 1 significantly decreased, the reduction
may be slightly conservative. Nearly a quarter of Group 1 reported becoming more
breast aware as a result of reading the information pack. This change in behaviour
may have prompted an increase in breast-cancer specific distress as breast awareness
could act as a cue to worry as participants in the telephone focus group study have
described.
The results suggest that psychosocial self-help information in the form of
techniques for coping with or reducing worry and advice on maintaining a healthy
lifestyle can effectively reduce cancer worry in this group ofwomen. However,
further research would be needed to identify which specific aspects of the
psychosocial topics make the greatest contribution to the reduction in cancer worry.
In addition, the results did not provide any evidence that the information pack
significantly increased cancer worry (there was limited upset reported which is
discussed in Section 6.14.4, page 185). However, for 20% ofGroup 1 CWS scores
were found to increase up to 5 points between baseline and post-intervention and to
increase up to 12 points for a third ofGroup 2. This particularly raises concern
regarding the results for Group 2. These suggest that providing scientific information
about familial risk ofbreast cancer without the addition of psychosocial information
to help control worry, may result in elevated breast cancer-specific distress for a
substantial proportion ofwomen. However, the clinical importance of these changes
in cancer worry remains unclear until further research on this scale is undertaken,
including deriving clinical thresholds.
6.14.2b Hypothesis 2: Scientific Written Information in addition to standard
care (Group 2) will reduce cancer worry to a greater extent than standard care
alone (Group 3).
The results of this study do not support the predictions of hypothesis 2.
The cancer worry of Group 2 did not significantly decrease from baseline to post-
intervention, but there was a significant decrease in the cancer worry ofGroup 3.
Although the median change in CWS scores ofboth groups indicated no difference
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in cancer worry from baseline to post-intervention, CWS scores had decreased for
45% ofGroup 3 compared to 35% of Group 2.
This finding that the control group (Group 3) experienced a greater reduction
in cancer worry may be the result of this group not being contacted about the study
for four weeks after returning the baseline questionnaire. As this group's
involvement in the study during these four weeks was at a minimum, they may have
experienced fewer cues to remind them about breast cancer. Indeed, the only CWS
individual item to have decreased to a level of near statistical significance was the
frequency they had thought about their own chances of developing cancer in the past
month. We have previously described the experiences ofwomen at increased risk of
breast cancer concerning increased anxiety prompted by a variety of breast cancer
cues (Appleton et al., 2000).
Another explanation for the decrease in the cancer worry of Group 3 may be
related to the significantly higher score on the Cognitive Uncertainty coping style
subscale that was observed at baseline. This means that this group had a stronger
tendency to cope with uncertain situations through cognitive means such as
information seeking. It may be possible that towards the end of the study period the
group were anticipating receiving the information pack (for ethical reasons, they
were told when randomised that they would be offered the information pack at the
end of the study). As we had observed a positive correlation between scores on the
Cognitive Uncertainty subscale and cancer worry at baseline, cancer worry may have
decreased as a result of anticipating receiving the information pack.
In addition, there were two women in Group 3 (the control group) who had
read information related to familial risk of breast cancer over the study period. As it
is possible that reading this information may have prompted an increase in breast
cancer-specific distress, the results on these measures still may be slightly
conservative.
6.14.2c Hypothesis 3: Written Information in addition to standard care
(Groups 1 and 2) will improve objective knowledge of breast cancer risk-
related topics to a greater extent than standard care alone (Group 3).
Objective knowledge of breast cancer risk-related topics at baseline was
generally poor. On average participants at baseline gave the correct response to less
than half of the questions, the incorrect response to about a quarter of the questions
and didn't know the answer to about a third of the questions. This was despite the
fact that the participants were a highly educated group (51% were educated or trained
after age 18) as is commonly found in health screening populations (Rimer et al.,
181
1996). Other studies that have objectively assessed knowledge relating to breast
cancer genetics in women with a family history of breast cancer have reported
varying levels of knowledge (e.g. Lerman et al., 1996; Wonderlick & Fine, 1997;
Cull et al., 1998; Bluman et al., 1999; Meiser et al., 2001a & b). Persistent errors in
understanding of certain issues were reported in British first-time attendees of
genetic risk counselling for breast cancer, despite receiving a video about breast
cancer genetics and screening (Cull et al., 1998). Therefore the baseline results alone
support the need for information, to update that which these women may have been
given when they first attended the familial breast cancer clinic several years
previously.
The results of this study provide evidence to support hypothesis 3. Objective
knowledge of breast cancer risk-related topics significantly improved in Groups 1
and 2, who received different versions of the information pack, but remained
unchanged in Group 3 (the control group). In Group 1, there was a significant
increase in the total of correct responses and a significant decrease in the total
number of "don't know" responses from baseline to post-intervention. In Group 2,
there was a significant increase in the total of correct responses and significant
decreases in the total of incorrect and "don't know" responses from baseline to post-
intervention. Objective knowledge had improved (i.e. more correct responses, fewer
incorrect responses and fewer "don't know" responses) for the vast majority of
women in Groups 1 and 2. In Group 3, there were no significant changes between
baseline and post-intervention on any of the objective knowledge total scores.
Although there was a slight decrease in the number of incorrect responses of
Group 1 between baseline and post-intervention, it was not found to be statistically
significant. This may be due to receiving the psychosocial as well as the scientific
topics of information. As these women were sent more material to read and absorb
than Group 2, it is possible that the full information pack was too lengthy to be
effectively retained. This is also reflected in the fact that Group 2's knowledge
seemed to improve to a greater extent than Group 1 as shown by the greater median
change in scores than Group 1 and differences in the distribution of these changes.
Although we didn't received any feedback from Group 1 that suggested there was
too much information in the pack, a smaller proportion of the women in Group 1
reported reading the whole of the information pack than Group 2. Future research
could investigate the effectiveness ofwritten information of varying detail and length
to enable the development of an intervention that is of optimal benefit to these
women.
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The persistent misunderstandings of Group 1 where over halfof the group
still gave the incorrect response post-intervention were concerning genetic testing
("Genetic testing: can find mistakes in all the genes that cause an inherited genetic
susceptibility to breast cancer") and screening ("The following are designed to
reduce the risk ofbreast cancer developing: mammography, clinical breast-
examination, breast awareness"; "Mammography: is proven to be useful for women
under 50 with a family history of breast cancer"). These findings highlight areas
where the information pack could perhaps have provided more emphasis and where
future interventions may choose to focus.
6.14.3 Aim 2: To explore the impact of a psychoeducational written
intervention on breast cancer specific-distress (as measured by the Impact of
Event Scale), generalised psychological distress (as measured by the GHQ-
12) and appraisal (as measured by perceived risk, perceived likelihood and
perceived control).
There was no evidence to suggest that the information pack caused a
significant increase in intrusive or avoidance thoughts about breast cancer risk.
Although it was not found to be statistically significant, the median IES scores for
Group 2 had increased substantially. Although the clinical significance of the size of
these changes remains unclear, it still raises concern about the impact ofproviding
scientific information about breast cancer in the absence of advice about dealing with
worry.
In Group 3, there was a statistically significant decrease in intrusive thoughts
about breast cancer risk from baseline to post-intervention. This finding mirrors the
decrease in cancer worry in this group and again may be due to the fact that the
group was not contacted about the study during the four weeks between
questionnaire assessments.
The results of the study do not provide any evidence that general
psychological distress was significantly increased by the information pack.
Moreover, the number of GHQ-12 cases in Group 1 decreased from baseline to post-
intervention at a level approaching statistical significance. This suggests that the
addition of the self-help psychosocial information helped to reduce general
psychological distress to a certain extent as well as cancer worry.
Although between- and within-group differences on perceived risk were not
tested due to the small numbers in some of the categories, the data shows that in
Group 1, fewer women post-intervention perceived their risk to be in the extreme
categories (i.e. lower than or much higher than the general population) than at
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baseline. It is possible that this shift reflects a general improvement in the accuracy
of the perceived risk of this group. Although this would require further investigation,
it may be due to improved scientific knowledge such as concerning breast cancer
genetics or risk factors for the disease.
In Group 2, there was a significant decrease in the perceived likelihood of
ever developing breast cancer from baseline to post-intervention. Perceived
likelihood had decreased for eight women in this group (from "likely" to "unlikely").
One possible explanation for this result could be that the information pack had
improved the accuracy of their perceived risk. However, we could not appropriately
assess this accuracy as we couldn't assume that the objective breast cancer risk the
participants had most recently been given at the clinic, were the same as the updated
risk estimates we used to describe the participants in this study. Further research
would be needed to investigate the role of the accuracy of risk perception both as a
moderator and outcome ofpsychoeducational intervention. Although perceived
likelihood had decreased for this group, we found no corresponding decrease in
breast cancer-specific or generalised distress. Research in first-time attendees of
genetic risk counselling for breast cancer has shown that a decrease in perceived risk
is not directly associated with a reduction in psychological distress (Cull et ah,
1999).
In Group 1, there was a statistically significant increase in perceived control
over ever developing breast cancer from baseline to post-intervention. Perceived
control had increased for nine women in this group (for seven women from "none at
all" to "a bit", for two women from "none at all" to "moderate"). Although, there
was also an increase in perceived control in Group 2, it did not reach statistical
significance. These results show that the addition of the self-help psychosocial
information can increase perceived control to a greater extent than the scientific
information alone. These results support our previous qualitative findings where
women with an increased risk of breast cancer described how adopting a healthier
lifestyle had enhanced their feelings of control over their risk of breast cancer: ".. .all
these things help you to feel you are in control of the situation rather than the
situation is in control of your life so I think it is very important to do things, positive
things, to make you feel you are doing all you can, you know, not to have it (breast
cancer)" (Appleton et ah, 2000). The increase in perceived control may also help to
explain the decrease in cancer worry and general psychological distress in Group 1.
It has been suggested that "low levels of perceived control may increase vulnerability
to cancer-specific distress" in women with a family history of breast/ovarian cancer
(Audrain et ah, 1997). Taylor et al. (1984) has shown that in breast cancer patients
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perceived control over breast cancer (both in terms of internal and external control)
was significantly associated with good adjustment to breast cancer.
6.14.4 Aim 3: To evaluate the acceptability of the psychoeducational written
intervention for women living with an increased risk of breast cancer.
Both versions of the information pack (scientific/scientific and psychosocial)
were generally found to be highly acceptable to participants. This was supported by
the high participation rate for the study and the high demand for the full information
pack after the post-intervention assessment. Participants' comments were extremely
positive about the information packs: " I feel that the information pack has been and
will continue to be a vital source of information and advice for me on the subject of
breast cancer and all the related issues" (woman from Group 1).
The information packs were well read by participants. At least 80% of
Groups 1 and 2 read all of the topics and leaflets they were sent at least once. Each
topic of information was read by at least 90% of the women who had been sent it,
whereas the accompanying leaflets were less well read (e.g. 20% of Group 1 did not
read the "How to.. .Stop Worrying" leaflet). Only two women (both in Group 1) had
not read any of the information pack (this is discussed in Section 6.14.5, page 187).
The vast majority ofparticipants found all of the topics and leaflets helpful.
For the majority ofwomen, at least some of the information included in each of the
topics was new to them. Therefore the information packs did not simply repeat the
information these women may have been given at the familial breast cancer clinic
several years previously, but provided them with new pieces of information. Almost
halfofGroup 1 and one third of Group 2 had discussed the information in their pack
with their husband, friends or other family members. Slightly more women from
Group 1 had given their information pack to their husband, friends or other family
members to read. These differences may reflect the wider relevance of the
psychosocial topics of information for other family members.
Only a small number of people (n = 12) had found any of the topics difficult
to understand, ofwhich the breast cancer genetics and genetic testing topics were
most frequently listed. As one woman in Group 2 commented: "I felt that this was
pitched at the correct level for a non-medically minded individual. A good balance of
information and not too technical or lengthy. Very user friendly. I, for one, would
have appreciated such a pack on referral to the clinic".
Only five women had found any of topics of information upsetting, ofwhich
the diagnosis and treatment of breast cancer topic was listed twice as often as any of
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the other topics. Of the five women who were contacted regarding their upset in
relation to reading the information pack, three responded, ofwhom two were willing
to discuss their upset. For one of the women, receiving the information pack had
acted as a cue to worrying about breast cancer, but she thought no more so than
watching a television programme about breast cancer. For the other woman, the
information pack had raised concerns about genetic testing and she was subsequently
contacted by a genetic breast care nurse from the Ardmillan clinic to discuss these
concerns.
The impact of the information pack on changes in or intention to change
particular health behaviours was good. This is encouraging since behavioural change
was not the main focus of this brief intervention. Nearly half of participants had or
intended to become more breast aware as a result of reading the information pack.
Similarly half of participants had or intended to adopt a healthier lifestyle where the
majority of these women were focusing on increasing their exercise and having a
healthier diet. Over half of participants had or intended to use the techniques to
relieve worry about breast cancer. However, these results should be interpreted with
caution as we did not take into account the social desirability of indicating an
improvement in health behaviour.
In addition, an intention to change a particular health behaviour is not
necessarily realised: "Although intention to change is associated with an increased
likelihood of doing so, it predicts only about 30% of the variance in behavioural
change (Marteau & Lerman, 2001). Therefore, further research could investigate the
addition of a follow-up intervention to help participants realise their good intentions.
The interventions most effective in changing behaviour tend to focus on reinforcing
people's beliefs about their ability to alter their behaviour and risk reduction
(Marteau & Lerman, 2001). In this study, given the lack of scientific evidence that
changing certain health behaviours can reduce the risk ofbreast cancer, the
intervention promoted health behaviours that reduce general health risks whilst also
providing practical self-help information in changing health behaviours. Future
interventions that aim to change health behaviours in this population could provide
similar information, but perhaps with more emphasis and detail than we have
provided in the present intervention.
The results show that the information pack generally met the needs of this
group ofwomen. As one participant at baseline stated: "I feel that as a woman under
50 years with a family history of breast cancer, I receive no additional information
that might increase my knowledge and decrease my anxieties". Only a few
participants thought there was information missing from the pack that they would
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have liked to know (most of these women were in Group 2 and the missing topics of
information were included in the psychosocial component of the other information
pack). As over 90% ofparticipants thought that the information pack covered their
need for information and support, this suggests that this type of psychoeducational
intervention may be sufficient in meeting these needs.
6.14.5 Methodological issues
There are a number ofmethodological issues with the study concerning the
participants, measures and analysis that should be considered when interpreting the
results.
Regarding the participants, two observations were noted that may have
slightly affected the results. Firstly, one participant, who stated she was an oncology
health professional (in Group 2), only gave an incorrect response to one of the
knowledge questions at baseline, leaving little room for an improvement post-
intervention. Therefore the improvement in knowledge for this group may be slightly
conservative. Secondly, nine of the participants (6%) at baseline were estimated to
have a low risk of breast cancer. As this rendered the sample more heterogeneous
with respect to their objective risk of breast cancer, the results particularly
concerning perceived risk and psychological distress may have been affected. The
familial breast cancer clinic was likely to be in the process of discharging these
women as they were now not deemed to be at sufficiently increased risk of breast
cancer to warrant clinical surveillance before the age of 50.
Despite the fact that the objective knowledge measure was developed
specifically for this study by amultidisciplinary group, it was an ad hoc instrument
and was not subjected to psychometric testing. At the time of designing the study,
using a study-specific measure that assessed the key points of information included
in the scientific topics was deemed more appropriate than using any of the existing
measures of objective knowledge (e.g. BCHK scale - Ondrusek et al., 1999). Use of
an existing scale or our knowledge measure (if subjected to validation) may be
appropriate on first time attendees of a familial breast cancer clinic to highlight areas
where knowledge is lacking to highlight an appropriate intervention. A few
participants did not understand some of the knowledge questions at baseline. Three
participants were not sure whether the questions about procedures designed to reduce
the risk of breast cancer developing, referred to breast cancer starting or spreading.
Some participants did not understand other terms in the objective knowledge items:
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genetic mistake, the genes BRCA1 and BRCA2 and prophylactic surgery. These
terms should perhaps have been further clarified in the questions.
As the data were analysed on an intention-to-treat basis, all participants were
included in the analysis even if they had not read all of the information pack. There
was a minority ofwomen in Groups 1 and 2 who had only read certain topics or
leaflets in the information pack. Reasons that were given for this included a recent
bereavement from cancer. An additional explanation may be the variation between
participants in the relevance of some of the topics (e.g. the HRT topic was more
relevant to the older women in the group). Only two women (both from Group 1) had
not read any of the information pack. One of these women said she couldn't face
reading it at the moment but would when her life had quietened down and the other
woman did not give a reason. Given that not all of the participants had read all of the
information they were sent, the reduction in cancer worry in Group 1 and
improvement in knowledge for Groups 1 and 2 are likely to be conservative
estimates. In addition, some of the women who indicated they had not read a
particular topic, did rate that topic for example on its helpfulness. It is likely that
these women may have glanced at this topic whilst looking through the information
pack, but may have felt they hadn't actually read it in detail. Future studies could
assess the degree to which participants read an information pack for example from
skimming through the topic headings to reading everything in detail. It would then be
possible to assess if the extent to which participants read the information pack was
related to a reduction in cancer worry or if simply providing information reassured
the women and reduced their cancer worry regardless ofwhether they actually read
the information.
In regard to widely accepted criteria for the design and reporting of
randomised controlled trials, this study meets the majority of criteria of the
CONSORT (Consolidated Standards ofReporting Trials) statement (Moher et al.,
2001). In particular, details on the following aspects were reported: a description of
the interventions administered to each group; specific objectives and hypotheses,
clearly defined key outcome measures, details of sample size calculations and
randomisation, the number of participants through each stage of the trial, methods of
analysis. However, due to resource constraints of the study only one researcher was
involved in the study procedure. This meant that, in contrast to CONSORT
guidelines, the same researcher was involved in the development of the intervention,
the recruitment of participants, randomisation and assessment of study outcomes. In
addition, although participants were randomised using a restricted random permuted
blocks method, the researcher was not blind to which group each participant had
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been assigned. Although these factors are unlikely to have influenced the results of
this particular trial, it would nevertheless have been desirable to have a second
researcher involved in the study procedure to prevent any potential bias.
6.14.6 Study limitations
A number of limitations with the present study were noted regarding missing
data, the clinical significance of findings, lack of long-term follow-up, Impact of
Event Scale and clinical appointment data.
Missing data pose a particular challenge to the interpretation of outcomes in a
randomised controlled trial. Data may be missing at random or they may represent
informative censoring (i.e. a greater proportion of participants dropped out of one
group compared to another/there is a consistent reason for participant drop-out). In
this study a similar number of participants dropped out from each of the three groups
between baseline and post-intervention. However, comparison of those women who
dropped out and those who completed the study revealed potential differences in
levels of intrusive and avoidant thoughts about breast cancer risk. This means that
the complete data used to evaluate the effect of the intervention may be biased with
respect to scores on these measures and therefore the results should be interpreted
with caution.
Although clinical thresholds have not yet been derived for the Cancer Worry
Scale, the results do suggest that the statistically significant reduction in the cancer
worry ofGroup 1 is likely to have some clinical significance. The vast majority of
participants found the worry about breast cancer topic to be helpful and it had
prompted many of the women to use or intend to use the suggested techniques to
relieve worry about breast cancer. It would be essential for further work to identify
clinical thresholds on this measure to aid the identification ofworried individuals and
to measure the clinical effectiveness of associated interventions. Similarly, the
interpretation of the objective knowledge results did not benefit from reference data
to indicate the clinical significance of improvements. This was an ad hoc instrument,
where items were simply summed to give total scores. Improvements in the objective
knowledge total scores ranged greatly between individuals. However, it could be
argued that even giving the correct response to only one more item post-intervention
than at baseline represents a worthwhile improvement in the knowledge of breast
cancer-risk-related information.
It may have been desirable to have another follow-up assessment in this study
several months later, to discover if any of the short-term improvements in the key
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outcomes were sustained. Although a long-term follow-up was outside the scope of
this study, this should be incorporated into future research.
Only a minority of participants, who had thought about the risk of breast
cancer in the past week, completed the Impact ofEvent Scale at baseline (43.8%)
and post-intervention (34.7%). Therefore, the results of this scale should be
interpreted with caution as they do not reflect data from the whole sample.
The participants were originally asked at baseline and post-intervention if
they had attended the clinic in the last two weeks or if they had an appointment in the
next two weeks. However, this data was not analysed as a subset was found to be
unreliable when checked with clinic records and it was outside the scope of this
study to collect clinic appointment data from case notes. As our previous research
has suggested it is likely an imminent or recent clinic appointment acts as breast
cancer cue to prompt an increase in thoughts and worries about breast cancer
(Appleton et al., 2000). Such breast cancer cues are likely to have affected an
individual's level of breast cancer-specific distress and their response to the
information pack. Future longitudinal studies in this area need to identify and collect
reliable clinical appointment data and investigate the relationship between this type
of breast cancer cue and an individual's levels of psychological distress.
6.14.7 Clinical implications and future research
This study supports the value of a scientific and psychosocial information
pack in providing up-to-date information related to familial risk of breast cancer for
long-term attendees of a familial breast cancer clinic.
However, the results indicate several ways in which the intervention could be
improved. Although the information pack reduced cancer worry and improved
knowledge, the results highlighted some persistent misunderstandings about genetic
testing and breast cancer screening. These areas in the information pack could be
expanded or further clarified in an attempt to improve knowledge in these areas.
Future studies could choose to include psychosocial self-help information about how
to cope with bereavement (recent or not) as cancer worry is likely to be related to the
experience of losing a close relative to breast cancer: as one woman in the study
commented "I can't relieve the worry as three ofmy sisters have died of cancer".
There are a number ofways in which the information pack could be
incorporated into clinical services these women are already receiving. The
information pack could be used routinely as part of clinical practice to complement
and expand on verbal information provided by the clinician. The information pack
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could be regularly updated and posted to participants or given to them when they
attend the clinic. However, one disadvantage of producing this type of information
pack is that it will require frequent updating and reprinting. A better alternative to
producing paper copies may be to place the information on a web page that is both
easy to update and access. At the time of designing the intervention study we decided
not to set up the information pack as a web page initially for several reasons: we
were responding to a specific need for written information; we had not received a
specific request for a web page; we did not want to limit participants to only those
with Internet access (less than half of participants in our previous qualitative study
had access to the Internet). Although we would expect access to the Internet to be
more widely available now, it may still be necessary to check that the intended
audience had Internet access otherwise a paper copy of the information could be
issued. Women who are currently attending for genetic risk counselling are likely to
receive more standardised and detailed information than the women in this study
received when they first attended the clinic several years ago. However, there is still
potential value in modifying this information pack specifically for first time
attendees to complement the information they are given by the clinicians and include
psychosocial information ofwhich they may not have discussed. Likewise, although
information pack was developed for women attending a specific familial breast
cancer clinic, it could easily be adapted to be applicable to other clinics in the U.K or
internationally.
191
Chapter 7: General Discussion
7.1 Review of the rationale for the current work
At the time of starting the current body ofwork, growing numbers ofwomen
with a family history of breast cancer were being referred for genetic risk
counselling. A substantial proportion of those women were identified as being at
increased risk of developing breast cancer. Genetic testing was initially expected to
be widely available and informative for all of these women. However, it became
apparent that for the foreseeable future genetic testing would not be informative for
the majority ofwomen at increased risk of breast cancer. In the absence ofproven
methods to prevent or reduce breast cancer, the clinical management of these women
focused primarily on breast cancer screening.
It remains the case today that large numbers of young women are attending
familial breast cancer clinics on a regular basis for clinical surveillance. These
women are faced with multiple uncertainties regarding their personal risk of
developing breast cancer and the effectiveness of risk management strategies. They
are likely to have to live with the knowledge of their increased risk ofbreast cancer
for the rest of their lives and face the prospect of years of clinical surveillance. Over
the years that they may attend a familial breast cancer clinic, their estimated risk of
breast cancer may be adjusted in response to their increasing age or changes in their
family history. Although their risk of developing breast cancer due to an inherited
susceptibility decreases as they get older, their risk of sporadic breast cancer
increases with age. Alterations in the clinical services that are offered to these
women may reflect both changes in risk and clinical resources. Given this long-term
situation full of uncertainty, the potential for adverse psychosocial effects on these
women was clear.
A review of the literature on the psychosocial outcomes of genetic risk
counselling for breast cancer revealed that research to date had only assessed
participants up to 25 months post-counselling (i.e. Evans et al., 1994; Cull et al.,
1999; Schwartz et al., 1999a; Watson et al., 1999; Hopwood et al., 2001; Meiser et
al., 2001b; Bish et al., 2002). A limited number of studies had conducted cross-
sectional surveys ofwomen at increased risk ofbreast cancer who were maintained
on regular clinical surveillance (i.e. Kash et al., 1992; Valdimarsdottir et al., 1995;
Lloyd et al., 1996; Zakowski et al., 1997, 2001). Both bodies of research have found
that a substantial number of healthy women with a family history of breast cancer
were experiencing significant levels of general psychological and breast cancer-
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specific distress. However, little was known about the longer-term psychosocial
consequences of living with an increased risk of breast cancer. It was apparent that
there was a lack ofpublished research in women at moderate or high risk of breast
cancer who had been receiving regular clinical surveillance for a number of years
and who were not eligible for genetic testing or prophylactic surgery.
Chronic psychological distress in these women would have important
implications for the individuals concerned, their families and the clinical services
they receive.
Research has already shown that high levels ofpsychological distress are
associated with non-adherence to mammography (e.g. Lerman et ah, 1993), clinical
breast-examination (e.g. Kash et ah, 1992) and breast self-examination (e.g. Kash et
ah, 1992). If these methods of breast cancer screening are proven to be effective in
young women at increased risk of the disease, chronic distress could interfere with
the early detection ofbreast cancer, thus affecting an individual's prognosis if they
are diagnosed with the disease.
Apart from the likely negative psychosocial impact on the family ofhaving a
relative who is chronically distressed, these women may represent maladaptive role
models for the next generation of their family. For example, their daughters and
granddaughters are also likely to face living with an increased risk of breast cancer
and may be influenced by how their relative coped when in a similar situation.
These women could also place additional demands on clinical services they
receive, that are already under pressure from growing numbers of referrals.
Chronically distressed women may miss their routine appointments or request
numerous appointments.
Given the lack of knowledge about the long-term psychosocial effects of
genetic risk counselling for breast cancer in the current literature, the absence of
routine psychosocial services and the far-reaching implications of psychological
distress in this group ofwomen, a need for further research was highlighted.
This thesis presented a series of three studies to investigate the psychosocial
effects of living with an increased risk of breast cancer in women who had
undergone genetic risk counselling and had subsequently been receiving regular
clinical surveillance for at least two years. The initial qualitative study aimed to
explore the important issues for these women using the novel methodology of
telephone focus groups. The second study, a larger quantitative cross-sectional
survey, tested and expanded on some of the main findings from the previous study. A
psychoeducational written intervention was then developed to meet the needs of
these women and evaluated in a randomised controlled trial.
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7.2 Summary of main findings
7.2.1 Telephone focus group study
Qualitative analysis of the seven telephone focus groups revealed six key
issues concerning the psychosocial effects of living with an increased risk of breast
cancer: (1) psychological adaptation, (2) behavioural adaptation, (3) family issues,
(4) clinical surveillance, (5) provision of information and (6) peer support.
These results provided qualitative evidence ofbetween- and within-individual
differences in terms of anxiety and distress. Participants described experiencing
varying degrees of anxiety and distress, with a subset reporting high levels ofbreast
cancer-specific distress. The impact of breast cancer cues (e.g. approaching the date
of a routine appointment at the familial breast cancer clinic) varied between
participants with some women becoming more distressed in response to these cues.
In addition to the impact of breast cancer cues, differences in the levels of anxiety
and distress could be due to variations in a number of factors including experiences
ofbreast cancer in the family, beliefs about the disease and perceived risk of breast
cancer.
A number of important internal and external coping resources were described
including positive cognitions, knowledge about breast cancer-related issues, clinical
surveillance and family members. There was qualitative evidence of between- and
within-individual variation in the coping strategies adopted which included cognitive
strategies such as avoidance and behavioural strategies such as reassurance seeking
and health behaviours.
There was a common need for information related to familial risk of breast
cancer which was confirmed by the results of the feedback questionnaire: all 25
participants reported that they would like to be provided with up-to-date information
on a variety of scientific and psychosocial topics related to familial risk of breast
cancer.
This study highlighted a number of possible directions for the subsequent
study including further assessment of needs for information and support,
investigation ofpsychological distress both between- and within-individuals,
assessment of coping strategies and their role in adapting to living with an increased
risk of breast cancer. The main findings that were chosen to be further explored were
the needs for information and support and between-individual variation in levels of
psychological distress. These findings were selected on the basis that requiring
further data in these areas would enable a response to these women's needs, through
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the development of an appropriate intervention. Although the other findings raised
by the telephone focus group study were not subjected to further investigation by the
current body ofwork, they still warrant more detailed exploration.
7.2.2 Cross-sectional study
The cross-sectional survey of 249 women living with an increased risk of
breast cancer tested and expanded on some of the main findings of the telephone
focus group study.
The prevalence ofprobable psychiatric morbidity (26%) and levels of breast
cancer-specific distress were similar to that reported in the literature in women with a
family history ofbreast cancer who had more recently attended genetic risk
counselling. This suggests that there may not be a cumulative effect over time on
levels ofpsychological distress in women living with an increased risk of breast
cancer. However this finding also indicates that any increase in levels of distress
experienced a few months after genetic risk counselling may be sustained during the
subsequent years. In addition, worries among participants about issues relating to
breast cancer risk were extremely common, suggesting that these were not the type
ofworries that could easily be resolved even over a period of years.
The results provided mixed degrees of support for the study hypotheses.
As predicted, greater perceived likelihood of developing breast cancer and a
higher Monitoring coping style were related to worry about breast cancer risk-related
issues, lower satisfaction with social supports was related to general psychological
distress and a higher Emotional Uncertainty coping style was related to general and
breast cancer-specific distress. In addition to these predicted factors, several other
exploratory variables were found to contribute to the prediction of general
psychological or breast cancer-specific distress: having a psychiatric history, lower
educational level and not being married or living with a partner.
However, there was no support for the hypotheses that perceived control over
developing breast cancer or the difference between age of their mother at diagnosis
of breast cancer and the current age of the woman were related to distress. Likewise,
there was no evidence of a relationship between a Monitoring coping style and
intrusive thoughts about breast cancer.
The findings of this study confirmed a widespread need for up-to-date
information related to familial risk ofbreast cancer. Over 90% ofparticipants were
interested in receiving information about at least one scientific or psychosocial topic.
195
There was an overall preference (85%) for the information to be presented in a
written format rather than a group meeting or telephone discussion group.
7.2.3 Randomised controlled trial
A psychoeducational intervention, consisting ofwritten information on
scientific and psychosocial topics related to familial risk of breast cancer, was
developed to meet the needs of these women.
The results of a randomised controlled trial of the intervention in 151 women
living with an increased risk ofbreast cancer provided some support for the study
hypotheses. The information pack containing both scientific and psychosocial topics
of information significantly reduced cancer worry and improved objective
knowledge of scientific issues related to familial risk of breast cancer. The
information pack that only contained the scientific topics of information significantly
improved knowledge whereas no improvement in knowledge was observed in the
control group who did not received any information.
In contrast with the hypotheses, the information pack that only contained the
scientific topics did not significantly reduce cancer worry and there was a significant
decrease in cancer worry and intrusive thoughts about breast cancer in the control
group.
There was no evidence that either version of the information pack
significantly increased general psychological or breast cancer-specific distress. The
information pack containing both scientific and psychosocial topics of information
significantly increased perceived control over developing breast cancer. The
information pack that only contained the scientific topics of information significantly
decreased the perceived likelihood of ever developing breast cancer.
Both versions of the information pack were shown be highly acceptable to
participants and to meet their needs for information and support.
7.2.4 Overall summary of main findings
The current body ofwork has provided an important contribution both to the
psychosocial literature and the development of clinical services for women living
with an increased risk of breast cancer. The work has provided evidence, in terms of
objective assessment ofpsychological distress and the subjective views of
participants, that there is a need for psychoeducational intervention among this group
ofwomen. The work has shown that such an intervention can effectively reduce
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breast cancer-specific distress and improve knowledge of key issues related to breast
cancer risk whilst successfully meeting the subjective needs of these women.
7.3 Limitations of the current work
Although the limitations have already been discussed for each study, this
section presents the main issues that are relevant to the current work.
7.3.1 Samples
Research in women attending familial breast cancer clinics faces a series of
potential sources of bias with regard to their samples ofparticipants. Women who
choose to attend genetic risk counselling are likely to be different from those who
choose not to attend in terms of sociodemographic factors such as educational level
and social class. Those women who then choose to attend a particular familial breast
cancer clinic may receive different services from those women attending another
clinic in the same country. In addition, those women who choose to participate in a
specific study may be different from those to refuse to participate in terms of
psychosocial factors such as levels of distress. These sorts of factors may also help to
explain why some women complete their participation in a study whilst others drop
out part of the way through.
As far as the current work is concerned, the participants were generally
highly educated and ofwhite ethnicity. They appeared to be representative of the
women attending familial breast cancer clinics, both nationally and internationally, in
terms of sociodemographic factors such as educational level and were typical of the
Scottish population in terms of ethnicity. However, it was not possible to ascertain
whether the participants were representative of those women who choose not to take
part on other psychological factors. Non-participants may have been biased in terms
of distress and coping style: highly distressed women or those with an avoidant style
of coping may have chosen not to participate. Despite these potential biases, the
current work obtained a range of distress levels and degrees of coping style from
participants. Nevertheless, generalising the results of the current work to all women
who have been living with an increased risk of breast cancer for a number of years
should be carried out with caution.
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7.3.2 Measures
The measures used to assess the key constructs in the current body ofwork
were selected on the basis ofbeing well validated. In this relatively new area of
psychological research, a limited number ofmeasures had been developed
specifically for use in women with a family history of breast cancer. Where such
measures did not yet exist in this area, the most appropriate measures were chosen
from other areas ofpsychological research or ad hoc items were developed
specifically for the study.
There are a number of limitations with the measures of general psychological
and breast cancer-specific distress used in the current work.
Like many other self-report measures of general psychological distress, the
GHQ is a screening tool to assess probable psychiatric morbidity (Goldberg &
Williams, 1991). A clinical interview is needed in order to make a clinical diagnosis
to confirm the presence and type ofpsychiatric disorder (Goldberg & Williams,
1991). The GHQ is limited in the type of disorder it may detect: it can detect
transient disorders which can diminish without intervention but may not be sensitive
to enduring traits such as personality disorders (Goldberg & Williams, 1991). The
choice of clinical threshold used to classify "case-level" distress should be based on
several factors: the best trade-off between sensitivity and specificity, the sample and
whether a clinical interview will be used to make psychiatric diagnoses (Goldberg &
Williams, 1991).
The effectiveness of the GHQ-28 as a screening measure for psychiatric
disorder has been investigated in 158 women three months after genetic risk
counselling for breast cancer (Hopwood et ah, 1998). The GHQ-28 (threshold >5)
was found to classify twice as many women as having a probable psychiatric illness
as was confirmed by a "gold-standard" psychiatric interview. Therefore, the
prevalence ofprobable psychiatric morbidity found by the current work is likely to
be an overestimation of the true prevalence. Further longitudinal research in women
who have been living with an increased risk of breast cancer for a number of years
could employ clinical interviews to confirm the prevalence and type of psychiatric
disorders over a period of years.
The Impact of Event Scale includes a conditional opening question that asks
participants to complete the scale only if they have thought about breast cancer in the
past week. In the current work, this has meant that the majority ofparticipants have
not completed this measure which has led to limitations with the interpretation of the
data from the whole scale. Further investigation on the use the opt-out box is
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warranted, perhaps including a comparison of results from this measure, with and
without the addition of the opt-out box.
Clinical thresholds for the measures ofbreast cancer-specific distress used in
the current work (i.e. the Impact ofEvent Scale, CancerWorry Scale) have not yet
been derived. Therefore, it is difficult to confirm that the statistically significant
findings on these measures in the current work were also of clinical significance. The
development of clinical thresholds for measures ofbreast cancer-specific distress
warrants further research.
There are limitations of using self-report measures of distress. Myers (2000)
reviews these limitations with regard to individuals with a repressive coping style,
estimated to form 10-20% of the general population. These individuals typically
produce low scores on trait anxiety but exhibit "high levels ofphysiological
activity". This is because they "disassociate their somatic reactions from their
perceptions of stress". This can affect the results of questionnaire studies measuring
psychological or physical outcomes. Research has linked a repressive coping style to
a number of poor physical health outcomes e.g. cancer and cardiovascular disease.
There is evidence that self-report questionnaires and face-to-face interviews will
produce different results in individuals with a repressive coping style. It is suggested
that the use ofmultiple methodologies may be the best way to overcome this
problem. Qualitative methodologies such as semi-structured interviews where the
data could be coded by several independent raters could be used in conjunction with
measures to identify repressive coping style.
7.3.3 Theoretical models
Like a substantial amount of the research in women with a family history of
breast cancer, the current work was directed from a clinical rather than a theoretical
perspective. At the time of starting the current work an appropriate theoretical model
that included the constructs of interest was not identified among the psychological
literature. Since that time, one particular model of stress and coping has been
published (i.e. Folkman & Greer, 2000) which may be relevant to the current work.
Support for this theoretical model from the results of the current work and
suggestions for further research to enhance our theoretical understanding of living
with an increased risk of breast cancer are discussed in Section 7.5, page 201.
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7.4 Clinical implications
Despite the limitations, there are still a number of important clinical
implications of the main findings of the current work regarding general
psychological distress, breast cancer-specific distress and psychoeducational
intervention.
Probable psychiatric morbidity was indicated in about one third of
participants which is similar to the prevalence in the general population. Given these
findings it could therefore be argued that it is not the responsibility of the familial
breast cancer clinic to screen for general psychological distress which would also
require diagnosis by clinical interview before referral to appropriate treatment.
Indeed performing such a screening assessment during a routine breast cancer
screening appointment is likely to produce biased results, as the measure may be
sensitive to transient increases in distress which are likely to accompany attendance
at the clinic.
Perhaps of greater clinical importance was the finding of a widespread
prevalence of breast cancer-specific distress, particularly in terms ofworry about
breast cancer risk. This emphasises the importance of identifying and providing
support to minimise this type of distress, which may be more clearly seen as the
responsibility of the familial breast cancer clinic. Firstly, it would be important to
determine if any breast cancer-specific distress was preventable. The findings of the
current work indicate that certain factors may be protective (e.g. greater knowledge
about issues related to familial breast cancer, being married or living with a partner,
greater satisfaction with social supports) whilst others may increase vulnerability to
distress (e.g. greater perceived risk of developing breast cancer, higher Monitoring/
Emotional Uncertainty coping style, having a psychiatric history, lower educational
level). The confirmation of the role of some of these factors that are amenable to
intervention could have the potential to minimise the negative psychosocial impact of
living with an increased risk of breast cancer. Secondly, it seems likely that a certain
amount of breast cancer-specific distress is inevitable for women in this situation.
Therefore, it would be important to determine the most effective ways ofminimising
distress in these women as a whole and to identify those women who may still suffer
from high levels of distress which may benefit from treatment on a more individual
basis.
The current work has shown that a psychoeducational intervention consisting
ofwritten information on psychosocial and scientific topics of information related to
familial risk ofbreast cancer was shown to effectively reduce cancer worry and
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improve scientific knowledge relevant to living with an increased risk ofbreast
cancer. The intervention was generally shown to be highly acceptable to these
women and to meet their needs for information and support. This type of intervention
could be incorporated into routine clinical practice, thus providing these women with
the type of ongoing psychosocial support that many familial breast cancer clinics are
currently lacking. Further investigation is warranted to determine how the
information pack could form part of the existing clinical service and what would be
required to maintain it e.g. regular updating of information. However, an economic
evaluation of the intervention would be required to determine whether it would be a
cost-effective addition to the clinical service. This type of intervention could be
compared to an alternative such as web pages, group meetings or telephone
discussion groups to determine the most cost-effective and clinically effective
service.
The psychoeducational intervention, if appropriately modified, also has
potential value in other groups ofwomen with a family history of breast cancer (e.g.
women estimated to be at low risk of breast cancer who are not enrolled in a familial
breast cancer clinic or who have been discharged from a familial breast cancer clinic
after several years attendance). This type of psychoeducational intervention also has
the possibility of being valuable in populations at increased risk of other forms of
cancer such as ovarian cancer.
7.5 Theoretical perspective
There is a clear need to develop a better theoretical understanding of the
within- and between-individual variation in levels of psychological distress in
women living with an increased risk of breast cancer.
One model which may be particularly useful in providing a theoretical
framework for the results of the current work is the model of stress and coping
proposed by Folkman & Greer (2000) (Figure 7.1). This recently developed model
was derived from a cognitive model developed by Lazarus & Folkman (1984) in an
attempt to explain the role of psychological well-being during serious illness. The
more recent version of the model makes substantial additions to the original model,
some ofwhich represent key constructs of the current work (i.e. person
characteristics represent sociodemographic factors, objective risk and coping style).
Two key processes are included in the model: appraisal and coping. Appraisal
consists ofprimary appraisal, which is an evaluation of the personal importance of a
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particular situation and secondary appraisal, the evaluation of resources to cope with
that situation. Appraisal is postulated to influence the type of coping that follows.
The thoughts and behaviour that an individual uses to cope with a particular situation
are classified by the model as "problem-focused" (which targets the source of
distress), "emotion-focused" (which manages distress) and "meaning-based coping"
(which sustains "positive well-being"). Both the outcome of the situation in terms of
distress and positive emotion and the appraisal of the situation are influenced by
these coping processes. In addition, stable or variable characteristics of an individual
or their environment can influence the appraisal and coping processes. Therefore,
this model is dynamic as the different aspects it includes are all interdependent.
Although the quantitative studies of the current work did not investigate
coping as a process (situation-specific coping) or positive psychological well-being,
the findings nevertheless provide some support for sections of the stress and coping
model. Firstly, certain characteristics of an individual both stable (e.g. coping style)
and variable (e.g. perceived likelihood of developing breast cancer) were shown to
impact on the relationship between living with an increased risk of breast cancer and
psychological distress. Secondly, primary appraisal in terms of perceived risk of
developing breast cancer and secondary appraisal in terms ofperceived satisfaction
with social supports were also found to affect this relationship. Thirdly, when
external resources to cope with the situation were enhanced (i.e. when the women
received a psychoeducational intervention), psychological distress in terms ofworry
about cancer was reduced. There was also evidence that knowledge of scientific
issues related to familial risk of breast cancer, which could be an internal coping
resource, was enhanced due to the presence of the psychoeducational intervention.
Therefore, the findings of the current work provide considerable support for
value of this model in enhancing our theoretical understanding of living with an
increased risk of breast cancer. However, it could be argued that this model does not
adequately account for the findings of the current work regarding the impact of
breast cancer cues on psychological distress. Future research in women living with
an increased risk ofbreast cancer could attempt to clarify the effect of different types
of breast cue on distress to enable this model to be further developed to provide a
better theoretical explanation of fluctuations in distress over time.
Two additional theoretical models (i.e. the monitoring process model and the
cognitive-behavioural model of health anxiety) have been identified from the
psychological literature. Although these models may also be of value when
considering the findings of the current work, this may arguably be to a lesser degree





Figure7.1:Theoreticalmodfst ssandc ping(Folkma&Gr er,2000)
The monitoring process model (MPM) focuses on how individuals with a
high monitoring coping style differ from those with a low monitoring coping style in
the way that they cope with a severe long-term health threat (Miller et al., 1995)
(Figure 7.2).
Figure 7.2: The monitoring process model (Miller et al., 1995)
According to this model, individuals with a high monitoring coping style tend
to scan and attend to cues related to the specific threat. These individuals are likely to
perceive ambiguous or non-threatening information about the specific threat as
extremely threatening which results in heightened perceived personal risk. This in
turn produces high levels of intrusive thoughts about the threat. The heightened
perceived risk together with the high levels of intrusive thoughts are likely to cause
psychological distress for those individuals with a high monitoring coping style.
Evidence to support the MPM has been obtained in several different samples
including women with a family history of ovarian cancer (Schwartz et al., 1995).
The findings of the current work provide limited support for the MPM. Some
relationships proposed by the model were not tested by the current work and of the
relationships that were tested, support for the model was not always obtained. A high
monitoring coping style and greater perceived likelihood of developing breast cancer
were both shown to be predictive of breast cancer-specific distress in terms ofworry
about breast cancer risk-related issues, but not general psychological distress. In
addition, there was no evidence of a relationship between monitoring and intrusive
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thoughts about breast cancer. Differences in the samples used in the current work and
those used in the development and support of the MPM (e.g. in terms of their specific
health threat, nationality) may help to account for the lack of support provided by the
current work for the MPM.
A cognitive-behavioural model of health anxiety was originally developed to
explain the development and maintenance of hypochondriasis (Warwick &
Salkovskis, 1990) (Figure 7.3). It has since been applied to less severe or transient
forms of health anxiety in the general population (e.g. Hadjistavropoulos et al.,
1998). The model proposes that both previous experience and information (e.g. from
the media) can lead to the formation of dysfunctional cognitions (e.g. every physical
symptom is a sign of serious illness). These dysfunctional cognitions can be
prompted by "critical incidents" (e.g. a physical symptom) which results in health
anxiety. The maintenance and exacerbation of this anxiety is caused by cognitive
processes (e.g. attentional bias towards illness-related information, cognitive bias
towards perceiving all information as highly threatening) and behavioural processes
(e.g. avoidance, excessive reassurance-seeking). The anxiety itself can cause
physiological symptoms which may act as "critical incidents", prompting
dysfunctional cognitions and further increasing health anxiety. Croyle (1992)
suggests that the ambiguous nature of a health threat is likely to allow cognitive
biases to be developed.
As this model has previously been used successfully to explain a wider
spectrum of levels of health anxiety than hypochondriasis alone, it may be relevant to
help understand the high levels ofbreast cancer-specific distress that were
experienced by some participants. However, it should be noted that the current work
did not quantitatively assess health anxiety, although the measures of breast cancer-
specific distress used in the current work could be regarded as related to health
anxiety.
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Figure7.3:Cognitive-behaviouralmod lofhealthanxiety(ad p edfr mW rwick&Salkovs is,1990)
There is evidence from the qualitative findings of the telephone focus group
study that this model may provide a useful theoretical framework to help understand
some of the participants' experiences. For example, one participant described a
relationship between the constructs included in the model (i.e. previous experience,
information, dysfunctional cognitions, critical incidents and health anxiety):
".. .there's quite a history of cancer in my family anyway and I would describe
myself as being a bit of cancer phobe.... My reaction tends to be if somebody's ill,
my first reaction is, 'Oh God it's cancer' or if there's something wrong with me or
people close to me like my partner or my son, my first reaction is, 'I hope it's not
cancer'". For this woman, information about breast cancer risk together with
personal experience of cancer in the family resulted in a belief that all physical
symptoms indicate cancer. This belief, triggered by illness in the family, led to a
phobia about cancer.
This model offers the means of both understanding and treating health
anxiety which may manifest itself in different forms (e.g. excessive levels ofworry,
breast self-examination and reassurance seeking) in women living with an increased
risk of breast cancer.
Consideration of the value of these three theoretical models in providing a
framework for our understanding of the psychosocial effects of living with an
increased risk of breast cancer, points to the potential use of a two-tier theoretical
model. The stress and coping model developed by Folkman & Greer (2000) seems
to be particularly valuable in explaining the experience of the majority ofwomen and
indicating factors that may be amenable to intervention. In contrast, the cognitive-
behavioural model of health anxiety (Warwick & Salkovskis, 1990) is useful in
explaining the experience of and suggesting effective treatment for the minority of
women who are highly anxious about their health. It would be pertinent for these
two models to form a basis of future theoretically-driven research in this group of
women. This research could have a view to developing a two-tier theoretical model
that would help to explain fluctuations in breast cancer-specific distress experienced
by the majority ofwomen, whilst also providing a framework for the explanation and
treatment of chronic high levels of anxiety about breast cancer.
7.6 Further research
Although suggestions for future research have been already been given for
each study, this section summarises some of the main areas worthy of further
207
research in women living with an increased risk of breast cancer. The findings of the
current work and evidence from the recent psychological literature have identified
main areas: coping process, psychological well-being, physical health and clinical
services.
7.6.1 Coping process
As indicated by the qualitative results of the current work together with
several theoretical models, further research could focus on the processes whereby
women cope with living with an increased risk of breast cancer. Unlike coping style,
which regards coping as a stable trait, coping process highlights within-individual
differences over time, between-individual variations and the influence of context
(Lazarus, 1993). Coping process is described as: "ongoing cognitive and behavioural
efforts to manage specific external and/or internal demands that are appraised as
taxing or exceeding the resources of the person" (Lazarus, 1993). Coping processes
are not inherently "good or bad", although some may be effective more frequently
than others (Lazarus, 1993). The effectiveness of coping processes in adapting to a
specific situation varies between individuals, situations, time-frames and outcomes
assessed (Lazarus, 1993).
It would be useful to investigate the coping processes used in the specific
context of living with an increased risk of breast cancer and in the common type of
situations that entails (e.g. coping between clinic appointments). This would enable
strategies that are generally adaptive to be identified and promoted through
appropriate interventions.
A limited number of studies to date have investigated coping processes in
women with a family history of breast cancer. Gilbar (1998) found that the coping
processes adopted (e.g. denial, information-seeking) when waiting for a breast
screening appointment were similar in women with and without a family history of
breast cancer. Audrain et al. (1999) evaluated a coping skills intervention including
problem-solving training which aimed to "enhance adaptive coping" concerning the
stressful experience of having a family history of breast cancer. The intervention was
found to be effective in improving adherence to breast self-examination and was
shown to be most beneficial in women with high levels of cancer-specific distress.
208
7.6.2 Psychological well-being
Recent psychological literature (i.e. Folkman & Greer, 2000) has suggested
that when conducting research on the psychological stress of confronting a serious
health threat, it is just as important to investigate positive outcomes of the situation
(i.e. psychological well-being) as negative outcomes (i.e. psychological distress),
which have traditionally been the focus ofmuch research. Psychological well-being
generally refers to "positive affective and positive cognitive psychological states"
(Folkman & Greer, 2000). The limited research that has investigated psychological
well-being has provided evidence that these positive emotions and cognitions can be
experienced even in extremely stressful situations (Folkman & Greer, 2000). Three
types of coping process have been proposed to enable individuals to "experience
positive emotions during long periods of severe stress" (Folkman & Moskowitz,
2000): positive reappraisal, problem-focused coping and creating positive events
(Folkman, 1997).
Future research in women living with an increased risk of breast cancer could
investigate various aspects ofpsychological well-being such as the role of positive
emotions in adapting to a long-term stressor as well as the coping processes that
sustain psychological well-being. The findings could then provide the potential for
developing and evaluating a psychological intervention to promote factors that are
found to be important in effective adaptation.
7.6.3 Physical health outcomes
There is a growing body of controversial research investigating the links
between psychological distress and physical health. In a recent review of the
literature on this relationship, there was evidence of a link between psychological
distress in terms of anxiety and depression and the onset and progression of various
diseases such as cancer (Kiecolt-Glaser et al., 2002). There are a number of direct
(e.g. immune function) and indirect (e.g. health behaviours) ways in which distress
affects physical health (Kiecolt-Glaser et al., 2002). In addition, several factors (e.g.
sociodemographic variables, personality traits, coping style, social support) may be
protective of or increase vulnerability to health outcomes. A review of
psychoneuroimmunology research provides evidence of an association between
psychological distress and immune suppression, particularly in terms of natural killer
cell activity (Kiecolt-Glaser & Glaser, 1999). The authors suggest that: "stress can
alter a potentially important defence against malignant disease".
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Of the limited number of studies to date investigating immune function in
individuals with a family history of cancer, Bovbjerg & Valdimarsdottir (1993)
found evidence of a psychoneuroimmunological relationship. The level of immune
functioning in 11 healthy women with at least one first-degree relative with cancer
was lower than for 32 healthy women without a family history of cancer in a first-
degree relative. Women from both groups with greater levels of distress showed
lower levels of immune functioning, which continued to be lower even when the
effect of distress was removed statistically. Given the small sample size in this study,
the results should be interpreted with caution.
Despite evidence of links between psychological distress and immune
function and immune function and physical illness, evidence of a causal role between
distress and cancer has yet to be proven. Although this controversial research is very
much in its infancy, it does have the potential to be extremely relevant to women at
increased risk of breast cancer. Further research in this population is warranted to
determine whether chronic distress in women living with an increased risk of breast
cancer further elevates their susceptibility to breast cancer. Longitudinal research in
women at increased risk of breast cancer could monitor distress levels and record
breast cancer morbidity and mortality and investigate the role of factors such as
immune functioning over a period of years.
Research has already shown that some psychological interventions can
impact on immune functioning both in healthy individuals and cancer patients. Miller
& Cohen (2001) conducted a meta-analytic review of 59 psychological interventions
that had assessed immune outcomes. There was evidence that psychological
interventions, particularly involving hypnosis or conditioning, could alter particular
aspects of immune function. For example, Fawzy et al. (1990a & b) found that a six-
week multifaceted psychiatric intervention in skin cancer patients resulted in
decreased psychological distress, enhanced adaptive coping processes and improved
aspects of immune function. All of these benefits were sustained up to six months
following the intervention. Flowever, these findings were not consistent across all of
the studies included in the meta-analysis, which the authors suggest may be
attributable to methodological limitations of the studies (Miller & Cohen, 2001).
They suggest that future trials are needed to clarify the relationship between
psychological intervention and immune function.
It is therefore possible that some form of psychosocial intervention could
benefit women living with an increased risk ofbreast cancer in a number ofways
including enhanced immune function. Future research is warranted to develop and
evaluate the impact of such an intervention that may have the potential to provide
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these women with long-term physiological benefits that could ultimately affect their
risk of developing breast cancer.
7.6.4 Clinical services
Recent changes in the clinical services that are offered to some women at
increased risk of breast cancer have raised important questions which warrant further
psychological research. Some women who have been attending a familial breast
cancer clinic for a number of years are being discharged. This is because advancing
knowledge ofbreast cancer genetics has shown that these women are at low risk of
developing breast cancer and due to limited resources within the National Health
Service, it has been necessary to prioritise the clinical services for women with a
family history of breast cancer who are most at risk of developing the disease.
However, this has important psychological implications for these women who have
been living with an increased risk of breast cancer for several years before they have
been informed that they are no longer at sufficiently increased risk to warrant routine
breast cancer screening out with the National Breast Cancer Screening Programme. It
would seem highly appropriate for future psychological research to monitor these
women after they had been discharged from the familial breast cancer clinic. This
research could provide the information necessary to prevent and treat any negative
psychological effects that these women could experience as a result of changes in
clinical guidelines and services.
7.7 Conclusion
The series of three studies presented in this thesis have made an important
contribution to our understanding of the psychosocial effects of living with an
increased risk ofbreast cancer. The findings have made a substantial addition to the
previously limited psychological literature on this large and growing group of
women. They have provided evidence of the inadequacy of the existing clinical
services in meeting the psychosocial needs of these women and have shown that
these needs can effectively be met through the introduction of a brief
psychoeducational written intervention. The results of the current work have helped
to inform both future psychological research and the development of clinical services
for women living with an increased risk of breast cancer.
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SUMMARY
Research to date has mainly focused on the short-term psychological impact of genetic risk counselling for breast
cancer. This study aimed to explore the long-term consequences for women of being informed about an increased
risk of breast cancer in terms of: the effect on their everyday lives, their coping strategies and their unmet needs
in terms of the current service. The participants were 25 women with a family history of breast cancer who had
received genetic risk counselling and had consequently been receiving clinical surveillance for at least 2 years. They
took part in one of seven telephone focus groups and subsequently completed a feedback questionnaire.
Transcripts of the focus groups were qualitatively analysed by three independent researchers with inter-rater
agreement between pairs of raters ranging from Kappa = 0.61-0.79. Six key issues emerged from the data, which
provide an important insight into the long-term consequences of living with an increased risk of breast cancer
concerning: (1) psychological adaptation, (2) behavioural adaptation, (3) family issues, (4) clinical surveillance, (5)
provision of information, and (6) peer support. These findings, together with the quantitative results of the
feedback questionnaire, have clinical implications that require further investigation in larger scale quantitative
research. Copyright © 2000 John Wiley & Sons, Ltd.
INTRODUCTION
A family history of breast cancer is an important
known factor that puts women at increased risk
of the disease (Claus et al., 1990; Slattery and
Kerber, 1993). Women who have a first-degree
relative affected by breast cancer are two to three
times more likely to develop breast cancer than
women without any family history of the disease
(Slattery and Kerber, 1993). As public awareness
of family history as a risk factor for breast cancer
has grown in recent years, increasing numbers of
women have sought information about their per¬
sonal cancer risk.
A growing number of clinics have been estab¬
lished to offer genetic risk counselling and advice
about risk management strategies to women with
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131 3436869; e-mail: s.appleton@icrf.icnet.uk
a family history of breast cancer. For the majority
(i.e. those who are not eligible for genetic testing),
their risk of developing breast cancer will be
derived from their own age and the characteristics
of their family history using epidemiological data
and mathematical models (e.g. Claus et al., 1990).
However, for the individual woman there are
large margins of uncertainty surrounding the risk
estimate. The majority of women who are found
to be at least at a moderately increased risk are
usually offered clinical surveillance in the form of
mammography and clinical breast examination.
The age at which surveillance begins for a woman
at increased risk and the recommended frequency
of mammography may vary according to the indi¬
vidual's age and history (e.g. the age at which
their youngest affected relative was diagnosed). In
the UK, all women are eligible to join the Na¬
tional Breast Cancer Screening Programme from
the age of 50. (The American Cancer Society,
2000, recommends all women aged 40 and over
have an annual mammogram and clinical breast
examination.) The efficacy of screening women
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with a family history of breast cancer aged less
than 50 years remains controversial. Data are
now emerging to support the value of regular
mammography and clinical breast examination in
this population (i.e. Kollias et al., 1998; Lalloo et
al., 1998) but the sample sizes to date have been
too small to provide unequivocal evidence. Given
the uncertainty of the risk estimate, the doubts
about the value of screening and the prospect of
years of surveillance, there is clearly a potential
for psychological morbidity in this population. In
our setting of a Familial Breast Cancer Clinic in
South-East Scotland, there is no formal provision
of psychosocial support specifically for these
women. Therefore, the only form of support rou¬
tinely available is limited to follow-up clinic ap¬
pointments that focus on breast cancer screening.
The majority of research to date on the psycho¬
logical impact of informing women of an in¬
creased risk of breast cancer has assessed women
up to 1 year after genetic risk counselling. Such
short-term effects have been investigated in terms
of psychological distress, risk perception and ad¬
herence to breast self-examination (BSE) (e.g.
Gagnon et al., 1996; Lerman et al., 1996; Hop-
wood et al., 1998; Cull et al., 1999; Watson et al.,
1999). Although some studies have found that
levels of general psychological morbidity in
women who have received genetic risk counselling
are not significantly different from other general
population samples (e.g. Cull et al., 1999), there is
evidence that these women experience high levels
of breast cancer-specific distress (e.g. Watson et
al., 1999). Of the very limited research to date into
the long-term psychosocial consequences of in¬
forming these women about their increased risk,
high levels of breast cancer-specific distress have
been found in women who had received genetic
risk counselling up to 25 months previously
(Lloyd et al., 1996). There could be a number of
important implications both for individuals and
clinical services if chronic psychological distress
was found to be prevalent in women who have
been living with an increased risk of breast cancer
for a number of years.
In terms of implications for the individual, re¬
search in women with a family history of breast
cancer has indicated that high levels of anxiety
and distress are associated with non-adherence to
BSE (e.g. Kash et al., 1992), clinical breast exam¬
ination (e.g. Kash et al., 1992) and mammogra¬
phy (e.g. Lerman et al., 1993). If surveillance is
proven to be effective in this population, chronic
distress may elevate the risk of death from breast
cancer for women already estimated to be at
increased risk of the disease.
As the number of referrals to familial breast
cancer clinics grows, resources are stretched and
clinical contact for women already living with an
increased risk may be progressively limited. Pres¬
sure on these services would be further increased
if chronically distressed individuals required more
frequent or longer appointments (or if some
of these women missed their appointments
altogether).
In addition, there may be important implica¬
tions for future generations within the same fam¬
ily. Women who are living with an increased risk
of breast cancer and who are chronically dis¬
tressed may represent maladaptive role models for
the next generation who are also likely to face
living with this constant threat.
It was clear that there is a need to investigate
how the expanding numbers of women on regular
surveillance over a period of years live with the
knowledge of their increased risk. The aim of this
study is to explore the long-term consequences of
being informed about an increased risk of breast
cancer in terms of: the effect on everyday life, the
coping strategies used and unmet needs in terms
of the current service.
In order to conduct this exploratory research,
we have used a novel methodology of telephone
focus groups. Focus groups are an ideal means of
undertaking exploratory research (Vaughn et al.,
1996) as information on a range of experiences
can be collected simultaneously (Seals et al.,
1995). However, adopting this methodology to
inform the study aims posed practical problems of
cost and inconvenience to women living within a
large radius. Therefore, the focus groups were
conducted via a telephone conferencing system,
operated by Community Network, a centre for
voluntary sector telephone conferencing.
METHODS
Sample
The sample was derived from a database of
women at least at moderately increased risk of
breast cancer who had been attending the South-
East Scotland Familial Breast Cancer Clinic for
no less than 2 years. Women were excluded if they
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had been diagnosed with cancer, had undergone
prophylactic surgery or were currently participat¬
ing in any other psychosocial research or clinical
trial.
An initial sample of 50 women was identified
by selecting every third woman from a list of 155
potential participants. When the participation rate
was found to be low after 2 weeks (44%), a
further 20 women were randomly selected from
the remaining 105 potential participants.
Instruments: Moderator Guide
Prior to this study, 12 pilot interviews were
conducted with women at increased risk of breast
cancer who were attending the South-East Scot¬
land Familial Breast Cancer Clinic for routine
follow-up. Data from these interviews were used
to develop standard stimulus questions and
probes which formed the main section of a semi-
structured moderator guide. This consisted of:
• a standard introduction to:
- welcome participants.
- set ground rules (e.g. participants identify
themselves before speaking by their first
name only).
- allow participants to introduce themselves.
• standard stimulus questions and probes to en¬
sure that each group discussed the following
three main topics:
- effects of living at an increased risk on
everyday life.
- coping with an increased risk.
unmet needs in terms of the current service.
® a standard conclusion to:
- thank participants.
- allow participants to say goodbye.
Instruments: Feedback Questionnaire
A short feedback questionnaire was developed
to clarify some of the opinions that were raised in
the telephone focus groups, to provide feedback
on participation and additional information on
participants. The questionnaire consisted of four
main sections:
1. Living with an increased risk of breast cancer:
eight items concerning effects on everyday life
and difficulties coping (e.g. 'Have you found it
difficult to cope with knowing that there is an
increased risk of breast cancer in your fam¬
ily?'—response on a 4-point Likert scale from
not at all to very much).
2. Service issues: ten items to clarify unmet needs
and preferences for the method of delivering
these services (e.g. 'Would you like to be
provided with the opportunity to meet up with
other women in the same situation?'— re¬
sponse as a yes/no choice).
3. Participating in a telephone focus group: seven
items to provide feedback on the acceptability
of the telephone focus group methodology
(e.g. 'How would you rate your general experi¬
ence of taking part in the telephone discussion
group?'— response on a 4-point Likert scale
from poor to excellent).
4. Genetic testing: four items to identify if any
participants had been through the genetic test¬
ing process (e.g. 'Has a faulty breast cancer
gene been identified in your family?'—re¬
sponse as yes /no choice).
Procedure
Each woman was sent information about the
study and invited to participate. Those who con¬
sented to take part were allocated to a telephone
focus group at a time to suit their convenience. A
short telephone call to the women several days
prior to their scheduled group reconfirmed their
participation and allowed the moderator to ex¬
plain how the group would be conducted.
Each group had the same moderator (SA) who
had been trained to facilitate telephone conference
calls. The participants were telephoned by the
Community Network operator to connect them to
the conference call (i.e. the participants were not
charged for the call). The telephone focus groups
were conducted following published guidelines for
focus groups (Tobin, 1996; Vaughn et ai, 1996;
Greenbaum, 1998), which were modified for use
with the telephone conferencing system. All
groups lasted for no longer than 1 hour and all
were audiotaped by Community Network.
Immediately after each group, the moderator
made a summary of the discussion. These sum¬
maries were compared with the final outcome of
the qualitative analysis as an indication of the
reliability of these results (Table 1; Stage 2, Step
4).
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Table 1. Qualitative analysis of telephone focus group data
Stage 1.
For each of the three research areas separately (i.e. Effect, Coping, Services):
1. Informative quotes identified (SA, AF, GR)a.
2. Consensus achieved on a final list of quotes (SA, AF, GR).
3. Themes developed from the quotes (SA).
4. Reliability of themes assessed. Quotes independently assigned to themes (AF, GR). Inter-rater reliability between
pairs of the three raters calculated.
5. Discrepancies negotiated to achieve consensus on a final set of themes with supporting quotes (SA, AF, GR).
Stage 2.
Completed by SA only:
1. Themes and supporting quotes from each of the three research areas collapsed to form 1 dataset of 44 themes and
756 quotes.
2. Extraction of 29 themes supported by quotes from at least 3/7 transcripts.
3. Related themes grouped to form six key issues.
4. Reliability of six key issues assessed by comparing to the moderator's summaries of the telephone focus groups.
a Initials refer to the named authors.
The participants were invited to give feedback
on their experience of participating several days
after their group through a short postal
questionnaire.
Analysis
The audiotapes of the telephone focus groups
were transcribed verbatim and analysed indepen¬
dently by three researchers using a modified ver¬
sion of published guidelines for analysing focus
group data (Vaughn et al., 1996). The process by
which quotes, themes and key issues were identi¬
fied in two main stages is explained in Table 1.
On completion of the qualitative analysis, the
feedback questionnaire was quantitatively
analysed in terms of descriptive statistics.
RESULTS
Participants
Of the 70 women invited to participate, 33
(47%) responded, of whom 25 (36%) participated
in the study (five women who responded were
unable to take part over the scheduled time period
and three were unwilling to participate for per¬
sonal reasons, e.g. mother had recently received a
diagnosis of recurrent breast cancer). The 37
women (53%) who did not respond to the initial
invitation were not contacted for a second time.
Seven telephone focus groups were conducted of
which five groups had four participants and the
remaining two groups comprised three and two
participants, respectively.
There were no significant differences between
the participants and non-participants in terms of
their age, marital status, number of children,
number of daughters, duration of clinic atten¬
dance and counselled risk of developing breast
cancer.
Participants ranged in age from 27 to 51 years
(mean 41.3 years, S.D. 5.9 years). The majority
were married or cohabiting (80%), had children
(76%) and of those that had children, 63% had at
least one daughter. They had been attending the
clinic for between 2.5 and 6.5 years (mean 5.2
years, S.D. 1.2 years). Their counselled risk of
developing breast cancer in their lifetime ranged
from 20 to 40% (mean 27.1%, S.D. 7.1%).
Key issues
The thematic structure of the six key issues is
shown in Table 2. Inter-rater agreement between
pairs of the three raters to assess the reliability of
the themes was good (Kappa = 0.61-0.79) ac¬
cording to published guidelines (i.e. Altman,
1997). The six key issues reflected the main issues
included in the moderator's summaries of the
telephone focus groups.
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Table 2. Structure of the key issues
Key issue Theme Number of Number of transcripts
supporting containing the theme
quotes (max 7)
Psychological adaption • Chronic emotions & cognitions 75 7
• Acute emotions & cognitions 31 7
• Sensitivity to breast cancer cues 27 7
• Time & age 23 6
• Focusing on the present 16 5
• Avoidance 18 6
• Positive thinking 7 5
• Decisions & plans 22 6
• Reassessment of life & priorities 24 7
Behavioural adaption • General health behaviours 25 7
• Control 6 4
• BSE 12 6
Family issues • Family 52 7
• Emotional support 14 6
• Breast cancer survivors 13 4
• Children 35 7
Clinical surveillance • Frequency of clinic appointments 12 3
• Duration of clinic appointments 7 3
• Continuous support 5 3
• Clinical services 21 6
• Specialist care 30 7
• Reassurance & security 36 7
Provision of information • Knowledge 22 7
• Getting a balance 6 3
• Type of information 37 7
• Method of information presentation 28 6
• Family involvement 14 6
• Immediate telephone contact 17 6
Peer support • Support from other women in the same 17 5
situation
Psychological adaptation
A common way of adjusting to knowing about
an increased risk in the long-term was described
as 'taking one day at a time'. Women discussing
their chronic emotions & cognitions commonly felt
there was nothing to be gained from considering
uncertain future scenarios. Other women de¬
scribed varying levels of breast cancer worry from
mild or subconscious to severe worry and intru¬
sive thoughts.
I think maybe the hardest thing I've had to do is to
accept that this (breast cancer) will be an ongoing
fear, there will never come a time in my life when I
will know, at least with current medicine as it is,
there probably will never come a time when I will
think, well this is something I won't get.
Acute emotional & cognitive responses such as
anxiety, depression, shock, surprise and feelings
of neglect were described as being triggered by
risk-related events, such as being initially in¬
formed about their increased risk (by a health
professional), receiving an appointment letter,
waiting for an overdue appointment, having
a mammography or biopsy and receiving the
results (even if they showed no signs of breast
cancer).
Some women described a heightened sensitivity
to breast cancer cues, such as changes in their
breasts, media reports about breast cancer and
Copyright © 2000 John Wiley & Sons, Ltd. Psycho-Oncology 9: 511-521 (2000)
516 S. APPLETON ET AL.
illness in the family. This either prompted in¬
creased vigilance through BSE, greater interest
in media reports, increased anxiety or the avoid¬
ance of these cues.
I would describe myself as being a bit of cancer
phobe . . . My reaction tends to be if somebody's ill,
my first reaction is, 'Oh God it's cancer' or if there's
something wrong with me or people close to me like
my partner or my son, my first reaction is, 'I hope
it's not cancer'.
Emotional & cognitive fluctuations over time
were described, particularly in relation to the
annual screening cycle.
. . . it's when the time of the year comes, May-June
period, that's when it actually, you're facing it front
on and that for me is the hardest thing to cope with,
waiting for the mammogram, waiting for the results
and wondering if it's positive, how you're going to
cope with it and then you get the letter through to
say it's negative and then you sigh another sigh of
relief for another year.
Breast cancer awareness, fear or worry com¬
monly increased as the women approached the
age at which an affected relative had been diag¬
nosed with breast cancer: an effect described as
'a psychological cut-off date', like 'a time bomb'
or 'a big shadow'. Conversely, once this age had
been passed, any increase in anxiety levels grad¬
ually subsided.
The women described a variety of cognitive
strategies for coping with the knowledge of their
increased risk, such as focusing on the present,
avoiding potentially worrying breast cancer cues
and thinking positively about the situation by
adopting an optimistic attitude about the future.
Although knowing about their increased risk
had generally not affected the women's decision¬
making or planning for the future, anxiety was
expressed about having to make important
choices in the future regarding genetic testing or
preventative surgery.
Knowing about their increased risk of breast
cancer had prompted several women to reassess
their lives & priorities in positive ways, such as
living life to the full and prioritising their
health.
Behavioural adaptation
Although some women were already maintain¬
ing a healthy lifestyle, for many knowing about
their increased risk had prompted them to adopt
new general health behaviours, such as a healthy
diet, exercise, stopping smoking, use of natural
remedies and stress management.
The women described how these behaviours
helped them to gain some control over their in¬
creased risk
... all these things help you to feel you are in control
of the situation rather than the situation is in control
of your life so I think it is very important to do
things, positive things, to make you feel you are
doing all you can, you know, not to have it (breast
cancer).
Others described making a conscious effort to
pass these healthy attitudes on to other family
members, especially their children.
For many women, knowing about their in¬
creased risk and attending the clinic prompted
increased vigilance about performing BSE. How¬
ever, one woman chose not to perform BSE
in order to avoid exacerbating her existing
anxieties.
Family issues
Some women openly discussed their increased
risk with other family members. This commonly
resulted in closer relationships with mothers or
sisters who had breast cancer or who were also
at increased risk. Partners were often described
as lacking insight into the women's feelings,
which limited the discussion and the support
provided. For these women, their increased risk
was very much a family affair, involving family
members in visits to the clinic and raising their
relatives' awareness of cancer.
Having an increased risk of breast cancer doesn't
(just) affect you, it affects everybody around you as
well.
Women in families where a close relative was
suffering from breast cancer or where discussion
about breast cancer was generally avoided, de¬
scribed their reluctance to discuss their increased
risk with family members. Other women re¬
garded their increased risk very much as their
own problem and thought it unnecessary to in¬
volve others at this stage.
Two main sources of emotional support were
described by the women: family and friends,
particularly mothers and sisters, and profession¬
als such as the clinic staff and counsellors.
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Breast cancer survivors, who tended to be the
women's mothers, were also an important
source of strength and support.
The women commonly expressed concerns
about the implications of their increased risk for
their children, especially their daughters. Women
with young children were predominantly worried
about their children's ability to cope if they de¬
veloped breast cancer. This reflected their own
experience of losing their mothers at a very
young age. Women with older children de¬
scribed their growing concerns regarding their
children's own inherited risk.
... I can cope with sort of having the gene or
whatever but it suddenly dawned on me about my
own 2 daughters and I think as time's gone on, I felt,
God, I hope not. I can cope with it myself but I
wonder about my children, maybe that's over the
years I've thought that now.
Clinical surveillance
Many women described how their annual
clinic appointments had become less frequent
with a shorter duration. Some women were con¬
cerned that these changes in service provision
added to existing uncertainties and could be
damaging to their health. Several women em¬
phasised a need for some alternative form of
continuous support to compensate for the exist¬
ing clinical pressures.
I sometimes think it's true what they say, I mean an
hour a year is better than nothing, but what happens
for the rest of the year. You're out there on your
own.
Although several women felt very closely
monitored by the current clinical services, some
women described their concerns about the possi¬
ble side effects of mammography together with
reservations about participating in research
trials.
Many women expressed how privileged they
felt to be receiving such specialist care and how
confident they felt both with the expertise of the
staff and the equipment. Much importance was
placed on the clinical service, in terms of allevi¬
ating any anxieties, providing the opportunity
for the early detection of breast cancer and in¬
forming them of any significant medical ad¬
vances.
Feelings of reassurance both from the clinic
and their own general practitioner were fre¬
quently voiced, particularly when the women
found BSE difficult. They also found that the
clinic provided them with a sense of security as
they were always aware that help was just a
phone call away. Many women found this a
comfort and an aid to coping with their in¬
creased risk.
1 think the fact that knowing that you can attend the
clinic once a year really makes quite a difference to
stopping you from worrying and having the same
sort of apprehension, if you like, in the back of your
mind, because you always know that although you
may check yourself there is always someone else
there, you know, to do the extra check for you, just
to make doubly certain.
Provision of information
Discussion about the role of knowledge in
coping with an increased risk uncovered con¬
trasting experiences. Many women found that
being informed about breast cancer-related
issues had helped them to cope by aiding their
decision-making and decreasing anxiety. In con¬
trast, other women felt that this sort of informa¬
tion often added to existing concerns.
Some women suggested it was about getting a
balance between being informed and increasing
worry.
I think it's dangerous. I think people can dwell on
things that aren't there and are maybe never going to
happen. I think it's very hard to get the balance right
and probably very hard when you're trying to
provide a service as well.
The women commonly expressed a need for
specific types of information, particularly up-to-
date, professionally approved, detailed informa¬
tion on a variety of topics including the clinical
services available (particularly genetic testing),
scientific research (concerning breast cancer
treatments, current trials and genetics), preventa¬
tive measures (such as diet), hormone replace¬
ment therapy, the oral contraceptive pill and
stress management.
There was a widespread positive response to
the idea of presenting this information via an
organised face-to-face meeting which would
provide the women with a direct opportunity to
ask questions.
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I think people these days, they like to be informed,
they want to know what's going on and what re¬
search is showing. But, you know, to have it ex¬
plained in a way they can grasp and understand and
1 think that's a problem with being sent stuff in the
post, if people don't understand it, there's nobody to
ask or to question. I think that would be the beauty
of having an informal type of meeting where people
could maybe get the chance to talk to people after
the presentations or whatever. I think that would be
invaluable.
Written information was seen to be very conve¬
nient and a valuable reference, but generally sup¬
plementary to gaining information on a face-
to-face basis. Other suggestions to be kept in¬
formed included a newsletter, web site and Inter¬
net news group.
Discussion about involving the family uncovered
some differences of opinion about who should
attend an organised meeting. Several women
thought that all family members should attend,
others felt that it would only be beneficial for
their partners and some expressed their reluctance
to attend if other family members were invited.
These women preferred to relay any relevant in¬
formation to their families.
Many women described problems contacting
the clinic and would welcome some form of
immediate telephone contact, such as a telephone
help-line, for gaining instant advice from a spe¬
cialist clinician. Several women felt that access to
such a service would provide them with an extra
source of reassurance.
Peer support
Many women suggested that it would be benefi¬
cial to have some form of contact with other
women in the same situation either face-to-face, by
telephone or via an Internet chat room. They felt
that it would be helpful to share their experiences
in a support group setting or as part of a social
event.
... if I was to go to some sort of group meeting
where people were in a similar position to me, I
suspect that's the group where I might feel comfort¬
able and be able to say, 'Look maybe I am worried',
where I might not say that at home because if I have
had somebody who's had breast cancer... I cer¬
tainly am the one being terribly positive with her (my
mother) and therefore would not want to take her
along and her hear me say, 'maybe I have been
worried', so I'd quite like, I think, the idea of empa¬
thy with a group with similar circumstances.
Feedback questionnaire
All 25 participants returned completed ques¬
tionnaires. Two questions asked participants
about the extent to which knowing about their
increased risk had affected their lives in positive
ways (e.g. encouraging them to maintain a
healthy lifestyle) or negative ways (e.g. causing
them worry). With respect to positive effects, 19
participants (76%) reported not at allla little and 6
(24%) reported quite a bit/very much. With respect
to negative effects, the corresponding numbers
were 23 (92%) and 2 (8%). No participants rated
the negative effects as very much. More than half
of the participants had found it a little or quite a
bit difficult to cope with the knowledge of their
increased risk (« = 14; 56%).
All participants reported that they would like to
be provided with updated information on a vari¬
ety of breast cancer-related topics (« = 25; 100%).
A majority would like advice/information on
stress management strategies (n = 19; 76%), the
opportunity to meet up with other women in the
same situation (n = 22; 88%) and the opportunity
to have any questions answered outside of the
clinic time (n = 23; 92%). Approximately half of
the participants (« = 12; 48%) would like to be
provided with a service for other family members.
With respect to the format of any additional
services, 14 participants (56%) indicated a general
preference for written materials rather than per¬
sonal contact and 60% (n = 15) preferred or¬
ganised meetings rather than one-to-one sessions.
Although 23 of the 25 participants had not
taken part in a telephone conference call before,
only one woman did not feel comfortable about
sharing her experiences in the telephone focus
group. Most of the participants found it quite or
very easy to make their opinions known (n = 21;
84%) and 76% (n = 19) thought that the modera¬
tor handled the discussion very well. Twenty par¬
ticipants (80%) found it quite a bit or very helpful
to share their experiences with women in the same
situation and 84% (« = 21) of participants rated
their general experience of taking part in a tele¬
phone focus group as good or excellent.
Both of the participants who reported that a
breast cancer gene had been identified in their
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family stated that they had been tested for this
faulty gene of whom one was a carrier and one
was still waiting for their result.
DISCUSSION
The telephone focus group methodology used in
this study provided a rich source of information
about the long-term psychosocial consequences of
genetic risk counselling for breast cancer. As the
information gained from later focus groups began
to reiterate that collected from earlier groups, it
encouraged us to believe that we had elicited the
full range of issues for these women. The qualita¬
tive data were supported by the quantitative re¬
sults of the feedback questionnaire. Before
considering the main findings and implications of
our results, several methodological observations
should be noted.
The low response (47%) and participation
(36%) rates were disappointing. This may in part
be explained by the practical difficulties of gaining
accurate contact information for women who only
attend the clinic on an annual basis and the
relatively short time frame offered for reply and
participation. Scepticism among the women about
the use of such a novel methodology may also
have acted as a barrier towards participation.
Therefore, the 25 participants may not be repre¬
sentative of the other 45 women invited to partic¬
ipate. Although these two groups did not differ
significantly on the six demographic measures as¬
sessed, the participants may be biased in terms of
the coping strategies they used (e.g. the invitation
to participate may act as a breast cancer cue,
stimulating an avoidant response) and may be
unrepresentative in terms of psychological distress
(e.g. highly distressed individuals may not have
responded to the invitation). However, the aim of
exploratory focus group research is not to gener¬
alise the findings to a larger sample, but to repre¬
sent a range of participant views (Vaughn et al.,
1996). The data collected did encompass a wide
range of opinions and experiences indicating that
they are likely to reflect the important issues in
this group.
Despite the low participation rate, the tele¬
phone focus group methodology was shown to be
a very useful and convenient means of accessing a
wide range of experiences. With thorough prepa¬
ration of the moderator guide and training in
facilitating telephone conferences, the groups were
relatively easy to organise and conduct and were
very cost-effective. Participant feedback about the
telephone focus groups was extremely positive.
Any initial scepticism among participants was
quickly dispelled as the anonymity of the tele¬
phone conferencing system made them feel less
inhibited about sharing their experiences. Many
participants expressed how beneficial they found
this experience and were keen to participate again
or follow up the group with a face-to-face meet¬
ing. There was also evidence that some women
had started to bond with other members of the
group despite the lack of face-to-face contact: as
one woman commented, 'I enjoyed the experience
and even felt momentarily "bereft" when I said
goodbye to the other participants'.
This study provides an important insight into
the women's experience of the long-term effects of
knowing about their increased risk on their every¬
day life. Firstly, there was wide variation in the
anxiety and distress that these women described
experiencing in the years since they first attended
the clinic. A few participants reported experienc¬
ing severe worry and intrusive thoughts on a daily
basis. There is a clear need to assess the preva¬
lence and specificity of psychological morbidity in
this population to enable interventions to be
targeted appropriately. Secondly, anxiety and dis¬
tress were often described as fluctuating over time
in response to breast cancer-related cues, such as
approaching the time of a clinic appointment.
Previous research provides evidence that levels of
acute psychological distress in women with a fam¬
ily history of breast cancer are high immediately
prior to routine mammography and are lowered
after receiving normal results (Valdimarsdottir et
al., 1995). Our findings suggest that the impact of
such cues may be related to the individual's level
of chronic anxiety and distress. The possible rela¬
tionship between chronic distress and a height¬
ened sensitivity to breast cancer cues requires
further investigation in a larger sample.
There was evidence that the women in this
study drew on a number of important internal
and external coping resources, including positive
cognitions, knowledge about breast cancer-related
issues, clinical surveillance and family members.
Of the range of cognitive and behavioural coping
strategies that were described, particular strate¬
gies, such as cognitive avoidance, were described
as minimising anxiety and distress over time,
which may suggest an adaptive role in the
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long-term. Behavioural coping strategies, such as
excessive reassurance seeking, were used in times
of acute anxiety and distress. The use of be¬
havioural coping strategies associated with adopt¬
ing a healthy lifestyle was seen to be adaptive by
promoting a degree of perceived control over a
woman's increased risk. The findings of this study
then highlight the incidental benefits of including
a general health behaviour component as part of
an educational intervention. Although the biologi¬
cal role of particular health behaviours in the
prevention of breast cancer remains unclear, these
behaviours may represent adaptive coping re¬
sources to be accessed in times of personal stress
(Ingledew et al., 1996). The long-term role of
specific coping strategies, particularly cognitive
avoidance, requires further investigation in terms
of specific outcomes such as psychological distress
and cancer worry. Interventions can then be
aimed at promoting the use of those strategies
that are shown to be adaptive in the long-term.
Every woman in this study indicated at least
one support need that was not being met by the
existing clinical service where the only form of
support is limited to an annual clinic appointment
focusing on breast cancer screening. This need for
additional support services is further strengthened
by the decreasing frequency and limited duration
of these follow-up appointments. Of top priority
was the provision of information on a wide vari¬
ety of breast cancer-related topics. There was a
general preference for this information to be pre¬
sented by an expert via a group meeting with
supplementary written materials. To date, there
have been a number of intervention studies in
women with a family history of breast cancer (e.g.
Gagnon et al., 1996; Lerman et al., 1996; Cull et
al., 1998; Schwartz et al., 1998; Audrain et al.,
1999; Kash et al., 1999; Wellisch et al., 1999).
These have varied greatly in terms of their aims
(e.g. reducing psychological distress, improving
adherence to BSE), sample (e.g. first-degree rela¬
tives of recently diagnosed breast cancer patients,
high-risk women maintained on regular clinical
surveillance) and format of the intervention (e.g.
newsletter, problem-solving training). Of particu¬
lar interest to our research are the recent psycho-
educational group interventions in women at
high-risk of developing breast cancer (i.e. Kash et
al., 1999; Wellisch et al., 1999). The preliminary
results of these studies in terms of reducing psy¬
chological morbidity and improving knowledge
are encouraging. Research is needed to establish
whether women at increased risk of breast cancer
who have been maintained on regular clinical
surveillance for a number of years would partici¬
pate in and benefit from psycho-educational
intervention.
In summary, this study provides qualitative evi¬
dence of between- and within-individual differ¬
ences in terms of anxiety, distress and the coping
strategies adopted and between-individual varia¬
tion in the impact of breast cancer cues. The
findings of this study suggest that there is a need
for psychological intervention for a minority of
participants who reported experiencing chronic
psychological symptoms. However, the findings
also highlight a need for intervention that may
not only be confined to those suffering from
psychological morbidity. Although the partici¬
pants represented approximately one third of the
women invited to participate, they all expressed a
need for updated information from professional
sources on breast cancer-related issues. The clini¬
cal implications that have arisen from these main
findings warrant further quantitative research in a
larger sample of women living with an increased
risk of breast cancer.
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FOCUS GROUP MODERATOR GUIDE:
LONG-TERM COPINGWITH AN
INCREASED RISK OF BREAST CANCER
Whilst waitingforparticipants to join the conference, break up the silence with a
general chat and welcome. Checkparticipants have a pen & paper handy.
Before we begin, can I just check that you are all here.
Firstly, I'd like to welcome you all to this telephone discussion group and to thank
you for giving up your time to help this research.
As you know, my name is Sally and I will be leading today's discussion.
Before we start, here are just a few ground rules to ensure that the discussion runs as
smoothly as possible:
• Try to remember to identify yourself before you speak just using yourfirst name.
• Although I would like everyone to contribute to the discussion, you do not need
to answer every question.
• If you find that you are always the first person to speak, then hold back and let
someone else have a chance. On the other hand, don't be shy, make your
opinions known.
• You do not need to address all your comments directly to me. Feel free to
respond directly to what someone else has said.
• Please be honest about your opinions.
• Remember that there are no right or wrong answers.
• As we have limited time for this group discussion (which will be about an hour),
I may need to stop you to redirect the discussion. 5 minutes before the end of the
session we should receive a warning from the telephone operator.
• Have you got a pen & paper handy to take down a telephone number. If for any
reason you leave the discussion group before we have finished and you would
like to rejoin the group, please ring this number and then they will call you back
to reconnect you to the group.
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• (Some of you taking part in this discussion group have the call-waiting facility
on your phone. If you or any other members of the group hear the signal, please
try to ignore it as much as possible).
• If this is the first time you have taken part in a telephone conference call it may
feel quite strange at first. But don't worry, it shouldn't take too long for you to
feel comfortable speaking in this situation.
You have all been invited to take part in this telephone discussion group as you have
known, for a number of years now, about the increased risk ofbreast cancer in your
family.
With the benefit of your experience we are trying to improve our understanding
about what it is like for women today who are trying to come to terms with the
information that they have an increased risk of breast cancer in their family and who
are working out how they are going to live with it.
As we would like to offer some new services to women like yourselves in the future,
we would be very interested to hear your opinions about the sorts of things that
could be ofhelp and I'll ask you about this later on.
Has anyone got any questions about the discussion before we begin?
To begin with, I would like to ask you to introduce yourselves to the group using
yourfirst names only, to say roughly how long you have been attending the
Ardmillan clinic and to just describe where you are sitting so that the other members
of the group can picture you.
I'll begin
EFFECT
We are going to begin today's discussion by considering what sort of long-term
impact knowing about an increased risk of breast cancer in the family has had on
your everyday lives. We will be looking at whether it has affected the way you do
things, the way you think, the way you feel and your relationships with other people
in your family. We are interested to hear about any positive changes as well as any
negative changes that may have occurred over the years.
1. Has knowing about an increased risk of breast cancer in your family,
changed the way you do things?




=> Has it affect your plans for or decisions about the future?
2. Has knowing about an increased risk of breast cancer in your family
changed the way you think about things?
For example, has it changed your attitudes to any health issues?
PROBE FOR:
=> Has it changed your priorities in life?
=> Has it tended to play on your mind at all?
3. How has knowing about an increased risk of breast
cancer in the family made you feel?
For example, does it cause you much worry or upset in your everyday life or
does it make you feel more positively about your life?
4. Has knowing about an increased risk of breast cancer in the family affected
your relationships with other people in your family?
It may be useful to think about this in terms of:
Who did you tell about the increased risk of breast cancer in your family?
What did you tell them?
Did this affect your relationship with them?
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COPING
So we've just talked about the how knowing about an increased risk ofbreast cancer
in the family can have a long-term impact on different aspects of your everyday life.
Now ifwe move on to the next part of the discussion, I would like to draw on your
years of experience to try to anticipate the hardest things that a women who has
recently learned of an increased risk ofbreast cancer in her family may have to face
over the next few years as she goes about her daily life.
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5. From your years of experience, what do think are the hardest things to
cope with?
This may involve any thoughts you have had, feelings about the
situation or things you have had to do?
6. Can you say what has helped you to cope?
This could be something you have done to help yourself or something
someone else has done to help you?
And these things that have helped could be practical things, things you
have thought about the situation or any feelings you might have had.
7. Overall, would you say that knowing about an increased risk of breast
cancer in the family has had a positive or negative effect on your life?
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SERVICES
Ifwe now move on to the last section where we will be discussing the possible
services that could be of benefit to women who find themselves in your situation in
the future. We are aware that the clinics are currently under a lot of pressure and
therefore enough time for you to get information or have any questions answered
during your yearly appointments may not always be available. This is just one of the
needs that we are interested in fulfilling in association with the Ardmillan clinic.
We would first like to consider what a new service should include and secondly we
would like to find out how we can best provide it.
8. If you look back on the number of years that you have known about the
increased risk of breast cancer in your family, do you think that anything
else could have been provided to help you to cope?
For example, would you be interested in a service that provided you with
updated information ? If so, on what sorts of topics?
PROBE FOR:
=> Would you be interested in having the direct opportunity to have any questions
answered outside of your clinic visits?
=> What about things to help you cope with any stress you may be experiencing?
=> What about the opportunity to meet up with other women in the same situation?
=> What about something for other family members?
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9. As we have just discussed what you would like a new service to include, we
would now like to find out the best way we can provide such a service. We
would like you to think about how you would like these services to be
provided?
For example, what do you think about an organised meeting as
opposed to a one-to-one session?
PROBE FOR:
=> What do you think about some sort ofpersonal contact either face-to-face, on
the telephone or via e-mail?
=> Would the time, location or frequency of services be important for you?
=> What do you think about information being provided as leaflets or via the
Internet?
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As this discussion now comes to a close, I would like to thank you all again for your
valuable contributions to this research.
I would like to remind you that you will be receiving a short questionnaire in the post
in the next few days just to clarify some of the issues raised here and to tell us what
you think about these discussion groups. We would be very grateful if you would
return this in the stamped addressed envelope provided as soon as possible.
Ifwe now go round in turn to say goodbye to the group and then I will say goodbye






Telephone discussion group no. :
Thank you for taking part in one of the telephone discussion groups about coping
with an increased risk of breast cancer. You made an extremely valuable contribution
to this research.
As I mentioned at the end of the telephone discussion group, we would be very
grateful if you would take a few minutes to complete this short questionnaire and
return it in the enclosed stamped addressed envelope as soon as possible.
We do appreciate that you may have already completed several questionnaires as part
of your annual follow-up at the Ardmillan Familial Breast Cancer Clinic and would
like to thank you for this information. Although some of the questions in this
questionnaire may be very similar to some that you have previously answered, we
feel that it is important to gain your opinions after you have taken part in the
telephone discussion group.
This questionnaire allows you to provide a more personal account of some of the
opinions you may have expressed in the discussion group. We are also interested to
hear what you thought about taking part in a telephone discussion group as this may
be useful for future research. I would welcome any additional comments you may
have about the discussion group or any of the issues raised during the session.






Although the questionnaires that you have kindly completed for us every year have
asked you about how you have been getting on during the previous year, we would
now like to put all this information together and find out about your overall
impression of being at increased risk of breast cancer over the number ofyears that
you have been attending the Ardmillan Familial Breast Cancer Clinic.
Please circle the answer that is most appropriate for you for each question.
1. How much has knowing about an increased risk of breast cancer in your
family changed the way you do things ?
Not at all A little Quite a bit Very much
2. How much has knowing about an increased risk of breast cancer in your
family changed the way you think about your life in general ?
Not at all A little Quite a bit Very much
3. How much has knowing about an increased risk of breast cancer in your
family changed the way you generally feel ?
Not at all A little Quite a bit Very much
4. How much has knowing about an increased risk of breast cancer in your
family changed your relationships with other people in your family ?
Not at all A little Quite a bit Very much
Some of these changes may have had a positive effect on your life such as
encouraging you to maintain a healthy lifestyle, whilst others may have had a
negative effect on your life such as causing you to worry a lot more.
5. To what extent has knowing about an increased risk of breast cancer in your
family had a positive effect on your life ?
Not at all A little Quite a bit Very much
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6. To what extent has knowing about an increased risk of breast cancer in your
family had a negative effect on your life ?
Not at all A little Quite a bit Very much
7. Have you found it difficult to cope with knowing that there is an increased
risk of breast cancer in your family ?
Not at all A little Quite a bit Very much
8. Has anything been particularly difficult for you to cope with ?
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We are interested to find out what additional services you would like to receive to
help you cope with being at increased risk so that we can offer these to women in
your situation in the future.
9. Would you like to be provided with:
a) Updated information ? Yes No
Ifyou answered YES to the above question, please list the following topics of
information in order ofpreference from 1= wouldmost like to 8= would least like.
Ifyou answered NO to the above question, please continue to part 9b.
i) Current breast cancer research
ii) Breast cancer screening
iii) Breast cancer treatment
iv) Breast cancer surgery
v) Other forms of cancer (e.g. ovarian cancer)
vi) Hormone Replacement Therapy
vii) Maintaining a healthy lifestyle









b) Things to help you cope with any stress you may Yes No
be experiencing ?
c) The opportunity to meet up with other women Yes No
in the same situation ?
d) Something for other family members ? Yes No
e) The opportunity to have any questions answered
outside of the clinic time ? Yes No
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10. If you would like any of these additional services, how would you like them
to be provided ?
Please indicate which one of the following pairs of options you would prefer by
ticking the appropriate box.
Would you prefer:
a) written materials or
personal contact
b) one-to-one sessions or
organised meetings
c) face-to-face contact or
telephone contact
11. Do you have access to the Internet/ e-mail ? Yes No
Ifyou answered YES, would this be a convenient way
to sendyou/give you access to information ? Yes No
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We would now like to find out what you thought about taking part in the telephone
discussion group as we may consider using telephone discussion groups in future
research.
11. Did you find it easy to make your opinions known ?
Not at all A little Quite a bit Very much
12. Do you think the leader handled the discussion well ?
Not at all A little Quite a bit Very much
13. Did you feel comfortable about sharing your experience in a telephone
discussion group ?
Not at all A little Quite a bit Very much
14. Did you find it helpful to share your experience with women in the same
situation ?
Not at all A little Quite a bit Very much
15. How would you rate your general experience of taking part in the telephone
discussion group ?
Poor Fair Good Excellent
16. Was this the first time you had taken part in a telephone conference call
(i.e. where you are able to talk to several people at once) ?
Yes No (Ifyou answered NO, approximately how many times
have you done this before and do you use telephone
conference calls as part ofyourjob or home life)
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When evaluating what you have told us, it is importantfor us to know whether or not
you have received genetic testingfor breast cancer. Therefore, we would be grateful
ifyou would answer thefollowing questions.
17. Has a faulty breast cancer gene been identified in your family ? Yes No
18. Have you been tested for this faulty gene ? Yes No Not Applicable
19. Have you had the results of the genetic test yet ? Yes No Not
Applicable
20. If so, were you found to carry the faulty gene ? Yes No Not Applicable
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We would welcome any further ideas you have about the telephone discussion
group and any of the issues that we discussed.
***********************************************
THANK YOU VERY MUCH FOR YOUR TIME
PLEASE RETURN YOUR COMPLETED QUESTIONNAIRE IN THE
ENCLOSED STAMPED ADDRESSED ENVELOPE AS SOON AS
POSSIBLE
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GUIDELINES FOR TELEPHONING PARTICIPANTS PRIOR TO
THEIR SCHEDULED DISCUSSION GROUP
When:
• Telephone each participant a few days before their scheduled discussion group.
Why:
• To ensure that they are still able to participate in the scheduled group as they may
have received their letter of confirmation up to several weeks previously.
• To introduce myself to each participant individually and familiarise them with my
voice.
• To give them an opportunity to ask me any questions about the telephone
discussion group on a one-to-one basis.
• To describe the procedure and structure of the telephone discussion group.
• To warn them that they may initially feel slightly uncomfortable with speaking in
a telephone group.
• To find out if any of the participants have a call-waiting service on their phones.
How:
• My name is Sally Appleton and I am a postgraduate psychologist working for the
Imperial Cancer Research Fund.
• Thank you for agreeing to take part in my research. I am just phoning to check
that you are still able to take part in the telephone discussion group
on at
• Have you got a few minutes to let me give you more of an idea about the
telephone discussion group and to give you the opportunity to ask me any
questions?
• I'd just like to tell you a bit about why we decided to do this research using
telephone discussion groups.
Why are we using discussion groups?
Discussion groups allow their participants to respond to what each other has said
and not just to answer a set list of questions. This is especially important for
generating new ideas as we are doing in this study.
Why are we doing this over the phone?
As all the women that are taking part in this study live in quite a large area, it
seems a lot less of a burden on your time to ask you to take part in this research
over the phone, rather than you having to travel to a meeting. We also feel that
some participants may feel more comfortable speaking over the phone, than in a
face-to-face discussion.
• As you know you will be telephoned on at
to join the group discussion. There will be myself and about 4 other women
including yourself.
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• I will start o ff b y g iving a b rief i ntroduction t o t he g roup w hich w ill i nclude
setting some ground rules for the discussion. Then I will ask you to introduce
yourselves to the group using your first names only.
• During the main discussion I will pose a number of questions to the whole group
which will cover 3 main themes. These are:
1. How the knowledge of being at increased risk of breast cancer has affected your
life.
2. How you have been coping with this knowledge.
3. What sort of services you think would help you to cope.
• I will also summarise what the group has said at appropriate points during the
discussion.
• The whole session should last about an hour.
• It will make it easier to identify who has said what if you remember to say your
first name every time before you speak, just something like "It's Sally here".
• Have you taken part in a telephone discussion group before or something similar
such as talking to a number of people on the phone at the same time?
If you haven't then it may feel at bit strange at first - but you should gradually
feel more comfortable as the discussion goes on.
If you have done this before, what was it initially like for you?
• Do you have a call-waiting facility on your phone? What does this sound like?
What does the other person hear? Please ignore the signal and try to let it distract
you at least as possible. Would you be expecting any calls at that time? Would
you be able to let those people know that you are taking part in a telephone
discussion group at that time and the group may be disturbed if they try to get in
touch with you?
• Do you have any questions you would like to ask me?
• Thanks for your time and I look forward to speaking to you on
All-14





This booklet should take approximately 30 minutes to complete.
Please don't thinkfor too long about each ofyour answers but give your
immediate response. There are no right or wrong answers to any of the
questions. Please try to answer all of the questions.
Please note, the questions areprinted on both sides of the page.
Ifyou have any queries about the study or the questionnaire booklet, do not
hesitate to contact Sally Appleton on the telephone number below.
When you have finished, please return the booklet as soon as possible in the
FREEPOST envelope provided.
THANK YOU VERY MUCH FOR YOUR HELP
For the attention of:
Sally Appleton, Imperial Cancer Research Fund, Postgraduate Psychologist, Department of Clinical
Psychology, Outpatient Building, Western General Hospital, Edinburgh EH4 2XU
Tel: 0131 537 1838 E-mail: S.Appleton@icrf.icnet.uk
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Please fill in today's date: (day/month/year) / /
We would like to start by askingyou some general questions about yourself. Please answer
all questions.
1. Date of birth: (day/month/year) / /
2. Are you: (please tick) Single
Married/living with a partner
Divorced/separated
Widowed
3. How many children do you have?
(Ifyou have children, please give the age and sex ofeach child)
1st child: Age Male Female
2nd child: Age Male Female
3rd child: Age Male Female
4th child: Age Male Female
(please continue on a separate piece ofpaper ifnecessary)
4. Please tick the situation which best describes your education:
Schooling until age 16
School/further education/training until age 18
Further education or training after age 18
University graduate
5. Ethnic group: (please tick)
White [ ] Black-Caribbean [ ] Black-African [ ] Black-other [ ]
(please describe)
Indian [ ] Pakistani [ ] Bangladeshi [ ] Chinese [ ]
Any other ethnic group (please describe)







7. Do you currently suffer from any medical conditions? Yes
No
(Ifyes, please specify)
8. Have you ever been treated for nervous or emotional problems such as anxiety or
depression in the past at any time?
Yes
(Ifyes, please give details) No
9. Have you ever had an admission to hospital for nervous problems? Yes
No
{Ifyes, please give details)
We know thatyou will have been asked in the pastfor information about your family history
ofbreast cancer and that this can be upsetting, but it would helpful ifwe could have up-to-
date information aboutyour family history.
10. How many of your relatives have been diagnosed with breast cancer?
11. What relation was this person to you (e.g. mother, sister), at what age were they first
diagnosed with breast cancer and how are they now? (please write the relationship, the
























(please continue on a separate piece ofpaper ifnecessary)












It would be helpful ifyou could give us some information aboutyour attendance at the
Ardmillan Familial Breast Cancer Clinic (Ifyou are unsure ofthe exact dates then please just
give the month andyear)
13. a) When did you last attend the Ardmillan Familial Breast Cancer Clinic?
(day/month/year) / /
b) When is your next appointment at the Ardmillan Familial Breast Cancer Clinic?
(day/month/year) / /_
We want to learn whatpeople understand about their risk ofdeveloping breast cancer.
Please answer the following questions by circling a number or ticking the appropriate box.
14. Do you think that your risk of ever developing breast cancer is:
a. Lower than the general population □
b. The same as the general population □
c. Slightly higher than the general population □
d. Much higher than the general population □
15. How likely do you feel it is that you will ever develop breast cancer?
Very Unlikely Likely Very Inevitable
Unlikely likely
1 2 3 4 5
16. Since you first started attending the Ardmillan Familial Breast Cancer Clinic do you think
that your risk of ever developing breast cancer has:
a. increased □
b. decreased □
c. stayed the same □
d. not sure □
17. How much control do you feel you have over whether you ever develop breast cancer?




18. We are interested to know ifyou have had any medical complaints, and how your health has
been in seneral over the past few weeks. Please answer ALL the questions on thefollowing
pages simply by circling the answer which you think most nearly applies to you. Remember
that we want to know about present and recent complaints, not those that you had in the past.
It is important that you try to answer ALL the questions. Thankyou very much for your
co-operation.
HAVE YOU RECENTLY






















































































been feeling perfectly well and in good health? Better Same as Worse than Much worse
than usual usual usual than usual
been feeling in need of a good tonic? Not at all No more Rather more Much more
than usual than usual than usual
been feeling run down and out of sorts?
felt that you are ill?
Not at all No more Rather more Much more
than usual than usual than usual
Not at all No more Rather more Much more
than usual than usual than usual
been getting any pains in your head? Not at all No more Rather more Much more
than usual than usual than usual
been getting a feeling of tightness or pressure
in your head?
been having hot or cold spells?
Not at all No more Rather more Much more
than usual than usual than usual
Not at all No more Rather more Much more
than usual than usual than usual
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19. We want to learn more about how people cope with worrying events in everyday life.
We know that everyone is different so there are no right or wrong answers.
From what you know ofyourselfandyour own reactions to worrying events in the past,
please try to predict your reactions to the following:
a. Vividly imagine that you are afraid of the dentist and have to get some dental work done.
Which of the following would you do? Tick all of the statements that might apply to you.
ask the dentist exactly what he or she was going to do
take tranquilizers or have a drink before going
try to think about pleasant memories
want the dentist to tell me when I would feel pain
try to sleep
watch the dentist's movements and listen for the sound of the drill
watch the flow of water from my mouth to see if it contained blood
do mental puzzles in my mind
b. Vividly imagine that, due to a large drop in sales, it is rumoured that several people in
your department at work will be laid off. Your supervisor had turned in an evaluation of
your work for the past year. The decision about lay-offs has been made and it will be
announced in several days. Tick aU of the statements that might apply to you.
I would talk to my fellow workers to see if they knew anything about the supervisor's
evaluation ofme.
I would review the list of duties for my present job and try to figure out if I had
fulfilled them all.
I would go to the cinema to take my mind off things.
I would try to remember any arguments or disagreements I might have had with the
supervisor that would have lowered his or her opinion ofme.
1 would push all thoughts of being laid off out ofmy mind
1 would tell all my family and close friends that I'd rather not discuss my chances of
being laid off
I would try to think which employees in my department might be thought by the
supervisor to have done the worst job


















20. Thefollowing statements describe different ways ofreacting to situations. Please read
each one carefully and circle the one alternative which you feel is most like you. The
alternatives are as follows:
(N) (S) (O) (A)
Never Sometimes Often Always
1. I tend to give up easily when I don't clearly understand a situation. N S o A
2. When I go shopping, I like to have a list of exactly what I need. N S o A
3. I feel better about myself when I know that I have done all I can to
plan my future accurately.
N s o A
4. Sudden changes make me feel upset. N s o A
5. When making a decision, I am deterred by the fear ofmaking
a mistake.
N s o A
6. When uncertain, I act very cautiously until I have more information
about the situation.
N s o A
7. I like to have things under control. N s o A
8. When the future is uncertain, I generally expect the worst to happen. N s o A
9. Facing uncertainty is a nerve-racking experience. N s o A
10. I get worried when a situation is uncertain. N s o A
11. Thinking about uncertainty makes me feel depressed. N s o A
12. Uncertainty frightens me. N s o A
13. When I feel uncertain about something, I try to weigh up
rationally all the information I have.
N s o A
14. Before making any changes, I need to think things over thoroughly. N s o A
15. I prefer to stick to tried and tested ways of doing things. N s o A
16. I like to have my weekends planned in advance. N s o A
17. When I feel a situation is unclear, I try to do my best to resolve it. N s o A
18. I like to know exactly what I'm going to do next. N s o A
19. When facing an uncertain situation, I tend to prepare as much N s o A










20. I feel relieved when an ambiguous situation suddenly becomes clear. N S o A
21. When I feel uncertain, I try to take decisive steps to clarify
the situation.
N s o A
22. When I can't clearly discern situations, I get apprehensive. N s o A
23. When I'm not certain about someone's intentions towards me,
I often become upset or angry.
N s o A
24. When uncertain about what to do next, I tend to feel lost. N s o A
25.1 feel anxious when things are changing. N s o A
26.1 try to have my life and career clearly mapped out. N s o A
27. When a situation is unclear, it makes me feel angry. N s o A
28.1 like things to be ordered and in place, both at work and at home. N s o A
29.1 get really anxious if I don't know what someone thinks about me. N s o A
30.1 am hesitant when it comes to making changes. N s o A
31.1 like to plan ahead in detail rather than leaving things to chance. N s o A
32. Before I buy something, I have to view every sample I can find. N s o A
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21. The following questions ask about people in your environment who provide you with help
or support. Each question has two parts. For the firstpart, list all the people you know,
excludingyourself, whom you can count on for help and support in the manner described.
Give each person's initials and their relationship to you (see example). Do not list more
than one person next to each ofthe numbers beneath each question. Do not list more than
nine people per question.
For the secondpart, using the scale below, circle how satisfiedyou are with the overall
support you have.
6 5 4 3 2 1
Very Fairly A little A little Fairly Very
Satisfied Satisfied Satisfied Dissatisfied Dissatisfied Dissatisfied
Ifyou have no supportfor a question, tick the words 'No one', but still rate your level of
satisfaction. The example below has been completed to help you. All your responses will
be kept confidential.
Example
Who do you know whom you can trust with information that could get you in trouble?
i) No one
1) J/\ (sister) 3) AF (friend) 6) 9)
2) DE (friend) 4) MA (father) 7)
5) AC (employer) 8)
ii) How satisfied? 0
a) Whom can you really count on to distract you from your worries when you feel
under stress?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
b) Whom can you really count on to help you feel more relaxed when you are under
pressure or tense?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
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c) Who accepts you totally, including both your worst and best points?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
d) Whom can you really count on to care about you, regardless ofwhat is happening
to you?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
e) Whom can you really count on to help you feel better when you are feeling generally
down-in-the-dumps?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
f) Whom can you count on to console you when you are very upset?
i) No one
1) 4) 7) 9)
2) 5) 8)
3) 6)
ii) How satisfied? 6 5 4 3 2 1
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22. The following questions ask about any concerns you may have regarding breast cancer. For
each question please circle the answer you think best describes how worriedyou have been in
the past week about thefollowing subjects:
IN THE PAST WEEK, HOW WORRIED HAVE YOU BEEN ABOUT:
Not at all A little Moderately Very
worried worried worried worried
a. .. .developing breast cancer anytime now?
b. .. .developing breast cancer in the future?
c. ...the possibility of having to make future
decisions about your increased risk
such as genetic testing or prophylactic
surgery?
d. .. .the frequency of your appointments at
the Ardmillan Familial Breast Cancer
Clinic?
e. .. .something else concerning your increased







Answer the following 2 questions only ifyou
have children:
IN THE PAST WEEK, HOWWORRIED HAVE YOU BEEN ABOUT:
f. .. .dying from breast cancer and leaving your 1 2 3 4
children?
g. ...your children's own risk of developing 1 2 3 4
breast cancer?
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23. We are interested in how people think about their risk ofbreast cancer. Please circle the
appropriate number to indicate howfrequently these comments were true for you during the
past week.
Ifyou have not thought about your risk ofbreast cancer in the past week, please tick this box
and go on to the nextpage.
I have not thought about the risk of breast cancer
(Ifyou have ticked this box, go on to the nextpage)
No
a. I thought about it when I didn't mean to
b. I avoided letting myself get upset when I
thought about it or was reminded of it
c. I tried to remove it from memory
d. I had trouble falling asleep or staying
asleep, because of pictures or thoughts
about it that came into my mind
e.
f.
I had strong waves of feelings about it
I had dreams about it
g. I stayed away from reminders of it
h. I felt as if it wasn't real
i. I tried not to talk about it
j. Pictures about it popped into my mind
k. Other things keep making me think about it
1. I was aware that I still had a lot of feelings
about it, but I didn't deal with them
m. I tried not to think about it
n. Any reminder brought back feelings about
it
o. My feelings about it were sort of numb

































24. We are interested to find out whether you have experienced anything in the past week that has
promptedyou to think aboutyour risk ofdeveloping breast cancer.
IN THE PAST WEEK .... (please tick each box as appropriate)
a) have you read, watched or listened to anything about breast cancer □
b) have you examined your breasts □
c) have you attended the Ardmillan Familial Breast Cancer Clinic □
d) have you had a breast biopsy or related medical investigation □
e) have you been waiting for the results of a mammogram or breast biopsy □
f) have you received the results of a mammogram or breast biopsy I I
g) have you had any significant family events such as the birthday of a □
deceased relative who died from breast cancer
h) have you spoken to a close relative or friend about your own risk of □
breast cancer
i) has a close relative or friend been diagnosed with breast cancer □
or is undergoing treatment
j) other □
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25. We recognise that among women like yourselfwho have been attending the clinic for a
number ofyears, there may be a needfor up-to-date information from experts on topics
related to your increased risk ofbreast cancer. We would like to find out which topics
mostpeople would be interested in as we hope to provide this information as part ofa
future study.
WOULD YOU BE INTERESTED IN INFORMATION ABOUT...
(please tick where appropriate)
a) Scientific research concerning breast cancer genetics?
b) Scientific research concerning breast cancer screening?
c) Scientific research concerning breast cancer treatment?
d) Research conducted at the Ardmillan Familial Breast Cancer Clinic?
e) Genetic testing?
f) Prophylactic surgery?
g) Hormone Replacement Therapy (HRT)?
h) The oral contraceptive pill?
i) Maintaining a healthy lifestyle?
j) Ways to help you deal with any stress you may be experiencing?
k) Another topic? {please specify)
IF WE WERE TO OFFER THE FOLLOWING AS PART OF A FUTURE STUDY,
WOULD YOU BE INTERESTED IN ...(please tick where appropriate)
1) Receiving written information?
m) A group meeting in Edinburgh (only for women attending the clinic)
where experts would present the information and be available to
answer any questions?
n) A group meeting in Edinburgh (for women attending the clinic and
their families) where experts would present the information and be
















o) Group discussions with other women in the same situation by telephone | |
where expert information would be presented and you would have the
opportunity to discuss the information as a group and ask any questions
(you would be telephoned at home at a time to suit your convenience)?
p) None of the above options? □
IF ANY OF THE ABOVE GROUPS WERE OFFERED,
WHEN WOULD BE MOST CONVENIENT FOR YOU? (please tick where appropriate)
q) Mornings | | Afternoons □ Evenings □
r) Weekdays □ Weekends □
26. Do you have any other comments that you would like to make about any of the areas
covered in this booklet?
THANK YOU VERY MUCH FOR YOUR HELP.
Please return this questionnaire
in the FREEPOST envelope provided.
If this questionnaire has raised any issues which are ofconcern to you please
do not hesitate to contact:
Mrs Joyce Campbell (Genetic Research Nurse)
Tel: 0131 651 1805
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PROFESSIONAL EVALUATION OF A PSYCHOEDUCATIONAL INFORMATION
PACK FOR WOMEN AT INCREASED RISK OF BREAST CANCER
Topic :
1. Content (including text, any diagrams andpublished leaflets):
a) Please rate the extent to which the topic covered all relevant information?
Poor Adequate Good Very Good
12 3 4
b) Do you think there was any relevant information missing from the topic?
Yes □ No □
If so, which information?
c) Do you think there was any information included in the topic that was not
relevant?
Yes □ No □
If so, which information?
2. Clarity:
a) Please rate the clarity of the topic?
Poor Adequate Good Very Good
1 2 3 4
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3. Presentation:
a) Please rate the presentation of the topic?
Poor Adequate Good Very Good
1 2 3 4
4. Overall Quality:
a) Please rate the overall quality of the topic?
Poor Adequate Good Very Good
1 2 3 4
5. Additional comments & suggestions:
We would welcome any further comments or suggestions on this topic or the
information pack in general (either write them here or on the topic sheets themselves)
THANK YOU VERY MUCH FOR YOUR HELP
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Telephone Feedback on Draft Information Pack from Pilot Sample
Check that theparticipant has got the information pack in front of them.
1. How much of the information pack did you read?
All Some None
1 Introduction to Breast Cancer
2 Breast Cancer Genetics
Cancer genetics leaflet
3 Genetic Testing
4 Ways to Manage Breast Cancer Risk
Breast awareness booklet
5 Breast Cancer Treatment
6 Hormone Replacement Therapy
7 Research at the Ardmillan Clinic
8 Healthy Lifestyle
9 Worry about Breast Cancer
How to... stop worrying booklet
10 Sources of Information
2. To what extent do you think the information pack covered the right amount
of information?
Too little Too much
0123456789 10
Which info missing?
Which info not relevant?
3. To what extent you do think the information pack contained the right amount of
detail?
Not enough detail Too much detail
0123456789 10
Which topics not enough detail?
Which topics too much detail?
AII-33




How to.. .stop worrying
5. To what extent did you find the information pack easy to understand?
Very easy to understand Very difficult to understand
0123456789 10
Which topics difficult to understand?
Genetics diagrams easy to understand/helpful?
6. To what extent was the information in the pack new to you?
None new All new
0123456789 10
Which topics new?
7. To what extent did you find the information in the pack upsetting?
None upsetting All upsetting
0123456789 10
Which topics upsetting?
8. To what extent was the information pack easy to use?
Very easy





9. Please could you rate the overall helpfulness of the information pack?
Not at all helpful Very helpful
0123456789 10
Why not helpful?
Any additional comments/suggested improvements:
Thank you foryour help.
Please could I ask you to keep this information pack confidential at the moment. In the
nextfew weeks we will be starting a new study to evaluate the usefulness ofthe information
pack. We will be comparing a group ofwomen who are sent the information pack and a
group who are not sent it. When this study is completed during the summer, we will send
you a copy ofthefinal information pack, which you can then use as you like.
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Providing Information for Long-term




This booklet should take approximately 20 minutes to complete.
Please don't think for too long about each ofyour answers but giveyour
immediate response. Please try to answer all of the questions.
Please note, the questions areprinted on both sides of the page.
Ifyou have any queries about the study or the questionnaire booklet, do not
hesitate to contact Sally Appleton on the telephone number below.
When you have finished, please return the booklet as soon aspossible in the
FREEPOST envelope provided.
THANK YOU VERY MUCH FOR YOUR HELP
For the attention of:
Sally Appleton, Imperial Cancer Research Fund, Postgraduate Psychologist, Department of Clinical
Psychology, Outpatient Building, Western General Hospital, Edinburgh EH4 2XU
Tel: 0131 537 1838 E-mail: S.Appleton@icrf.icnet.uk
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Please fill in today's date: (day/month/year) / /2001
Please fill in your Date of Birth: (day/month/year) / /
We want to learn what people understand about their risk ofdeveloping breast cancer.
1. Do you think that your risk of ever developing breast cancer is:
(please tick the appropriate box)
a. Lower than the general population
b. The same as the general population
c. Slightly higher than the general population
d. Much higher than the general population
2. How likely do you feel it is that you will ever develop breast cancer?
(please circle the appropriate number)
Very Unlikely Likely Very Inevitable
Unlikely likely
1 2 3 4 5
3. How much control do you feel you have over whether you ever develop breast cancer?
(please circle the appropriate number)
None A bit Moderate A lot
at all
12 3 4
4. It would be helpful ifyou could give us the following information by ticking the
appropriate box.
a) Have you attended the Ardmillan Familial Breast Cancer Clinic in the last 2 weeks?
YesQ No | |
b) Do you have an appointment at the Ardmillan Familial Breast Cancer Clinic
in the next 2 weeks?
Yes | | NoQ |







5. We are interested in what people feel they do and do not understand about the issues
surroundingfamilial breast cancer. Please answer all ofthe following questions by ticking the
appropriate box. Please don't thinkfor too long about each ofyour answers. We are interested
in your immediate response to each question.
a) The main cause of all breast cancer is:








2. inherited genetic susceptibility □ □ □
Most women diagnosed with breast cancer:







2. carry an inherited genetic mistake □ □ □
3. are diagnosed at age 50 or over □ □ □
An increased risk of breast cancer can be passed down through families:







2. only by people who have inherited
a genetic mistake
□ □ □
3. by men □ □ □
Genetic testing:








2. can find mistakes in all the genes
that cause an inherited genetic
susceptibility to breast cancer
□ □ □
3. can only be offered if a mistake in the □ □ □
genes BRCA1 or BRCA2 has been
identified in the family
AII-38
e) If a person has inherited a mistake in the genes BRCA1 or BRCA2:
TRUE FALSE DON'T KNOW
1. they will definitely develop breast cancer [ | ] | j
2. their risk of developing breast cancer □ □ □
is increased
3. they are more likely to develop breast □ □ □
cancer at a younger age
f) The children of a person who has inherited a mistake in the genes BRCA1 or BRCA2:
TRUE FALSE DON'T KNOW
1. will definitely inherit the genetic mistake □ □ □
2. have a 50% chance of inheriting
the genetic mistake
3. can only inherit the genetic mistake if
they are the same sex as their parent who
has inherited the genetic mistake
□ □ □
□ □ □
g) The following are designed to reduce the risk of breast cancer developing:
TRUE FALSE DON'T KNOW
1. mammography □ □ □
2. clinical breast-examination □ □ □
3. breast awareness □ □ □
4. prophylactic surgery □ □ □
5. tamoxifen □ □ □
h) Mammography:
1. can prevent breast cancer
2. is proven to be useful for women
under 50 with a family history of
breast cancer
3. aims to detect breast cancer at an
early stage when it is easier to treat





In the National Breast Screening Programme:
TRUE
1. mammograms are only offered to women □
aged 50-64 years
□2. women aged 65 and over can request
mammograms
3. mammograms are offered every 3 years
4. women with a significantly increased
risk of breast cancer cannot continue to












For women in the general population the risk of breast cancer:
1. increases after one year of using
Hormone Replacement Therapy (HRT)
TRUE
□
2. increases after five years of using HRT □
3. returns to normal levels 1 year after □
stopping HRT












For women with a family history of breast cancer:
1. the effect of using HRT on the risk of
breast cancer is not clear
2. MRI breast screening is widely available










6. We are interested to know ifyou have had any medical complaints, and how your health has
been in general over the vast few weeks. Please answer ALL the questions on the following
pages simply by circling the answer which you think most nearly applies to you. Remember
that we want to know about present and recent complaints, not those that you had in the past.
It is important that you try to answer ALL the questions. Thankyou very much for your
co-operation.
HAVE YOU RECENTLY





















































































7. The following questions ask about any concerns you may have regarding breast cancer.
For each question please tick one box to indicate your answer.
a. During the past month, how often have you thought about your own chances of developing
cancer? Would you say (Please tick one box to indicate your answer)
Not at all or rarely —
Sometimes —
Often
Almost all of the time
b. During the past month, have thoughts about your chances of getting cancer affected your
mood? Would you say
Not at all or rarely —
Sometimes —
Often
Almost all of the time
c. During the past month, have thoughts about your chances of getting cancer affected your
ability to perform your daily activities? Would you say
Not at all or rarely —
Sometimes —
Often —
Almost all of the time
d. How concerned are you about the possibility that you might get cancer someday?
Would you say




e. How often do you worry about developing cancer? Would you say










8. We are interested in how people think about their risk ofbreast cancer. Please circle the
appropriate number to indicate howfrequently these comments were true for you during the
past week.
Ifyou have not thought about your risk ofbreast cancer in the past week, please tick this box
and go on to the nextpage.
I have not thought about the risk of breast cancer
(Ifyou have ticked this box, go on to the nextpage)
No
a
a. I thought about it when I didn't mean to
b. I avoided letting myself get upset when I
thought about it or was reminded of it
c. I tried to remove it from memory
d. I had trouble falling asleep or staying
asleep, because of pictures or thoughts
about it that came into my mind
e.
f.
I had strong waves of feelings about it
I had dreams about it
g. I stayed away from reminders of it
h. I felt as if it wasn't real
i. I tried not to talk about it
j. Pictures about it popped into my mind
k. Other things keep making me think about it
1. I was aware that I still had a lot of feelings
about it, but I didn't deal with them
m. I tried not to think about it
n. Any reminder brought back feelings about
it
o. My feelings about it were sort of numb




























9. D o you have any other comments that you would like to make about any of the areas
covered in this questionnaire?
THANK YOU VERY MUCH FOR YOUR HELP.
Please return this questionnaire
in the FREEPOST envelope provided.
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Providing Information for Long-term




This booklet should take approximately 30 minutes to complete.
Please don't think for too long about each ofyour answers but giveyour
immediate response. Please try to answer all of the questions.
Please note, the questions areprinted on both sides of the page.
Ifyou have any queries about the study or the questionnaire booklet, do not
hesitate to contact Sally Appleton on the telephone number below.
When you have finished, please return the booklet as soon aspossible in the
FREEPOST envelope provided.
THANK YOU VERY MUCH FOR YOUR HELP
For the attention of:
Sally Appleton, Imperial Cancer Research Fund, Postgraduate Psychologist, Department ofClinical
Psychology, Outpatient Building, Western General Hospital, Edinburgh EH4 2XU
Tel: 0131 537 1838 E-mail: S.Appleton@icrf.icnet.uk
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Please fill in today's date: (day/month/year) / /2001
Please fill in your Date of Birth: (day/month/year) / /
We want to learn what people understand about their risk ofdeveloping breast cancer.
1. Do you think that your risk of ever developing breast cancer is:
(please tick the appropriate box)
a. Lower than the general population □
b. The same as the general population □
c. Slightly higher than the general population □
d. Much higher than the general population □
2. How likely do you feel it is that you will ever develop breast cancer?
(please circle the appropriate number)
Very Unlikely Likely Very Inevitable
Unlikely likely
1 2 3 4 5
3. How much control do you feel you have over whether you ever develop breast cancer?
(please circle the appropriate number)
None A bit Moderate A lot
at all
12 3 4
4. It would be helpful ifyou could give us the following information by ticking the
appropriate box.
a) Have you attended the Ardmillan Familial Breast Cancer Clinic in the last 2 weeks?
YesD NoQ
b) Do you have an appointment at the Ardmillan Familial Breast Cancer Clinic
in the next 2 weeks?
YesQ] NoQ]
c) Are you currently waiting for the results of a mammogram or breast biopsy?
YesQ NoQ
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5. We are interested in whatpeople feel they do and do not understand about the issues
surroundingfamilial breast cancer. Please answer all ofthe following questions by ticking the
appropriate box and without referring back to the information pack. Please don Y thinkfor too
long about each ofyour answers. We are interested in your immediate response to each
question.
a) The main cause of all breast cancer is:








2. inherited genetic susceptibility □ □ □
Most women diagnosed with breast cancer:







2. carry an inherited genetic mistake □ □ □
3. are diagnosed at age 50 or over □ □ □
An increased risk of breast cancer can be passed down through families:







2. only by people who have inherited
a genetic mistake
□ □ □
3. by men □ □ □
Genetic testing:








2. can find mistakes in all the genes
that cause an inherited genetic
susceptibility to breast cancer
□ □ □
3. can only be offered if a mistake in the □ □ □
genes BRCA1 or BRCA2 has been
identified in the family
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If a person has inherited a mistake in the genes BRCA1 or BRCA2:
TRUE FALSE DON'T KNOW
1. they will definitely develop breast cancer □ □ □
2. their risk of developing breast cancer
is increased
□ □ □
3. they are more likely to develop breast □ □ □
cancer at a younger age
The children of a person who has inherited a mistake in the genes BRCA1 or BRCA2:
TRUE FALSE DON'T KNOW
1. will definitely inherit the genetic mistake □ □ □
2. have a 50% chance of inheriting
the genetic mistake
3. can only inherit the genetic mistake if
they are the same sex as their parent who
has inherited the genetic mistake
□ □ □
□ □ □
The following are designed to reduce the risk of breast cancer developing:
TRUE FALSE DON'T KNOW
1. mammography □ □ □
2. clinical breast-examination □ □ □
3. breast awareness □ □ □
4. prophylactic surgery □ □ □
5. tamoxifen □ □ □
Mammography:
1. can prevent breast cancer
2. is proven to be useful for women
under 50 with a family history of
breast cancer
3. aims to detect breast cancer at an
early stage when it is easier to treat





In the National Breast Screening Programme:
TRUE
1. mammograms are only offered to women □
aged 50-64 years
□2. women aged 65 and over can request
mammograms
3. mammograms are offered every 3 years □
4. women with a significantly increased □
risk of breast cancer cannot continue to










For women in the general population the risk of breast cancer:
1. increases after one year of using
Hormone Replacement Therapy (HRT)
TRUE
□
2. increases after five years of using HRT □
3. returns to normal levels 1 year after □
stopping HRT












For women with a family history of breast cancer:
TRUE
1. the effect of using HRT on the risk of
breast cancer is not clear
2. MRI breast screening is widely available






6. We are interested to know ifyou have had any medical complaints, and how your health has
been in seneral over the past few weeks. Please answer ALL the questions on thefollowing
pages simply by circling the answer which you think most nearly applies to you. Remember
that we want to know about present and recent complaints, not those that you had in the past.
It is important that you try to answer ALL the questions. Thankyou very much for your
co-operation.
HAVE YOU RECENTLY





















































































7. The following questions ask about any concerns you may have regarding breast cancer.
For each question please tick one box to indicate your answer.
a. During the past month, how often have you thought about your own chances of developing
cancer? Would you say (Please tick one box to indicate your answer)
Not at all or rarely —
Sometimes —
Often
Almost all of the time
b. During the past month, have thoughts about your chances of getting cancer affected your
mood? Would you say
Not at all or rarely —
Sometimes —
Often
Almost all of the time
c. During the past month, have thoughts about your chances of getting cancer affected your
ability to perform your daily activities? Would you say
Not at all or rarely —
Sometimes —
Often —
Almost all of the time
d. How concerned are you about the possibility that you might get cancer someday?
Would you say









f. How much of a problem is worrying about cancer to you? Would you say





8. The following questions ask about any changes you may have experienced in your level of
worry about breast cancer in the past month.
DURING THE PAST MONTH...
a. Do you think that your level ofworry about cancer has:
(please circle the appropriate number)
Decreased Decreased Decreased Stayed the Increased Increased Increased
a lot moderately a bit same a bit moderately a lot
1 2 3 4 5 6 7
b. If you think that your level ofworry about cancer has changed in the past month,
what do you think may have caused this change?
9. Did you answer questions 7 & 8 (on this page and the previous page) in relation to worry
about... (please tick one box)
1. breast cancer only ?
2. breast cancer & other cancers ? (please specify other cancers:
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10. We are interested in how people think about their risk ofbreast cancer. Please circle the
appropriate number to indicate how frequently these comments were true for you during the
past week.
Ifyou have not thought about your risk ofbreast cancer in the past week, please tick this box
and go on to the nextpage.
I have not thought about the risk of breast cancer
(Ifyou have ticked this box, go on to the nextpage)
No
a
a. I thought about it when I didn't mean to
b. I avoided letting myself get upset when I
thought about it or was reminded of it
c. I tried to remove it from memory
d. I had trouble falling asleep or staying
asleep, because of pictures or thoughts
about it that came into my mind
e. I had strong waves of feelings about it
f. I had dreams about it
g. I stayed away from reminders of it
h. I felt as if it wasn't real
i. I tried not to talk about it
j. Pictures about it popped into my mind
k. Other things keep making me think about it
1. I was aware that I still had a lot of feelings
about it, but I didn't deal with them
m. I tried not to think about it
n. Any reminder brought back feelings about
it
o. My feelings about it were sort of numb




























We would like to find out what you think about the information pack you received.
11. How many times have you read each topic in the information pack?
(please circle the appropriate numberfor each topic)
Topic None
1. Introduction to Breast Cancer 0
2. Breast Cancer Genetics 0
3. Genetic Testing 0
4. Options for Women with a Family 0
History of Breast Cancer
5. Hormone Replacement Therapy 0
6. Diagnosis and Treatment of Breast 0
Cancer
7. Research at the Ardmillan Familial 0
Breast Cancer Clinic
8. Healthy Lifestyle 0
9. Worry about Breast Cancer 0
10. Sources of Information 0
















12. How many times have you read each of the printed leaflets that were included at the
back of the information pack?




3. "How to... Stop Worrying'







13. When was the last time you read any of the information pack?
1. In the past week □
2. 1-2 weeks ago □
3. More than 2 weeks ago □
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14. To what extent was the information included in each topic in
(please circle the appropriate numberfor each topic)
the pack new to you?
Topic
1. Introduction to Breast Cancer
2. Breast Cancer Genetics
3. Genetic Testing
4. Options for Women with a Family
History of Breast Cancer
5. Hormone Replacement Therapy
6. Diagnosis and Treatment of Breast
Cancer
7. Research at the Ardmillan Familial
Breast Cancer Clinic
8. Healthy Lifestyle
9. Worry about Breast Cancer
10. Sources of Information












15. Have you discussed the information in your pack with anyone else?
Yes □ No □
If so with whom?
16. Has anyone else read the information in your pack?
Yes □ No □
If so who?
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17. Did you find any of the topics of information difficult to understand?
Yes □ No □
If you answered Yes, please tick which topics of information you found difficult to
understand:
Topic
1. Introduction to Breast Cancer
2. Breast Cancer Genetics
3. Genetic Testing
4. Options for Women with a Family History of Breast Cancer
5. Hormone Replacement Therapy
6. Diagnosis and Treatment of Breast Cancer
7. Research at the Ardmillan Familial Breast Cancer Clinic
8. Healthy Lifestyle
9. Worry about Breast Cancer
10. Sources of Information
18. Did you find any of the topics of information upsetting?
Yes □ No □
If you answered Yes, please tick which topics of information you found upsetting:
Topic
1. Introduction to Breast Cancer
2. Breast Cancer Genetics
3. Genetic Testing
4. Options for Women with a Family History of Breast Cancer
5. Hormone Replacement Therapy
6. Diagnosis and Treatment of Breast Cancer
7. Research at the Ardmillan Familial Breast Cancer Clinic
8. Healthy Lifestyle
9. Worry about Breast Cancer
10. Sources of Information
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19. How helpful did you find each topic of information?
(please circle the appropriate numberfor each topic)
Not at A little Quite a Very
all Helpful bit much
Topic Helpful Helpful Helpful
1. Introduction to Breast Cancer 0 12 3
2. Breast Cancer Genetics 0 12 3
3. Genetic Testing 0 12 3
4. Options for Women with a Family 0 12 3
History of Breast Cancer
5. Hormone Replacement Therapy 0 12 3
6. Diagnosis and Treatment of Breast 0 12 3
Cancer
7. Research at the Ardmillan Familial 0 12 3
Breast Cancer Clinic
8. Healthy Lifestyle 0 12 3
9. Worry about Breast Cancer 0 12 3
10. Sources of Information 0 12 3
20. How helpful did you find each of the printed leaflets that were included at the back of
the information pack?
(please circle the appropriate numberfor each leaflet)
Not at A little Quite a Very
all Helpful bit much
Leaflet Helpful Helpful Helpful
1. "Cancer Genetics" 0 12 3
2. "Breast Awareness" 0 12 3
3. "How to...Stop Worrying" 0 12 3
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21. Which of the following statements corresponds most closely with your response to the
information in this pack about:
(please tick the one responsefor each question that is closest to your situation)
a) Being Breast Aware:
1. Since reading the information pack, I have become more breast aware. □
2. Since reading the information pack, I intend to become more breast aware. □
3. 1 was already being breast aware. □
4. In spite of reading the information pack, I don't intend to become more breast aware. □
b) Having a Healthier Lifestyle:
1. Since reading the information pack, I have adopted a healthier lifestyle. □
2. Since reading the information pack, I intend to adopt a healthier lifestyle. □
3. I was already adopting a healthy lifestyle. □
4. In spite of reading the information pack, I don't intend to adopt a healthier lifestyle. □
bi) If you ticked 1 or 2 in response to the last question (i.e. you have adopted or intend
to adopt a healthier lifestyle), please tick the appropriate boxes to show which aspects
you have changed or intend to change?
1 Healthier diet
2 Stop smoking
3 Reduce alcohol intake
4 Increase skin protection from sun
5 Increase exercise
6 Other {please specify:
)
c) Ways to Relieve Worries about Breast Cancer:
1. Since reading the information pack, I have been using the techniques to relieve worry
about breast cancer.
□
2. Since reading the information pack, I intend to use the techniques to relieve worry □
about breast cancer.
3. I was already using techniques to relieve worry about breast cancer.
4. In spite of reading the information pack, I don't intend to use the techniques to relieve




22. Do you think you will obtain any of the further reading listed in the information pack?
Yes □ No □
If so which topic(s)?
23. Do you think there was any information not included in the pack that you would have
liked to know?
Yes □ No □
If so which topic(s)?
24. Do you think the information pack covers your need for information and support?
Yes □ No □
If you answered No what other type of service do you think would be helpful?
25. Do you have any other comments that you would like to make about the information
pack or any of the areas covered in this questionnaire?
THANK YOU VERY MUCH FOR YOUR HELP.
Please return this questionnaire
in the FREEPOST envelope provided.
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Objective knowledge of breast cancer risk-related topics: results for individual
items for the intervention study total sample at baseline





a build up of genetic
mistakes in breast cells? T
155 61 (39%) 27 (17%) 67 (43%)
inherited genetic
susceptibility? F






have a family history of
breast cancer? F
162 72 (44%) 73 (45%) 17(11%)
carry an inherited genetic
mistake? F
159 53 (33%) 60 (38%) 46 (29%)
are diagnosed at age 50 or
over? T







only by women with breast
cancer? F
161 95 (59%) 42 (26%) 24(15%)
only by people who have
inherited a genetic mistake?
T
162 88 (54%) 27 (17%) 47 (29%)
by men? T 158 52 (33%) 47 (30%) 59 (37%)
Genetic testing: can tell if a person will
develop breast cancer? F
161 65 (40%) 66 (41%) 30 (19%)
can find mistakes in all the
genes that cause an inherited
genetic susceptibility to
breast cancer ? F
162 41 (25%) 66 (41%) 55 (34%)
can only be offered if a
mistake in the genes
BRCA1 or BRCA2 has been
identified in the family? T
161 67 (42%) 17(11%) 77 (48%)





they will definitely develop
breast cancer? F
163 68 (42%) 10 (6%) 85 (52%)
their risk of developing




1 (1%) 44 (27%)
they are more likely to
develop breast cancer at a
younger age? T







will definitely inherit the
genetic mistake? F
161 83 (52%) 5 (3.%) 73 (45%)
have a 50% chance of
inheriting the genetic
mistake? T
162 84 (52%) 10(6%) 68 (42%)
can only inherit the genetic
mistake if they are the same
sex as their parent who has
inherited the genetic
mistake? F












162 45 (28%) 117
(72%)
0
breast awareness? F 161 41 (26%) 119
(74%)
1 (1%)
prophylactic surgery? T 161 67 (42%) 27 (17%) 67 (42%)
Tamoxifen? T 162 103
(64%)
19(12%) 40 (25%)
Mammography: can prevent breast cancer? F 163 147
(90%)
14 (9%) 2 (1%)
is proven to be useful for
women under 50 with a
family history of breast
cancer? F
163 11 (7%) 135
(83%)
17(10%)
aims to detect breast cancer
at an early stage when it is


















4 (3%) 23 (14%)
mammograms are offered




women with a significantly
increased risk of breast
cancer cannot continue to
have mammograms more














162 31 (19%) 14 (9%) 117
(72%)
increases after five years of
using HRT? T
161 50(31%) 6 (4%) 105
(65%)
returns to normal levels 1
year after stopping HRT? F
161 14 (9%) 9 (6%) 138
(86%)
returns to normal levels 5
years after stopping HRT? T






the effect of using HRT on
the risk of breast cancer is
not clear? T
162 75 (46%) 17(11%) 70 (43%)
MRI breast screening is
widely available? F
162 54 (33%) 43 (27%) 65 (40%)
Tamoxifen is widely
available? F
162 49 (30%) 34 (21%) 79 (49%)




Information pack consisting of scientific and psychosocial topics related to familial risk
of breast cancer and three published leaflets (Chapters 5 & 6). *
* for the purposes of inclusion as an appendix, the information pack is not presented in its original
ring-binder with coloured topic dividers.
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Introduction to this Information Pack
The Imperial Cancer Research Fund has funded this information pack, which
has been written specifically for women with a family history of breast cancer who
have been attending the Ardmillan Familial Breast Cancer Clinic for several years.
We have included 10 topics of up-to-date information related to familial risk of breast
cancer. In order to decide which topics to include we followed the advice of staff from
the Ardmillan clinic and from many women attending the clinic.
You may want to read the whole information pack from cover to cover or you
may just want to look at specific topics of information. We have therefore colour-
coded the topics and separated them by topic dividers so you can easily find a
particular topic. You may find some sections more interesting than others and
different topics may be more helpful at different times. As many of the topics are
related to each other, we will sometimes refer you to pages in another topic for more
information on a specific issue.
At the end of some topics of information you will find a "Key points" box which lists
the main points of information included in that topic.
Throughout the information pack there are "Further Information" boxes. These
suggest where you can get more information on a specific topic. A number of
different symbols show you if the information is available:
• as a leaflet B
• online (via the Internet)
• as a book
• by telephone ^
If you would like to obtain the further information we have suggested, turn to the
appropriate page in Topic 10 "Sources of information" to get the contact details of
the relevant organisation.
For some topics, we have included published leaflets and you can find these in
the plastic pockets at the back of the file. There is also room for you to add any other
relevant information you collect.
We hope that you find this information pack useful.




We are extremely grateful to the following people for their help in producing this
infonnation pack:
From the Department ofClinical Genetics, Western General Hospital, Edinburgh:
Dr Mary Porteous (Consultant in Clinical Genetics)
Dr Sixto Garcia-Minaur (Specialist Registrar in Clinical Genetics)
Mrs Joyce Campbell (Genetic Breast Care Nurse)
Ms Nicola Bradshaw (Genetics Associate)
Ms Sarah Drummond (Research Nurse)
Mrs Pat Walsh (Local Co-ordinator for the MRI Study)
From Edinburgh Breast Unit, Western General Hospital, Edinburgh:
Miss Elaine Anderson (Consultant Breast Surgeon)
From the ICRF Psychosocial Research Group, Western General Hospital, Edinburgh:
Ms Gwyneth Rees (Postgraduate Psychologist)
Dr Alison Fry (Former Research Fellow)
From theMRC Human Genetics Unit, Western General Hospital, Edinburgh:
Dr David FitzPatrick (Consultant in Clinical Genetics)
From the Family Planning and Well Woman Services, Edinburgh:
Dr Ailsa Gebbie (Consultant Gynaecologist)
From the School ofBiology, University ofSt. Andrews:
Professor Michael Steel (Professor in Medical Science)
From The Royal Marsden Hospital, Surrey:
Dr Maggie Watson (Consultant Clinical Psychologist)
Mrs Audrey Arden-Jones (Clinical Nurse Specialist in Cancer Genetics)
From the Institute ofCancer Research, Surrey:
Dr Claire Foster (Senior Research Fellow in Flealth Psychology)
From Beth Israel Cancer Center, New York, U.S.A:
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Topic 1: Introduction to Breast Cancer
What is Cancer?
Cancer is a common disease, which can occur in any organ of the body. A
cancer is an uncontrollable new growth of cells (often called a "malignant tumour").
It results from one cell, which has managed to escape normal cell control. The cell can
then divide, invade neighbouring tissue and even spread ("metastasise") to areas
further away in the body.
A number of factors are involved in the development of cancer. These can







Most cancer, including breast cancer, is sporadic. This means it occurs mainly
by chance due to environmental factors.
It is estimated that only 5-10% of all cancers, including breast cancer, are due
to hereditary factors (i.e. due to an inherited genetic susceptibility) (see topic 2, page
8).
All Breast Cancer Patients
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Breast cancer is a malignant tumour which develops in the cells of the breast.
It is the commonest cancer in women in the U.K (excluding non-melanoma skin
cancer), accounting for 20% of all new cases of cancer. The average lifetime risk of
breast cancer for women in the U.K. is 8%. That means that approximately 1 in 12 of
all women in the U.K will develop breast cancer before the age of 74 years. However,
at the age of 40-50 years, the risk of developing breast cancer is about 1% (about 1 in
100 women aged 40-50 years will develop breast cancer). This is because a woman's
risk of breast cancer continues to increase after the menopause ("change of life").
Breast cancer can also occur in men, although it is much more rare (fewer than 1 in
100,000 men in the U.K. will develop breast cancer).
Research has shown that people can inherit a genetic susceptibility to
developing breast cancer. This was shown by the fact that:
• Several individuals in the same family often develop breast cancer.
• The risk ofbreast cancer is increased in relatives of individuals with the disease.
Studies also showed that breast cancer in these families develops at a
relatively early age (i.e. in the 30's or 40's), more commonly affects both breasts
{bilateral breast cancer) and is often associated with cases of ovarian cancer in
relatives.
Key Points about Breast Cancer:
• Both inherited and environmental factors are involved in the development of
cancer.
• 90-95% of breast cancer is sporadic which means that it is mainly caused by
chance due to environmental factors.
• 5-10% of breast cancer is hereditary which means that it is mainly caused by an
inherited genetic susceptibility.
To obtain further information on this topic see:
® Imperial Cancer Research Fund "Breast Cancer: background", topic 10 page 42.
® Cancer Research Campaign: Cancer Help UK "About Cancer: cells and cancer",
topic 10 page 41.
® 0 Royal Marsden Hospital "Cancer of the Breast"(in Patient Information),




Topic 2: Breast Cancer G^r\^Y\cs
What are Genes?
We are all made up ofmillions of tiny building blocks called cells. Inside each
of these cells we have 23 pairs of chromosomes that are actually long strands ofDNA
("Deoxyribonucleic Acid").
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Set of Normal Female
Chromosomes (23 pairs)
(from http://www.pathology.washington.edu/Cytogallery/cytogallery.html)
The DNA in our chromosomes is organised into about 30,000 different genes.
Genes are responsible for making us what we are. For example, some genes determine
eye colour and other genes determine blood group. Each gene is located in a particular
place on a particular chromosome.
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In some families, breast cancer has partly been caused by a mistake in one
particular gene on one particular chromosome. People with an inherited mistake in a
specific gene are at increased risk of developing breast cancer. If someone does have a
mistake in this gene predisposing them to breast cancer, their children will have a
50% chance of inheriting this mistake. This is because we inherit one of each pair of
chromosomes from our mother and the other from our father.
What are Genetic Mutations?
Cells grow and divide to produce identical copies of themselves. Each of the
cells produced in turn grows and divides to produce identical copies of itself. Each
time cells divide they have to produce identical copies of all their components,
including their unique pattern ofDNA. This process is very complicated and when a
cell is dividing, errors may occur in the genetic code. Things in our environment such
as ultra violet light and tobacco smoke are continually causing these errors. These
errors can be known as mutations. However, control mechanisms usually quickly
identify these errors and either correct them or cause the affected cell to die.
How does Cancer normally occur?
All forms of cancer are abnormalities in the normal control of cell growth.
Therefore, a cell which loses its normal pattern of growth, can be transformed into a
cancer cell. If the control mechanisms are not working properly, a cell, which contains
mistakes in its DNA, can be encouraged to grow and divide at a higher rate.
It takes several genetic mistakes for the cell to grow out of control and these
mistakes take time to accumulate. This is why sporadic cancer tends to occur in older
individuals.
Can Breast Cancer be inherited?
90-95% of cancers are "sporadic" not "inherited" diseases. However, about 5
to 10% ofbreast cancer is thought to be caused by hereditary factors. This means that
although an affected person's children have not inherited cancer, they may have
inherited a susceptibility or predisposition to develop it. This susceptibility can be
inherited from either their mother or their father (as we have 2 copies of each gene)
and some people inherit a susceptibility to breast cancer without ever developing
breast cancer themselves.
If they have inherited this susceptibility, the time span for the cancer to
develop may be shortened, as it will not take as long for further genetic mistakes to
occur. Often, the same type of cancer tends to develop in more than one family
member at a young age. This is because the genetic mutations that are inherited occur





In the 1990's two genes for breast cancer susceptibility were identified. The
genes were called BRCA1 and BRCA2 and they play an important role in the control
of cell growth and division. These two genes account for a large proportion ofbreast
cancer in high-risk families (where four or more family members in three generations
develop breast cancer). If someone has a mistake in BRCA1 or BRCA2 they have a
50% chance ofpassing this susceptibility to breast cancer on to each of their children.
It is currently estimated that about 45% of cases of familial breast cancer are
due to BRCA1 mutations and a further 40% to BRCA2 mutations (these estimates
vary between different cultures and regions). Although there is evidence for at least a
third familial breast cancer gene, this has not yet been identified.
There is also evidence for overlap between breast and ovarian cancer
susceptibility. BRCA1 mutations account for most families with inherited breast and
ovarian cancer susceptibility, particularly where the onset of breast cancer is at 45
years or younger. BRCA2 mutations account for a strong susceptibility to breast
cancer and a smaller risk of ovarian cancer than BRCA1 mutations. People who carry
a BRCA2 genetic mutation are also predisposed to other cancers.
Key Points on Breast Cancer Genetics:
• Inherited mistakes in the genes BRCA1 or BRCA2 increase a person's risk of
developing breast cancer.
• Only 5-10% of breast cancer occurs as a result of inheriting a genetic mistake in
BRCA1 orBRCA2.
• The children of a person who carries a mistake in BRCA1 or BRCA2, will each
have a 50% chance of inheriting the susceptibility to breast cancer.
To obtain further information on this topic see:
Genetic Interest Group "An Introduction to Genetics"(in Education), topic 10 page 42.
0 CancerNet "Understanding Cancer" (in NCI Publications: Genetics),




Topic 3: Genetic Testing
What is Genetic Testing?
Genetic testing aims to find mistakes in the two genes, BRCA1 and BRCA2,
which are known to cause an inherited genetic susceptibility to developing breast
cancer. Mistakes can occur at almost any position along a gene. So far, over 200
different mistakes in BRCA1 and about 100 in BRCA2 have been reported.
Therefore, trying to find a mistake in one of these genes is very time consuming,
technically demanding and expensive. Genetic testing for mistakes in BRCA1 and
BRCA2 has only recently been introduced in the U.K.
We have included the South East of Scotland Clinical Genetic Service leaflet
on "Cancer Genetics" at the back of this pack for your information. It contains
information on genetic testing.
Who should be tested?
In order to offer genetic testing, the laboratory has to be able to identify if
there is a genetic mistake being inherited in the family. To do this, they search for a
mistake in BRCA1 or BRCA2 using a sample of blood from a family member with
breast or ovarian cancer. If a mistake is identified, the healthy relatives that may be at
risk can then be offered a blood test to determine if they have inherited this specific
genetic mistake.
To decide who is eligible for this process, familial breast cancer clinics follow
national guidelines (for more information on genetic testing in Scotland see topic 7,
page 23).
Women at moderate risk of breast cancer
Most women referred to a familial breast cancer clinic, because of a family
history of the disease, are considered after appropriate assessment to be at moderate
risk of developing breast cancer (between 2 and 3 times the general population
lifetime risk). Women in this group are not usually eligible for genetic testing.
Women at high risk of breast cancer
A small number ofwomen referred to a familial breast cancer clinic, because
of a strong family history of the disease, are considered to be at high risk of
developing breast cancer (greater than 3 times the general population lifetime risk).




What do genetic test results mean?
A "positive" test result means that the woman is found to carry a genetic
mistake in BRCA1 or BRCA2 and has therefore inherited a genetic susceptibility to
breast cancer. Some studies have estimated that carriers of BRCA1 or BRCA2
mutations have between a 60-85% risk of developing breast cancer by the age of 70.
Therefore, even if you receive a positive test result, it does not mean that you will
definitely develop breast cancer.
Women who receivepositive genetic test results are offered appropriate breast
cancer screening and information on which to base their choices about ways of trying
to reduce the risk of breast cancer developing, such as "prophylactic mastectomy"
(surgical removal of the breasts) (for further information on prophylactic surgery see
topic 4, page 14).
A "negative" test result means that the woman's risk of breast cancer is
reduced to the general population lifetime risk of breast cancer (i.e. 8% in the U.K.),
as she is not found to carry the specific genetic mistake identified in her family.
Therefore, she is not at sufficiently increased risk to require screening and she is
advised to join the NHS Breast Screening Programme when she is 50.
Key Points on Genetic Testing:
• Genetic testing can only be offered to healthy individuals once a genetic mistake
in BRCA1 or BRCA2 has been identified in a family member with breast cancer.
• Only a small number ofwomen at high risk of breast cancer are usually eligible
for genetic testing.
• Apositive test result means that a genetic susceptibility to breast cancer has been
inherited.
• Apositive test result does not mean that you will definitely develop breast cancer.
• A negative test result reduces breast cancer risk to the general population level.
To obtain further information on this topic see: (the websites/leaflets listed below are from
the U.S.A. You need to be aware that genetic testing is more widely available in the U.S.A.
Therefore, some information may not be applicable to British women)
® 0 CancerNet "Understanding Gene Testing" (in Genetics, Causes, Risk Factors,
Prevention: Cancer Genetics: General Cancer Genetics Information),
topic 10 page 41.
® E=) CancerNet "Genetic Testing for Breast Cancer Risk: It's Your Choice" (fact sheet &
booklet in Genetics, Causes, Risk Factors, Prevention: Cancer Genetics: Type of
Cancer), topic 10 page 41.
® 0 CancerNet "Understanding Cancer" (in NCI Publications: Genetics),
topic 10 page 41.
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Topic 4: Options for Women with a Family History
of Breast Cancer
Since the actual causes of breast cancer are not completely understood, it is
currently not possible to prevent the development of cancer.
However, there are a number of different ways to manage an increased risk of
breast cancer which aim to:
• Detect breast cancer at an early stage when it is easier to treat.
OR
• Reduce the risk of breast cancer developing.
Screening
Breast cancer screening is considered to be the key way to manage breast
cancer risk. Screening does not reduce the risk of cancer, but aims to diagnose it at an
early stage so that appropriate treatment can be started to improve the chances of
survival. There are several forms of screening that are currently available for detecting
breast cancer: mammography, clinical breast-examination and breast self-
examination (or "breast awareness"). However, there is still uncertainty about the
usefulness of screening in women under 50 with a family history of breast cancer.
Research trials are also evaluating new forms of screening for women with a family
history of breast cancer such as "Magnetic Resonance Imaging"(see topic 7, page 23).
Mammography:
• Mammograms are X-rays of the breast that can often detect cancer before it can be
felt. Mammography is currently the best form of breast screening available.
• The National Breast Screening Programme currently offers mammography every
three years to all women between the ages of 50-64 who are considered to be at
general population risk of developing breast cancer. This is because breast cancer
is most common in this age group in the general population. Women aged 65 and
over are not automatically invited for screening but they can still request
mammograms.
• Research has shown that screening by mammography can reduce the number of
deaths from breast cancer in women in the general population by up to 40%. The
benefit is greatest in women aged 50 to 70 years, as their breast tissue is generally
less dense which allows tumours to be more easily detected.
• In women at increased risk of breast cancer, screening by mammography at a
specialist clinic generally begins between the ages of 25-35 (usually from 5 years
younger than the age at which their youngest relative was diagnosed with breast
cancer). It is generally recommended to be performed every 2 years up to the age
of 40 and annually up to the age of 50. Women over 50 are advised to join the
National Breast Screening Programme - if they have a significantly increased risk
of breast cancer, they are usually offered an extra mammogram between their
National Breast Screening Programme mammograms which means they are




• The usefulness ofmammography in women with a family history of breast cancer
aged under 50 is currently unclear. Although the results of recent research have
supported the value of mammography in this group ofwomen, this research has
used relatively small numbers ofwomen.
• Some women have expressed concern about the possible effect of the radiation
from mammograms on their risk of breast cancer. However, the amount of
radiation emitted is so small that the benefits of detecting breast cancer early far
outweigh the risk of these X-rays causing any harm.
Clinical breast examination (CBE):
• A CBE is a physical examination of the breasts performed by a doctor or nurse.
• Research suggests that CBE can detect cancers that are difficult to identify by
mammography. Therefore, CBE is a valuable component of screening in addition
to mammography.
• CBE is particularly important for younger women in whom mammography is less
sensitive (this is because their breast tissue is generally more dense).
• In women at increased risk of breast cancer, CBE is generally recommended to be
performed annually at a specialist clinic and usually beginning at age 35 (or at a
younger age if a woman's risk is significantly increased).
• You can also ask your GP to perform a CBE.
Breast Awareness:
• "Breast Awareness" (or "Breast self-examination" as it's sometimes called) means
getting to know how your breasts look and feel normally so that you are able to
notice any changes that might be unusual for you.
The Breast Awareness 5-point code:
*t* Know what is normal for you.
♦> Know what changes to look and feel for.
♦♦♦ Look and feel.
♦> Report any changes to your GP without delay.
❖ Attend for routine breast screening if you are aged 50 or over.
• Research to look at the impact of being breast aware on breast cancer survival is
so far inconclusive.
• Nevertheless, being breast aware is part of looking after your general health and it
is generally recommended that you check your breasts once a month, starting from
your early 20's.
• As some cancers can be difficult to detect by mammography, it is important to be
breast aware.
• We have included the Breast Cancer Care leaflet " Breast Awareness" at the back




To obtain further advice on being breast aware please ask when you next attend the
Ardmillan clinic or see:
NHS Breast Screening Programme & the Cancer Research Campaign "Be Breast Aware",
topic 10 page 43 or 41.
Imperial Cancer Research Fund "Breast Cancer- Spot the Symptoms Early",
topic 10 page 42.
Prophylactic Surgery
In the U.K., only women at high risk of developing breast cancer are generally
offered prophylactic mastectomy (the removal of the breasts before cancer has been
diagnosed). Many of these women will have been found to carry a mutation in the
genes BRCA1 or BRCA2 (see topic 3, page 11).
Research has shown that prophylactic mastectomy may reduce the risk of
developing breast cancer by about 90%. Therefore, it will not definitely prevent the
development of breast cancer. This is because all of the breast tissue cannot be
removed during prophylactic mastectomy, so there is still a chance that breast cancer
could occur.
As prophylactic mastectomy is irreversible, it is extremely important that any
woman considering prophylactic mastectomy receives help in understanding the
potential risks and benefits (both physical and psychological) of surgery before they
come to a final decision. Women who decide to opt for prophylactic mastectomywill
be supported before, during and after surgery.
Research also suggests that prophylactic oophorectomy (removal of the
ovaries before cancer has been diagnosed) can reduce the risk of developing breast as
well as ovarian cancer.
Tamoxifen
Tamoxifen is part of a group of drugs called "Anti-oestrogens". These drugs
are usually used to treat women with advanced breast cancer and are known as
"Hormone therapies" (see topic 6, page 20). Tamoxifen works by blocking the effect
of the hormone oestrogen, which normally encourages breast cancer cells to grow.
Research with breast cancer patients has shown that Tamoxifen halves the risk
of cancer developing in the other breast. In light of these results, research was started
to determine whether Tamoxifen could prevent breast cancer developing in women at
increased risk of the disease. Studies are currently under way to determine its
effectiveness and safety in women at increased risk ofbreast cancer (see topic 7, page
22). Tamoxifen, however, may cause some side effects such as hot flushes and these




Research is also currently investigating the effect of other anti-oestrogen drugs
such as "Raloxifene" on the prevention of breast cancer in women at increased risk.
These two drugs (Tamoxifen & Raloxifene) are currently not licensed to be
used outside of research studies in the U.K.
Key Points on Options for Women with a Family History of Breast Cancer:
• Breast cancer screening includes mammography, clinical breast examination and
"breast awareness" and aims to detect breast cancer at an early stage when it is
easier to treat.
• The usefulness of breast cancer screening in women with a family history of
breast cancer who are under the age of 50 is still unclear.
• Prophylactic surgery and Tamoxifen aim to reduce the risk of breast cancer,
although they cannot prevent it developing.
To obtain further information on this topic see:
Imperial Cancer Research Fund "Breast Cancer: symptoms and diagnosis",
topic 10 page 42.
B CancerBACUP "Understanding cancer of the breast: symptoms and diagnosis'




Topic 5: Hormone Replacement Therapy (HRT)
What is HRT?
HRT involves replacing the female sex hormones oestrogen and progesterone.
These hormones are produced by the ovaries and are no longer in high levels after the
menopause.
The menopause is when a woman's ovaries stop producing eggs each month
and menstrual periods stop. A woman is considered to be menopausal when her
periods have completely ceased for at least a year and it occurs at an average age of
50.
HRT can help to relieve the symptoms of the menopause such as hot flushes,
night sweats and vaginal dryness. It can also improve quality of life, mood and sense
ofwell being as well as helping to reduce the risk osteoporosis (thinning of the bones
which can cause bone fractures).
There are two different types ofHRT: one contains oestrogen only and the
other, more commonly used type, combines oestrogen with progesterone.
HRT <& the Risk of Breast Cancer: What does the research
show?
As oestrogen is known to promote the growth of some breast cancers, research
was needed to see if taking extra oestrogen in the form ofHRT could promote the
development of breast cancer.
Research in women in the general population has shown that using HRT for
more than five years appears to slightly increase a woman's risk of developing breast
cancer. The risk increases the longer the time that HRT is used. For every 1,000
women who have been using HRT for 5 years, there would be 2 extra cases of breast
cancer diagnosed and for every 1,000 women who have been using HRT for 10 years,
there would be 6 extra cases of breast cancer diagnosed. However, the risk of breast
cancer returns to normal levels (i.e. the general population risk of breast cancer) five
years after stopping treatment.
Mammography is less sensitive in women who are taking HRT, as it increases
breast density. However, cancers diagnosed in women taking HRT tend to be less
advanced than those diagnosed in women who have not used HRT. Current evidence
suggests that HRT does not increase the number of deaths from breast cancer.
Further research is needed to investigate the effect ofHRT on the risk of
breast cancer, particularly in women with a family history of the disease where the
risks are not yet clear. The Imperial Cancer Research Fund is currently involved in
"The Million Women Study" which is the world's largest study looking at HRT and




If you are considering HRT, please discuss this with your GP. There are also
natural alternatives to HRT which some people find helpful. For more advice, please
consult your GP.
Key Points on HRT:
• HRT replaces the hormones oestrogen and progesterone that are no longer in
high levels after the menopause.
• HRT can help to relieve unpleasant symptoms of the menopause, improve quality
of life and reduce the risk of osteoporosis.
• Although research has shown that using HRT for more than five years appears to
increase a woman's risk of developing breast cancer, it is not clear how these
risks relate to women with a family history of breast cancer.
To obtain further information on HRT, please ask your GP, ask when you next attend
the Ardmillan clinic or see:
Imperial Cancer Research Fund "Breast Cancer: background - risk factors",
topic 10 page 42.
Cancer Research Campaign: Cancer Help UK "Questions and Answers: causes




Topic 6: Diagnosis <& Treatment of Breast Cancer
Diagnosis
On occasion, you may be called back to the Ardmillan Clinic for a second visit
which might involve further investigations. This could be because, for example, a
breast change has been noticed between your last 2 mammograms (this is not
necessarily an abnormal change).
Further investigations may include a second mammography, clinical breast
examination or ultrasound (which uses sound waves to see if a lump is solid or
contains fluid). A tissue biopsy (where a sample of breast tissue is removed to be
examined under a microscope) is the only definite way to tell if a breast lump is
benign or malignant (cancerous). There are several different types of biopsy which
include needle aspiration (when a thin needle is used to remove cells from a breast
lump), needle biopsy (when a slightly larger needle is used to remove a small piece of
tissue from a breast lump) and surgical biopsy (where the whole breast lump is
removed).
If you are called back to the Ardmillan Clinic for further investigations, it is
sometimes possible to give you a definite diagnosis on the same day.
About two thirds ofbreast abnormalities detected by mammography prove to
be benign (not cancerous) on further examination. Benign breast lumps are easily
treated and can be caused by cysts (which are fluid-filled sacs) orfibroadenomas
(which are non-cancerous solid tumours).
Introduction to the Treatment of Breast Cancer
Research published in May 2000 has shown that in the last 10 years, the
number of deaths from breast cancer in the U.K. has decreased by 30%, which is
partly due to improved treatments for breast cancer.
There are a number of different ways of treating breast cancer. These can be
divided into 2 main groups:
• Local treatments that target the breast.
• Systemic treatments that target cancer cells anywhere in the body.
The treatments that are offered to a patient with breast cancer will depend on
several factors including their age, the size of the tumour, the stage of the cancer (how
much it has spread) and grade of the cancer (how fast the cancer cells are growing
when viewed under a microscope). Women who have been found to carry a mutation
in the genes BRCA1 or BRCA2 and subsequently develop breast cancer, may initially
receive very intensive treatment. Most patients with breast cancer will have a
combination of local and systemic treatments and can have a share in treatment
decisions with their cancer specialist if they wish. Full support before, during and




Additional information and support is available from the Maggie's Cancer
Caring Centre at the Western General Hospital, Edinburgh (see topic 10, page 43).
The prognosis (how likely you are to get better and how long you are likely to
live) for a patient with breast cancer depends upon the stage of the cancer when it was
diagnosed. Therefore, you are more likely to have a better prognosis if your cancer is
diagnosed at an early stage. For example, 85 out of every 100 (85%) women
diagnosed with localised breast cancer between 1985-1989 lived for at least 5 years
after being diagnosed, compared to 21 out of every 100 (21%) women who were
diagnosed with metastatic breast cancer (cancer that has spread from the breast).
Local Treatments
Surgery:
• There are several different types of breast cancer surgery. The most common types
are breast conservation surgery and mastectomy.
• Breast conservation surgery includes a lumpectomy (where the breast lump is
removed with a small amount of surrounding breast tissue) and apartial
mastectomy or quadrantectomy (where up to one quarter of the breast is removed).
• All forms of breast conservation surgery are usually followed by a course of
radiotherapy.
• Mastectomy removes the whole breast and varying degrees of surrounding chest
muscle and lymph glands (which are in the armpit). Most patients treated by
mastectomy are offered some form of surgery to reconstruct the breast such as
breast implants.
• After any form of surgery, patients usually receive follow-up checks to make sure
that breast cancer hasn't recurred or developed in the other breast. This because all
patients with cancer in one breast are at increased risk of developing cancer in the
other breast.
Radiotherapy:
• Radiotherapy uses high-energy rays to kill cancer cells.
• All patients who undergo breast conservation surgery and some patients who
undergo mastectomy, receive radiotherapy for a few weeks after surgery.
• Radiotherapy can also be given before surgery to reduce the size of a breast lump
so that it can be removed more easily.
Systemic Treatments
Chemotherapy:
• Chemotherapy uses anti-cancer drugs to kill cancer cells. As the drugs are carried
round the body in the blood they can kill cancer cells anywhere in the body.
• Chemotherapy can be given before surgery to reduce the size of a breast lump,
after surgery to reduce the risk of the breast cancer recurring/spreading to another




• Chemotherapy can be given as a tablet or injected and often includes a
combination of different drugs.
• Different combinations of drugs can also have different side effects such as
tiredness, hair loss, nausea and vomiting. Information on the possible side-effects
is given by breast care nurses, in particular a patient's named nurse will provide
full support throughout treatment.
• A full course of chemotherapy can take up to 6 months to complete.
Hormone Therapy:
• Hormone therapy prevents the female hormone, oestrogen, from working. This
hormone, which naturally occurs in the body, affects the growth of some breast
cancer cells. Therefore, hormone therapy aims to decrease the level of oestrogen
or stop it from working altogether.
• Hormone therapy can be given before surgery to reduce the size of a breast lump,
after surgery to reduce the risk of the breast cancer recurring/spreading to another
part of the body or to treat metastatic breast cancer.
• Hormone therapy seems to work best in women who have "oestrogen receptor
positive cancers" (i.e. their cancer cells have molecules on the surface which
activate oestrogen which stimulates breast cancer cells to grow).
• There are several different types ofhormone therapy, including Tamoxifen which
is the commonest (see topic 4, page 14).
New Treatments
There are a number of new ways of treating breast cancer that are currently
being tested and could potentially become standard treatments for breast cancer in the
future. One study by the Imperial Cancer Research Fund is looking at whether
vaccines can effectively treat metastatic breast cancer, by triggering the body's
immune system. Another study by the Imperial Cancer Research Fund is investigating
a new "cell suicide gene " technique in which cancer cells are killed while healthy
cells remain intact. Other research is looking to see if new hormone therapies can
improve on the performance of Tamoxifen.
Key Points on the Diagnosis & Treatment of Breast Cancer:
• About two thirds of breast changes detected by mammography prove to be non¬
cancerous on further examination.
• The type of treatment a breast cancer patient will be offered depends on their age,
the size of the tumour, the stage and grade of the cancer.
• Patients can have a share in treatment decisions if they wish.
• Local treatments for breast cancer target the breast and include surgery and
radiotherapy.
• Systemic treatments for breast cancer target cancer cells anywhere in the body




To obtain further information on this topic see:
® Imperial Cancer Research Fund "Breast Cancer: treatment", topic 10 page 42.
® B CancerBACUP "Understanding cancer of the breast: treatments", topic 10 page 41.
® Cancer Research Campaign: Cancer Help UK "Breast Cancer: treating breast




Topic 7: Research at the Ardmillan Familial
Breast Cancer Clinic
The Ardmillan Familial Breast Cancer Clinic started in Edinburgh in 1992 for
women in Southeast Scotland with a family history of breast cancer. It is now funded
by Lothian Primary Care Trust and provides cancer risk counselling and breast
screening services for over 1,000 women. A large number ofwomen attending this
clinic have been involved in various research projects over the years.
Women who meet the specific criteria for a research study are informed about
the study and invited to participate. However, there is no pressure placed on anyone to
join these studies and if someone agrees to take part, they can withdraw at any time.
We would like to take the opportunity to thank you if you have taken part in
any of these studies and to provide you with an overview of some of the past and
present research that has been conducted in the clinic.
International Breast Cancer Intervention Study (IBIS)
IBIS is a 5-year study, which is being run by the Imperial Cancer Research
Fund and the Cancer Research Campaign. It aims to discover whether the use of
Tamoxifen can help to prevent breast cancer in women at increased risk of the disease
(see topic 4, page 14).
Women aged 35-70 who have at least twice the general population risk of
developing breast cancer due to their family history of the disease, have been taking
part in this study.
The study is being run as a double blind placebo controlled trial. This means
that neither the participants nor the medical staff know which type of tablet the
participants are receiving, Tamoxifen or the placebo (which is an inactive substance).
Taking part in this study requires a big commitment from the women. They
take a trial tablet daily for 5 years and attend the clinic for a clinical breast
examination every 6 months and a mammogram every 12 or 18 months.
This study is a multi-centre trial with centres in Australia, New Zealand and
Europe, including 4 centres in Scotland. The study has now stopped recruiting women
as it has reached its target of 7,000 women taking part worldwide. In Edinburgh, 250
women have taken part in the study and of those 7 have already completed their 5





MRI Breast Screening Study (Magnetic Resonance Imaging)
This study aims to see if "Magnetic Resonance Imaging" (MRI) can detect
breast cancer at an earlier stage than current mammography methods in women with
an increased risk of breast cancer. MRI uses magnetic waves to create detailed
pictures of the breast (whereas mammography uses X-rays).
The criteria for women to participate in the study are very strict. They are aged
between 25-49 years and the majority have four 1st or 2nd degree relatives diagnosed
with breast cancer under the age of 60. Many of the women participating have
received genetic testing and are known to be carrying a genetic mutation that
predisposes them to breast cancer (see topic 3, page 10). The women taking part in
this study have an annual mammogram, clinical breast-examination and MRI breast
scan for up to 5 years.
This is a multi-centre study with 17 different centres taking part all over the
U.K. The trial began in Edinburgh in 1998 and has so far recruited 47 women.
Cancer Genetics in the Community
For the last 3 years, over 300 women newly referred for genetic counselling
about their family history of breast cancer have been taking part in a study to compare
2 different ways of organising the service.
Half of the women were referred to the clinic in the usual way. If they did not
have a family history which suggested an increased risk of breast cancer, they and
their GP would receive a letter to explain why an appointment was not necessary.
Those women who were at increased risk of breast cancer were seen at the clinic in
the usual way.
The other half of the women were referred to a clinic in their community run
by a specially trained genetics nurse. She would see everyone referred and refer on to
the Ardmillan clinic only those she found to be at sufficiently increased risk. The
results of this study, including the women's reactions to the service they received, are
still being analysed and will be used to inform the future service.
Genetic Testing
The Scottish Health Service has now released funds to the Regional Genetics
Services in Aberdeen (which serves Edinburgh) and Glasgow to allow them to offer
genetic testing for mutations in BRCA1 and BRCA2, the 2 major genes involved in
familial breast cancer (for further information on genetic testing for BRCA1 and
BRCA2, see topic 3, page 10). The testing will be offered to families with a living
member with breast cancer who meet specific high-risk criteria (i.e. families with 4 or
more members with breast or ovarian cancer [including male breast cancer] in 3
generations; families with one member with breast and ovarian cancer). The
laboratories hope to start genetic testing by the end of 2001. We anticipate that further






When clinics were first set up to provide genetic counselling and breast cancer
screening to women with a family history of cancer, there was uncertainty about how
useful these clinics would be. It was understood that it would take many years to see
whether they would be effective in reducing the number of deaths from breast cancer.
There was a particular worry that information about breast cancer risk would cause
people distress particularly since we could not prevent breast cancer developing.
Funding from the Imperial Cancer Research Fund enabled a team of
psychologists to become involved in the Ardmillan Familial Breast Cancer Clinic. We
wanted to monitor the experience of this clinic through the eyes of the women who
attended. We are extremely grateful to the women who have completed questionnaires
for us over the years. The information they have given us has informed what we do
locally and has also helped others to learn from the experience of this clinic.
Study 1: Impact of the clinic on new attendees (Cull et al. 1999)
In 1992, we wanted know who would come to the clinic and what they thought
their risk was. If they were mistaken about their risk we wanted to know whether the
information they were given at the clinic would change their view. We were
concerned that the clinic might cause distress to women if they were told that their
risk of breast cancer was greater than they previously thought. This study involved
nearly 500 women and took several years to complete.
Understanding the risk ofdeveloping breast cancer
About half of the women who took part in this first study came to the clinic
already having a pretty accurate idea of their risk. However there were quite a lot of
women (nearly 40%) who underestimated their risk and a much smaller proportion
who greatly overestimated their risk. This was different from the experience in the
U.S.A where many of the women studied tended to overestimate their risk. We were
able to show that the information given at the clinic in Edinburgh did help most
women to develop a more accurate view of their risk. When we asked them about it
again a year or more after they had attended the clinic we found they had been able to
maintain this more accurate view. We, of course, need to try to learn more about the
people who get stuck with an inaccurate view of their risk to try to work out how best
to help them.
We did notice that although most people seemed to understand their risk, there
were quite a lot of pieces of information about genetics which they didn't understand




Did the clinic cause distress?
We were very relieved to find that for most people, attending the clinic did not
affect them one way or the other; 30% actually reported lower levels of distress after
the clinic than they had before attending. Many people told us they were relieved that
the clinic was in existence. However we did notice a small proportion (about 3 in 20
women) who reported higher levels of distress after the clinic than they had before.
This was not, as we feared, related to learning that their risk of breast cancer
was greater than they had thought. We did want to try to understand better the reasons
for their distress in order to know how best to help. We found these women tended to
already be quite distressed before they came to the clinic and our continuing research
in this area led us to pay more attention to people's personal experiences of breast
cancer in their families (see study 4, page 26).
Study 2: Is videotaped information about breast cancer genetics useful?
(Cull et al. 1998)
Cancer genetics is a new and rapidly growing field. The information, which
can be given to individuals about their own risk, is complicated and can be difficult to
understand. We were concerned about whether there was more we could do to help
people understand this type of information, particularly at a time when the clinic was
getting busier. But we were also anxious to avoid overloading people with
information they did not want or need.
We developed a video about familial breast cancer and tried it out on over 100
women in the clinic. Some women received the video before their appointment
whereas others didn't see it until afterwards. After the clinic, the women were asked
how well they understood a number of issues related to the genetics ofbreast cancer
and they were also asked a number of factual questions. Women who had seen the
video before the clinic felt they understood the issues better and got more factual
answers right than the women who had only had the information given to them at the
clinic. There was no evidence that the video caused distress to those who watched it
nor did it put them off coming to the clinic. In fact women who saw the video
beforehand reported more satisfaction with the clinic.
We made a second video for the much smaller number ofwomen at high risk
ofbreast cancer, in anticipation of genetic testing becoming available. In fact that took
longer to happen than expected and this video proved most useful to those who were
weighing up the pros and cons of prophylactic surgery as a way of reducing their risk
of developing breast cancer (see topic 4, page 14).
Although the videos proved useful, they were expensive to make and have
become out of date quite quickly in this rapidly developing field. We have not
continued using videotaped information in the clinic. However, we are continuing to
find how to provide the best service possible within the resources we have available




Study 3: Living with an increased risk of breast cancer (Appleton et al. 2000)
Up until now, our studies had focused on women who were recently referred
to the clinic. We now felt that it was important to find out how women who had been
attending the clinic for several years were managing with the knowledge of their
increased risk. We wanted to ask them about the effect on their everyday lives, how
they were coping and if they had any needs in terms of information or support that
were not being met by the existing service.
In 1999, 25 women who had been attending the clinic for at least 2 years took
part in telephone discussion groups to talk about these issues. These women gave us a
real insight into what it is like to live with an increased risk of breast cancer.
Although some women described themselves as being generally more worried
about breast cancer than others, most women described worries about breast cancer
being triggered by events in their lives such as receiving a clinic appointment letter or
hearing about breast cancer on the news. All of the women expressed a need for up to
date information about topics related to familial breast cancer.
In order to confirm and expand on the results of this small study, 249 women
who had been attending the clinic for at least 2 years took part in a subsequent
questionnaire study.
The results of both of these studies have helped us to develop the information
pack which you are now reading.
Study 4: Understanding distress in women at increased risk
Our previous research suggested that people's personal experiences of breast
cancer in their families may help to explain why some women were more distressed at
the clinic than others. This study aimed to look at the possible link between distress,
experiences of cancer in the family and beliefs about breast cancer.
In 1999-2000, we compared the beliefs of 117 women attending the clinic with
the beliefs of 100 women in the general population who hadn't experienced breast
cancer in their family or friends.
Although, women at increased risk were more distressed about breast cancer
than women in the general population, they were also less confused about the disease
and believed that breast cancer held greater consequences for the patient and
their family. The women who showed higher levels of distress were those women at
increased risk who believed breast cancer to have more symptoms, to be of longer
duration and to have more consequences. Women who held these particular beliefs
about breast cancer tended to have experienced a recent bereavement in their family.
A better understanding of the reasons why some women are distressed gives




Topic 8: Healthy Lifestyle
Lifestyle <& the Risk of Breast Cancer. What does the research
show?
Although a large amount of research is currently investigating the effect of
lifestyle on the risk of breast cancer, there is no clear evidence as yet that:
• Any lifestyle factor causes breast cancer
• Changing your lifestyle can prevent breast cancer
• Changing your lifestyle can reduce your risk of breast cancer
However, research has identified certain lifestyle choices that may influence
breast cancer risk. This research has compared groups ofwomen with and without a
particular characteristic (such as women who consume a "low" compared to a
"moderate/high" amount of alcohol) and has found differences between the two
groups in the incidence of breast cancer (number ofwomen who develop breast
cancer).
So far, this type of research has linked a number of lifestyle factors with an
increased incidence of breast cancer. These factors are high fat intake, moderate/high
alcohol consumption, smoking, low levels of physical exercise and obesity
(particularly in post-menopausal women).
These lifestyle factors may influence breast cancer risk as they affect hormone
levels (for further information on the relationship between hormones and breast
cancer see the section on Tamoxifen topic 4, page 14).
Further research is now needed to confirm if any of these lifestyle factors have
a direct effect on breast cancer risk. In particular, there is currently little evidence that
lifestyle affects the risk of breast cancer in women with a strong family history of the
disease.
For further details of research investigating the effect of lifestyle on the risk of breast
cancer see: (Although the following book was primarily written for American women, it does
contain some useful information for British women)




If there is no clear evidence that lifestyle causes breast
cancer, why should I maintain a healthy lifestyle?
There are a number of important reasons why you should try and maintain a
healthy lifestyle:
• To reduce your risk of developing other common cancers which are proven to
be affected by lifestyle:
For example
Stopping smoking reduces your risk of developing lung cancer.
A diet rich in fibre reduces your risk of bowel cancer.
• To look after your General Physical Health:
For example
There is evidence that a healthy lifestyle reduces your risk of heart disease, lung
disease and premature ageing of the skin.
• To look after your General Psychological Health:
For example
There is evidence that exercise can help to relieve stress and depression.
By maintaining a healthy lifestyle, you can gain all those proven benefits for
your overall health. As an added bonus, if future research shows that your lifestyle
does affect your risk of breast cancer, you will have already been doing something




How can I maintain a healthy lifestyle?
The following sections contain up-to-date guidelines on six aspects of
maintaining a healthy lifestyle: diet, vitamin & mineral supplements, alcohol,
smoking, sun and exercise. These guidelines are taken from the Health Education
Board for Scotland leaflet "The Guide to Preventing Cancer", the Cancer Research
Campaign leaflet "Reducing Risk" and from NHS Direct.
Diet
The sections below give advice on the types and proportions of the five food groups
that are needed to form a healthy, well-balanced diet.
*
Fruit and Vegetables:
Try to eat at least 5 portions of fruit and vegetables every day (this includes fresh,
frozen, tinned and dried fruit and vegetables, and fruit juice).
To increase your fruit and vegetable intake, substitute some of the meat in your
main meal with kidney beans, replace some of the chips with salad or have fruit as
a pudding.
Bread, Cereals and Potatoes:
This food group includes bread, rice, pasta, breakfast cereals and potatoes- it
should form the main part of each meal.
To increase your intake of fibre, eat more wholemeal bread, wholemeal pasta,
high fibre breakfast cereals and brown rice.
Meat, Fish and Alternatives:
We only need to eat small portions ofmeat, fish, eggs, beans and lentils - they
should fill about a quarter of your plate.
Try to eat fish (fresh, frozen or tinned) 2-3 times per week, particularly oil-rich
fish such as mackerel, sardines and salmon.
GBP Milk and Dairy Products:
- We can eat these foods every day, but try to have low-fat varieties - about a half a
pint of semi-skimmed milk or low-fat yoghurt per day is good for you.
Fatty and Sugary Foods:
Try to avoid eating sweets, chocolate, biscuits, cakes, crisps and chips every day.




For further advice on healthy eating see:
Health Education Board for Scotland "Eating for Health", topic 10 page 42.
Health Education Board for Scotland "Hassle Free Food", topic 10 page 42.
Vitamin A Mineral Supplements
• For most people, the required types and amounts of vitamins and minerals are
present in the foods they eat, therefore supplements are not normally necessary.
• For certain groups of people (e.g. pregnant women), specific types and amounts
of supplements are recommended.
• If you are considering taking supplements, please seek medical advice from your
GP first (too large a dose of supplements can be damaging to your health).
For further advice on taking vitamin and mineral supplements ask your GP or see:
NHS Direct "Healthy Living: Eating for Health: Questions and Answers",
topic 10 page 43.
M NHS Direct on 0845 46 47.
Alcohol
• If you drink alcohol, do so in moderation - try to avoid drinking 3 or more units of
alcohol per day on a regular basis.
• 1 unit of alcohol = 14 pint of ordinary strength lager, beer or cider.
= 1 small glass ofwine or sherry.
= 1 single measure of spirits.
For further advice on reducing alcohol consumption:





• If you don't already smoke, don't start.
• If you smoke, try to stop - your risk of certain forms of cancer will immediately
be reduced.
For further advice on stopping smoking see:
1® Health Education Board for Scotland "Stopping smoking made easier",
topic 10 page 42.
Smokeline on 0800 84 84 84.
Sun & Sunbeds
Take care to avoid getting sunburnt, whether you are on holiday or at home:
• Avoid being exposed to the sun between 11 a.m. and 3 p.m.
• Stay in the shade.
• Use a sunscreen with a sun protection factor (SPF) of at least 15.
• Wear a T-shirt and sun-hat.
• Avoid using sunbeds - the harmful effect ofultraviolet radiation on the skin from
sunbeds is the same as from the sun.
For further advice on sun protection see:
Health Education Board for Scotland "Take Care of Yourself in the Sun",
topic 10 page 42.
Exercise
• Regular exercise can help prevent you becoming overweight.
• Increasing physical activity can have both physical and mental benefits:
For Example
Gives you more energy.
Helps to strengthen your muscles, joints and bones.
Improves your circulation.
Gives you a sense of achievement.
Helps you to sleep better.
For further advice on how to build more activity into your daily routine and improve
your health see:
Health Education Board for Scotland "Hassle Free Exercise", topic 10 page 42.
AIII-31
Topic 9: Worry about Breast Cancer
Introduction
This topic aims to help you recognise and cope with any worries you may
have about breast cancer.
Although everyone worries at some time in their lives, people vary a lot in
how much they worry and what they worry about. Some people describe themselves
as "born worriers" whereas others don't seem to worry about anything at all. However
you would describe yourself, it is likely that learning about your increased risk of
breast cancer has caused you some worry at some time.
Living with an uncertain situation such as an increased risk of breast cancer,
can be particularly difficult to deal with and it may cause you to ask a number of
questions about your situation. For some people, information that helps to answer
these questions can reduce some of the uncertainty and perhaps help to relieve some
of their worries. Other people may find that they cope better by trying to avoid
thinking about their risk of breast cancer.
We hope that by providing you with the up-to-date information we have
included in the rest of this pack, we have given you the opportunity to have some of
your questions answered.
However, you may have other questions that science is currently unable to
answer. It is therefore a good idea to be aware of other ways to relieve the worry that
these unanswered questions might cause. You may find that different ways may be
more helpful at different times or for particular worries.
We have included a booklet produced by the charity "MIND" on "How to...
stop worrying" for your information in the back of this pack. This booklet gives
general advice on different ways to help reduce or control worrying.
In the following sections, we will talk about:
• Stress and the risk of breast cancer.
• Worries about breast cancer.
• Different ways to help relieve worrying.
"...in some ways I think that
(information) can be a





Stress & the Risk of Breast Cancer: What does the research
show?
Although there is a common belief that stress causes breast cancer, evidence of
such a link from research is unclear.
However, recent research (Petticrew et al. 1999) has combined the results of
all good quality studies conducted worldwide to investigate the relationship between
stress and the risk of breast cancer. The combined results do not provide any evidence
to suggest that experiencing a stressful life-event such as bereavement or divorce
causes breast cancer.
In another recent study (Protheroe et al. 1999), 332 British women attending a
breast clinic for a biopsy of a suspicious breast lump were asked about any stressful
life events they had experienced in the last 5 years. The 106 women who were later
diagnosed with breast cancer were no more likely to have experienced a very stressful
event in the last 5 years than the 226 women who were found to have benign breast
disease.
Although further research is needed to investigate the possible link between






Worry about Breast Cancer
We recognise from our research that worry about breast cancer affects women
in your situation to varying degrees and at different times. For example, some women
describe their worries about breast cancer being triggered by things they experience in
their everyday lives.
We also recognise that women in your situation may have different sorts of
worries about breast cancer and particular things may be more worrying for you at
different times in your life.
(The quotes in speech bubbles were taken from one of our previous studies. For further details see topic
7, page 26).
As we said earlier, it is likely that learning about your increased risk of breast
cancer has caused you some worry at some time. A certain amount ofworry about
breast cancer only seems natural for women in your situation. But how do you
recognise ifworrying about breast cancer begins to get out of control? It may be
helpful to ask yourself the following questions:
• How much time am I spending worrying about breast cancer?
• To what extent is worrying about breast cancer interfering with my daily life (e.g.
how bad are the physical or psychological effects of worrying that I'm
experiencing?) (for more information on the physical and psychological effects of
worrying, see the MIND booklet "How to... stop worrying" at the back of this
pack).
If you can recognise when worrying about breast cancer is getting out of





Common Worries about Breast Cancer: What can I do?
Although there are many different sorts ofworries about breast cancer, we
have identified some of the common worries you might have and have provided
practical ways that might help to relieve those worries.
Worry about symptoms ft
If you are worried about a change in your breasts, please make an appointment in the
first instance to see your GP and if it is appropriate they will then refer you to the
Ardmillan Clinic. Do remember that most changes in the breasts will turn out to be
benign and therefore harmless.
Worry about a change in your family history iffo
If you are worried about a change in your family history of breast cancer and the
implications this could have for your own risk or the risk of other family members,
you can telephone one of the nurses from the Ardmillan Clinic on 0131 651 1805.
m
Worry about what you have read in the newspapers or
seen on the television
The media frequently report on research about breast cancer, particularly about
the causes of breast cancer. You may find that hearing these reports sometimes causes
you concern. Here are a few suggestions of things to think about when you see or hear
reports of this kind, to try to minimise the worry it may cause you:
• Remember that headlines are often used to grab our attention to boost
newspaper sales or television ratings. Headlines don't always give an accurate
summary of the information, particularly if it is a scientific or medical story.
What exactly do the results show? It is important to consider the information you
are given carefully. Look at what the report does not say as well as what it does
say. For example, if research shows that eating 10 chocolate bars a day is
associated for linked) with breast cancer, it only means that these two things have
been seen together. It does not mean that one has been shown to cause the other.




• How many people took part in the study? Studies where only small numbers of
people participated may need to be tested with more people before we can have
confidence in the results. When a new scientific discovery is made, there is always
a period of time when other scientists need to check if they can get the same results
by following the same procedures. Although these subsequent studies are also
important, they don't often attract media attention. When a new medical treatment
is announced, there is usually a long process of testing the new treatment on large
numbers of people before the treatment can become available. These checks are
extremely important to ensure the safety of a new treatment.
• Who were the people who took part in the study? Do these people differ from
you in terms of their age, nationality etc.? This is relevant to how confident you
can be that the results might apply to you. For example, although there is good
evidence that breast screening is useful for women over 50 years, further research
is still needed to find out if it is useful in younger women (for further information
on breast screening, see topic 4, page 12).
• Where was the study published? Check to see if the results of the study have
been published (if they have the reporter should mention where they were
published). Respected scientific journals like "Nature" or medical journals like the
"Lancet" or "British Medical Journal" will have sent the study to other leading
researchers for their opinion before agreeing to publish it.
• Who funded the study? This could bias the results if the organisation has a vested
interest in the outcome of the study. For example, suppose a dairy company funds a
study whose results show that the calcium which is contained in dairy products
prevents breast cancer. As the dairy company stands to benefit from these results, it
raises the question ofwhether the study might have been biased in some way to
obtain these results.
• Statistics can be misleading. Many different forms of statistics may be given in a
report. Sometimes one statistic may be given without anything to compare it with.
For example, a report could read "New Treatmentfor Breast Cancer Cures 1,000
Women Your reaction to this piece of information may be different if you knew
that the treatment had not cured 9,000 other women, or if existing treatments that
are already available are just as effective as the new treatment. If you really want to
understand statistics you need to be sure you know how the figures were collected,
when and by whom so that you can place them into some sort of context.
For further information on understanding statistics see:
Cancer Research Campaign: Cancer Help UK "About Cancer: cancer statistics",




What other things can I do to help relieve worry?
The following sections suggest a number of different ways that can help
reduce worry. These include ways to help yourself and ways of getting help from
others. Many of these different ways are described in more detail in the MIND
booklet "How to... stop worrying" which we have included in the back of this pack.
Helping Yourself
• Taking action: For some worries there maybe something that you can practically
do to help relieve the worry such as make an appointment with your GP.
• Confronting worry: If you can confront a worry, you can look at how you could
cope, what you could do and who could support you if the worst happened.
• Listing worries: It may be helpful to write your worries down with reasons why
the things you are worried about may never happen.
• Remember positive information: It may be helpful to remind yourself of current
scientific knowledge about breast cancer. Focus on positive points which are
relevant to you. You may find it helpful to write these on a list so that you can
read them when you feel yourself becoming worried.
• Controlling worry: Try limiting your worries to certain times of the day or to a
specific place.
• Talking about your worries: You might find it helpful to talk to someone about
your worries. This could be a member of your family, a close friend or a
counsellor (see the following section on psychological therapies page 40).
• Healthy Lifestyle: Physical exercise and cutting down on caffeine-based drinks
can help relieve worry. When you are worried, it is easy to forget about what and
when you eat. It is particularly important to eat healthily and not miss out meals
(for more information see topic 8, page 29).
For further information on how diet can affect your psychological well-being see:
13 MIND "The MIND guide to food and mood", topic 10 page 43.
• Make time for yourself: Making time for leisure activities that you enjoy, such
as soaking in a hot bath or listening to music, can distract you from your worries




• Relaxation: Relaxation can help control the level ofworry you experience and
can be a useful way of relieving the physical symptoms ofworry. The following
simple relaxation exercise is from the "The Mind guide to.. .managing stress" and
should take about 5 to 10 minutes.
Simple relaxation (with deep breathing):
| • Have a stretch. Then let your shoulders and arms relax into a
comfortable position. Shrugging, wriggling and shaking all help
your muscles to stop tensing and to relax.
| • Ease off the tension in your feet, ankles, calves, knees, thighs,
chest, arms and neck.
• If you are sitting in a chair, or lying on the floor, allow
yourself to feel as if the chair or the floor is supporting your
whole weight; feel yourself letting go.
> • Try to be peaceful, loosen your jaw and face. A bland expression
will help your face muscles to relax.
• Become aware of your breathing, its rhythm, depth or shallowness
and its speed.
• Put one hand on your upper chest, and one just below your ribs on
your abdomen.
• Slowly let out your breath.
•> • Gently breathe in, so that you feel your abdomen rise slowly under
your hand (if you find that only the hand on your abdomen moves,
then you are breathing correctly; the abdomen is moving as your
diaphragm rises and falls rhythmically. You should find little or
no movement in your upper chest; your hand should stay still) .
• Breathe out again, feeling your abdomen fall, and make sure you
exhale a little longer than you inhaled.
• Pause for a few moments and then repeat the breathing exercise
again.
i • Close your eyes and imagine a peaceful scene - an exotic, desert
island, the shady depths of a forest or sunlight glistening on a
lake.
• Choose your own special place, whatever seems most restful to you.
Then for a few moments, imagine that you are really there.
• Complementary and alternative therapies: These can help you to relax and
relieve the physical symptoms ofworry such as sleeping problems. They include
herbal remedies and physical therapies such as aromatherapy. They can be used as
an alternative or alongside conventional medical treatment. It is a good idea to get
advice from your GP before starting any therapy.
For further information on complementary and alternative therapies please ask your
GP or see:




Getting Help From Others
Some people may find that they need additional help as the things they can do
to help themselves are not enough. It may then be a good idea to seek some advice
from your GP. They may either help you themselves or refer you to a counsellor,
psychologist or other specialist for help.
• Psychological therapies: These are often called "counselling" or "talking
therapies" as they give you the chance to talk about your worries. They can also
help to teach you how to control worrying.
For further information on psychological therapies see:
MIND "Understanding Talking Treatments", topic 10 page 43.
• Medical treatment: Medication can often help to relieve periods of extreme
worrying. However, it does not help in identifying the cause of the worry, can
have undesirable side-effects and can be addictive.
For further information on stress, anxiety, depression and bereavement see:
MIND "How to.. .look after yourself', topic 10 page 43.











Topic 10: Sources of Information
Organisations:
The following section lists organisations in alphabetical order where you can
obtain the suggested further reading and organisations where you can obtain
additional relevant information.
Although there are a large number of organisations and websites providing
information about breast cancer, we have just listed a small number here, those we
feel may be most useful.
Most of the organisations we have listed are British but a few are American
(although not all of the information given by the American organisations will be
applicable for British women, we still felt that their websites provide useful
information).
® If you haven't got access to the Internet at home, many local libraries are now
providing Internet access and training.
American Cancer Society
® Website: http://www.cancer.org/
Includes an online cancer resource centrefull of information about cancer.
Breast Cancer Care (Scottish Office)
H 46 Gordon Street
Glasgow G1 3PU
® Tel: 0141 221 2233
S Helpline: 0808 800 6000
S Fax: 0141 221 9499
B E-mail: breastcancercareScotland@BTInternet.com
® Website: http://www.breastcancercare.org.uk
Offers information and support to those affected by breast cancer or other breast health
concerns.
The Breast Cancer Fund (U.S.A)
® Website: http://www.breastcancerfund.org/
An American charity that provides information about breast cancer.
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%£ Tel: 0141 553 1553
5 Fax: 0141 553 2686
S E-mail: jennyw@cancerbacup.org
3 Website: http://www.cancerbacup.org.uk
Offers information and support to people with cancer, theirfamilies andfriends.
CancerNet - National Cancer Institute (U.S.A)
3 Website: http://www.cancernet.nci.nih.gov/
An online information service provided by the American National Cancer Institute containing
comprehensive information about cancer and genetics.
The Cancer Research Campaign
R1 10 Cambridge Terrace
London NW1 4JL
W Tel: 020 7224 1333
B E-mail (for information leaflets): publications@crc.org.uk.
3 General Website: http://www.crc.org.uk
3 Specific Website for information about cancer: http://www.cancerhelp.org.uk
The Cancer Research Campaign provides an Internet information service about cancer and
cancer carefor the generalpublic called "Cancer Help UK".
Genetic Information Systems (genlSYS) (U.K)
3 Website: http://www.cee.hw.ac.uk/genisys
This website provides information and Internet resources about cancer genetics screening
from the South East Scotland Clinical Genetic Service. The site is for Patients, General
Practitioners, Geneticists and other Healthcare Workers. The areas of interest to non-medical
users should be easy to use andfollow, but the language in some areas, aimedprimarily at




The Genetic Interest Group (U.K.)
Website: http://www.gig.org.uk
The website ofa British alliance ofover 120 charities which support children, families and
individuals affected by genetic disorders. Provides information on genetics and links to other
genetics websites.
The Health Education Board for Scotland
(information leaflets are available in GP surgeries, hospital information centres
orfrom:)
H Health Promotion Library Scotland
Health Information Division




® Tel: 0845 912 5442
B E-mail: library.enquiries@hebs.scot.nhs.uk
Website: http://www.hebs.scot.nhs.uk
Provides health informationfor the general public.
Hereditary Breast Cancer Helpline (U.K.)
^ Tel: 01629 813000 (answer phone available outside office hours)
Provides information and support to anyone concerned about hereditary breast cancer.
Imperial Cancer Research Fund - Cancer Information Service





Provides a wide variety of information on cancerfor the general public.
InTouchLive (U.S.A)
Website: http://www.intouchlive.com
An online American magazine dedicated to information about cancer and written by cancer
experts. Includes a useful section on "Myths & Facts about Breast Cancer".
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^ Tel: 0131 537 3131
5 Fax: 0131 537 3130
H E-mail: maggies.centre@ed.ac.uk
® Website: http://www.maggies.ed.ac.uk
Offers information and support to cancerpatients and theirfamilies.
MIND (National Association for Mental Health)
0 15-19 Broadway
London El 5 4BQ
© Tel: 020 8519 2122
'MS Mindz@oLine: 0845 766 0163
® Website: http://www.mind.org.uk
Provides information on various aspects ofmental distress.
NHS Direct (U.K.)
E Helpline (24-hour): 0845 46 47
® Website: http://www.nhsdirect.nhs.uk
Provides healthcare advice and information on a range ofhealth concerns.
Patient UK
® Website: http://www.patient.co.uk
A directory ofUK websites thatprovide information on health, disease and illness.
The Royal Marsden Hospital (U.K.)
® Website: http://www.royalmarsden.org.uk









Tel: 0141 568 7000 (2 - 4.30 p.m., Monday to Friday only)
3 Fax: 0141 568 7001
B E-mail: info@samh.org.uk
® Web site: http://www.samh.org.uk
Provides information on mental health and relevant services in Scotland.
UK Breast Cancer Awareness Website
® Website: http: //hosted.aware.easynet.co.uk/
Patient information website which includes a list ofall U.K breast cancer organisations and
book reviews.
Additional Rsfsrsncss; (additional scientific and medical journal articles and
books we have used to write this information pack)
To obtain scientific and medical journal articles, please ask at your local public
or university library. Some journals such as the "British Medical Journal" are
also available online (http://www.bmj.com).
UJ Alberg AJ, Singh S, May JW, Helzlsouer KJ. 2000. Epidemiology, prevention, and
early detection of breast cancer. Current Opinion in Oncology 12: 515-20.
£Ql Appleton S, Fry A, Rees G, Rush R, Cull A. 2000. Psychosocial effects of living with
an increased risk of breast cancer: an exploratory study using telephone focus groups.
Psycho-Oncology 9: 511-521.
£0 Blarney RW, Wilson ARM, Patnick J. 2000. Screening for breast cancer. British
Medical Journal 321:689-93.
Collaborative Group on Hormonal Factors in Breast Cancer. 1997. Breast cancer and
hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological
studies of 52 705 women with breast cancer and 108 411 women without breast cancer.
Lancet 350: 1047-1059.
£0 Cull A, Anderson EDC, Campbell S, Mackay J, Smyth E, Steel M. 1999. The impact of
genetic counselling about breast cancer risk on women's risk perceptions and levels of
distress. British Journal ofCancer 79(3/4): 501-508.
£□ Cull A, Miller H, Porterfield T, Mackay J, Anderson EDC, Steel CM, Elton RA. 1998.
The use of videotaped information in cancer genetic counselling: a randomised
evaluation study. British Journal ofCancer 77(5): 830-837.
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Eccles DM, Evans DGR, Mackay J, on behalf of the UK Cancer Family Study
Group. 2000. Guidelines for a genetic risk based approach to advising women with a
family history of breast cancer. Journal ofMedical Genetics 37: 203-209.
Eeles RA, Ponder BAJ, Easton DF, Horwich A (Editors). 1996. Genetic Predisposition
to Cancer. London: Chapman & Hall Medical.
Goodwin, P J. 2000. Management of familial breast cancer risk. Breast Cancer
Research and Treatment 62: 19-33.
Hodgson SV, Maher ER. 1999. A Practical Guide to Human Cancer Genetics
(2nd Edition). Cambridge: Cambridge University Press.
Kelly, P T. 2000. Assess Your True Risk ofBreast Cancer. New York: Henry Holt.
McPherson K, Steel CM, Dixon JM. 2000. Breast cancer-epidemiology, risk factors,
and genetics. British Medical Journal 321:624-8.
Nawaz H, Katz DL. 1999. American College ofPreventive Medicine Practice Policy
Statement: perimenopausal and postmenopausal hormone replacement therapy.
American Journal ofPreventiveMedicine 17:250-4.
Petticrew M, Fraser J M & Regan M F. 1999. Adverse life-events and risk of breast
cancer: a meta-analysis. British Journal ofHealth Psychology 4: 1-17.
Protheroe D, Turvey K, Horgan K, Benson E, Bowers D & House A. 1999. Stressful
life events and difficulties and onset of breast cancer: case-control study. British
Medical Journal 319: 1027-1030.
Rahman N, Stratton MR. 1998. The genetics ofbreast cancer susceptibility. Annual
Review ofGenetics 32:95-121.
Sainsbury JRC, Anderson TJ, Morgan DAL. 2000. Breast cancer. British Medical
Journal 321:745-50.
Scottish Intercollegiate Guidelines Network. October 1998. Breast Cancer in Women: A
National Clinical Guideline. Royal College of Physicians, Edinburgh.
Vogel, V G. 2000. Breast cancer prevention: a review of current evidence. CA - A
Cancer Journalfor Clinicians 50(3): 156-170.
Vogelstein B, Kinzler KW (Editors). 1998. The Genetic Basis ofHuman Cancer. New
York: McGraw-Hill.
Welcsh PL, Owens KN, King M-C. 2000. Insights into the functions of BRCA1 and
BRCA2. Trends in Genetics 16:69-74.
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3 published leaflets to accompany the information
pack (Appendix HI):
"Cancer genetics" (South East of Scotland
Clinical Genetics Service, 2001)
- "Breast awareness" (Breast Cancer Care, 2000)
"How to... stop worrying" (MIND, 1998)
GENETIC TESTING
Should I be tested for a faulty gene:
If you have a strong family history of breast cancer
ovarian cancer, or bowel cancer, it may be
possible to offer you a genetic test. It is important
to remember that there is no pressure on you to have
this test. If you are interested in it, all the important
implications will be discussed beforehand. If
you decide not to have the test but are at a
greater risk of an inherited form of cancer than
the general population, you may still be eligible
for extra screening.
What happens if I have the test and discover
I have the faulty gene:
Your risk of developing an inherited form of
cancer is high. So you may wish to take up the
option of extra screening because early detection
and treatment of cancer usually improves your
outcome. In some cases you may be able to join
research studies aimed at preventing the
development of the disease. You may also
consider surgery to reduce the risk.
What happens if I have the test and do not
have the faulty gene:
Your risk of developing cancer is the same as
anyone else of your age. You are encouraged to
join the standard population screening
programmes, where appropriate.
For instance there is a National Breast Screening
Programme for women over the age of 50.
Where do I get further information:
If you think you fit into one of the groups for the
screening programmes listed, or if you have a
strong family history ofbreast, ovarian or bowel
cancer you may ask your GP to refer you to your
local NHS clinical genetics service for risk
assessment.
If you would like further information
contact:-






Tel 0131 651 1012
Fax 0131 651 1013
CANCER
GENETICS
Genes are the blueprints of life which are
passed down from generation to generation.
They determine characteristics such as
whether you are tall or short, dark or
fair-haired.
A very small number of cancers (5 to 10
percent) may be caused by faulty genes
which are inherited at birth. But, even if
one is in your family, it does not mean you
will automatically have it.
This leaflet gives pointers on whether a
cancer is likely to be caused by an inherited
faulty gene. It outlines screening programmes
for those at increased risk of this developing








A WAY OF DIAGNOSING SOME CANCERS EARLY AND TRYING TO PREVENT THEM \
Is a family history of cancer important:
Where several cases of cancer occur in the same family
it is natural to wonder whether there is an inherited
factor. The pointers to a cancer which may be
running in a family are:
• The number of people in the family who have
developed breast, ovarian and bowel cancers.
The more people in the family who have developed
one of these cancers, the more likely it is to be due
to the inheritance of a faulty gene.
• The age at which the cancer developed.
The younger the person when diagnosed, the more
likely it is to be due to hereditary factors.
• The pattern of different types of cancer seen in the
family.
We sometimes see breast and ovarian cancer
running together in the same family, or ovarian
and bowel cancer.
Adding these pointers together we can work out
if you are likely to have an increased risk of
developing cancer from an inherited faulty gene.
Your first degree relatives are your mother, father,
sister, brother, daughter and son.
Your second degree relatives are your grandmother,
grandfather, grandchild, aunt, uncle, niece and
nephew.
Bowel Cancer
Your risk of developing cancer of the bowel is
moderately increased if you have one of the
following:
• A first degree relative with bowel cancer
diagnosed under 45.
• Two first or second degree relatives on the same
side of the family with bowel cancer, one
diagnosed under 55.
• 3 or more affected first or second degree relatives
If you fit one of these groups you may be able to
enter a screening programme. This will involve
regular examination of the bowel using a flexible
telescope (called a colonoscope) to try and detect
early cancer.
Breast Cancer
Your risk of developing breast cancer is moderately
increased if you have one of the following:
• A first degree relative with breast cancer
diagnosed under 40.
• Two first or one first and one second degree relative
on the same side of the family with breast cancer
diagnosed under 60 or with ovarian cancer.
• Three first or one first and two second degree relatives
on the same side of the family with breast or ovarian
cancer.
• A first degree relative with breast cancer in both
breasts or breast and ovarian cancer.
• A first degree male relative with breast cancer.
If you fit one of these groups you may be able to
enter a screening programme. This will involve
regular mammograms, which are X-rays of the
breast, to try and detect early cancer.
Ovarian Cancer
Your risk of developing ovarian cancer may be
increased if you have one of the following -
• Two first degree relatives or one first and one
second degree relative on the same side of
the family with ovarian cancer
• A first degree relative with breast and ovarian
cancer.
• One first degree relative with ovarian cancer and
one first or second degree relative with breast
cancer on the same side of the family diagnosed,
under 50.
• One first degree relative with ovarian cancer and
two first or second degree relatives with breast
cancer on the same side of the family diagnosed
under 60.
If you fit one of these groups you may be able to
enter a screening programme. This will involve
regular screening with an annual ultrasound and a
blood test to try and detect early cancer.
Breast Cancer Care is the national
organisation offering information
and support to those affected by
breast cancer or other breast health
concerns. Our services are free,
confidential and accessible.
For more information about
our services, or to talk in complete
confidence, telephone the
Breast Cancer Care helpline












when you need it
Breast Cancer Care is a national organisation offering
information and support to those affected by breast
cancer. Its services are free, confidential and accessible,
and include:
• a national helpline - run by
specially trained nurses and
volunteers
• information - booklets,
factsheets and a website
• volunteer services - providing
one-to-one emotional support
for women and men with breast
cancer and their partners, and
volunteer support and outreach
networks for women from
minority ethnic communities,
lesbian and bisexual women,
women from socially deprived
communities and younger
women
• aftercare services - including
prosthesis fitting, telephone
support groups for younger
women and women with
secondary breast cancer, and
support services for those living
with breast cancer
• regional services - providing
local information, aftercare
services and local volunteers in








Kiln House 210 New Kings Road
London SW6 4NZ
Telephone 020 7384 2984 (administration)
Fax 020 7384 3387
E-mail bcc@breastcancercare.org.uk
Website w w w.breastcancercare.org.uk
Scotland Office
Breast Cancer Care
46 Gordon Street Glasgow G1 3PU
Scottish services 0141 221 2233
Fax 0141 221 9499
E-mail breastcancercareScotland@BTInternet.com
Breast Cancer Care helpline
0808 800 6000
Breast Cancer Care is committed to equal
opportunities and access for all.
Charity registration no 1017658
Registered in England company no 2447182
Company limited by guarantee
ISBN 1 870577 06 X
Breast Cancer Care relies on donations from the
public to provide its services free to clients.
Ifyou would like to make a donation, please send your cheque to:
Breast Cancer Care, Freepost Ton 644, London SW6 4BR.
This booklet is copyright. No part of this publication may be reproduced, stored or
transmitted, in any form or by any means, without the prior permission in writing of the publishers.
© Breast Cancer CareJune 2000
Illustrations © Alexa Rutherford
Know what is normal for
you
Your breasts will go through many
perfectly normal changes
throughout your lifetime. They are
affected by hormonal changes
during your menstrual cycle,
pregnancy, breast-feeding, the
menopause (change of life) and
weight loss or weight gain.
The menstrual cycle
Each month, during your
child-bearing years, your breasts
prepare for pregnancy and
breast-feeding. Breasts often
become enlarged, tender and
lumpy shortly before a period starts
but return to normal once the
period is over (although some
women may have tender, lumpy
breasts throughout their cycle).
The menopause
Breast tissue changes after the
menopause; it is often less dense
and firm, and becomes more fatty,
making your breasts feel softer. As
you grow older your breasts may
get smaller. If you take HRT
(hormone replacement therapy)




1. Know what is normal
for you
2. Know what changes to
look and feel for
3. Look and feel
4. Report any changes to your
GP without delay
5. Attend for routine breast
screening if you are 50 or
over
Breast awareness
What changes should I be
aware of?
These are the changes that you
should be aware of when you look
at and feel your breasts:
• a change in size - it may be
that one breast has become
noticeably larger or noticeably
lower
• a nipple has become inverted
(pulled in) or changed its
position or shape
• a rash around the nipple
• discharge from one or
both nipples
• puckering or dimpling of
the skin
• a swelling under your armpit or
around your collarbone (where
the lymph nodes or glands are)
• a lump or thickening in your
breast that feels different from
the rest of the breast tissue
• constant pain in one part of
your breast or in your armpit.
Don't worry that you may be
making an unnecessary fuss, and
remember that most breast
changes will be benign
(non-cancerous) and harmless.
When your GP examines your
breasts s/he may be able to
reassure you that there is nothing
to worry about. (If s/he thinks the
change may be connected with
your hormones, your GP may ask
you to come back at a different
time in your menstrual cycle.)
Alternatively, s/he may decide
to send you to a breast clinic for a
more detailed examination.
For more information about
benign breast problems, what
happens at a breast clinic and the
tests used to make a diagnosis,
see Breast Cancer Care's booklet
Making a diagnosis: breast problems
and breast cancer.
What shall I do if I find
a change?
You will know better than anyone
how your breasts feel and look
normally, so if you do notice a
change, see your GP as soon
as possible.
If you want more information
or practical advice about
being breast aware, contact




If you are between 50 and 64 you are entitled to be
screened every three years as part of the National Breast
Screening Programme.
Your name will be taken from your
GP's list and you will be sent an
invitation to come for a
mammogram (breast x-ray). This
may not happen the year you turn
50 but it will within three years of
you turning 50.
At present younger women are
not invited for screening as part of
the NHS programme. A clinical trial
is underway to look at whether the
NHS breast-screening programme
should be extended to include
younger women.
However, breast screening is
available for women over 40 from
private health-screening centres.
If you are 65 or over you will not
be invited for screening. However,
you are still at risk of breast cancer
and entitled to free breast
screening every three years on
request. All you need to do is ask
your GP or practice nurse to
arrange an appointment for you,
or you can contact the
breast-screening unit yourself.
You can find out where your
local breast-screening unit is by
calling the free Health Information
Service on 0800 665544 (or the
NHS Health Helpline on 0800
224488 in Scotland), or by
contacting your GP practice.
Breast awareness
Being breast aware
Every woman should be breast aware throughout her
adult life. It is an important part of caringfor your
body.
Being breast aware means knowing
how your breasts look and feel
normally so that you notice any
change that might be unusual for
you. Detecting a change early
means that if cancer is diagnosed
any treatment may well have a
better outcome. Most breast
changes will prove to be benign
(non-cancerous) but you should
always report any concern to
your GP.
Men too need to be aware of
any changes in their breast tissue,
as approximately 200 men in the
UK get breast cancer each year.
Becoming breast aware
Breast awareness is about
becoming familiar with your
normal breast tissue and how it
changes, for example at different
times of the month.
Get into the habit of looking at
and feeling your breasts from time
to time. One way of looking is by
using a mirror so that you can see
your breasts from different angles.
You may find feeling your breasts
is easier to do with a soapy hand
in the bath or shower, or you may
prefer to do it lying down. You
can decide when is convenient
for you and what you are
comfortable with.
Breast awareness
How to... find, out KW€
Mind is the leading
mental health charity in
England and Wales. It
works for a better life for
people diagnosed, labelled
or treated as mentally ill.
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How to... StvJ? wvrryiny
;Y; b I think of myself as a born worrier. I've
always worried ever since I was little. I'd
worry about what people at school thought
about me and about homework and all sorts
of things.
I worry so much that for my last birthday
a friend bought me a plaque with the slogan
'Worrying is like riding a rocking horse - it
doesn't get you anywhere'.
As a child every night when I went to bed I would
worry about members ofmy family dying. I am not
religious but I ended up saying a prayer each night which
was basically a list ofmy worries which I asked God to take
care of. This helped me to go to sleep. As I grew up the list of
worries became so long that I used to worry about going to
bed. The 'prayer' took so long and there was so much to
remember. In the end it was a worry offmy mind
when I stopped saying the prayer.
u
f
Worrying means spending a lot of time thinking about bad
things — being preoccupied with negative possibilities. The
more you worry the larger your worries become. You may
even find yourself worrying about all the time you have spent
worrying. There are many different types of worries; they
include worries about things that might happen in the future,
woriying about things that are actually taking place, and
retrospective worry about events that have already passed.
Mental Health Promotion
If you would like to order any of the titles listed, please
photocopy these pages, and indicate in the appropriate boxes
the number of each title you require. Please add 10% to the
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British Association for Counselling 1 Regent Place, Rugby,
Warwickshire CV21 2PJ, tel. 01788 578328. Will send a list of
trained counsellors in your area ifyou write enclosing an A5 sae.
British Association for Behavioural and Cognitive Therapy
PO Box 9, Accrington, Lancashire BB5 2GD. Canprovide
information on CBTand how tofindpractitioners.
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send out a list ofpractitioners ifyou enclose a sae.
NO PANIC 93 Brands Farm Way, Randlay, Telford, Shrops TF3 2JQ,
Helpline 01952 590545 10a.m.-10p.m. Help with panic attacks.
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These worries include concerns about things that could
possibly happen, and things that veiy probably won't
happen. For example, despite the fact that it is
statistically unlikely, you may worry about whether you
will have a car accident, or catch a fatal disease. Worries
about what might happen in situations over which you
have some control can also be very troubling. You might
be very worried that you're going to fail an exam or not
meet a deadline because of not putting in enough work.
If you were able to stop wonying and do some work the
likelihood of a bad outcome could decrease.
Again, these can include feelings of anxiety both about
situations that you can change, and those you are
powerless to change. Example of the latter would be
worrying about the fact that you are caught in traffic, or
that your train has been delayed. An example of the
former would be worrying about a persistent cough; if
you go to the doctor your mind could be put at rest, or
you could be given the relevant treatment, both of which
are better than wonying.
There is often nothing that can be done about these worries.
An example of this would be wonying about whether you
have failed an exam, or made a mistake at work.
Almost everyone worries. A certain amount of worrying
is a healthy response to life; it can prevent us being
reckless, or stimulate us to do our best or to take control
of a situation. However, some people worry a lot more
than others, and sometimes to the point that it has a





'I think my worrying has a lot to do with my lack of self-
confidence. Although it's hard to admit, it's often easier for
me to worry about something than to do something about
it. Over the years I've learnt that the less time 1 give myself
to worry and the cjuicker I act the better. I may feel ill
before I make that phone call and shake a bit afterwards
but when it's over I feel so much better, having blasted a
worry — however small — into oblivion.'
Worries are basically fears. Everyone gets scared, but we all
handle fear in different ways. Sometimes it is easier to dwell on
a fear than to do something about it, or to accept that there is
nothing to be done. This may be because of a lack of confidence
- we may not believe we are capable of taking action or
handling a bad situation. (If this seems to be the case for you,
you might find Mind's booklet How to Assert Yourselfuseful;
see Further reading p. 10.)
Physical effects
Our bodies react chemically to the fear which worrying entails.
When we are scared our bodies release adrenalin in what is
called a 'fight or flight' response which nature evolved to enable
us to counter or to escape threats. This adrenalin affects the
digestive system, and can make you feel ill. The more you woriy
the worse it gets, and a real 'rush' of adrenalin can lead to you
having 'butterflies in the stomach', a headache, or feeling very
sick and being unable to eat.
Woriying can make it very difficult to go to sleep, as worries often
come on at their strongest at night. When you're trying to go to
sleep there's nothing to distract you from the worries that may
have been lurking in the background. It is then very easy to start
feeling anxious about the sleep you are missing through having
these thoughts. In addition, at night, especially if alone, it is easier
for concerns to get out of perspective, and of course harder to do
something about them. We also worry more when we are tired.
(If worrying affects your sleep, you may find Mind's booklet How








When you are about to go into a situation which worries
you, such as a doctor's appointment or a job interview, it
can be useful to focus on something other than the
problem in hand. This could be as simple as picking up a
good book or a listening to a personal stereo. If you feel a
worry taking hold you could push it out of your mind by
looking at other people and imagining their lives, or by
really examining your surroundings in a very detailed way.
Worrying means we are overly concerned with what's
going on in our heads, and exercising can help to focus
us on our physical sides instead. It can also help to
relieve the tension associated with worrying by using up
the adrenalin produced. You don't have to go for a long
run or to the gym; a good steady walk can be just as
effective, and it's good for your heart as well as your
head. Worry beads and stress toys can be useful as a kind
of portable exercise'. They can be used both as a
distraction and to relieve tension.
It helps to cut down on tea, coffee and other caffeine-
based drinks such as colas and canned drinks. These are
stimulants, and can heighten the physical effects of worry,
such as headaches and stomachaches.
Sometimes antidepressants or minor tranquillisers are
prescribed for people where extreme worrying has
manifested itself as anxiety. Both forms of medication
have side-effects and minor tranquillisers especially can
be addictive. Medication can be effective in easing the
burden in times of extreme anxiety, but do not help to
get at the 'root' of continuous and perpetual worrying.
A growing number of people use herbal remedies such as
the Bach Flower Remedies, or homoeopathic preparations
(now available in many high street chemists). There are
also physical therapies such as acupuncture, reflexology
and aromatherapy which some people find useful. Yoga
or meditation classes can be effective; they can teach you
to relax your muscles and breathe more deeply in order
to control the shallow breathing and rapid heartbeat often
associated with worrying.






There is often something we can do about a situation we feel
anxious about. Consider each preoccupying thought one by
one, and then consider whether there is something that could
be done about it. Make a list of these possible actions, with the
actions for the most concerning worries at the top. It can then
be possible to work slowly through the list, concentrating on
one thing at a time. Cross out the action once it has been
completed, to reflect the fact that you have acted positively
and dealt with a worry.
If you're not sure what would be the best action to take you
could try making a list of possible actions along with their
advantages and disadvantages. As well as helping you make a
decision, this could help you feel more confident about what
you decide to do.
You may feel that there is something that you could do about a
particular worry but that you are not confident enough to do it.
In this instance self-assertiveness classes may help.
You could try allocating certain times and places to your worries.
For this to work it is important to be strict, and not let worries
intrude on your thoughts at other times. It might be helpful to
try to visualise a box to put your worries in that you can open at
a later date or time. Some people set aside say thirty minutes a
day for worrying, taking quite literally the phrase 'I'll worry
about that later'. It is helpful if you set this period at the same
time of the day/week, and have it in the same place.
Relaxation exercises are useful in dealing with anxious feelings,
often involving trying to replace negative worrying thoughts with
positive ones. This can include imagining somewhere where you
would like to be - an ideal beach, garden or home. You could
also try seeing your worries as actual objects that you can
discard — for example, stones that you can throw into the water.
Unfortunately sometimes trying to do a relaxation exercise itself
can be worrying. You might feel that it's not working or that
you're doing it wrong. It's best to take the attitude that you're
just 'giving it a go' and that these negative thoughts are normal.





Worries can make you feel very helpless; the more
worries you have the less able you feel to cope with
them. This reduces confidence and makes us more
vulnerable to feelings of anxiety. A lack of self-confidence
can affect how people relate to you, and how you feel in
response. In this way a kind of negative spiral sets in,
and some people experience panic attacks as a result of
the build-up of these kind of feelings. (See Useful
organisations p.10 and Further reading p.10 for help with
panic attacks.)
Worries also make it very difficult to concentrate and
carry on with eveiyday life, so that problems build up.
It can be very emotionally draining to feel constantly
anxious. Sometimes it can feel as though worries have
taken over your life. In order to assert some sort of
control some people may develop behaviour that could
be described as obsessional. An example of this would
be checking that a door was locked many times before
being able to leave the house. Some people may also
develop eating disorders as a way to control their anxiety.
'Many people think that worrying is a complete
waste of time. Personally I don't think that's true.
It seems to me that if I worry and think about the
worst that could possibly happen the outcome is
rarely as bad as I've imagined.'
If something is 'niggling' at you and you try to disregard
it but it keeps bringing itself to your attention, this can be
a helpful push to do something about it. For example,
you might have a mole on your skin that you are worried
about; you try to ignore it but can't, and this forces you to
visit the doctor. Sometimes worry makes us act and this
can be positive. Also, wonying about the worst that could
happen can help us to deal with and prepare for what
does take place.
How to... Stvj? mriyuy?
The adrenalin that is sometimes released through worrying can
be helpful. For example, if someone is worried about a race they
are about to take part in the adrenalin might give them the extra
push they need to succeed. However, if they get too worrried it
could mean that they feel ill and unable to perform.
Having the occasional worry for a short period of time is very
different to worrying about several things every day or having a
worry that seems to dominate everything. These worries can
make us too anxious to be able to think and act in a useful way




Confronting the worst that could happen
It can be useful to visualise the worst thing that could happen in
any worrying situation. Often a worry is a fear of the unknown,
and tiying to define that fear can help overcome it. Having
confronted the woriy or fear for what it is, it is sometimes easier
to know what to do about a situation. If you confront the worst
that could happen you can then look at how you could cope,
what you could do and who you could turn to.
Talking
'As a child my mum really helped with my worrying. She
would notice when I was quiet and when I couldn't eat
because of the butterflies in my stomach and she'd take me
to one side. She'd ask me what was wrong, and suddenly
facing the worries with someone else really helped. She
could help me to see which ones didn't matter and what I
could do about others.'
Some people find that talking to someone about their worries
really helps. Simply bouncing a worry off another person can
help to put it into perspective; you may realise that even the
worst possible outcome really isn't the end of the world. Talking
about worries can also help when trying to think of a possible
course of action to take, as discussion can often throw up




You may feel the need to talk about your worries with
someone who is not involved in your life. For example
you might want to tiy talking to a counsellor; counselling
can help you to gain understanding of your worries and
their effects, and it can also support you in doing
something about them. Another kind of therapy that can
be effective in dealing with worries is cognitive
behavioural therapy, which looks practically at the ways
in which our thought processes affect our lives, and how
we can try to solve the problems they cause by learning
to alter destructive patterns of thought.
If you are religious, you might find praying useful in
dealing with worries.
It can help to try writing down all your worries. Some
people find it more useful to write their worries as
statements rather than questions; so for example 'What
will happen if I don't get there on time?' might be more
usefully expressed 'I am worried that I won't get there on
time.' In this way it is possible to focus on precisely what
the fear is.
As we have seen, people often worry about events
that are very unlikely to happen. It is often difficult to
realise just how unlikely something is when you are
preoccupied with it. It might be a good idea to keep your
list of worries for a while, before going back to it after a
few weeks. You may find that you can cross out some
worries, because the event that you were worried about
didn't happen or because the worry simply isn't
important any more. Of course, you might feel you have
a whole new set to replace them with, but if you keep
writing them down and then going back to the lists you
may see that worries can just 'dissolve'. Some people find
that it helps to tear up, burn or otherwise destroy the
piece of paper on which they have written their worries.
Another constructive way to put worries into perspective
is to tiy to write down the reasons why something bad
might not happen. This may help you to see more
realistically which situations are worthy of worry, and
which are not.
